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Abstract 
Fish meal (FM) and fish oil (FO) have traditionally been central in aquaculture feed 
formulation but the finite global supply situation limiting future use along with issues of 
contaminant levels in these feed ingredients have become critical issues. The objectives of the 
present study were to investigate alternative feed ingredients as substitutes for both FM and FO 
in feeds for Atlantic salmon (Salmo salar) to ensure optimal growth, feed efficiency and health 
of the fish as well as maintaining the nutritional quality of the fish product to the human 
consumer, especially the levels of n-3 highly unsaturated fatty acid (HUFA), eicosapentaenoic 
acid (EPA) and docosahexaenoic acid (DHA), in the flesh. The results of the present study 
revealed that there were no negative effects on growth performance, feed utilisation and 
apparent digestibility in Atlantic salmon when FO was substituted with vegetable oil (VO) but 
these parameters were affected when FM was replaced with alternative protein sources from 
plants and animals at high levels, despite dietary supplementation with crystalline amino acids 
and lecithin. Reduction in feed intake was a factor affecting growth retardation when FM 
inclusion decreased. However, replacing FM with alternative plant and animal proteins along 
with partial replacement of FO had no major effect on nutritional quality, particularly n-3 
HUFA content of salmon tissues. Replacing Northern FO with decontaminated FO or blends of 
southern hemisphere FO and VOs strategies to reduce POP contaminants and retain high 
nutritional values in flesh were very successful. Dietary treatments and genetic origin of fish 
both had effects on tissue compositions and gene expression. All fish groups (strain/family),  
consist of CAL, LEAN and FAT strains, fed a diet containing VO showed significant 
differential expression of lipid metabolism-related genes compared to fish fed a FO diet with 
LEAN strain appearing to adapt to VO inclusion better than FAT strain. This thesis has 
demonstrated dual replacement of FM and FO with alternative raw materials in salmon feeds 
without a major negative impact on nutritional quality.  
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Chapter 1 - General Introduction 
1.1  Fatty acid structure and nomenclature  
Lipids are a large group of chemically heterogeneous compounds, having in 
common the property of insolubility in water, but a ready solubility in organic solvents 
such as chloroform, hydrocarbons or alcohols (Gurr & Harwood 1991). The basic units 
or building blocks for many lipids are fatty acids (FA). Lipids that contain FA are thus 
termed complex lipids, whereas lipids that do not contain FA, and so cannot be 
saponified, are termed simple lipids (Gurr & James 1975; Kjorsvik et al. 2004).  
In vertebrate species, FA contain a long hydrocarbon chain ranging from 14 to 
24 carbon atoms with a carboxylic acid group at one end and a methyl group at the 
opposite end (Gurr & Harwood 1991). They most commonly contain an even number of 
carbons in a straight chain, but can be odd numbered and branched. FAs are classified 
as saturated and unsaturated depending on the whether the carbons are fully combined 
with hydrogen and so a saturated FA (SFA) contains the maximum number of hydrogen 
atoms and no carbon double bonds, whereas unsaturated FA have C-C double bonds. 
The unsaturated FA can be further divided into monounsaturated FA (MUFA) with one 
double bond with Z (cis) configuration, and polyunsaturated FA (PUFA) with two or 
more double bonds. Highly unsaturated FA (HUFA) is a subgroup of PUFA 
distinguished by having chain lengths of ≥ C20 and with ≥ 3 double bonds up to 6 
double bonds (Gunstone 1991; Jobling 1993). The structure of some lipids and FA are 
shown in Figure 1.1. 
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Figure 1.1. Structures of triacylgylcerol, phosphatidic acid, the basic phospholipid, and 
 some fatty acids. Numbering of carbon atoms from the methyl terminus, is 
 indicated as numbers above the structures. Source: Gurr & Harwood 1991. 
Arachidonic acid (ARA,20:4n-6) Eicosapentaenoic acid (EPA, 20:5n-3) 
   Linoleic acid (18:2n-6) 
 
    Linolenic acid (18:3n-3) 
      Phosphatidic acid  Triacylglycerol (TAG) 
Docosahexaenoic acid (DHA, 22:6n-3) 
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FA nomenclatures are designed to denote the chain length, the degree of 
unsaturation and the position of the double bonds, according to the International Union 
of Pure and Applied Chemistry (IUPAC). Shorthand systems (the omega/n-designation 
system) and the delta ( ) configuration are two accepted nomenclature systems used in 
lipid chemistry and aquaculture. Both systems are similar in that they consist of two 
numbers separated by a colon. The number before the colon gives the number of 
carbons in the chain and the figure after the colon denotes the number of double bonds. 
However, the nomenclatures differ in the way they describe the double bond position. 
The delta configuration uses numerical values to indicate the position of each double 
bond in relation to the carboxyl terminus of the chain. For example, -linolenic acid, 
18:3  9,12,15 contains a carbon chain length of 18 and 3 double bonds, which are 
situated at carbon 9,12 and 15 from the carboxylic end of the chain. The shorthand 
systems designate the location of the first double bond from the methyl end of FA. For 
example, 16:0 represents a FA with 16 carbons and no double bonds, and -linolenic 
acid is 18:3n-3 representing an 18 carbon chain with 3 double bonds, and n-3 defines 
the position of the first double bond with respect to the methyl end of the chain (Gurr et 
al. 2002). Examples of FA denoted by trivial name and their relative nomenclatures are 
illustrated in Table 1.1. 
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Table 1.1. The systematic, trivial names and designations of fatty acids.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Gunstone & Norris (1983) 
1.2 Lipid classes in fish 
As mentioned above, lipids are a chemically heterogeneous group of 
compounds, having a range of different functions and roles in cells (Gurr and James, 
1975). Lipids serve as storage, transport of energy, structural components of biological 
membranes and precursors of vitamins and hormones (Zubay 1993; Turner et al 2006; 
Nelson & Cox 2008). Dietary lipids provide energy and essential FA (EFA), and they 
also assist the absorption of fat-soluble vitamins. Generally, lipids can be divided into 
two broad classes depending on their polarity, specifically neutral lipids, that are 
completely soluble in non-polar solvents, and polar lipids that are generally more 
amphipathic (Gurr & Harwood 1991).  
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The main neutral lipids in fish are triacylglycerols (TAG), wax and steryl esters 
and sterols. TAG and wax esters are important primarily as energy stores, while sterols 
have a structural role in cell membranes and also function as a precursor of steroid 
hormones with steryl esters generally being a store of sterol rather than FA. TAG 
consists of three molecules of FA esterified to the three alcohol groups of glycerol. In 
land animal TAG, the FA is saturated with have no double bonds, so the chains are 
linear due to the molecules can pack tightly and the resulting fats are solid. Plant and 
fish oils contain unsaturated FAs with one or more double bonds, and so the chains are 
not straight. The angled structures of these chains prevent close packing so they tend 
have low melting point and to be liquids at room temperature (Turner et al 2006). The 
stereochemistry of TAGs can be described by the“stereospecific numbering”(sn) system 
(IUPAC-IUB system), with the carbon atoms of the glycerol moiety numbered 1-3. In a 
natural L-glycerol derivative, the secondary hydroxyl group is shown to the left of C-2. 
The carbon above this then becomes C-1, that below becomes C-3 and the prefix sn is 
placed before the stem name of the compound (Gurr et al. 2002). Generally, SFA and 
MUFA are preferentially located at the sn1 and sn3 positions of glycerol while PUFA 
are preferentially located at the sn2 position of glycerol (Gurr & James 1975) (Figure 
1.1). Wax esters can be abundant in some aquatic animals, marine zooplankton, plant 
and microorganisms, but not in land animals (Hanahan 1960). Wax esters consist of a 
single molecule of FA esterified to a single molecule of a long-chain fatty alcohol 
(Christie 2003). Sterols are tetracyclic hydrocarbon compounds that are integral to 
membranes of animal tissues. The major sterol in animal, including fish, tissues is 
cholesterol. It can exist non-esterified as free cholesterol as in cell membranes where it 
has a role in maintaining membrane fluidity, or it can be esterified to FA as steryl 
(cholesterol) esters, that can be found in blood plasma and steroidogenic tissues such as 
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the adrenal cortex (Sargent et al. 2002). Free fatty acid (FFA) are also classed as neutral 
lipids but may be liberated from any of the complex (FA containing) lipids by post-
mortem enzymatic hydrolysis (Gurr & Harwood 1991).  
The polar lipids of fish are principally composed of a group of compounds 
generally, and sometimes incorrectly, termed phospholipids. Phospholipids are 
amphipathic molecules that have important functions of bilayer cell membrane structure 
and fluidity, and they may act as precursors for the synthesis of a series of biologically 
active compounds (Jobling 1993; Sargent 2001). The glycerophospholipids or 
phosphoglycerides are the major group of phospholipids that have a common backbone 
of phosphatidic acid (Figure 1.1), which consists of a glycerol molecule esterified to 
two FAs in sn1 and sn2 and a phosphate group esterified at sn3. The phosphate group at 
the sn-3 is then esterified to the “bases” choline, ethanolamine, serine and inositol to 
form the major phosphoglycerides of animals, including fish, namely 
phosphatidylcholine (PC) or lecithin, phosphatidylethanolamine (PE) or cephalin, 
phosphatidylserine (PS) and phosphatidylinositol (PI). PC and PE are generally the 
most abundant phospholipids in fish tissues (Hanahan 1960; Jobling 2004) reflecting 
their important function in membrane structure (Spector 1999). In fish, the highest 
levels of DHA (22:6 n-3) are usually contained in PE (Sargent et al. 2002). PC 
commonly has the lowest levels of DHA in fish tissues, being rich instead in 16:0 and 
18:1n-9, and appears to be more easily influenced by dietary FA than the other 
phosphoglycerides. The amino phosphoglyceride, PS, and PI are present in smaller 
quantities in cells, with PS rich in DHA and PI having the highest level of ARA (20:4n-
6) of all the fish phosphoglycerides (Sargent et al. 1989) and is also rich in 18:0 
(Spector 1999). Indeed the sn2 position of fish PI has a distinct preference for C20 
PUFA. Thus, 20:5n-3 and 20:3n-6 can also be found in PI (Sargent et al. 2002). 
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Lysophosphatidylcholine (LPC), a lipolysis product of PC with one FA removed by 
hydrolysis, can be found in small amounts in fish tissues (Gunstone 1991). Another 
class of polar lipids is the sphingolipids (Christie 2003). The most abundant member of 
sphingolipids is sphingomyelin (SM) that contains phosphocholine esterified to the 
alcohol group of sphingosine and is thus also a phospholipid (Sargent et al. 2002). 
1.3 Fatty acid metabolism 
1.3.1 Fatty acid digestion, absorption, transport and esterification 
The digestion process in fish is thought to be essentially the same as occurs in 
mammals. Digestion, absorption and transport of lipids occurs in three different sites, 
i.e. intestinal lumen, enterocytes (intestinal epithelial cell), and lymph or blood. The 
apparent digestibility of dietary lipids depends on their degree of unsaturation and 
temperature, generally increasing as water temperature rises (Leger 1985). The greatest 
lipolytic activity occurs in intestine, both proximal intestine and pyloric caecum (Tocher 
2003). Pyloric caeca aids digestion in fish by prolonging exposure time to digestive 
enzymes and providing greater surface area for absorption (Buddington & Diamond 1987).  
Lipid digestion is accomplished in the small intestine by the action of hydrolytic 
enzymes, including pancreatic lipase, bile salt-activated lipase (BSAL) and 
phospholipases, which act on dietary TAG and phospholipids, respectively (Kjorsvik et 
al. 2004). The products of pancreatic lipase hydrolysis of dietary TAG are FA and 
diacylglycerols and, especially, monoacylglycerols (Lie & Lambertsen 1991). 
Pancreatic lipase exhibits low hydrolytic activity towards TAG with HUFA at sn-1 and 
sn-3 (Olsen & Ringo 1997). Alternatively, BSAL is capable of hydrolysing wax esters 
and steryl esters as well as TAG (Leger 1985). The intestinal phospholipases hydrolyse 
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the ester bonds between FA and the glycerol backbone. Thus, phospholipase A2 
hydrolyses the fatty acyl ester bonds at the sn2 position while phospholipase A1 
hydrolyses the fatty acyl ester bonds specifically at the sn1 position with the products of 
phospholipase action are lyso-PL and FA (Henderson et al. 1995).  
The products of digestion, including FA, glycerol, monoacylglycerol and lyso-
phospholipids penetrate the brush-border of enterocytes in a monomolecular form. FA 
absorption rate increases with decreasing melting point, and so MUFA and PUFA are 
better absorbed than SFA (Leger 1985). As in mammals, the absorption of lipids in fish 
takes place mainly in the proximal intestine or in pyloric caeca. However, with high 
dietary lipid loads, absorption may extend to the distal intestine. In the mucosal 
epithelial cells of the mid gut, FFAs are re-esterified with monoacylglycerol and 
glycerol to reform TAG in the smooth endoplasmic recticulum and become temporarily 
deposited as large lipid droplets in the cells (Kjorsvik et al. 2004).  
After passage across the intestinal cell wall, dietary lipids are mainly recovered 
in the lymph, but also in the blood, in the form of specific lipoproteins, namely 
chylomicrons and very low-density lipoprotein (VLDL)-like particles (Hames & 
Hooper 2000). Most lipids are present in plasma in the form of the combination of lipid 
and protein in variable amounts, collectively termed lipoproteins (Nelson & Cox 2008). 
The lipoproteins provide an efficient system for transport of lipids into the vascular 
system from the site of absorption (enterocytes) and/or biosynthesis (mainly 
hepatocytes and enterocytes) to the sites of conversion, storage or energy utilisation. 
The three main classes of plasma lipoproteins, VLDL, low-density lipoprotein (LDL), 
and high-density lipoprotein (HDL), are all present in fish (Leger 1985). In humans, 
VLDL contains mainly 50% TAG, LDL contains mainly 37% cholesterol ester, HDL 
contains mainly 55% protein (Nelson & Cox 2008). VLDL carries cholesterol, 
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cholesterol ester and TAG from liver to other tissues (Zubay 1993). LDL carries 
cholesterol to peripheral tissue (Stryer 1988). HDL removes cholesterol from the blood 
carrying it to the liver (Nelson & Cox 2008). HDL is generally the most predominant 
class of lipoproteins present in the plasma of fish suggesting an important role for HDL 
in the transport of lipids in most fish (Leger 1985). 
FFA are normally found in only small amounts in fish tissues as FA exist mainly 
in their esterified form as components of the complex, saponifiable lipids (Henderson & 
Tocher 1987). Therefore, after FA are transported into the cytosol, via FA binding 
proteins (FABP), they are esterified in structural lipid of membranes (phospholipids), or 
assimilated in TAG. In adipose tissue, when energy supply exceeds expenditure, excess 
FA is deposited as TAG and stored in lipid droplets. In other tissues, usually associated 
with steroid hormone production, a small quantity of FA can be esterified to cholesterol 
to form cholesterol ester, which is the storage form of cholesterol in cells (Buzzi 1996). 
Esterification, however, is a selective process in fish, based mainly on degree of 
unsaturation, such that HUFA are preferentially incorporated into PL compared to TAG. 
For example, SFA and MUFA, as well as 18:3n-3 and 18:2n-6, are generally more 
esterified into TAG, whilst ARA, EPA and DHA are found in higher concentrations in 
PL (Henderson & Tocher 1987). 
1.3.2 Fatty acid biosynthesis 
The basic pathways of FA synthesis from non-lipid precursors are believed to be 
similar in fish to those in animals (Henderson & Sargent 1985a; Henderson 1996). FA 
in fish can ultimately be derived from two sources: synthesis de novo from non-lipid 
carbon sources within the fish, or obtained directly from dietary lipid (Henderson 1996). 
Glucose from carbohydrate is generally used as the main carbon source for FA synthesis 
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in mammals (Stryer 1988). However, carbohydrate is very low in the natural diet of 
many species, such as marine and carnivorous fish, that have diets rich in protein, 
resulting in amino acids (AA) generally being the main carbon source for endogenous 
FA synthesis in fish (Henderson & Sargent 1981). Both liver and adipose tissue are 
capable of FA and TAG synthesis to different extents that vary with species (Henderson 
1996). In salmonids, on a whole body basis, cytoplasm in liver is the principal site of 
FA synthesis de novo whilst adipose tissue is adapted for the uptake and storage of FA 
originating from the diet or hepatic synthesis (Henderson 1996). 
The pathway of FA biosynthesis is initiated when the two-carbon acetyl-CoA 
unit is carboxylated by acetyl-CoA carboxylase (ACC) to form a three-carbon 
intermediate, malonyl-CoA. Saturated FA are now synthesised by successive additions 
of 2-carbon subunits, supplied by malonyl-CoA, to an initial acetyl group attached to 
acyl carrier protein in the FA synthase (FAS) multienzyme complex (Baeverfjord & 
Krogdahl 1996). The reaction proceeds via a series of condensation, reduction and 
dehydration steps involving the utilisation of NADPH (Henderson & Sargent 1985a; 
Gurr & Harwood 1991). Therefore, with each cycle two saturated carbon atoms from 
malonyl-CoA are added to the original acetyl-CoA moiety, ultimately forming 16:0, 
palmitic acid, which in turn can be further elongated to 18:0, stearic acid (Stryer 1988; 
Nelson & Cox 2008). The SFA products of FAS are then able to undergo separate 
elongation or desaturation reactions in order to yield longer-chain SFA and MUFA, 
respectively (Henderson 1996).  
1.3.3 Fatty acid desaturation and elongation 
As described above, SFA produced de novo and dietary FA can be modified by 
desaturation and/or elongation (Gurr & James 1975). Fatty acyl desaturation enzymes 
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include 9, 6 and 5 desaturases, which introduce cis double bonds at the 9
th
, 6
th
 and 
5
th
 carbon atom counting from the carboxylic end, respectively (Gurr & Harwood 
1991). All animals, including fish, contain a 9 desaturase, sometimes termed stearoyl-
CoA desaturase, that acts on SFA 16:0 and 18:0 (Tocher 2003). Therefore, fish can 
produce 16:1
9
 = 16:1n-7 (palmitoleic acid) and 18:1
9
 = 18:1n-9 (oleic acid) from the 
endogenously synthesised 16:0 and 18:0 FA, respectively (Sargent et al. 2002). 
However, vertebrates, including fish, lack the 12 and 15 desaturases which are 
generally found only in plants and some invertebrates and other lower animals (Tocher 
et al. 1998). The 12 desaturase is responsible for converting 18:1n-9 into 18:2n-6 
(linoleic acid, LA) and the 15 desaturase converts the 18:2n-6 to 18:3n-3 ( -linolenic 
acid, ALA), and thus the LA and ALA are often termed as EFA since most animals are 
unable to manufacture these de novo, and they must be obtained through the diet 
(Sargent et al. 2002). In vertebrates, including fish, the three families of unsaturated FA, 
n-9, n-6 and n-3, can be acted upon by a common enzyme system of alternating 
desaturases and elongases to give a series of FA of increasing length and unsaturation 
(Henderson & Sargent 1985a). Animals have the ability to convert ALA to EPA and 
ultimately to DHA, and LA to ARA (Nakamura & Nara 2004). Thus, once obtained 
from the diet, LA and ALA acids can be further desaturated, by 6 and 5 desaturases, 
and elongated to produce the LC-PUFA, ARA, and EPA and DHA, respectively 
(Tocher 2003). 
The HUFA biosynthetic pathway in fish appears to be similar to that in 
mammals (Buzzi 1996; Tocher 2003). HUFA biosynthesis, as shown in Figure 1.2, can 
be summarised as the following; a) the elongations and desaturations only occur within 
the same family of FA and cannot interconvert between families. Thus, n-6 FA cannot 
give rise to n-3 FA and vice versa, b) as there is competition for the same enzymes, 
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whether elongases or desaturases, between the n-3 and n-6 series, a dietary excess of, 
say, LA will depress the further desaturation and elongation of ALA and vice versa, c) 
synthesis of DHA does not occur through direct 4 desaturation of 22:5n-3, which must 
be further elongated to 24:5n-3, followed by desaturation to 24:6n-3 by 6 desaturase. 
The 24:6n-3 is then chain shortened to DHA by limited peroxisomal -oxidation (Voss 
et al. 1991; Buzzi 1996). Similarly, the same pathway is able to produce 22:5n-6 via 
elongation of ARA to 24:4n-6, followed by 6 desaturation to 24:5n-6 and chain 
shortening (Tocher 2003), d) 5 fatty acyl desaturase acts at only one step in the 
pathway, involving 20:3n-6 or 20:4n-3, whereas 6 FA desaturase occurs at two steps, 
firstly involving the C18 PUFA, LA or ALA, and secondly involving the C24 HUFA, 
24:4n-6 or 24 :5n-3 (Sargent et al. 2002). Direct synthesis of DHA from 22:5n-3, as has 
been described in the marine microheterotrope, Thraustochytrium sp. requires 
desaturation of PUFA at the 4 position (Qui et al. 2001), but this activity has not been 
demonstrated in any vertebrate (Tocher et al. 1998; Tocher 2003). It has been reported 
that Zebrafish (Danio rerio) has no 4 desaturase activity but was able to desaturate 
24:5n-3 to 24:6n-3 suggesting that a single 6 desaturase may be responsible for the 
desaturation of both C18 and C24 substrates (Tocher et al. 2003a). The synthesis of 
DHA proceeded via C24 PUFA intermediates through a pathway requiring two 
sequential elongations of 20:5n-3 to 24:5n-3, which is then desaturated by a 6 
desaturase to 24:6n-3, and that this intermediate is chain shortened to 22:6n-3 in rat 
liver (Sprecher 2000) and in fish (Tocher et al. 2003a)  
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Pathways of HUFA synthesis 
 
De novo Diet 
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Figure 1.2. Pathways of chain elongation and desaturation of fatty acid families.         
Sources: Jobling (1993); Sargent et al (2002).  
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1.3.4 Fatty acid beta-oxidation 
A major role of lipids is as an energy store to fuel future energy requirements. 
Excess dietary lipid is generally deposited as TAG in adipose tissue and other sites 
depending upon species and then provides a source of FA for catabolism (Nelson and 
Cox 2008). Metabolic energy is recovered from lipid by the catabolism of the FA via 
beta-oxidation, a process that involves the sequential removal of two-carbon units by 
oxidation at the beta-carbon position of the fatty acyl-CoA molecule, occurring in both 
mitochondria and peroxisomes, although mitochondrial -oxidation is quantitatively 
more important and can utilise a wide range of FA substrates whereas peroxisomal 
oxidation is restricted to one round reducing longer-chain FA substrates (Henderson 1996).  
Mitochondrial -oxidation of FA requires four reactions; oxidation, hydration, 
second oxidation, and thiolysis to yield acetyl-CoA (Gurr and James 1975). The acetyl-
CoA enters the citric acid cycle yielding FADH2 and NADH, which are transferred to 
the electron transport chain to provide the energy for oxidative phosphorylation and 
ATP production. The fatty acyl-CoAs >12C require an acyl-carnitine to penetrate 
mitochondrial membranes which is mediated by carnitine palmitoyltransferases (CPT-I 
and CPT-II) and translocase. In peroxisomal -oxidation, it produces the same two 
carbon acyl-CoA as mitochondrial -oxidation, however, it produces hydrogen peroxide 
in place of FADH2. The peroxisomal -oxidation system is incapable of oxidising long-
chain fatty acyl-CoAs completely (Gurr et al. 2002), and may therefore act as a chain 
shortening system with the medium chain FA being transferred via acyl-carnitines to the 
mitochondria for further oxidation (Gurr and Harwood 1991; Henderson 1996). 
Mitochondrial -oxidation dominated in all tissues of adult Atlantic salmon 
(Salmo salar L.) while peroxisomal -oxidation prevailed in liver (Henderson 1996). 
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The rate of oxidation decreased with increasing FA chain length (Henderson & Sargent 
1985a). In fish, mitochondrial -oxidation preferred SFA and MUFA such as 16:0 
18:1n-9, 20:1n-9 and 22:1n-11, over PUFA with EPA usually oxidised to a lesser extent 
and DHA mainly selectively retained in tissues rather than catabolised (Sargent et al. 
1989; Tocher 2003) 
1.4 Lipid-soluble substances  
1.4.1 Carotenoids - structure and function 
Carotenoids are classified as non-polar lipids (Hanahan 1960). Most carotenoids 
are polyunsaturated hydrocarbons, containing 40 carbon atoms, and comprising two 
terminal ring systems, resulting in as symmetrical molecular structure, which has in the 
region of 7-15 conjugated double bonds as shown in Figure 1.3. Carotenoids that are 
composed entirely of carbon and hydrogen are thus hydrocarbons and known as 
carotenes, such as alpha-carotene, beta-carotene, while those that contain oxygen are 
termed xanthophylls such as astaxanthin, canthaxanthin, lutein and zeaxanthin 
(Armstrong & Hearst 1996). 
 
 
  Astaxanthin    Canthaxanthin 
Figure 1.3. The structure of astaxanthin and canthaxanthin that have been used as 
 pigment sources in salmon feed. Source: Metzler (1977). 
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Apart from serving to pigment the flesh, carotenoids have been reported to have 
possible metabolic functions in fish e.g. antioxidant protection against free radical 
damage (Edge et al. 1997) possibly encompassing UV protection in fish eggs, pro-
vitamin A activity (Craik 1985), associated with the egg yolk protein lipovitellin (Ando 
& Hatano 1986), respiration function: the oxygen supply of pelagic eggs is rich and the 
presence of a large amount of pigments is not required (Pavlov et al. 2004). It has been 
suggested that carotenoids, including -carotene, astaxanthin, and canthaxanthin, are 
potent antioxidants and that they operate synergistically with vitamin E (Nishigaki et al. 
1994; Bell et al. 2000). Astaxanthin has been shown to be one hundred times more 
effective than vitamin E as an antioxidant (Miki 1991). Carotenoids have been shown to 
be important in normal embryonic development and could affect hatching rates and 
larval survival (Torrissen 1984; Craik 1985; George et al. 2001). It has been 
demonstrated that carotenoid supplementation of broodstock diets resulted in increased 
carotenoid in eggs (Torrissen 1989), improving egg quality and larval production in red 
sea bream (Pagrus major) (Watanabe & Miki 1993), yellowtail (Seriola 
quinqueradiata) (Verakunpiriya et al. 1997), and Atlantic cod (Gadus morhua) 
(Sawanboonchun et al. 2008). Dietary carotenoids also showed a positive relationship 
between egg pigmentation and fertilisation and survival in rainbow trout eggs (Harris 
1984). Cold-water fishes, like salmon, have a high level of PUFA in their membranes, 
and protection of lipid tissue from peroxidation is likely to be a major metabolic role 
that dietary carotenoids such as astaxanthin could play (Bell et al. 2000).  
1.4.2 Carotenoids - absorption and deposition 
The duodenal intestine of fish contains a large number of pyloric caecum and is 
the main site of lipid absorption in salmonids (Ostos Garrido et al. 1993). The 
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carotenoids, however, are lipid-soluble and thus the ingested carotenoids are mainly 
absorbed in the midgut (from pylorus to hindgut) and hindgut (the posterior, folded part 
of the intestine) section (Torrissen et al. 1990), and transported in the blood in 
lipoproteins and ultimately deposited in the tissues (Torrissen 1986). Carotenoids 
cannot typically be synthesised by fish, including salmonids; therefore, salmon must 
obtain carotenoids from dietary sources (NRC 1993). In wild salmon, the carotenoids 
are present as a mixture of astaxanthin and its esters in a number of prey organisms 
consumed by the fish including zooplankton and crustaceans, and this naturally 
pigments the flesh (Storebakken & No 1992). The absorption of astaxanthin and 
canthaxanthin in salmonids is 10 to 20 times more efficient than lutein and zeaxanthin, 
and free astaxanthin is absorbed more efficiently than the astaxanthin ester (Schiedt et 
al. 1986). In farmed salmon, flesh colour is a very important commercially as 
consumers prefer pigmented products similar to wild salmon (Nickell 1997), therefore, 
dietary formulations must be supplemented with carotenoids by adding pigment-
containing natural products or chemically-synthesised pigments (Jobling 2004). 
Pigments supplied in the diet are relatively poorly retained in salmonid muscles (Jobling 
1993). In order to meet the consumer preference for red colouration, salmonid flesh 
should contain at least 3-4 mg of astaxanthin / kg (Torrissen et al. 1989), and 
astaxanthin and other alternative forms of carotenoids such as canthaxanthin, have been 
added to the formulated feed as a pigment source for farmed salmonids at the levels of 
40-100 mg/kg dry diet (Jobling 1993). A combination of astaxanthin and canthaxanthin 
in the diet gave a higher total carotenoid deposition in the flesh than either astaxanthin 
or canthaxanthin alone (Torrissen et al. 1989),  and this is deposited as the free form in 
flesh (Storebakken et al. 1987) and in esterified form, mono- or di- ester astaxanthin, in 
skin (Schiedt et al. 1986). The deposition of astaxanthin in the fish fillet occurs at 
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different rates depending on dietary sources (Choubert et al. 1995), dietary pigment 
concentration (Torrissen et al. 1995), size of fish (Torrissen 1985), stage of maturation 
(Bjerkeng et al. 1992), feeding period (Torrissen et al. 1995), genetic factors (Iwamoto 
et al. 1990; Storebakken & No 1992), digestibility of carotenoids (Choubert et al. 
1995), absorption from intestine (Torrissen et al. 1990) and transport in blood by 
lipoprotein and metabolism (Nickell 1997). 
The quantity and distribution of lipid around the fillet and its effects on 
pigmentation are also important to flesh quality tissues in salmonids. Astaxanthin binds 
non-specifically to hydrophobic binding sites in the white muscle of salmonids (Hemni 
et al. 1990). The number and size of white muscle fibre varies in different parts of the 
muscle of fish which could lead to variability in the number of astaxanthin binding sites 
around the fillets, and could explain the differences in astaxanthin concentrations 
between fillet areas (Kiessling et al. 1991). 
Salmonid muscle shows a preferential accumulation of astaxanthin. In rainbow 
trout, it was reported that astaxanthin was the preferred carotenoid absorbed followed 
by canthaxanthin, while zeaxanthin, lutein and -carotene were poorly absorbed 
(Guillou et al. 1992). Although dietary dose can affect flesh carotenoid concentration to 
some extent, increased dietary dose of carotenoids has been shown to have no 
significant effect on the pigment variation in Atlantic salmon, while an increase in the 
duration of feeding dietary astaxanthin has been reported to reduce variation of flesh 
pigment concentration in Atlantic salmon (Torrissen et al. 1995) and in chinook salmon 
(Oncorhynchus tshawytscha) (March & MacMillan 1996) by producing a more 
homogenous distribution of pigment around the fillet (Torrissen et al. 1995). 
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1.5 Organic contaminants 
Persistent Organic Pollutants (POPs), chemical substances persisting in the 
environment, bioaccumulate through the food web and causing harmful effects to 
human health and the environment (Walker 2001). The POPs include dioxins, including 
polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans (PCDD/Fs), 
polychlorinated biphenyls (PCB), dioxin-like PCBs (DL-PCBs), polybrominated 
diphenyl ethers (PBDEs), dichlorodiphenyltrichloroethane (DDT), dieldrin among 
others (Lundebye et al. 2004). Generally, these compounds are only slightly soluble in 
water and are more stable in the presence of sunlight, moisture, air, and heat, which 
make them persistent in the environment (Walker 2001). Aquatic organisms take up 
these organic compounds directly from water, probably through the gills, or via the food 
chain (Edward 1970).  
The persistent nature of POPs results in the processes of bioaccumulation, with 
concentration increasing in an organism throughout its lifespan and bioaccumulation, 
and the concentrations increasing higher up the food chain (Hendricks 2002). The 
contamination of aquaculture products with POPs due to human activity has become an 
issue of public concern particularly after the recent publication of information referring 
to the contaminant levels of farmed salmon. The source of the contaminants was related 
to the traditional practice of feeding marine FM and FO that can be contaminated with 
dioxins, PCBs and other chemicals including pesticides (Jacobs et al. 2002a, 2002b; 
Hites et al. 2004a). The contamination of FM and FO with POPs therefore has potential 
implications in fish nutrition, quality of farmed fish as final products and consequently 
to public health.  
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The POPs are not distributed equally in all tissues of the fish, but are 
concentrated in the fatty tissues. In the case of an “oily” fish like salmon that stores 
much of its fat in the flesh, it means that the contaminants are passed on to the human 
consumers. This is the paradox with salmon, as an oily fish they are an excellent source 
of the beneficial n-3 HUFA but, as with all oily carnivorous fish, the oil-rich flesh can 
accumulate lipophilic organic pollutants, including dioxins/furans, PCBs and PBDEs 
derived largely from their feed (Bell et al. 2005a). As POPs are only slightly soluble in 
water, when there is exposure the blood, it is rapidly saturated and, as a consequence of 
this saturation, the POP compounds partition into lipid, in which they are much more 
soluble, and are deposited in the fatty tissues where they accumulate as they do not then 
return to the aqueous phase (Walker 2001). Several studies have reported the levels of 
contaminants and their accepted limits, as regulated by the European Union (EU) and 
the World Health Organisation (WHO), in FM and FO (Jacobs et al. 2002a), in farmed 
and wild fish (Hites et al. 2004a, 2004b), especially oily fish like Atlantic salmon, as 
well as their potential effects on human health (Jacobs et al. 2002b; Mozaffarian & 
Rimm 2006). Jacobs et al (2002a) investigated the PCBs, organochlorine pesticides, and 
PBDEs in farmed and wild Atlantic salmon, aquaculture feeds, and FOs used to 
supplement the feeds. The results showed that the concentrations of POPs varied among 
the samples, and showed an increasing in concentration in the order salmon flesh > feed 
> FO. The DL-PCBs appear to be more efficiently transferred than dioxins from the 
feed to the flesh of Atlantic salmon (Lundebye et al. 2004). However, reducing the level 
of dietary FO in fish feed by replacement of FO with VOs decreased the organic 
contaminant levels in farmed salmon while still providing a good dietary source of 
marine n-3 HUFA (Bell et al. 2005a; Bethune et al. 2006).  
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1.6 Essential fatty acids in nutrition  
1.6.1 Essential fatty acids in human nutrition 
In recent years the possible beneficial roles of marine lipids, particularly n-3 
HUFAs, in human development and health have been extensively considered (Jobling 
2004). Deficiency of dietary n-3 HUFA, particularly DHA, associated with an over high 
dietary intake of 18:2n-6 causes the occurrence of pathologies and health disorders in 
developed societies especially those involving inflammatory responses e.g. 
inflammatory bowel diseases (Calder 2008), breast cancer (Bougnoux et al. 1994), 
cardiovascular disease (CVD), (Von 2004; Holub & Holub 2005), atherosclerosis, 
(Whyte et al. 2007), diabetes (Das 2001), Alzheimer‟s disease (Das 2008), cognitive 
impairement (Fontani et al. 2005), mental health (Mamalakis et al. 2002; Ross et al. 
2007) and performance (learning and mood) (Richard 2007). There are now 
accumulating evidences in humans that cardiac pathologies are associated with an over-
high dietary ratio of n-6/n-3 PUFA, and that the developing embryo is vulnerable to an 
over-high maternal ratio of dietary n-6/n-3 PUFA during pregnancy (Sargent 2001).  
SFA and n-6 PUFA are the major FA constituents of fat consumed in developed 
countries. It has been advised that 5:1 is a desirable ratio of n-6 PUFA : n-3 PUFA for 
the UK national diet (Anon 1992), compared to the current estimates of dietary n-6/n-3 
ratio in western diets of 10:1 to 25:1, averaging around 15:1 (Simopoulos 1999). A 
major beneficial effect of n-3 HUFA is that they provide a better metabolic 
counterbalance to this dietary imbalance than short-chain n-3 PUFA as well as having 
specific roles such as DHA being essential for normal neurological and visual 
development in humans and vertebrates in general (Uauy et al. 1999; Lauritzen et al. 
2001; Richard 2007).  
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There is considerable variation in recommended intakes for PUFA in adults. 
Recommended intakes for LA ranges from 4.4-20g/day: ALA ranges from 1.35-2.2 
g/day; and LC-PUFA range from 0.16-1.6 g/day (Meyer et al. 2003). The daily intakes 
of EPA/DHA in most European countries are in region of 0.1 to 0.5 g/day, and the 
current intake in the UK is reported to be at the lower end of this range, at 0.18 g/day. It 
was noted that an intake of 0.85 g/day of EPA/DHA reduced mortality from subsequent 
myocardial infarction and recent recommendations have advised daily intakes of 0.45 g 
EPA/DHA per day for healthy adults (Williams 2007).  
Ensuring adequate dietary intake of HUFA from fish or other aquatic animal 
products is therefore important to optimal nutritional health in humans. In addition to 
the essential role of DHA in neural development and function, dietary supplementation 
with FO provides EPA, which can be beneficial by damping down possible excess 
eicosanoid production from ARA when diets are otherwise rich in n-6 PUFA. 
Increasing the amount of oily fish in the human diet will help re-balance the n-6: n-3 
PUFA ratio and reduce diseases associated with dietary n-3 PUFA deficiencies, which 
can be most effectively reversed by providing the biologically active n-3 HUFA, EPA 
and DHA. In addition, reducing the intake of SFAs, unsaturated FAs and cholesterol in 
the diet and partly substituting them with MUFA and PUFA reduced both serum 
cholesterol and the risk of developing coronary heart disease (CHD) (Nordoy 1999). 
As the appropriately balanced intake of n-3 and n-6 PUFA and HUFA partly 
determines the relative production of eicosanoids, the amounts and balance of these FA 
in the human diet will affect the body's eicosanoid-controlled functions. The 
eicosanoids are oxygenated derivatives of a group of C20 HUFA produced by the action 
of cyclooxygenase and lipoxygenase enzymes. Almost every tissue in the body 
produces eicosanoids and they have a wide range of physiological actions, e.g. in blood 
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clotting, the immune response, the inflammatory response (predominantly those of the 
joints, skin and eyes), cardiovascular tone, and renal, neural and reproductive functions 
(Sargent et al. 2002; Tocher 2003). Eicosanoid production is generally associated with 
stressful situations, and the excessive eicosanoid production often occurring in 
pathological conditions. In mammals, ARA is the main substrate for synthesis of 
eicosanoids whilst the EPA and to a lesser extent dihomo- -linolenic acid (20:3n-6) 
competitively depress the production of eicosanoids from ARA (Funk 2001). Thus, 
eicosanoid actions are determined by the ratio of ARA to EPA in cellular membranes, 
this in turn being determined by the dietary intake of n-6 and n-3 FA (Sargent et al. 
1989, 2002). 
1.6.2 Essential fatty acids in fish nutrition  
Lipids and their constituent FA are very important as a source of metabolic 
energy in fish, particularly carnivorous fish which do not utilise carbohydrate as 
efficiently as herbivorous fish (Tocher 2003). TAG is the dominant energy and carbon 
storage product in higher animals, including fish. Apart from being an energy source, 
FA are functionally essential for normal growth, development and reproduction in all 
vertebrates. Thus, dietary lipids are also a source of FA required for the synthesis of 
new cellular lipid for growth and reproduction and for turnover of existing lipid 
(Sargent et al. 1989, 2002). Phospholipids together with cholesterol and sphingolipids 
are the structurally and functionally important lipids as ubiquitous constituents of cell 
membranes (Kjorsvik et al. 2004). Aquatic cold-blooded animals are characterised by 
having phospholipids containing a high proportion of PUFA. Like all other vertebrates, 
fish can synthesise SFA and MUFA de novo, but they cannot synthesise FA with two or 
more double bonds (PUFA). These FA must be obtained from the diet and are therefore 
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known as EFAs (Kjorsvik et al. 2004). However, vertebrates, including fish, have 
varying abilities to convert dietary C18 PUFA, LA and ALA, by desaturation and 
elongation, to the main biologically active HUFA, ARA, EPA, and DHA (Henderson 
1996; Sargent et al. 2002). Therefore, in some species of fish there is some synthesis of 
EPA from ALA, but the conversion of ALA and/or EPA to DHA appears somewhat 
limited in most fish species (Tocher et al. 1992). 
As alluded to above, the specific EFA requirement of fish differs between 
species that can be classified as essentially freshwater or marine, and this difference 
appears to be associated with the FA compositions of the natural diets of the fish species 
and also, to some extent, whether the species is herbivorous, omnivorous, or 
carnivorous (Sargent et al. 1989). Although the lipid and FA compositions in freshwater 
environments are perhaps less well defined than in the marine environment, it is clear 
that C18 PUFA are at least as well represented as C20 PUFA at the base of the 
freshwater food webs and that both LA and ALA are present in relatively high 
concentrations (Sargent 2001). This correlates with the broad ability of freshwater fish 
in converting C18 PUFA to the biologically active C20 and C22 HUFA and with 
freshwater fish having substantial dietary requirements for both n-6 and n-3 PUFA 
(Sargent et al. 2002).  
In contrast to freshwater and/or herbivorous fish that have the ability to convert 
C18 PUFA to C20 and C22 homologues, the ability of marine and/or 
carnivorous/piscivorous fish to perform these conversions is very limited probably 
related to the fact that their natural diets invariably contain DHA (Sargent 2001). 
Certainly, the PUFA in the marine food-web and the carnivorous lifestyle of the main 
marine species are dominated by n-3 HUFA. The predominantly carnivorous marine 
species consume smaller fish that are rich in EPA and DHA derived ultimately from the 
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primary producers, the phytoplankton, and passed up through the food chain to 
zooplankton, and thus they have no need to convert ALA to EPA and DHA (Tocher 
2003). The biochemical mechanism of this inability of marine fish to convert C18 
PUFA to HUFA is based on enzyme deficiencies within the desaturation/elongation 
pathway (Olsen et al. 2004). Due to the abundance of EPA and DHA in the marine 
environment, there has been no evolutionary pressure for marine fish to retain the 
capacity to elongate and desaturate C18 PUFA and so the activities are inferior to 
freshwater fish where LA and ALA are abundant in natural diets (Sargent et al. 2002). 
1.6.3 Quantitative essential fatty acid requirements 
EFA supplied in the food are crucial for a) growth or de novo formation of 
tissues and differentiation, b) membrane activity and metabolism: membrane transport, 
respiration and enzyme activity c) regulation of metabolism: prostaglandins and their 
hormonal function (Olsen et al. 2004). The principal signs of EFA deficiency are known 
that it interferes with growth, reproduction and causes increased mortality (Castell et al. 
1972). The signs of EFA deficiency can be prevented by adding n-3 FA in the diet, a 
level of 5% or more of marine FO in the diet usually provides sufficient dietary input of 
n-3 FA for salmonids (Lovell 2002). Most fish species, including salmonids, have a 
dietary requirement for n-3 FA, but can grow well on diets low in n-6 (Jobling 1993). In 
general, freshwater fish require either dietary LA or ALA, or both, whereas stenohaline 
marine fish require dietary EPA and/or DHA (NRC 1993).  
The EFA requirements of salmonids are 1% LA (Castell et al. 1972; Takeuchi 
& Watanabe 1982), 0.8-1% ALA (Watanabe et al. 1974; Takeuchi & Watanabe 1982) 
or 20% of lipid as ALA or 19% of lipid as EPA and DHA (Takeuchi & Watanabe 
1977). The EFA requirement of adult Atlantic salmon is about 1.0 % of ALA or perhaps 
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0.5 – 1.0 % of n-3 HUFA, although it has not been precisely defined (Sargent et al. 
2002). The requirements of salmon parr may be different, because at the parr stage 
Atlantic salmon naturally consumes a diet consisting largely of freshwater invertebrates 
rich in C18 PUFA. Atlantic salmon parr may perform better on diets containing both 
ALA and LA than on diets with high levels of n-3 HUFA (Bell et al. 1997). In juvenile 
salmon fed semipurified diets with graded amounts of methyl esters of either 18:2 n-6, 
18:3n-3 or a 1:1 mixture of 20:5n-3 and 22:6 n-3, increasing levels up to 1% of dietary 
dry matter improved growth and survival, and no requirement has been established for 
n-6 FA (Storebakken 2002).  
1.7 Current Issues in Aquaculture  
1.7.1 Atlantic salmon aquaculture  
Aquaculture has showed potential of increasing production in satisfying the 
demand for fish and fishery products for human consumption. Global aquaculture (fish, 
crustaceans and molluscs) has contributed to this increase and reached 140 million 
tonnes in 2007. Aquaculture production excluding China has continued to increase at an 
average annual growth rate of 6.5% from 36.8 million tonnes in 2002 to 50.3 million 
tonnes in 2007 (FAO 2009a). Moreover, the growth rate of aquaculture production 
including China is increasing at 8.5% per year (FAO 2009b). In 2007, the share of 
aquaculture production was estimated at 44% of total fish food supply (FAO 2009a). 
Traditional wild capture fisheries for Atlantic salmon have not increased in recent years 
and so the demand for fish production has been met by a great expansion of salmon 
aquaculture as shown in Figure 1.4 (FAO 2009b). Atlantic salmon and rainbow trout 
production account for more than 80 % of total European aquaculture production with 
Norway being the major producer of salmon. Salmon aquaculture became commercial 
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in the 1970s (Jobling 1993). Salmon aquaculture production grew more than ten-fold 
during the 25 years from 1982 to 2007. Total salmon production in 2007 was almost 3.2 
million tonnes of which farmed salmon contributed 69 % and wild salmon 31 %. 
Geographically, salmon production was dominated by Norway with 33 %, Chile with 
31 %, and other European producers including Scotland with 19 % (FAO 2009b). 
Among all fish, Atlantic salmon production has trend to increases for years, and in 
Europe the production of Atlantic salmon has grown to over 1.6 million tonnes in 2006 
(FAO 2007). In Scotland, Shetland has been the largest regional producer of Atlantic 
salmon since 1996, and it currently accounts for 34 % of Scottish output, and the 
remainder of Scottish production is divided between the following regions: NW 
Highlands (28%), Western Isles (15%), SW (Argyll and the Inner Hebrides not 
including Skye) (18%), and Orkney (5%). (Henserson & MacBean 2004).  
 Capture Atlantic salmon        Culture Atlantic salmon 
  
 
 
 
 Global Atlantic salmon capture Global Atlantic salmon aquaculture 
Figure 1.4. Global capture and global aquaculture of Atlantic salmon. 
Source:FAO (http://www.fao.org/fishery/species). 
Atlantic salmon, brown trout (Salmo trutta), chinook salmon, chum salmon 
(Oncorhynchus keta), coho salmon (Oncorhynchus kisutch), pink salmon 
(Oncorhynchus gorbuscha), rainbow trout, and sockeye salmon (Oncorhunchus nerka) 
belong to the family of Salmonidae (Jobling 1993). In the wild, Atlantic salmon are 
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found on both the European and North American sides of the North Atlantic (FAO 
2004a). It is an anadromous species that lives in the ocean after spending 1-3 years in 
freshwater, and then returns as an adult to breed in freshwater. Thus, spawning and 
smoltification take place in freshwater prior to the main growing period, which takes 
place in the sea. During the adult period, which can take up to 4 years, wild Atlantic 
salmon feed on pelagic species such as herring, sprat and squid (FAO 2004a). Once 
large enough, Atlantic salmon are ready to return to the precise freshwater in which they 
hatched. If this is after one sea winter the fish are termed grilse but it is normally after 
two or more sea winters when they are called salmon (Laid & Needham 1991). 
In aquaculture, Atlantic salmon are usually farmed in two stages. The salmon 
are hatched from eggs and raised in freshwater tanks to the smolt stage. When they are 6 
to 18 months old, the smolts are transferred to seawater where fish are ongrown in 
floating sea cages or net pens (Purser & Forteath 2003). They are fed formulated, 
pelleted feed for another 12 to 24 months until they attain marketable size, which may 
vary from 2-6 kg, and they are harvested (FAO 2004a). The pellet diets of Atlantic 
salmon are traditionally based on FM and FO, used as the main sources of protein and 
lipid. Atlantic salmon feeds contain high amounts of protein, lipid and energy (Helland 
et al. 1991; Lovell 2002). As global FM and FO production is limited, these marine 
products are being increasingly substituted with vegetable protein and oil sources in 
salmon feeds at the same time as the trend to increase dietary lipid level continues with 
the aim to enhance protein sparing (Helland et al. 1991; Hillestad & Johnsen 1994; 
Einen & Roem 1997; Lovell 2002; Solberg 2004). 
Chapter 1 
 29 
1.7.2 Dietary protein/energy  
Fish require dietary energy for maintenance of bodily functions, activity and 
reproduction. Once these energy requirements are mets, any addition dietary input can 
be utilised for growth (Jobling 1993). All carbohydrates, proteins and lipids can be used 
as energy sources by fish, but these organic compounds are not equally well suited in 
providing energy for promotion of tissue synthesis and growth (Jobling 2004). Lipid 
rather than protein or carbohydrate is the favoured source of metabolic energy in most 
species of fish and can have a major protein-sparing effect in many fish species (Sargent 
2001). The application of high-energy lipid in fish feeds is mainly designed to increase 
the growth performance of the fish for a given amount of feed intake by maximising the 
utilisation of lipids for energy with a consequence of protein-sparing effect allowing as 
much of the dietary protein as possible to be converted into flesh protein instead of 
energy production (Sargent et al. 2002). Some protein is essentially utilised for energy 
through direct oxidation of AAs via the tricarboxylic cycle, or after conversion of AAs 
to glucose via gluconeogenesis, but these processes can be diminished by including a 
large quantity of energy-providing nutrients in the diet. Salmonids can utilise lipids 
efficiently, an increased fat content in diet allows protein sparing and has an effect on 
growth and feed utilisation in rainbow trout and salmonids, and also contributes to an 
improvement in utilisation of protein (Hillestad et al. 1998; Bendiksen et al. 2003). 
Thus, high dietary fat levels are commonly used in salmonid diets as an important 
source of energy to promote protein sparing and to decrease nitrogenous losses. 
However, the high dietary lipid level can also lead to increased lipid deposition in fish 
fillet and a marked reduction in the proportion of body moisture rather than protein 
(Schreckenbach et al. 2001). 
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The culture of marine and anadromous carnivorous fish species, such as salmon, 
mainly has depended on the utilisation of FM and FO as the protein, energy and protein 
sparing sources in diet (FAO 2002). However, as global supplies of FM and FO are 
becoming more and more limited, it is therefore crucial for the aquafeed industry to 
optimise the use of feed protein and to improve protein utilisation in salmon diets. One 
problem in considering the effects of high-energy diets in aquaculture is that what 
precisely constitutes a high-energy or high-fat content in diet is rather undefined 
(Sargent et al. 2002). It was known that lipid in the range of 10-20 % of the dry weight 
of the diet is sufficient to allow protein to be effectively utilised for fish growth without 
depositing excessive lipid in the fish tissues (Watanabe, 1982 reviewed by Sargent et al 
2002). Rainbow trout fed dietary lipid at 21 % increased growth over than that of fish 
consuming diets with 8 and 11 % dietary lipid (Luzzana et al. 1994). Atlantic salmon 
fed diets containing 38 and 47% lipid showed great growth in comparison to fish fed a 
diet containing 31 % lipid (Hemre & Sandnes 1999). However, limits to the 
effectiveness of feeding high-energy diets and growth-promotion were also found, and 
vary with the stage of development of fish. In sea bass larvae (Dicentrachus labrax), no 
effect on growth was observed when fish were fed diets containing lipid varying from 
12 to 20 % (Salhi et al. 1994). However, the growth rate of sea bass juveniles was 
higher in fish fed a diet containing 24 % lipid than that of fish fed diets containing 12, 
18 %, and 30 % lipid (Pereira & Oliva-Teles 2002). However, the „optimum‟ 
protein/energy ratios are not rigid values. The actual value can vary according to fish 
species, fish stage, water temperature, and feed utilisation etc. For instance, the African 
catfish, Clarius gariepinus, cultured in high water temperature requires a higher 
protein/energy ratio, and larger fish showed a higher rate of energy expenditure per unit 
gain than small fish (Ng et al, 2003). Moreover, diets containing lower protein at a 
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constant dietary energy level inclusion resulted in an increase in energy expenditure 
(Steffens 1989). 
1.7.3 Fish oil and fish oil replacement 
FOs are virtually unique sources of the n-3 HUFA, predominantly EPA and 
DHA, which comprise 10% to 30% of total FA in most FOs. Moreover, FOs are 
excellent sources of energy owing to their high content of 16:0 and 18:0 as the 
predominant SFA and substantial amounts of the MUFA 18:1n-9, 20:1n-9 and 22:1n-11 
(Sargent et al. 2002). The abundance of 20:1n-9 and 22:1n-11 FAs is a characteristic of 
all commercial FOs produced from northern Atlantic fisheries, which are currently used 
extensively in aquaculture (Tocher 2003). The precise FA compositions of the FOs are 
ultimately derived from the diets of the wild fish from which the oils are obtained. The 
FA profiles of marine phytoplankton and zooplankton tend to be dominated by n-3 
PUFA, particularly EPA and DHA, and this pattern is generally retained at higher levels 
in the food chain (Jobling 1993). Zooplankton – consuming fish in northern latitudes, 
e.g. herring, menhaden and capelin accumulate body TAGs whose FA compositions 
very largely reflect the composition of the zooplankton diets including the calanoid 
copepods who deposit large amount of lipid as wax esters. Therefore, the fish TAGs are 
rich in 20:1n-9 and 22:1n-11 MUFA that are derived from the corresponding 20:1n-9 
and 22:1n-11 fatty alcohols present in the zooplankton wax esters (Sargent et al. 1989). 
In contrast, wax ester-containing zooplankton do not form a major part of the diet in 
fish from the southern latitudes such as sardine, anchovy and pilchard, and so these 
species only contain low levels of 20:1 and 22:1 and have higher proportions of n-3 
HUFA. FO from livers tend to have lower EPA and DHA and intermediate levels of 
20:1 and 22:1 (Tocher 2003).  
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FO, a world-wide commodity, is presently used mainly in the feeds for farmed 
fish, and is used in only relatively small quantities in land animal feed (FAO 2002). The 
main global FO producing countries are Peru, Chile, China, Thailand, USA, Japan, 
Denmark, Norway, Iceland and South Africa (Fishmeal Information Network (FIN). 
2007). In general, FO falls into two broad categories. First, the body oils produced by 
the processing of mainly pelagic species that deposit oil in the flesh including sardines, 
anchovy, menhaden, capelin, mackerel and herring. Second, the liver oils produced 
from mainly demersal species that deposit oil in the liver, predominantly cod and 
halibut liver oils (Tocher 2003). Irrespective of source, global total FO production has, 
at best, reached its sustainable limit in line with declining or static FM production 
worldwide. The limiting global production means current forecasts predict that the 
supply of traditional marine FO resources for fish feed will be exceeded by the demand 
of the aquaculture industry by 2010 (FAO 2004b).  
Due to the situation of limited supply, high demand continues to make the prices 
of FO upwards, causing the production of feeds using the marine sources to become 
critical (FAO 2006). It is estimated that in 2006 the global aquaculture region consumed 
835 thousand tonnes of FO (88.5% total global FO in 2006) or equivalent of 16.6 
million tonnes of small pelagic forage fish (Tacon & Metian 2008). For the continued 
future development and expansion of aquaculture activities, alternative oil sources are 
required to be developed for aquafeeds, and also to contribute to the long-term 
sustainability of the world aquaculture industry (Hardy 2008). As the feed costs account 
for over 50% of the fish production cost (Lovell 2002), any dietary changes using 
alternative plant-derived materials must ensure that the growth of the fish, and the 
quality of the final product, including its highly beneficial properties for human health, 
should not be compromised. Thus, the strategy to develop alternative dietary oils using 
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a variety of oil sources should be focused on obtaining FA compositions in the final fish 
similar to the FA profile of current marine oil sources. The replacement of FO with VO 
can thus be rather challenging due to the fact that VOs are devoid of the n-3 HUFA 
which are abundant in FO including EPA and DHA that are essential for optimal growth 
and development in salmon (Sargent et al. 2002). The n-3 HUFA in FO is generally 
around 15 – 30 % of total FAs, while VO generally contain no HUFA at all and, in most 
cases, only moderate levels of the C18 n-3 PUFA, 18:3n-3. Furthermore, FOs also 
contain low levels of the n-6 HUFA, ARA, and also 18:2n-6, whereas VO contain no 
ARA and are usually rich sources of the n-6 PUFA, especially 18:2n-6 (Hertrampf & 
Piedad-Pascual 2000). However, although anything but ideal in terms of EFA, VOs are 
the most obvious candidates for FO replacement as the global production of the major 
seed oils in recent years has steadily increased such that the price and availability of 
VOs have been relatively constant. 
The substitution of FO with alternative oils should provide sufficient energy in 
the form of the preferred FA in order to minimise any reduction in growth rate. SFA and 
MUFA are preferred over PUFA as substrates for energy production in fish e.g. 16:0, 
18:1n-9 (Henderson 1996). Oil and fat alternatives to FO can be rich in energy-
providing FA. Thus, fats from land animals, beef and pork lards, mutton and poultry 
fats, are rich in SFAs and MUFAs, but they generally lack EFAs, especially n-3 HUFA 
(Jobling 2004). Oilseeds can contain high levels of unsaturated FAs, but no HUFA. 
Palm oil (PO) is rich in SFA, particularly 16:0 (Bell et al. 2002), whereas olive oil (OO) 
and rapeseed oil (RO) are rich in MUFA, more specifically 18:1n-9 (Torstensen et al. 
2004b). The very high content of 16:0 in PO with some 18:1n-9, and the high 18:1n-9 
and moderate SFA in OO, along with relatively low levels of 18:2n-6, means that PO 
and OO provide sufficient energy for adequate/good growth (Ng 2002a, 2002b). Other 
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VOs are rich in PUFA, with sunflower oil, corn oil and soybean oil (SO) all very rich in 
18:2n-6 (Bell et al. 1993; Rora et al. 2005). RO and SO have often been considered as 
possible alternative oil sources for salmonid production, as they are high volume, 
relatively low-cost oils and, although SO is particularly rich in n-6 PUFA, especially 
18:2n-6, they also contain some 18:3n-3 (Caballero et al. 2002). Moreover, RO contains 
high levels of MUFA, especially 18:1n-9 (Bell et al. 2001). High levels of 18:3n-3 are 
not common in VOs, with LO the most common exception (Bell et al. 2003b, 2004). 
However, Camelina seed is a promising new lipid source of 18:3n-3 for aquafeeds and it 
also has other good nutritional qualities. Camelina seed contains 42.5 % crude protein 
containing considerable amounts of essential amino acids (EAA), and also 43.3 % crude 
oil (Zubr 2003). Camelina oil (CO) is less unsaturated than LO and more unsaturated 
than SO or canola oil. The balance of SFA and unsaturated fats is similar to that of SO, 
but it contains significantly higher proportions of 18:3n-3 (Putnam et al. 1993). CO is 
characterised by a high content of LA and ALA, together constituting about 52.6% 
(Zubr 2003). Moreover, it contains 12 % SFA, 34% MUFA primarily oleic acid (18:1) and 
eicosenoic acids (20:1), and 54 % PUFA, primarily 18:3n-3 and 18:2n-6 (Putnam et al. 1993). 
The adequate balance of EFA and FAs for energy in aquafeeds is a key 
requirement in the replacement of FO with VO in order to sustain high growth and 
survival, feed conversion efficiency, immune competence, disease resistance, and high-
quality of fillet (Peng et al. 2008). The use of VOs in the diets of salmonids has been 
investigated, with regards to the growth and feed utilisation efficiency, and changes in 
tissue FA composition and FA metabolism, for years (Bell et al. 1997; Turchini et al. 
2003; Torstensen et al. 2008). Although it has been reported that it is possible to 
replace dietary FO with single VO as the added lipid source in aquafeeds without 
compromising growth in various fish, flesh FA composition and subsequent quality of 
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the fillet products in all fish, including salmonids, largely modified irrespective of the 
capacity of the fish to convert 18:3n-3 to EPA and DHA (Greene & Selivonchick 1990). 
Hence, replacement of FO with blended VOs is possibly more likely to provide a 
balanced dietary FA composition both for the requirement of the fish and to maintain 
flesh n-3 HUFA as high as possible. 
Replacement of marine FO with VO in aquafeeds should consider not only the 
supply of lipid at the correct level with a balance of EFA to sustain optimum growth, 
but also to maintain normal immune function in fish (Montero et al. 2003). Substitution 
of FO with blend of VOs had no affects on fish histology while replacement with a 
single VO showed some affect on fish health. Thus, 60 % of FO can be replaced by a 
blend of different VOs without affecting gilthead sea bream (Sparus aurata) health, but 
when 60 % of FO was replaced by a single VO it affected the immunosuppression or 
stress response. For instance, RO affected head kidney macrophage activity, SO 
affected serum alternative complement pathway activity, and LO altered the stress 
response of fish (Montero et al. 2003). In European sea bass, partial substitution of 
single VOs, LO, RO and OO at 60% replacement of FO altered some immune 
parameters including the number of circulating leucocytes and macrophage respiratory 
burst activity, and promoted accumulation of large amounts of lipid droplets in 
hepatocytes, although no signs of cellular necrosis were evident (Mourente et al. 2005). 
Similarly, in rainbow trout, partial substitution of dietary FO with 60% VOs resulted in 
increasing lipid deposition in hepatocytes (Caballero et al. 2002). Other authors have 
also described histological changes, mainly large vacuoles in liver of Arctic charr 
(Salvelinus alpinus), and effects on the immune/stress response of gilthead sea bream 
and European sea bass when fish were fed dietary VOs (Olsen et al. 1999, 2000; 
Benedito-Palos et al. 2008). However, in other studies no histological signs of liver and 
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intestine damage were observed when gilthead sea bream were fed blended VOs (RO, 
SO, PO) replacing 60 – 69 % of dietary FO (Benedito-Palos et al. 2008; Fountoulaki et 
al. 2009). Similarly, Atlantic salmon fed dietary VO at up to 100 % replacement of FO 
showed no reduction in growth performance, feed conversion or development of 
histology (Bell et al. 2001, 2003a). 
The nutritional quality of the final flesh product in terms of content of n-3 
HUFA, particularly EPA and DHA, supplied to the human consumer must also be taken 
into account. Hence, the inclusion of VOs in the feeds for farmed fish can lead to 
alteration of the FA profile and reductions of EPA, DHA and the n-3/n-6 FA ratio 
(Martinez-Llorens et al. 2007), with a direct effect on the fish fillet quality (Regost et 
al. 2004) and sensory characteristics (Guillou et al. 1995; Izquierdo et al. 2005). Since 
it is desirable to produce fish fillets with a high content of HUFA, feeding fish 
previously fed VO with a 100 % FO diet (finishing diet) during the last part of their 
ongrowing period before harvest in order to allow recovery of the n-3 HUFA levels in 
their fillets is well documented (Bell et al. 2003b, 2004; Benedito-Palos et al. 2009).  
1.7.4 Fish meal and fish meal replacement 
FM, a light brown flour or meal, is an excellent and rich source of high quality 
protein containing the ten EAAs that animals, including fish, cannot synthesise. It is 
also a rich source of energy, EFA, vitamins and minerals, and also enhances the 
palatability of diets and feed efficiency in fish (NRC. 1993). FM is produced from fresh 
raw fish and fish trimmings by cooking followed by pressing, separation, drying and 
milling (Jobling 1993). The chemical composition of different FM may vary 
significantly depending on the source of fish used for its production (Hertrampf & 
Piedad-Pascual 2000). The quality of FM is influenced by fish species, seasonal 
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variations in compositions of the fish and the freshness of raw materials used (Jobling 
1993, 2004). High quality FM show protein contents of 70-72 % in herring, capelin and 
sand eel meals, 65% in anchovy and horse mackerel, 60-62 % in menhaden, and 55-60 
% in fish processing waste (Hardy 1996).  
The top main FM-producing countries are Peru, Chile, China, Thailand, USA, 
Japan, Denmark, Norway, Iceland and South Africa (Fishmeal information network, 
FIN, 2007). The source of the FM thus varies geographically and includes a variety of 
fish species caught for the sole purpose of FM production, by-catches from another 
fisheries, or fish trimmings/offals from the food fish processing industry (Jobling 1993). 
Most FM is produced from small pelagic fish species e.g. anchovies, blue-whiting, 
herrings, mackerels, capelin, pilchard, menhaden, sardines, sand eel, Norway pout, 
sprat, and other (Jobling 2004). There are four different grades/qualities of FM products 
available: High quality - usually for small-scale aquaculture units (trout farms) or 
marine species; LT (low temperature) meal - is highly digestible and used in salmon and 
piglet production; prime and FAQ (fair average quality) - lower protein content feed 
ingredient for pigs and poultry (Fishmeal Information Network (FIN). 2007). Similar to 
FO production, FM manufacture has been critical for aquafeeds production (FAO 
2006). The aquaculture sector consumed 3724 thousand tonnes of FM in 2006 (68.2% 
total global FM production) (Tacon & Metian 2008). Hence, aquaculture feed 
manufacturers are searching for suitable sources of plant materials rather than marine 
materials in their fish feed formulas, as the plant materials have a more stable supply 
and often much cheaper price compared to the FM.  Animal by-products can also 
possibly be used in aquafeeds as substitutes for FM. Meals produced from a range of 
animals by-products e.g. meat and bone meal, blood meal, feather meal, poultry by-
product meals are available and have been included in formulated feed for fish, 
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although the use of many of these is not currently permitted in the EU (Jobling 2004). 
However, their nutritional quality is variable depending upon the specific products. 
Meals derived from various animal by-products have a relatively high ash content and 
often low digestibility. Animal by-product meals can be rich sources of the EAAs lysine 
and histidine, but they may be deficient in the sulphur-AAs (cysteine, cystine and 
methionine) (Jobling 1993).  
Substantial effort is being applied in investigation the use of plant proteins as 
substitutes for FM and this presents several challenges. Many plant protein products 
(meals etc) have the potential to be used as sustainable substitutes for FM because plant 
ingredients have high global availability at competitive prices compared to FM, and 
they generally have nutritional properties that can largely satisfy the requirements of the 
fish (NRC 1993). However, there are several issues with plant proteins that must be 
considered. First, the AA compositions of plant proteins can differ significantly from 
FM and feeding such diets may induce EAA deficiencies that would restrict growth and 
protein utilisation unless supplemented (Espe et al. 2006). Furthermore, many if not 
most plant protein sources contain anti-nutritional factors (ANF) that may affect 
growth, nutrient utilisation and fish welfare in general (Francis et al. 2001). Thus, 
cereals generally contain high carbohydrate and thus lower protein contents with a poor 
AA profile, often deficient in lysine, that limits their potential use as protein sources 
(Jobling 1993). Legumes such as peas, beans, lupins and lentils have been used as 
ingredients in feed ingredients of domestic animals, and some of these have been tested 
for suitability in fish feeds (Hertrampf & Piedad-Pascual 2000). However, possibly the 
most important plant protein sources are the oilseed meals, for example soybean, 
derived from the dried residues after the oil has been extracted. Oilseed meals may also 
be deficient in some AAs, particularly methionine and lysine (Jobling 1993).  
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One potentially major disadvantage of using plant materials in aquafeeds is the 
presence of ANFs. These substances are naturally occurring toxins or antimetabolites, 
whose main function in plants is as natural insecticides or, generally, as part of survival 
mechanisms that prevent grazing and consumption of plants by insects and other 
herbivores (Hendricks 2002). Common ANFs include trypsin inhibitors, hemagglutinins 
(Refstie et al. 1998), phytic acid, gossypol, phytoestrogens, cyclopropenoic FAs, 
glucosinolates, erucic acid, alkaloids and thiaminase (NRC 1993). However, some of 
the ANFs can be destroyed or inactivated by the heating and drying procedures involved 
in the production of oilseed meal (Jobling 1993). Another disadvantage of utilisation of 
plant products in aquafeeds is that they may contain up to 70 % of their phosphorus 
bound in phytic acid (phytate) (Selle et al. 2000; Francis et al. 2001). The phosphorus 
in phytate has low bioavailability to non-ruminant animals, including fish (Selle et al. 
2000). Phytic acid can both reduce the availability of minerals and reduce the protein 
digestibility of salmonid diets (Jobling 1993). Thus, the presence of such substances in 
aquafeeds may affect their nutritional value that may result in a variety of physiological 
effects on fish (Francis et al. 2001). 
The levels of inclusion of alternative plant protein ingredients in fish diets 
should be set such that they do not cause harm to fish, and the level of each ANF in the 
diet should be low. The use of plant protein concentrates such as soybean protein 
concentrates or canola protein concentrate (60-65 % protein) can overcome many of the 
problems associated with the presence of ANFs. The plant protein concentrates provide 
a source of protein with an EAA profile that, with the exception of methionine, would 
seem to fulfill the requirement for fish growth (Jobling 1993, 2004). Generally, the 
replacement of up to 20 – 40 % of FM with single plant meals does not normally 
compromise fish growth (Nengas et al. 1996; Refstie et al. 2000). However, complete 
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replacement of FM by plant protein has not been very successful and growth has been 
compromised (Refstie et al. 2000, 2001; De Francesco et al. 2004; Sitja-Bobadilla et 
al. 2005; Espe et al. 2006).  
The palatability and digestibility of the plant protein-based diets both appear to 
be factors that affect growth performance of fish. In salmonids, using plant protein 
ingredients in feeds with and without AA supplementation resulted in lower growth 
performance that was related to reduced feed intake (Gomes et al. 1995; De Francesco 
et al. 2004; Espe et al. 2006). In Atlantic cod, SGR was reduced and FCR increased 
when 75 % of dietary FM was replaced with plant protein consisting of wheat gluten, 
soy protein concentrate and bioprocessed soybean, and reduced appetite of the fish was 
found when total substitution of FM was applied (Hansen et al. 2007a). 
Growth and histology are good indicators of the adverse affects of plant-based 
ingredients on fish health and welfare. Although the full range of potential effects of 
ANFs has yet to be established, there have been several studies of the effects of dietary 
ANFs on fish growth and health. In salmonids, ANFs can decrease digestion and reduce 
utilisation of proteins (Krogdahl et al. 1994). In addition, high levels of dietary soybean 
products damage the distal part of the gut in salmon, where cells show extensive 
endocytotic activity and high numbers of intracellular vacuoles. Damage is basically 
characterised by alters in the number of mucus-producing goblet cells, intracellular 
absorptive vacuoles, amount of connective tissue, cellularity of the laminar propria, and 
degrees of mucosal folding and infiltration of the epithelium or lamina propria by 
inflammatory cells (Baeverfjord & Krogdahl 1996). The dietary effect on goblet cells 
may be caused by phytate or fibre in diets (Olsen et al. 2007). In extreme cases, massive 
necrosis was also found, a condition that referred to as soybean-induced enteritis 
(Baeverfjord & Krogdahl 1996). 
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Substitution of up to 75 % of dietary FM with plant protein ingredients appears 
not to affect health to any major degree in Atlantic cod (Olsen et al. 2007). However, 
total replacement of FM with plant protein meals may induce enteritis-like conditions in 
the guts of some fish and also activate heat shock protein (HSP) 70 gene mRNA 
expression in the intestine tissue. HSP70 is known as a biomarker of stress (Iwama et al. 
1998). Plant proteins do not seem to induce HSP activation in cod liver (Hansen et al. 
2006), but the HSP70 expression was found up-regulation in hindgut of Atlantic salmon 
fed diets with full fat soybean meal (Sagstad et al. 2007). Nevertheless, using the plant 
protein products (wheat gluten, soybean protein and bio-processed soybean meal) up to 
75 % of diet protein produced only marginal effects on fish growth and fish health 
(Olsen et al. 2007). 
1.8 General objectives 
Due to the limited and, at best, static availability of the marine raw materials, FO 
and FM, and the ecological concerns of using non-sustainable marine resources, along 
with issues of POP contaminant levels in these feed ingredients, substitution of FO and 
FM must be investigated for development and expansion of aquaculture to continue. 
The overall aim of the present study was to develop alternative, sustainable diets for 
farming Atlantic salmon.  More specifically, the aim was to investigate alternative feed 
ingredients as replacements/substitutes for both FO and FM in Atlantic salmon diets, 
and different strategies for their application and use, to ensure optimal growth, feed 
efficiency and health of the fish at the same time as maintaining, as much as possible, 
the nutritional quality of the fish product to the human consumer, especially the levels 
of n-3 HUFA, EPA and DHA, in the flesh. 
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To achieve this overall aim, the study involved four dietary trials with specific 
objectives. In trials 1 & 2, the focus was primarily on FO replacement. In trial 1, the 
objective was to investigate and compare the effects on n-3 HUFA and POP 
contaminant levels following substitution of standard northern FO (NFO) with either 
decontaminated northern FO (DFO) or with VOs blended with southern FO (SFO) as 
two alternative strategies. In trial 2, the effects of long-term (> 1 yr) replacement of 100 
% of dietary NFO with blended VOs followed by a subsequent FO “finishing” diet 
period was investigated as an alternative strategy. This study was performed in different 
families (strains) of Atlantic salmon to determine genetic effects on the adaptation to 
alternative diets. In both trials 1 and 2, FM was also partially replaced as the diets were 
formulated to be practical and thus reflect current feed formulation practices. In trials 3 
& 4, the focus was on substitution of FM.  In trial 3, a regression design was employed 
to investigate the effect of graded substitution of FM with plant products.  In trial 4, the 
effects of alternative protein substitute blends as replacement for FM were investigated. 
In line with the ethos that the diets investigated should be practical, in trials 3 & 4, the 
maximum level of FM inclusion used was 25 %, and 60 % of added oil was supplied by 
VO.  Therefore, all trials in this study were examples of dual FM and FO substitution.  
Overall therefore, the study had a range of specific objectives as described below: 
1) To investigate the effects of the total replacement of NFO with 
decontaminated NFO on growth, nutrients digestibility, tissue proximate and FA 
composition, tissues contaminant levels and liver gene expression in Atlantic salmon. 
2) To evaluate the effects of the total replacement of NFO with SFO/VO blends 
on growth, nutrients digestibility, tissue proximate and FA composition, tissues 
contaminant levels and liver gene expression in Atlantic salmon. 
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3) To elucidate the effects of long term dual replacement of 100 % FO in dual-
substituted diets (25% FM, 45 % PPs) in three families/strains of Atlantic salmon on 
growth, tissue proximate and FA composition, and liver gene expression in Atlantic salmon.  
4) To determine the effects of a 100 % FO finishing diet in the three strains of 
salmon on tissue proximate and FA compositions in Atlantic salmon.  
5) To elucidate the effects of graded substitution of FM in dual-substituted diets 
on growth, feed efficiency, nutrient digestibility and FA composition in Atlantic salmon.  
6) To investigate the effects of different blends of replacement proteins in dual-
substituted diets with high replacement of FM on growth, feed efficiency and tissue FA 
composition in Atlantic salmon. 
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Chapter 2 - Materials and Methods 
The materials used and the procedures followed that represent techniques used 
throughout this study are presented below.  
2.1 Materials  
All reagents used for chemical, biochemical and molecular analysis in this study 
were HPLC grade. The reagents and materials used consist of cupric acetate, potassium 
hydrogen carbonate (KHCO3), sodium hydrogen carbonate (NaHCO3), iodine, neutral 
and polar lipid standards, butylated hydroxytoluene (BHT), 17:0 free fatty acid standard 
were obtained from Sigma (Poole, UK.).  Chloroform, methanol, toluene, iso-hexane, 
diethyl ether, ethyl acetate, ethanol, acetonitrile, acetone, propan-2-ol, methyl acetate, 
potassium chloride, sulphuric acid and glacial acetic acid were obtained from Fisher 
Scientific UK, (Loughborough, England). Herring sperm DNA, bovine serum albumin 
(BSA), sodium dodecyl sulfate (SDS) and dimethyl sulfoxide (DMSO), TriReagent, 
SSC buffer, Poly(A) (10 mg/ml in H2O) were obtained from Sigma (poole, UK.). Ultra 
HyB buffer and Amino Allyl Messenger Amp II aRNA Amplification kit were obtained 
from Ambion (Ambion, Huntingdon, UK.). Cy3 monoreactive dye, Cy5 monoreactive 
dye, and Illustra AutoSeq G-50 columns were obtained from GE Healthcare (Chalfont, 
UK). Pre-coated silica gel 60 thin-layer chromatography (TLC) (20  20  0.25 cm) and 
high-performance thin-layer chromatography (HPTLC) (10  10  0.15 cm) plates, 
without fluorescent indicator were obtained from Merck (Darmstadt, Germany). All 
compressed gases: oxygen-free nitrogen, hydrogen, oxygen and helium were obtained 
from the British Oxygen Company (Glasgow, UK).  
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2.2 Experimental fish and diets 
The experimental fish, Atlantic salmon, and diets used in this thesis are 
described in detail in the relevant chapters. The experimental diets were all formulated 
to satisfy the nutritional requirements of salmonid fish (National Research Council, 
1993). The diets for trials 1,3 and 4 were manufactured at the BioMar TechCentre, 
Brande, Denmark while the diet for trial 2 was produced at the Skretting  Aquaculture 
Research Centre (ARC) Stavanger, Norway. The specific dietary formulations and 
experimental conditions are described in the appropriate chapters. 
2.3 Experimental sampling and processing 
2.3.1 Biometric measurements 
For all weighings, fish were anaesthetised with metacaine sulphonate (MS222). 
(50 mg/L) and, if not required for further sampling, fish were placed in clean aerated 
water and allowed to recover before being returned to the cage/pen. Weighing under 
anaesthesia and recovery was supervised by fish farm staff who had obtained the 
appropriate Home Office training and licenses. In some cases fish were bulk weighed 
but when fish were measured individually they were weighed to the nearest 0.5 g, and 
the total fork length was measured to the nearest millimeter. After the fish were killed 
by a blow to the head, the gut cavity was opened and entire livers and intestines were 
weighed to the nearest 0.1g. 
2.3.2 Calculations of growth performance and carcass composition  
Growth performance and carcass composition of fish were evaluated according 
to the followed calculations (Carter and Hauler 2000; Opstvedt et al. 2003; Torstensen 
et al. 2008).   
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Feed conversion ratio (FCR) = feed intake (g) / wet weight gain (g) 
Feed consumption (g/day) = feed intake (g)/ (number of fish  day) 
Weight gain = final weight – initial weight 
Specific growth rate, SGR %day
-1
 = 100  (ln final mean weight - ln initial mean weight)/ days 
Thermal growth coefficient,TGC  = 1000  ((final weght )1/3- (initial weight)1/3)/ (days  temp.) 
Hepatosomatic Index (HSI,%) = 100  (weight of liver (g) /weight of fish(g)) 
Visceromatic Index (VSI,%) = 100  (weight of viscera (g) /weight of fish(g)) 
Protein efficiency ratio, PER = (final mean weight (g) – initial mean weight (g))/ protein fed (g)  
2.3.3 Sampling fish and tissues for biochemical and molecular analyses 
Sampling for all biochemical and molecular analyses was carried out initially at 
random. At the time of sampling fish from each treatment, the runt fish were first 
removed and then only those fish that were around the mean weight of the remaining 
sample of fish were used in the biometrics and subsequent analyses. When required, 
whole fish for proximate analyses were immediately frozen and stored at -20
o
C prior to 
analysis. Tissue samples (e.g. liver and viscera) were dissected and immediately frozen 
in liquid nitrogen and stored at - 70
o
C prior to analyses. For flesh samples, Norwegian 
quality cuts (NQC) were taken, frozen and stored at -20
o
C before analysis. The flesh 
samples for contaminant analyses were wrapped in aluminum foil before being frozen at 
-20
o
C. The processing of specific samples from each trial is described in detail in the 
appropriate chapter.  
2.4 Chemical analysis  
The gross chemical compositions of the experimental diets, fish tissues and 
faeces samples were determined by proximate analyses based on official methods of the 
Association of Official Analytical Chemists (AOAC 2000). Moisture content was 
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determined directly from wet samples whereas protein, lipid, fibre and ash content were 
determined from dry samples. Samples of the dried experimental diets were finely 
ground, and the dry tissue samples were blended into homogeneous crumbles prior to 
proximate composition analysis.  
2.4.1 Proximate analysis of diet, tissues and faeces 
2.4.1.1 Moisture content (drying oven) and dry matter 
Approximately 1.0 g of the wet samples (diets and tissues) were placed into a 
drying oven at 110
o
C for 24 h or until constant weight was achieved (AOAC 2000). 
2.4.1.2 Moisture content (freeze drying) 
The faeces samples were freeze dried before analysis using a CHRIST Alpha 1-
4 LSC freeze dryer (Osterode am Hartz, Germany). Fish faeces were stored at -70
o
C for 
at least 6 h prior to place into a freeze dryer at -50
o
C under vacuum for at least 16 h 
until constant weight.   
2.4.1.3 Crude protein content  
Crude protein content was determined from the nitrogen content of each sample, 
which assumes that protein contains 16% nitrogen, using automated Kjeldahl analysis 
(Tecator Kjeltec TM 2300 analyser, Foss, Warrington, UK.) according to the standard 
method (AOAC 2000) and manufacture‟s protocol.  
2.4.1.4 Crude lipid content  
Crude lipid content was determined according to the Soxhlet method (Tecator 
Soxtec system 2050 Auto Extraction apparatus, Foss, Warrington, U.K). Dry samples 
approximately 1.0 - 3.0 g were extracted with petroleum ether (40 – 60oC boiling point).  
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2.4.1.5 Crude lipid extraction with acid hydrolysis 
In some samples a portion of the fat is bound as lipoproteins and 
liposaccharides, which interferes with efficient solvent extraction. Thus, boiled samples 
with 3N hydrochloric acid for 1 h (Hotplate 2022, Foss, UK) and then extracted using a 
Tecator Soxtec Unit according to the manufacture‟s protocol. The samples were re-
weighed and calculated as in the above formula.   
2.4.1.6 Ash content 
The total ash content was determined by incineration of the samples in a muffle 
furnace at 600
o
C for 16 h (AOAC 2000).  
2.4.1.7 Crude fibre content (Foss fibercap) 
The fibre content was determined by removing all the digestible materials from 
the sample by sequential boiling with acid and alkali solutions, drying and incinerated 
in a furnace using foss fibercap according to foss fibercap manufacture‟s protocol and 
the standard method (AOAC 2000).  
2.4.2 Nitrogen Free extract (NFE)- carbohydrate equivalent 
Nitrogen free extract was determined by substraction the crude protein, crude 
lipid, crude fibre, ash and moisture from 100%. 
2.4.3 Energy content of diets 
The gross energy contents of the diets were determined by Bomb Calorimetry 
(Foss, Warrington, UK) where dry samples are completely combusted in an oxygen 
filled container, and the heat released measured and energy content calculated 
(Manufacture‟s manual).  
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2.4.4 Apparent digestibility using yttrium trioxide (Y2O3) as an indicator  
Dried diets and faeces samples were analysed for dry matter, protein and lipid 
according to the standard method (AOAC 2000). FA contents of diets and feaces were 
analysed and quantified followed the method of Folch et al. (1957) and Christie (2003). 
Quantification of yttrium trioxide was performed at the University of Plymouth. In 
short, approximately 0.2 - 0.5 g of diet or 0.1 g freeze-dried faeces were digested with 
concentrated nitric acid overnight under a fome cupboard. A blank was prepared in the 
same manner. The quantity of yttrium trioxide was analysed by inductively couple 
plasma-optical emission spectrometry (ICP-OES) using a Liberty 200 instrument 
(Varian, Surrey, UK.). Values for faeces and diets were calculated using a series of 
calibration standards prepared from a 10,000 ppm stock solution (BDH, Poole, UK).  
ADC% = 100 - 100  ((Y feed / Y faeces)  (N faeces / N feed)) 
Where Y feed is yttrium oxide in feed, Y faeces is yttrium oxide in feed, N faeces is 
yttrium oxide in faeces, N feed is yttrium oxide in feed.  
2.4.5 Lipid analyses 
2.4.5.1 Total lipid extraction and quantification 
Total lipid for biochemical analyses was extracted from diets, tissues and faeces 
by homogenisation in chloroform/methanol following a standard protocol (Folch et al. 
1957). Approximately 1 g of sample was homogenised in 30 ml glass tubes with 16 ml 
ice-cold chloroform/methanol (2:1,v/v) containing 0.01 % (w/v) BHT using a tissue 
disrupter at 8500-9000 rpm (Ultraturrax 
TM
 system, Fisher Scientific, Loughborough, 
England). The homogenates were kept on ice for 1 h prior to adding 4 ml of aqueous 
0.88 % (w/w) KCl, followed by mixing and being left on ice for a further 5 min. The 
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tubes were centrifuged at 1500 rpm (400 gave) for 4 min (Joauan C312, France) and the 
supernatant non-lipid phase was aspirated and discarded. The lower organic phase was 
filtered through a pre-washed (chloroform/methanol, 2:1, v/v) 9 cm filter paper 
(Whatman no.1, Schleicher & Schuell, Maidstone, UK) into a clean pre-weighed 10 ml 
test tube. Solvents were evaporated under a stream of oxygen-free nitrogen (OFN) on an 
N-Evap evaporator (Organomation Associates Inc., Berlin, MA, USA). The lipid weight 
was determined gravimetrically after overnight desiccation in a vacuum. The total lipid 
was re-dissolved in chloroform/methanol (2:1,v/v) to a concentration of 10 mg/ml and 
stored under nitrogen at -20 
o
C for further analysis. 
2.4.5.2 Determination of lipid class composition 
Separation of lipid classes was performed by single-dimension double-
development high performance thin-layer chromatography (HPTLC). A 10 x 10 cm 
HPTLC plate, pre-coated with silica gel 60 was pre-washed by fully developing in 10 
ml chloroform/methanol (2:1, v/v) and activated at 100
o
C for 20 min. Approximately 10 
g (1 l of a 10 mg/ml solution) of total lipid was applied in a 2 mm streak 1 cm above 
of the bottom edge of the plate using a 10 l syringe (Hamilton, Fisher, Loughborough, 
UK.). The plate was developed to 5.5 cm in a freshly prepared solvent mix which 
consist of methyl acetate/isopropanol/chloroform/methanol/0.25%KCL (25:25:25:10:9, 
v/v) in an HPTLC tank. The HPTLC plate was desiccated in a vacuum desiccator for 15 
min prior to being fully developed to 9.0 cm in a freshly prepared solvent mix 
consisting of iso-hexane/diethyl ether/ glacial acetic acid (80:20:1, v/v) and desiccated 
for a further 15 min. The lipid classes were visualised by charring the plates at 160
o
C 
for 20 min after spraying with 3 % (w/v) copper acetate in 8 % phosphoric acid reagent. 
The lipid classes were quantified by densitometry with a tungsten lamp at 370 nm using 
a Camag 3 TLC Scanner (Camag, Muttenz, Switzerland) with winCATS Planar 
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Chromatography Manager software, version 1.2.0 (Henderson & Tocher 1992). The 
identities of individual lipid classes were confirmed by comparison with reference to Rf 
values of authentic class standards that were run alongside the samples on the HPTLC 
plates and developed in the above solvent solutions. 
2.4.5.3 Determination of fatty acid compositions  
Fatty acid methyl esters (FAME) were obtained from total lipid subjected to 
acid-catalysed transesterification according to a standard method, and quantified by gas 
chromatography (Christie 2003). Approximately 1 mg of total lipid (100 l of 10 mg/ml 
solution) and 0.1 mg of 17:0 free fatty acid internal standard (100 l of a 1 mg/ml 
solution in chloroform/methanol, 2:1,v/v) were transferred to a clean test tube and the 
solvent evaporated to dryness under a stream of OFN. Acid-catalysed transesterification 
was performed by adding 1 ml of toluene and 2 ml of freshly prepared 1% sulphuric 
acid in methanol, gassing tubes with OFN, lightly stoppering followed by incubation at 
50
o
C for 16 h. FAME were extracted, after neutralising the acid with 2 ml of 2 % 
KHCO3, with 5 ml iso-hexane/diethyl ether (1:1, v/v) containing 0.01% (w/v) BHT. The 
solutions were mixed well and centrifuged at 1500 rpm (400gave) for 3 min. The upper 
organic layer was transferred to a new test tube and the lower layer extracted with a 
further 5 ml iso-hexane/diethyl ether (1:1, v/v) without BHT. After centrifugation, the 
upper layer was combined with the previous one and the solvent evaporated under a 
stream of OFN. The FAME extract was re-suspended in 100 µl isohexane and applied to 
a 20  20 cm thin-layer chromatography (TLC) plate in 2.5 cm streaks, 1.5 cm from the 
bottom of the plate using a glass microsyringe (Hamilton, UK.). The plates were 
developed to within 2 cm of the top of the plate in iso-hexane/diethyl ether/acetic acid 
(90:10:1, v/v). After separation, the plate was partially sprayed with 1 % iodine in 
chloroform (w/v) to visualise the FAME (Tocher & Harvie 1988). The bands of silica 
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containing FAME were scraped from the TLC plate with a scalpel and transferred to a 
clean test tube. To elute FAME from the silica gel, 1 ml iso-hexane/diethyl ether (1:1, 
v/v) containing 0.01% BHT and 9 ml iso-hexane/diethyl ether (1:1, v/v) without BHT 
were added, and the tubes vortexed and centrifuged at 1500 rpm (400 gave) for 3 min. 
The solvent was transferred to a clean 15 ml glass test tube and the solvent evaporated 
under OFN. The FAME were re-dissolved in an appropriate volume of iso-hexane 
containing BHT to produce a 1 mg/ml solution of FAME. The FAME were separated 
and quantified by gas-liquid chromatography using a Fisons GC 8600 gas 
chromatograph (ThermoFisher Scientific, Hemel Hempstead U.K.) equipped with on-
column injection and a wall-coated capillary column (CPWAX52CB column, 30 m  
0.32 mm id, 0.25µm film thickness, Chrompack Ltd., London, U.K.) and a flame 
ionisation detector (FID) at 250
o
C. Hydrogen gas was used as carrier at a constant flow 
rate 2.0 ml/min. The temperature programming was initially at 50
o
C to 180
o
C at a rate 
of 40
o
C/min and then to 225
o
C at 2
o
C/min and then held at 225
o
C for 5 min. Individual 
FAME were identified by comparison to known standards and by reference to published 
data (Ackman 1980). Data were collected and processed using Chromcard for windows, 
version 1.19 computer package (Thermoquest Italia S.p.A., Italy). 
2.4.6 Determination of carotenoid pigments 
2.4.6.1 Pigment composition of diets  
Diet carotenoids were extracted and analysed according to the method of Barua 
et al. (1993). Approximately 1 g of ground diet was digested with 110 mg of Maxatase 
enzyme (International Biosynthetics, Rijswijk, Netherlands) in 10 ml distilled water for 
30 min at 50
o
C. Ten ml of ethyl acetate/ethanol (1:1, v/v) were added and the mixtures 
centrifuged at 1500 rpm (400 gave) for 4 min. Five ml iso-hexane and 2 ml of ethanol 
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were then added and the combined solvents mixed and centrifuged as above. The 
solvent was transferred into a 25 ml glass tube before a final extraction with ethyl 
acetate/ethanol/ iso-hexane (5:2:10,v/v). The mixture was centrifuged as above, and the 
upper solvent layer combined with the previous extract. The pooled solvent extracts 
were evaporated under OFN and desiccated overnight under darkness. The residues 
were resuspended in 40 l iso-hexane, and mixed well before transferring into 
microcentrifuge tubes and being centrifuged at 12,000 x g for 5 min (MH-2/18100, 
Degaspeed, Sarsted Ltd, Leicester, UK). The clear solvent was pipetted into 2 ml glass 
vials, flushed under OFN and stored in darkness. The carotenoids were separated by 
HPLC (Waters, St Quentin, France) using a stainless steel column 150 mm x 4.6 mm 
i.d., stationary phase 5µ Ascentis 
TM
 silica gel HPLC column (Phenomenex, 
Macclesfield, UK) with iso-hexane/acetone (86:14, v/v) as a mobile phase at a flow rate 
1 ml/min., and detected at 470 nm using a Waters
TM 
486 multiwavelength UV/vis 
detector (Millipore, Watford, UK) and quantified by comparison with authentic external 
standards (Roche, Heanor, UK). Data was processed using Millennium software 
(Waters, St Quentin, France) and calculation according to the following formula.  
Calculation the concentration of standard from the spectrophotometer 
Standard concentration ( g/ml) = [Abs@470 nm]  10,000 
                       2,100 
Where10,000 is dilution factor of the standard astaxanthin and  2,100 is the standard 
absorption of a 1% all -E-extinction solution (w/v) in a 1 cm cuvette at 470 nm in iso-hexane. 
(Preparation of the standard see Appendix I).  
Calculation total and individual pigment concentration from the HPLC  
Concentration (mg/kg) = SC  peak area  dilution factor 
       std area  weight of sample (g) 
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2.4.6.2 Pigment composition of flesh  
Pigments were extracted from flesh by homogenising approximately 1g of tissue 
in 10 ml of ice-cold ethyl acetate/ethanol (1:1,v/v) using a tissue disrupter (Ultra-Turrax 
T25, Fisher, Loughborough, England). The homogenate was centrifuged at 1500 rpm 
(400 gave) for 4 min and the upper layer removed to a clean glass tube. The pellet was 
re-extracted, with 5 ml ethyl acetate, and then 5 ml iso-hexane, and in both cases, 
centrifuged and combined with the previous extracts. The solution was evaporated to 
dryness under OFN and desiccated overnight in darkness. The residues were 
resuspended in 4 ml iso-hexane, transferred into 2 ml plastic microcentrifuge tubes 
followed by centrifugation at 12,000 x g for 5 min. Carotenoids were separated by 
HPLC using a stainless steel column 150 mm  4.6 mm i.d., stationary phase SYNERGI 
4µ MAX-RP 80A column (Phenomenex, Macclesfield, UK) with acetonitrile/methanol 
(95:5, v/v) as a mobile phase at a flow rate of 0.8 ml/min, detected at 470 nm using a 
Waters
TM 
490 programmable multiwavelength detector (Millipore UK, Watford) and 
quantified by comparison with authentic external astaxanthin standards (Roche, Heanor, 
UK). Data was processed using Millennium software.  
2.4.7 Molecular analyses 
2.4.7.1 RNA extraction  
Approximately 100 mg of frozen liver was weighed and homogenised on ice in 
1 ml TRIzol  in a 1.5 ml microcentrifuge tube using a hand-held Ultra-Turrax tissue 
disrupter (Fisher Scientific, Loughborough, England). The homogenised sample left at 
room temperature for 5 min before 200 µl of chloroform (Sigma, Dorset, UK) was 
added, then shaken vigorously for 15 s and incubated for a further 3 min at room 
temperature. The sample was centrifuged at 12,000 g for 15 min at 4 
o
C (Sigma 4K15, 
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Osterode am Hartz, Germany), the supernatant phase transferred to a clean 1.5 ml 
microcentrifuge tube, and 500 µl of isopropanol (Sigma) added and the tube gently 
shaken and left at room temperature for a further 10 min to precipitate the RNA. The 
sample was centrifuged at 12,000 g for 10 min at 4 
o
C, the supernatant discarded and 
the RNA pellet washed by addition of 1 ml 75 % ethanol (v/v) in MilliQ-H2O and 
vortexing. The tube was centrifuged at 7500 g for 5 min at 4
o
C, the supernatant 
discarded, and the pellet allowed to dry at room temperature for 5 min. The pelleted 
RNA was re-dissolved in an appropriate volume of MilliQ-H2O and the RNA quantity 
and purity were determined at absorbance wavelength ratios of 260/280 nm and 
260/230 nm by spectrophotometry (NanoDrop, ND 1000, Thermo Scientific, 
Wilmington, USA). The quality of the RNA was confirmed by agarose gel 
electrophoresis using 1 % agarose gel in 1  TAE/TBE buffer containing 10 ng 
ethidium bromide (see Appendix I) and UV fluorescent detection (INGENIUS, syngene 
bio imaging, Cambridge, UK). The RNA solution was stored at -70 
o
C prior to further 
analysis. 
2.4.7.2 Transcriptomic (microarray) analysis  
To obtain sufficient material for array hybridisation and to improve the 
reliability of array results, RNA amplification was used. The total RNA was reverse 
transcribed to first strand and second strand complimentary DNA (cDNA), which was 
subjected to in vitro transcription to synthesise anti-sense RNA (aRNA). The aRNA 
amplification, aRNA purification, aRNA dye coupling reaction, and dye labeled aRNA 
purification were performed according to the instruction manual for the Amino Allyl 
message Amp II aRNA amplification kit, RNA amplification for array analysis 
(Ambion, UK.). 
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2.4.7.2.1 First strand and second strand cDNA reverse transcription and 
purification 
First strand and second strand cDNA were prepared by reversed transcription 
following the instruction manual (Ambion, UK.). In short, 500 ng of total RNA was 
mixed with 1 l of T7 oligo (dT) primer in a nonstick, sterile, RNase-free, 0.5 ml tube 
and adjusted with nuclease-free water to a final volume of 12 l, vortexed for 5 s and 
then briefly centrifuged to collect the mixture at the bottom of the tube. The mixture 
was incubated in a thermocycler (PCR machine, Thistle Scientific, Luton, UK.) at 70
o
C 
for 10 min to denature the RNA followed by brief centrifugation, and placed on ice. 
First strand cDNA synthesis was performed by adding 8 l of reverse transcription 
master mix (including 2 l 10  first strand buffer, 4 l dNTP mix, 1 l RNase inhibitor 
and 1 l ArrayScript enzyme), mixing well and centrifuging briefly prior to incubation at 
42
o
C for 2 h in an  incubator. Proceeding immediately to the second strand cDNA 
synthesis, 80 l of second strand master mix (including 10 l 10  second strand buffer, 
4 l dNTP mix, 2 l DNA polymerase, 1 l RNase H and 63 l nuclease-free water) was 
added to the first strand cDNA reaction, centrifuged briefly, and the mixture incubated 
at 16
o
C for 2 h in a thermal cycler and then placed on ice. The second strand cDNA was 
purified by adding 250 l of cDNA binding buffer, and mixing thoroughly before being 
transferred into a cDNA filter cartridge, placed in a 1.5 ml collection tube, prior to 
centrifuging for 1 min at 12,000  g (260D, Denville Scientific Inc., Metuchen, NJ, 
USA.). A volume of 500 l wash buffer was then added to the filter cartridge and 
centrifuged as above before transferring the filter cartridge into a new 1.5 ml collection 
tube (Ambion, UK.). The cDNA on the filter was eluted into the collection tube by 
adding 9 l of warm (50-55
o
C) nuclease-free water and centrifuging as above. The 
elution step was repeated once and the purified cDNA placed on ice prior to aRNA 
synthesis and amplification.  
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2.4.7.2.2 aRNA synthesis and amplification 
The aRNA was synthesised by in vitro transcription (IVT) kit, following the 
manufacturers instructions (Ambion, UK.). For this, 26 l of in vitro transcription 
double strand (ds) master mix (including 3 l of aaUTP, 12 l of 25 mM ATP/CTP/GTP 
mix, 3 l of 50 mM UTP solution, 4 l of T7 10  reaction buffer and 4 l of T7 enzyme 
mix) was added to the sample prior to incubation at 37 
o
C for 16 h. The reaction was 
then stopped by adding 60 l of nuclease-free water to bring the final volume to 100 l 
before aRNA purification. For purification, 350 l of aRNA binding buffer (containing 
-mercaptoethanol) was added, immediately followed by 250 l of 100 % ethanol, with 
thorough mixing. The sample was transferred to the centre of an aRNA filter cartridge, 
placed in a 1.5 ml collection tube, centrifuged for 1 min at 12,000 g and the flow-
through discarded. For washing the filter, 650 l of wash buffer was added to the aRNA 
filter cartridge, centrifuged and the flow-through discarded. The purified aRNA was 
eluted by applying 100 l of warm (50 - 55
o
C) nuclease-free water into the center of the 
aRNA filter cartridge, incubated at room temperature for 2 min and then centrifuging at 
12,000  g for 1.5 min. The concentration of purified aRNA was determined 
spectrophotometrically using the NanoDrop spectrophotometer (Wilmington, DE, USA) 
and the aRNA then stored at -70 
o
C. 
2.4.7.3 aRNA labelling  
The aRNA was labelled for microarray analysis by the NHS-ester containing 
dye coupling reaction. Thus, 10 l of each aRNA biological replicate were combined by 
transfer into a clean tube to prepare a pooled reference, with the final concentration 
verified spectrophotometrically (Nanodrop 1000). The aRNA samples were labelled 
with either Cy3 for treatment samples or Cy5 for the pooled reference (GE healthcare, 
UK). A volume containing 1.25 g of each aRNA treatment sample and the pooled 
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sample was transferred into another microcentrifuge tube prior to the appropriate 
nuclease-free water was added to bring the volume to 4 l. One l of 0.5 M NaHCO3 
(2  coupling buffer) was applied into the tube and then vortexing briefly. A 5 l aliquot 
of Cy dye dissolved in 100 l dimethyl sulfoxide (DMSO) was added to the aRNA and 
gently mixed by pipetting before incubation at room temperature (25
o
C) for 1.5 h in the 
dark. To remove the un-incorporated dye, the labeled aRNA (total volume 10 l) was 
pipetted directly onto the resin-bed surface of the pre-spin Illustra AutoSeq G-50 dye 
terminator (GE Healthcare, UK) and centrifuged at 2000  g for 1 min. The eluted 
purified labeled aRNA was then quantified spectrophotometrically (Nanodrop 1000) at 
microarray setting (RNA-40). In addition, the dye-labeling was assessed by 
electrophoresis of 0.4 l of sample in a thin-agarose gel (1 % agarose gel in 0.5  TAE 
buffer without ethidium bromide) and subsequently visualising the fluorescent products 
using a Typhoon fluorescent scanner (GE Healthcare, Chalfont, UK.). The purified 
labeled product was stored at -70
o
C prior to hybridisation.  
2.4.7.3.1 Microarray hybridisation and scanning  
For hybridisation, 40 pmol of each Cy3 and Cy5 labelling sample was combined 
and brought to a final volume of 25 l with nuclease-free water, before denaturing at 95 
o
C for 3 min and cooling to 4 
o
C. The mixture was then added to 225 l freshly 
prepared and heated (60
o
C) hybridisation buffer master mix (Ultrahyb, Ambion, UK.) 
(containing 185 l of 0.7  ultra-hybridisation buffer, 20 l of 10 mg/ml in H2O poly 
(A), 10 l of herring sperm DNA (ca 10 mg/ml), and 10 l of ultra pure BSA). The 
hybridisation mixtures, treatment (Cy3-labelled) and pooled reference (Cy5-labelled) 
samples, were incubated at 60
o
C in a hot block in the dark before being applied to the 
17 K salmon cDNA TRAITS/SGP microarray. For hybridisation, 200 l of the 
hybridisation mixtures were injected using a microsyringe (Hamilton, UK.) into 
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hybridisation chambers (Lucidea slidepro, Amersham Biosciences, Chalfont, UK), 
where the cDNA microarrays were previously inserted. The chambers were heated to 70 
o
C for 10 min and cooled to 42
o
C before hybridisations were performed at 60
o
C for 17 
h. The slides were automatically washed with first wash 1 buffer (1.0  SSC; 0.1% SDS 
solution) and second wash 2 buffer (0.3  SSC; 0.2% SDS). The microarray slides were 
then removed from the Lucidea hybridiser after the chambers were cooled down to 40 
o
C, and subsequently washed manually twice in wash 2 buffer at 45
o
C for 3 min, and 
three times in wash 3 buffer (0.2  SSC; 0.2% SDS) for 2 min, in an incubator set at 
125 rpm. The slides were finally washed in wash 4 buffer (0.1  SSC) for 20 s at room 
temperature and then placed in a dry EasyDip container and centrifuged at 500  g for 5 
min at room temperature (Sigma, 4K15) to remove residual buffer. The hybridised 
slides were autoscanned at 10 m resolution with wavelength 635 nm and 532 nm for 
Cy 3 and Cy 5 respectively, by using Gene Pix autoloader 420042A2 (Axon 
Instruments, Inc, Union city, CA, USA.) at the Roslin Institute Edinburgh. The 
hybridisation data were obtained in GenePix Array List (GAL) file. 
2.4.7.4 Quantitative PCR (qPCR) analysis 
2.4.7.4.1 First strand cDNA synthesis by reverse transcription (RT) 
First strand cDNA synthesis of total RNA from the liver was performed using 
the Verso
TM
 cDNA kit (Thermo scientific, Fisher Scientific, Loughborough, England). 
Briefly, 1 g RNA of each sample was brought to a volume of 11 l with nuclease-free 
water in a PCR plate, denatured at 70
o
C for 5 min in a PTC-100 thermocycler PCR 
machine (MJ Research, MA, USA.) and then cooled on ice for 5 min. To each sample, 9 
l of the reverse transcription mix, containing 4 l of 5  cDNA synthesis buffer, 2 l of 
dNTP mix, 0.75 l of random hexamers (400 ng/ l) and 0.25 l of anchored oligo-dT 
primer (500 ng/ l), 1 l of RT enhancer and 1 l of verso enzyme mix, was added. The 
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plate was then briefly mixed and centrifuged before being placed in a PCR thermocycler 
to synthesis cDNA at 42
o
C for 60 min followed by enzyme inactivation at 95
o
C for 2 
min (manufacturer‟s protocol). The cDNA was stored at -20oC prior to further analysis. 
2.4.7.4.2 qPCR determination of gene expression  
Gene expression was determined by quantitative real-time polymerase chain 
reaction (qPCR) using a Quantica thermocycler (Techne, Cambridge, UK). Quantitative 
PCR analysis for each gene was performed on 6 biological replicates, 2 technical 
replicates, in a total volume of 20 l containing 5 l of 10
 20 
dilution of 1
st
 strand 
synthesis cDNA, 1 µL (10 pmol) of each forward and reverse PCR primer, 10 µl of 2 × 
Absolute QPCR SYBR Green Mix (ABgene Ltd, Epsom, UK), and 3µL of nuclease-
free water. A non-template control (NTC) containing no cDNA was included in each 
run to control genomic DNA contamination and the formation of primer dimer. The 
primer sequences of each gene are given in the appropriate chapter. Thermal cycling 
was initiated with incubation at 95°C for 15 min to activate the Thermo-Start
TM
 DNA 
polymerase, and forty cycles of PCR were performed. Each PCR cycle consisted of 
heating at 95°C for 15 s for denaturing, followed by 15 s at 60°C and 30 s at 72°C for 
annealing and extension. Cycle threshold (CT) corresponded to the number of cycles at 
which the fluorescence emission monitor in real time exceeded the threshold limit. PCR 
melting curve analysis was performed to confirm the production of a single product in 
these reactions. Standard dilution curves were established using five different serial 
dilutions (in triplicate) of pooled cDNA sample solutions and plotting the CT values 
against the log10 of the five dilutions of cDNA. Real-time efficiency was thus 
determined for each gene from the slopes given by Quantsoft software, applying the 
equation E = 10 
(-1/slope)
. The relative expression ratio of each gene was calculated using 
REST© software (http://www.gene-quantification.info). The relative expression ratio 
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for a considered gene is based on the PCR efficiency (E) and the CT of the sample 
compared with a control, and expressed in relation to reference genes. In this work, 
normalised relative expression was obtained by using the genomic mean expression of 
the following references genes: -actin, elongation factor-1  and an unresponsive EST. 
The unresponsive liver EST is an anonymous cDNA feature selected from a salmon 
cDNA microarray study and identified as a suitable flatliner reference gene on the basis 
of constant expression between different dietary treatments and sampling time points 
(Taggart et al. 2008). The relative expression in comparison to the reference genes was 
determined according to Pfaffl‟s mathematical model (Pfaffl, 2001):  
Ratio = (E target)
 ∆CT target(control-sample)
/(E reference)
 ∆CTreference(control-sample) 
2.4.8 Statistical Analysis 
2.4.8.1 Biochemical data analysis 
All the biological data are presented as means  SD, and the significance of 
differences (P  0.05) among the dietary treatments were determined by one-way or 
two-way analysis of variance (ANOVA) according to the experimental design, followed 
when appropriate by Turkey‟s post-hoc test. Data that were identified as non-
homogeneous were subjected to transformation using log10, natural log, square root 
prior to ANOVA (Zar, 1999). All calculations performed by SPSS 14.0 for windows 
(SPSS Inc., 2005). 
2.4.8.2 Microarray data analysis 
The BlueFuse software version 3.2 (BlueGenome, Cambridge,U.K.) was used to 
analyse the TIFF images obtained from scanning the microarrays, and to thus identify 
features and extract fluorescence intensity data. A manual spot removal procedure was 
applied to eliminate obvious artefactual spots and the software used proprietary 
Chapter 2 
 62 
algorithms to fuse duplicate spots. The BlueFuse software was also used to filter data 
using its own quality metrics and to perform “block LOWESS” data normalisation 
(block lowess normalisation does correcting the brightness/lowest intensity of spots in 
each local square block on the array). The resulting fluorescence intensity and quality 
data were transferred into GeneSpring GX version 10.0.2 (Agilent Technologies, 
Cheshire, UK). All control features, including positive and negative spots, were 
excluded from the analysis. Data transformation, normalisation, and quality control 
filtering were as follows: (a) all intensity values < 1 were set to 1 (threshold = 1), (b) the 
block LOWESS normalisation carried out in BlueFuse was verified by intensity with 
whisker box-plots, which showed that the median intensities and range of all the arrays 
used in this were similar such that no further normalisation was required, (c) data were 
quality control filtered using a BlueFuse spot quality of  0.5 in 75 % of the arrays in 2 
out of 4 conditions, (where the 4 conditions comprise: FO-FAT, FO-LEAN, VO-FAT 
and VO-LEAN), and a BlueFuse confidence of  0.3 in  75 % of the arrays in 2 out of 4 
conditions, to filter out features which were below the threshold. The 14772 genes out 
of the initial 16725 genes remaining following quality filtering were eligible for 
statistical analysis. The hybridisation data were analysed by both two-way and one-way 
ANOVA without multiple test correction, which was not employed in this study as it 
was found to be too conservative for this type of data, in previous studies. The two- way 
ANOVA examined the effect of the variables “diet” and “strain” and the interaction 
between the diet and strain at a p-value cut off P < 0.05. The one-way ANOVA was 
performed without multiple test correction, after the hybridisation data were filtered on 
the volcano plot at the p-value cut off at P < 0.05 and at the fold change cut off at 1.2, 
respectively. All the Atlantic salmon expression sequence tags (ESTs) were identified 
by basic local alignment tool, BLASTN and BLASTX homologs searching against 
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Tentative Consensus (TC) contigs from the Atlantic salmon gene index (ASGI) 
(http://compbio.dfci.harvard.edu/tgi/tgipage.html). In addition, the sequences of the 
blasted TCs were used to interrogate the nr NCBI (non-redundant sequences) database. 
Gene ontology (GO) analysis was used as a visualising tool to assist allocation of 
biological function. 
2.4.8.3 qPCR analysis 
The relative expression results obtained on liver RNA by microarray analysis 
were verified by quantitave qPCR on the same liver RNA. The statistical differences in 
gene expression between the control and the samples were evaluated in group means by 
randomisation tests (Pfaffl et al. 2002) using REST© software (REST, 2005). Fifty 
thousand allocations were performed and the significant differences were considered at 
P  0.05. 
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Chapter 3 - Comparison of effects of vegetable oils blended 
with southern hemisphere fish oil and 
decontaminated northern hemisphere fish oil on 
growth performance, composition and gene 
expression in Atlantic salmon (Salmo salar L.) 
3.1 Introduction  
FOs are the most important source of lipid providing essential PUFA especially 
n-3 HUFA, EPA and DHA for both humans and fish (Sargent et al. 2002). The n-3 
HUFA have been shown to have beneficial effects in a number of imflammatory and 
pathological conditions, including cardiovascular and neurological diseases in human 
being. Demand for fish and seafood is increasing such that an increasing proportion of 
these are derived from aquaculture production (Tidwell & Allan 2001). However, 
aquaculture production itself has been dependent upon FO for providing n-3 HUFA, as 
well as other FAs required for energy production, for feeds (Sargent & Tacon 1999). 
Marine FO production depends on wild fisheries that have, at best, reached their 
sustainable limit whereas the demand of FO for aquaculture and human consumption 
continues to increase (FAO 2006). Lipids are a major source of energy and FOs have 
been the main source of dietary lipid in fish farming. Thus FOs, derived from the 
industrial fisheries e.g. capelin, herring, sand eel, mackerel, anchovy and sardine among 
others, have been major components of the feed for intensively farmed fish for many 
years (Sargent & Tacon 1999). However, as alluded to above, FO supplies are finite and 
at their sustainable limited (FAO 2006) and so continued aquaculture development 
requires replacement of FO with alternative nutritionally suitable and sustainable oils. 
As well as providing essential PUFA, especially the EPA and DHA, to promote normal 
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growth and development (Sargent et al. 2002),  FO can also contain undesirable 
contaminants (e.g. persistent organic pollutants, POPs) that may affect human health, 
and the composition of FO can vary among sources both in terms of n-3HUFA and POP 
concentrations (Hites et al. 2004b). 
Successful replacement of FO requires retention of the health-promoting 
properties of the end product for the consumer, which means retaining as much as 
possible the current high levels of EPA and DHA in farmed fish (Sargent & Tacon 
1999). Presently, VOs are the only viable, cost competitive alternative lipid source for 
aquaculture diets, and a number of VOs have been used as partial and complete 
replacements for FO (Bell et al. 2005b). Several research papers reported that the partial 
replacement of FO by VO was possible without compromising the growth of fish 
including studies with oils such as sunflower oil (Bell et al. 1993), LO (Bell et al. 
2003b; Menoyo et al. 2005), PO (Bell et al. 2002), RO (Bell et al. 2003a; Jordal et al. 
2005), and SO (Regost et al. 2003). Nevertheless, VO are generally rich in C18 PUFA, 
such as 18:2n-6 and 18:3n-3 but devoid of n-3 HUFA and thus they have a major 
impact on the FA composition of the final fish products if added at high inclusion 
levels. For that reason, some studies have investigated the use of “finishing diets” 
containing FO to restore levels of n-3HUFA in the flesh (Caballero et al. 2004; 
Torstensen et al. 2005; Mourente & Bell 2006). However, the use of FO finishing diets 
has a conceptual drawback in that, in addition to adding back the valuable and highly 
desirable n-3HUFA, it could be challenged as a potential mechanism for increasing 
POPs in a previously low contaminant load product as VO do not normally contain the 
POPs concentrations found in marine FO (Bell et al. 2005b).  
Consumer awareness of the potential contaminants in fish products has 
increased in the last few years. Most POPs are lipophilic and so accumulate in the fatty 
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tissues particularly in oil rich aquatic animals (Walker 2001). Atlantic salmon is such an 
oil-rich species and so, as with all other oily fish, can accumulate lipophilic undesirable 
compounds, including polychlorinated dibenzo-para-dioxins (PCDD) and 
polychlorinated dibenzofurans (PCDF) (collectively known as dioxins or PCDD/F), 
dioxin-like non-ortho and mono-ortho polychlorinated biphenyls (PCB), known 
collectively as dioxin-like (DL-PCB) and the polybrominated diphenyl ether (PBDEs) 
flame retardants. All fish, whether oily or not, accumulate the undesirable compounds 
from their food e.g. pelagic marine fish in the wild or feeds containing FM and FO in 
aquaculture production (Jacobs et al. 2002a). Although there are around 210 dioxin 
congeners and 209 PCB congeners (isomers) that have been identified only 17 dioxins 
and furans and 12 DL-PCBs have known toxicity and have been assigned toxic 
equivalency factors (TEFs) by the World Health Organisation (WHO), according to 
their relative toxicity compared to the reference, 2,3,7,8 tetra chlorinated dibenzo dioxin 
(TCDD). The concentration of the toxic POPs is expressed as toxic equivalents (TEQ), 
where a TEF is applied to the concentration of the individual congeners and summed to 
generate the total TEQ in a mixture of the 17 congeners (Van den berg et al. 1998). For 
these reasons there is currently considerable interest to investigate the transfer of POPs 
from feed to farmed fish as well as assessing the potential for transfer to humans and 
any consequences for human health. 
With the introduction of the revised EU limits for dioxins and DL-PCBs in 
2006, some of the FOs previously used in aquafeeds would no longer comply with these 
new limits and so would have to be removed from the food chain. Although the content 
of POPs in farmed fish, including salmon, has been shown to be below all national and 
international limits (FDA, UK, and European FSA, WHO, EU), their presence in 
farmed fish, especially salmon, has received some negative reporting (Hites et al. 
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2004a). Therefore, it may be desirable to formulate finishing diets with decontaminated 
FO in order to restore n-3 HUFA levels without “adding back” the undesirable POPs. 
Although the current availability of decontaminated FO is still limited, market demand 
for using this cleaned oil in aquaculture may change this situation in the near future to 
reduce POPs levels in the farmed product, and so it is important to evaluate potential 
effects of the decontamination process on the nutritional quality of the oil and how it 
may affect growth performance and product quality. 
In recent years a number of studies have been conducted where FO was replaced 
by terrestrial VO in salmon feeds. The fish produced using diets with a high VO content 
contained significantly lower levels of POPs compared to fish grown on diets with a 
high marine FO content, but also had significantly lower n-3 HUFA (Berntssen et al. 
2005; Bell et al. 2005a). At lower inclusion levels, dietary VOs have correspondingly 
less impact on flesh FA compositions (Robin et al. 2003). Therefore, an alternative to 
high VO replacement followed by FO finishing diets would be the use of lower levels of 
FO substitution, particularly if the FO and VO blends used are carefully chosen to limit 
n-3 HUFA reduction (Torstensen et al. 2004a). For instance, southern hemisphere FO 
contain higher levels of n-3HUFA, especially EPA, and so can deliver similar levels of 
n-3HUFA at lower inclusion levels than the northern hemisphere FOs traditionally used 
in salmonid diets in Europe (Sargent et al. 2002). On the other hand, the southern 
hemisphere FOs are also lower in C20 and C22 monoenes, traditionally regarded as 
excellent energy sources for salmonids (Tocher 2003) as well as containing higher 
levels of SFA (Karalazos 2007). Different VOs also have contrasting nutritional and 
economic qualities. RO is nutritionally balanced but is relatively expensive, whereas SO 
is readily available and its price is favorable, although it contains high levels of 18:2n-6, 
which limits the use of this oil due to greater reduction of the flesh n-3/n-6 ratio when 
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using this product. In addition, EU legislations limit the commercial use of SO to non-
GM products containing a maximum of 1.0 mg kg
-1
 endosulfane (pesticide residue). 
In the present study, two hypotheses were tested. Firstly, that the blending of RO 
and SO with southern hemisphere FO is a strategy that may result in lower impact upon 
tissue n-3HUFA levels in Atlantic salmon. Secondly, that the decontamination 
(stripping) of FO will have no major effects on the nutritional quality of the oil as a feed 
ingredient for Atlantic salmon. Specifically, we investigated the effects of replacement 
of northern hemisphere FO by decontaminated northern FO or blends of southern 
hemisphere FO with RO and SO on growth performance and composition of Atlantic 
salmon. The use of decontaminated FO and VO substitution as two alternative methods 
for reducing contaminant loads in the flesh of farmed Atlantic salmon was also 
investigated.  
3.2 Materials and Methods 
3.2.1 Experimental fish  
 Atlantic salmon of initial mean weight 0.78  0.01 kg were fed one of the five 
diets for 10 weeks in triplicate 5 m
3
 net pens (n = 3 per treatment), with 120 fish per 
pen, at the Fjord Research Station, DØnna, Norway. The experiment was performed 
between July 2006 and October 2006 under natural photoperiod and when the mean 
seawater temperature was 12.7  1.5
o
C, the mean salinity was 31.9  0.8 ppt. and the 
average water visibility by Secchi disk was 11.5  2.7 m. Feed was supplied manually 
to apparent satiation twice a day with waste feed collection via an up-lift system. Feed 
fed, waste feed and the resulting net feed intake and mortality were registered daily.  
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3.2.2 Experimental diets  
The diets were formulated to satisfy the nutritional requirements of salmonid 
fish (NRC. 1993), and to contain 33 % crude protein and 34 % crude lipid. The five 
experimental diets (9 mm pellets) had the same basal composition but were coated with 
five different oil sources that were 100 % northern hemisphere FO (diet NFO) as 
control, 100 % decontaminated northern hemisphere FO (diet DFO), and the three 
blends of the VOs with southern hemisphere FO (collectively termed the SVO diets), 
specifically 40 % southern FO/60 % RO (diet SRO), 40 % southern FO/30 % RO/30 % 
SO (diet SRO/SO) and 40 % southern FO/60 % SO (diet SSO). All diets were 
formulated and manufactured at the BioMar TechCentre, Brande, Denmark. The 
northern FO was sprat (Sprattus sprattus) oil obtained from FF Skagen, Skagen, 
Denmark. Decontamination of the sprat oil to produce decontaminated northern FO was 
a two-step procedure that included treatment with activated carbon followed by thin 
film deodorisation to remove POPs. An initial adsorption using activated carbon that 
was designed to remove ~90% of the PCDD/Fs. The second step was a thin-film 
deodourisation step that should remove up to 95% of PCBs as well as pesticides and 
other contaminants, FFA and peroxides. The DFO oil was representative of 
decontaminated oil currently commercially available in Europe. The southern 
hemisphere FO was from anchovetta (Engraulis ringens), and the RO (low in erucic 
acid and glycosinolates, the latter responses for the bitter or sharp taste of plants) and 
SOs were both non-GM, degummed quality. All diets contained yttrium oxide (Y2O3) as 
an indicator to determine the ADC of nutrients. The feed formulation is given in Table 3.1.  
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Table 3.1. Formulations of experimental diets fed to Atlantic salmon for 10 weeks.  
NFO DFO SRO SRO/SO SSO
Feed ingredients (g/kg)
LT fish meals 
1 378.0 378.0 378.0 378.0 378.0
Legume/oil seed meals 149.0 149.0 149.0 149.0 149.0
Northern fish oil (sprat oil) 325.0 - - - -
Decontaminated sprat oil - 325.0 - - -
Southern fish oil (anchovetta) - - 130.0 130.0 130.0
Rapeseed oil
 2 - - 195.0 98.0 -
Soybean oil 
3 - - - 98.0 195.0
Binders 140.0 140.0 140.0 140.0 140.0
Vitamins and minerals 9.2 9.2 9.2 9.2 9.2
Yttrium oxide 0.1 0.1 0.1 0.1 0.1
Proximate composition (%)
Protein 32.6 32.2 31.4 32.8 32.6
Lipid 33.6 34.3 34.5 34.2 34.7
Moisture 6.0 5.5 6.3 5.5 5.2
Fibre 2.1 2.2 1.9 2.0 2.0
Ash 7.8 7.7 7.6 7.8 7.8
DE (kJ g-1) 25.3 25.3 25.2 25.2 25.3
Pigment Content (mg/kg)
Total pigment 24.0 19.2 18.4 22 21.1
Astaxanthin 22.6 18.1 15.2 20.1 18.5
Astacene 1.1 0.7 0.7 0.6 0.6
Lutein 0.3 0.4 2.4 2.4 2.0
Components
Diets
 
Results are means of triplicate analysis. DFO; decontaminated northern fish oil, NFO; 
northern fish oil, SFO/RO; southern fish oil and rapeseed oil 60%, SFO/RO/SO; 
southern fish oil, rapeseed oil 30% and soybean oil 30%, SFO/SO; southern fish oil and 
soybean oil 60%.
 
 1
 Blend of Peruvian super prime and standard fishmeals produced from Anchoveta.
  
2
 low erucic acid and glycosinolates.
  
3
 Non-GM, degummed quality. 
 
3.2.3 Experimental sampling protocol 
At the start and end of the trial, all the fish in each pen were bulk weighed. At 
the end of week 10, six fish per pen (18 per dietary treatment) were anaesthetised by 
metacaine sulphonate (MS222; 50 mg/L). The fish were then killed by a blow to the 
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head and samples taken for compositional analyses. The gut cavity was opened on three 
fish per pen and any remaining contents of the intestine removed before each whole fish 
was cut into pieces and minced thoroughly and samples collected and stored at -20
o
C 
prior to proximate analysis.  
The remaining three fish per pen were used for biochemical and organic 
contaminant (POP) analyses. Flesh was sampled by taking the NQC and each NQC 
steak was cut in half; one side was immediately frozen at -20
o
C for lipid and FA 
analyses, and the other side was wrapped in foil and then immediately frozen at -20
o
C 
for contaminant analysis. The livers were removed from the same fish and three 
samples were collected from each. Approximately 0.5 g of liver was placed into a glass 
vial (8 ml) containing ice-cold chloroform/methanol (2:1, by vol.) and stored at -20
o
C 
prior to lipid class analysis. A further piece of < 0.5 g was collected into a 
microcentrifuge tube (1.5 ml) for gene expression analysis, and the remaining liver for 
FA analysis was placed in a plastic test tube (10 ml), with both these samples 
immediately frozen in liquid nitrogen before being stored at -70
o
C and -20
o
C, 
respectively, prior to analyses.  
At the end of the trial faeces samples were obtained by stripping according to 
Austreng method (Austreng 1978). The fish were anaesthetised as above and faeces 
collected by gently squeezing the hindgut of the fish. Faeces were collected from at 
least three fish per pen and the faeces from each fish were pooled providing one sample 
per pen. Ethoxyquin (ETQ; 400 mg/L, 1 ml/60g wet faeces) was added to each faeces 
sample before being stored at -20 °C until analysis. The faeces samples were freeze 
dried prior to gross nutrients and FA analysis as described in Chapter 2. 
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3.2.4 Proximate composition analysis 
The moisture, crude protein, and ash contents of the diets and minced whole fish 
were determined by standard procedures (AOAC 2000). Crude fat of the experimental 
diets were acid hydrolysed before fat extraction. The gross energy content of the diets 
was determined by Bomb Calorimetry (Foss, UK.). Yttrium oxide (Y2O3) was analysed 
to determine the nutrient and FA digestibility values. The methods followed for the 
above extractions and the analyses are described in detail in Chapter 2.  
3.2.5 Pigment composition analysis 
Pigment content and composition were determined as described in detail in 
Chapter 2. Diets and flesh samples were homogenised and prepared according to the 
method of Barua et al (1993), with diet samples extracted using the same solvent 
mixtures as used for tissue samples but following enzymatic digestion with Maxatase 
enzyme. Measurement of individual carotenoids was carried out by HPLC.  
3.2.6 Lipid extraction and analysis 
The liver and flesh tissues from all three fish per pen were combined to prepare 
pooled homogenates for lipid analyses. Thus, lipid analyses were based on n = 3 with 
each replicate being pooled from 3 fish from one cage. Total lipids of tissue and diet 
samples were extracted by homogenising in 20 volumes of ice-cold 
chloroform/methanol (2:1, by vol.) according to Folch et al. (1957). Lipid class 
composition of total lipid was determined by densitometry after separation of lipid 
classes by HPTLC (Henderson & Tocher 1992). FAME were prepared from total lipid 
by acid-catalysed transesterification (Christie 1993), extracted and purified by TLC 
(Tocher & Harvie 1988), separated and quantified by gas-liquid chromatography and 
Chapter 3 
 73 
individual FAME identified by comparison to known standards (marinol oil, Sigma) 
and by reference to published data (Ackman 1980). The methods are all described in 
detail in Chapter 2.  
3.2.7 Dioxin, DL-PCB and PBDE analysis 
Samples of the NFO, DFO and SRO/SO diets and salmon flesh samples from 
fish fed these diets were selected for the analysis of POPs. Determinations of the 
contents of dioxins, DL-PCBs and PBDEs of flesh tissue and diet samples were carried 
out according to the method of the United States Environmental Protection Agency 
(USEPA), methods 1613 and 1668 (USEPA 1994, 1999) and conducted by the 
Nutrition Analytical Service, Institute of Aquaculture, University of Stirling.  
Samples of approximately 10 g diet were weighed and ground, and weighed 
samples of approximately 50 g of flesh were freeze-dried for at least 12 h before 
grinding and extraction. For analysis of dioxins and DL-PCBs, the samples had a 
solution of 2,3,7,8-chloro-substituted 
13
C12 – labeled PCDD/Fs internal standard (1 ml 
of a 2 ng/ml standard; EPA-1613-LCS; Wellington Laboratories, Guelph, Canada) prior 
to extraction with isohexane at 125
o
C and 1500 pounds per square inch (psi) in an 
accelerated solvent extractor (ASE™, Dionex, Camberley, UK). Fat and organic matter 
were removed from the 100 ml ASE
TM
 extract by sulphuric acid treatment using 50-100 
ml of 95-97% sulphuric acid for 72 h. The extract obtained was purified using a Power 
Prep automated purification System™ (Fluid Management Systems, Waltham, MA, 
USA) via a series of columns (H2SO4 on silica, multi-layered silica, basic alumina and 
carbon column, in sequence; as per Fluid Management protocols). This procedure 
separated and purified the dioxin/furan and DL-PCB congener fractions. The different 
fractions were reduced on a rotary evaporator before a further extraction with 
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concentrated sulphuric acid in isohexane was used to remove any traces of residual 
lipid. At this stage 10 µl of recovery standard (EPA-1613-ISS for dioxins & 68A-IS for 
PCBs; Wellington Laboratories, Guelph, Canada) was added. The dioxin and non-ortho 
PCB fraction was finally resuspended in nonane and evaporated to 10-50 µl subsequent 
to gas chromatography/ion trap tandem mass spectrometry (GC/MS/MS, Thermo Fisher 
Scientific Polaris Q, Hemel Hempstead, UK). The mono-ortho PCB fraction was treated 
similarly but only the PCB recovery standard was added and the nonane evaporated to 
100 µl prior to analysis. Analysis of the 29 dioxin and DL-PCB congeners with WHO 
TEFs was conducted using GC/MS/MS on a Trace GC 2000 coupled to a Polaris Q ion 
trap MS/MS (Thermo Finnegan, Hemel Hempsted, UK). The chromatographic 
separations were conducted on a Rxi-5ms (5% phenyl/95% dimethyl polysiloxane) 
fused silica column (Thames Restek Ltd., Saunderton, England) 30 m x 0.25 mm i.d. x 
0.25 mm film thickness with helium as carrier gas at 0.8 ml/min. Injector temperature 
was kept at 250
o
C and samples and standards were injected in the splitless mode. MS 
conditions were in positive electron ionisation mode (EI+) using automatic gain control 
with electron energy of 70eV and emission current of 250 µA. The transfer line and ion 
source were kept at 305 and 250
o
C respectively. Xcalibar version 1.3 software was used 
for data acquisition and processing of results. Non-detected congeners were set at limit 
of quantification, which was the concentration that produced an instrument response of 
monitored ions with 3 times a signal to noise ratio of 3:1 (limit of detection, LOD). 
Quantification of each congener is based on the isotope dilution method of the USEPA 
methods 1613 and 1668 of the United States Environmental Protection Agency (USEPA 
1994, 1999). The range of limits of quantification for whole fish sample were 0.03-0.18 
pg g
-1
 wet weight for PCDD/Fs, 0.03-0.06 pg g
-1
 wet weight for non-ortho PCBs and 
mono-ortho PCBs. The congeners analysed included the 17 PCDD/Fs and 12 dioxin-
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like PCBs for which the World Health Organisation has established TEFs from 1997 
(Van den Berg et al. 2006). 
For PBDE analysis, 2.5 g of dried ground flesh or diet was extracted with 
isohexane using the ASE™ apparatus at 40oC and 1500 psi after addition of 1 ml of 10 
ng of internal standard (PBDE 119; Wellington Laboratories, Guelph, Canada). The 
extract from the ASE™ is reduced to ~5ml by rotary evaporation and then reduced to 
1ml under nitrogen. Five ml of isohexane and 2ml of concentrated sulphuric acid were 
added and vortex mixed and centrifuged (1000 x g, 15 min). The organic phase was 
transferred to a clean tube and the procedure repeated. The combined organic phases 
were reduced to 1 ml under nitrogen and 100 µl of concentrated sulphuric acid added, 
mixed and centrifuged (500 x g, 4 min). The iso-hexane layer was then removed and 
added to 0.5 ml nonane and the solvent evaporated to the nonane mark. The nonane is 
transferred to an autosampler vial prior to analysis by GC/MS (Thermo Fisher Scientific 
Trace DSQ, Hemel Hempstead, UK). Analysis of the seven PBDE congeners (28, 47, 
99, 100, 153, 154 & 183) was conducted using a Thermo Finnegan Trace GC Ultra 
equipped with a ZB5-MS column (30m x 0.25 mm i.d. x 0.25 micron phase; 
Phenomenex, Macclesfield, England). Helium was used as carrier gas and coupled to a 
Trace DSQ MS, (Bremen, Germany) in negative chemical ion (CI-) mode and methane 
as reagent gas at a flow rate of 2.0 ml/min. Xcalibar version 1.4 software was used for 
data acquisition and processing of results. The range of limits of quantification for 
whole fish samples were 0.06-0.15 pg g
-1
 wet weight for PBDEs. 
3.2.8 Gene expression 
Effect of dietary treatments on the expression of selected candidate genes was 
analysed in six biological replicates per treatment determined by real time qPCR.  The 
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methodology is described in detail in Chapter 2 but, in summary, total RNA was 
extracted from individual liver samples by homogenising in TriReagent, and first strand 
cDNA synthesis of total RNA performed followed by quantification of gene expression 
by qPCR (Quantica thermocycler, Techne). The PCR primer sequences for the three 
target genes ( 5 and 6 fatty acyl desaturases and fatty acyl Elovl5 elogase) and house 
keeping genes were used successfully in previously studies, and are given in Table 3.2. 
Table 3.2. Primer sequences for target and housekeeping genes used in real-time qPCR. 
Gene Primer Sequence 5'-3' Size (bp)
Desaturase 5 F GTGAATGGGGATCCATAGCA 192
R AAACGAACGGACAACCAGA
Desaturase 6 F CCCCAGACGTTTGTGTCAG 181
R CCTGGATTGTTGCTTTGGAT
Elongase F TGATTTGTGTTCCAAATGGC 219
R CTCATGACGGGAACCTCAAT
Elongation factor-1alpha 
(Housekeeping)
F CTGCCCCTCCAGGACGTTTACAA 175
R CACCGGGCATAGCCGATTCC
Beta-actin  (Housekeeping) F ACATCAAGGAGAAGCTGTC 141
R GACAACGGAACCTCTCGTTA
 
3.2.9 Calculations and statistical analysis 
Feed Conversion Ratio (FCR), Specific Growth Rate (SGR) and Thermal 
Growth Coefficient (TGC) were calculated according to the formulae defined in 
Chapter 2. The effects of dietary treatment were determined by one-way ANOVA as 
described in Chapter 2. Statistical analyses were performed using SPSS 14 (SPSS Inc, 
2005), and differences were regarded as significant when P < 0.05 (Zar, 1999). 
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3.3 Results 
3.3.1 Lipid class and fatty acid compositions of the oil sources 
There were some relatively minor differences in lipid class compositions of the 
dietary oil sources (Table 3.3). All the oils contained only neutral lipid with TAG as the 
dominant lipid class, with the VOs containing about 81 % and the FOs containing 
around 77 % TAG. The VOs had lower levels of FFA compared to the FOs, and within 
the FOs, FFA was higher in southern hemisphere FO than in northern FO. Within the 
VOs, sterol and FFA were higher in RO than in SO (Table 3.3). 
Table 3.3. Lipid class composition (percentage of total lipid) of dietary oil sources. 
Lipid class NFO SFO RO SO
Total PL n.d. n.d. n.d. n.d.
Total NL 100 100 100 100
Triacylglycerol 76.8 76.6 81.8 81.4
Sterol 11.1 9.1 10.3 7.7
Free fatty acid 12.1 14.3 7.9 5.9
Unidentified NL n.d. n.d. n.d. 5.0
Values are means of triplicate analysis. n.d., not detected; NL; neutral lipid; PL; polar lipid 
The FA compositions of the dietary oil sources are shown in Table 3.4. The FOs 
showed some differences compared to the VOs. The FOs contained high total saturated 
and n-3 HUFA, particularly EPA and DHA, while the VOs were rich in n-6 PUFA and 
lacked the n-3 HUFA. However, the VOs contained 18:3n-3, the precursor of n-3 
HUFA. Total monoenes were high in both FO and VO sources, with RO showing the 
highest level (60 % of total FA). The major FA of SFA, MUFA and n-6 PUFA in all 
oils were 16:0, 18:1n-9 and 18:2n-6 respectively, while the major n-3 FA were EPA and 
DHA in FOs and 18:3n-3 in VOs. The rank order of the FA composition in NFO was 
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total monoenes > total saturated > total n-3 PUFA > total n-6 PUFA, whereas the rank 
order of FA in SFO was total saturated > total n-3 PUFA > total monoenes > total n-6 
PUFA. The rank order of the FA composition in RO was total monoenes > total n-6 
PUFA > total n-3 PUFA> total saturated, and the rank order of the FA composition in 
SO was total n-6 PUFA > total monoenes > total saturated > total n-3 PUFA (Table 3.4).  
 
Table 3.4. Fatty acid compositions (percentage of total fatty acids) of dietary oil sources. 
Parameters NFO SFO RO SO
14:00 5.2 9.5 0.1 0.1
16:00 19.5 22.8 4.6 11.1
18:00 2.2 4.3 1.7 3.8
20:00 0.3 0.5 0.6 0.4
22:00 0.5 0.5 0.6 0.7
Total saturated
1 28.4 38.3 7.6 16.5
16:1n-7 6.1 8.3 0.2 0.1
18:1n-9 25.4 7.3 60.0 26.4
18:1n-7 2.3 3.1 3.1 1.6
20:1n-9 2.0 1.0 1.2 0.3
22:1n-11 1.9 0.6 0.1 tr.
24:1n-9 1.6 0.4 0.1 n.d.
Total monoenes
2 40.3 21.3 64.8 28.6
18:2n-6 4.0 1.3 17.4 49.3
18:3n-6 0.1 0.3 0.6 0.2
20:2n-6 0.6 0.2 0.1 n.d.
20:4n-6 0.6 1.3 n.d. n.d.
22:5n-6 0.3 0.4 n.d. n.d.
Total n-6 PUFA 5.7 3.9 18.1 49.6
18:3n-3 2.8 0.8 9.5 5.4
18:4n-3 2.3 2.9 n.d. n.d.
20:4n-3 0.5 0.8 n.d. n.d.
20:5n-3 7.1 18.3 n.d. n.d.
22:5n-3 0.7 2.0 n.d. n.d.
22:6n-3 12.0 11.1 n.d. n.d.
Total n-3 PUFA
3 25.6 36.5 9.5 5.4
Total PUFA 31.3 40.4 27.6 55.0  
Results are means of triplicate analysis. 
1
 includes 15:0 up to 0.6%, 
2
 includes 20:1n-7 
up to 0.2%. 
3
 includes 20:3n-3 up to 0.2%. FO, fish oil; n.d., not detected; PUFA, 
polyunsaturated fatty acids; tr,  0.05.  
Chapter 3 
 79 
3.3.2  Proximate and pigment composition of the diets 
There were some slight differences in proximate compositions and pigment 
contents of the five experimental diets (Table 3.1). The experimental diets contained 
protein in the range 32 – 33 % and lipid in the range 34 – 35 %. The NFO control diet, 
contained the highest total pigment, particularly astaxanthin and astacene, compared to 
the four other dietary treatments. In contrast, the SVO diets contained higher lutein than 
the NFO and DFO diets (Table 3.1). 
3.3.3 Lipid class and fatty acid compositions of the diets  
The lipid class composition of the DFO diet showed few differences compared 
to the NFO diet. DFO diet contained a slightly higher level of TPL, PC and TAG but 
lower level of sterol and FFA compared to diet NFO (Table 3.5). The SRO and SRO/SO 
diets had a slightly lower level of TPL and PC while the SSO showed the opposite trend 
compared to the NFO diet. However, the SVO diets showed higher levels of TAG and 
lower levels of sterol and FFA compared to the NFO diet. Within the SVO diets, the SSO 
diet had a slightly higher level of PC but lower level of TNL and TAG compared to the SRO 
diet (Table 3.5). 
The FA composition of the DFO diet showed some small differences compared 
to the NFO diet including lower levels of total MUFA, 18:1n-9 and 18:3n-3, but higher 
levels of 18:0, 20:1, 22:1, 18:2n-6 and EPA (Table 3.6). However, most of these 
differences were relatively minor. The SVO diets, the three blends of the VOs with 
southern hemisphere FO, all showed increased 18:0, 18:2n-6 and 18:3n-3, and lower 
levels of 14:0, 16:0, ARA, EPA and DHA compared to the NFO and DFO diets. Within 
the SVO diets, 16:0, 18:0 and 18:2n-6 increased with increasing inclusion of SO so that 
the rank order for their levels was SSO > SRO/SO > SRO, whereas 18:1n-9 and 18:3n-3 
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increased with increasing inclusion of RO such that the rank order for their levels was 
SRO > SRO/SO > SSO. Similarly the total SFA, n-6 PUFA and PUFA increased in the 
SSO diet while the total MUFA and n-3 PUFA increased in the SRO diet (Table 3.6). 
 
Table 3.5. Lipid class composition (percentage of total lipid) of the experimental diets 
 fed to Atlantic salmon for 10 weeks. 
Lipid class NFO DFO SRO SRO/SO SSO
PC 2.8 3.1 2.1 2.6 3.3
Total PL 2.8 3.1 2.1 2.6 3.3
Total NL 97.2 96.9 97.9 97.4 96.7
TAG 72.3 82.5 80.0 79.9 75.2
Sterol 13.0 10.2 8.9 8.5 9.2
Free fatty acids 11.9 4.2 9.0 9.0 9.5
Unidentified NL n.d. n.d. n.d. n.d. 2.8
 
Results are means of triplicate analysis. DFO, decontaminated northern fish oil; n.d., not 
detected; NFO, northern fish oil; NL, neutral lipid; PC, phosphatidylcholine; PL, polar 
lipid; SRO, southern fish oil and rapeseed oil (40/60); SRO/SO, southern fish oil, 
rapeseed oil and soybean oil (40/30/30); SSO, southern fish oil and soybean oil (40/60). 
TAG, triacylglycerol.  
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Table 3.6. Fatty acid compositions (percentage of total fatty acid) of the experimental 
 diets fed to Atlantic salmon for 10 weeks.  
Parameters NFO DFO SRO SRO/SO SSO
14:00 5.2 5.6 2.9 2.9 2.9
16:00 19.2 18.8 10.9 13.5 15.0
18:00 2.2 3.3 3.8 4.4 4.8
20:00 0.3 0.4 0.7 0.6 0.5
22:00 0.3 0.6 1.5 1.4 1.4
Total saturated 27.8 29.3 20.0 23.1 24.9
16:1n-9 0.4 0.3 tr. n.d. n.d.
16:1n-7 6.0 5.8 2.7 2.7 2.6
18:1n-9 25.9 21.6 41.2 29.5 21.2
18:1n-7 2.5 2.5 2.9 2.6 2.2
20:1n-9 2.1 3.2 1.2 0.9 0.6
22:1n-11 2.4 4.1 0.3 0.3 0.4
22:1n-9 0.4 0.5 0.2 0.2 0.2
24:1n-9 2.0 1.6 0.3 0.3 0.2
Total monoenes 42.0 40.0 48.9 36.5 27.5
18:2n-6 3.8 4.3 12.6 23.1 32.0
18:3n-6 0.1 0.1 0.1 0.1 0.1
20:2n-6 0.6 0.5 0.1 0.1 0.1
20:3n-6 0.1 0.1 0.1 0.1 0.1
20:4n-6 0.6 0.6 0.4 0.4 0.4
22:5n-6 0.3 0.3 0.1 0.1 0.1
Total n-6 PUFA 5.6 5.9 13.4 23.9 32.7
18:3n-3 2.7 2.3 6.3 5.1 3.7
18:4n-3 2.2 2.3 0.9 0.9 0.9
20:3n-3 0.2 0.2 n.d. n.d. n.d.
20:4n-3 0.5 0.5 0.2 0.2 0.2
20:5n-3 6.7 7.2 5.4 5.2 5.1
22:5n-3 0.7 0.7 0.4 0.6 0.6
22:6n-3 11.6 11.4 4.3 4.3 4.2
Total n-3 PUFA 24.7 24.7 17.7 16.5 14.9
Total PUFA 30.3 30.6 31.1 40.4 47.7  
Values are means of triplicate analysis. Values within a row with different superscript 
letters are significantly different (P  0.05) as determined by ANOVA. DFO, 
decontaminated northern fish oil; n.d., not detected; NFO, northern fish oil; PUFA, 
polyunsaturated fatty acids; SFO/RO, southern fish oil and rapeseed oil (40/60); 
SFO/RO/SO, southern fish oil, rapeseed oil and soybean oil (40/30/30); SFO/SO, 
southern fish oil and soybean oil (40/60); tr,  0.05.  
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3.3.4 Contaminant (dioxins, DL-PCBs and PBDEs) content of diets 
The NFO diet contained 17.4 ng toxicity equivalents (TEQ)/kg of the 29 dioxin 
and DL-PCB congeners, and these values were decreased to 0.45 and 0.53 ng TEQ/kg 
in the DFO and SRO/SO diets, respectively. (Table 3.7). The summed concentration of 
the 7 principal PBDE congeners in the NFO diet was 5.9 ng/g, with these values 
reduced to 1.9 and 0.31 ng/g in the DFO and SRO/SO diets, respectively.  
Table 3.7. Contents of dioxin and DL-PCB (ng TEQ/kg wet weight) and PBDE (ng/g 
 wet weight) congeners in experimental diets fed to Atlantic salmon for 10 weeks. 
Congener/Diet                      NFO DFO SRO/SO
Sum PCDD                         2.17 0.15 0.15
Sum PCDF                          6.48 0.11 0.09
Sum mono-ortho PCB  2.27 0.06 0.04
Sum non-ortho PCB           6.40 0.12 0.25
Sum dioxins + PCBs           17.32 0.45 0.53
Sum PBDE                         5.94 1.90 0.31
 
DFO, decontaminated northern fish oil; NFO, northern fish oil; PBDE, polybrominated 
diphenyl ethers; PCB, polychlorinated biphenyls; PCDD, polychlorinated dibenzo-p-
dioxins; PCDF, polychlorinated dibenzofurans; SRO/SO, southern fish oil, rapeseed oil 
and soybean oil (40/30/30). 
3.3.5 Growth performance, whole body composition and pigment content 
There were no significant differences in growth performance (final weights, 
SGR and TGC) among the dietary treatments (Table 3.8). There was also no dietary 
effect on feed efficiency (FCR). The different dietary oils also had no effect on the 
gross composition of the whole salmon or the concentration of astaxanthin (Table 3.8).  
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Table 3.8. Growth performance, carcass proximate composition (percentage of wet 
 weight) and pigment content (mg kg
-1
) of Atlantic salmon flesh after feeding 
 the experimental diets for 10 weeks. 
Parameters NFO DFO SRO SRO/SO SSO
Growth performance
Initial wt. (kg) 0.77 ± 0.0 0.78 ± 0.0 0.78 ± 0.0 0.77 ± 0.0 0.79 ± 0.1
Final wt. (kg) 2.19 ± 0.0 2.18 ± 0.1 2.18 ± 0.1 2.19 ± 0.1 2.20 ± 0.0
FCR 0.98 ± 0.00 0.98 ± 0.02 0.98 ± 0.00 0.96 ± 0.02 0.96 ± 0.01
SGR % d
-1 1.35 ± 0.05 1.34 ± 0.01 1.34 ± 0.01 1.35 ± 0.03 1.33 ± 0.03
TGC 3.92 ± 0.15 3.86 ± 0.04 3.87 ± 0.07 3.89 ± 0.10 3.87 ± 0.10
Proximate composition (%)
 Protein 16.9 ± 10.3 16.7 ± 0.4 16.7 ± 0.5 17.0 ± 0.7 17.0 ± 0.4
 Lipid 19.1 ± 1.4 18.9 ± 1.8 18.8 ± 1.4 19.4 ± 1.9 17.8 ± 2.7
 Ash 0.28 ± 0.0 0.31 ± 0.0 0.28 ± 0.1 0.31 ± 0.1 0.29 ± 0.0
 Moisture 61.6 ± 1.1 61.1 ± 1.2 61.4 ± 0.8 60.1 ± 0.5 60.6 ± 1.3
Pigment content (mg/kg)
Astaxanthin 4.7 ± 0.3 4.3 ± 0.3 4.8 ± 0.4 4.8 ± 0.6 4.4 ± 0.6
 
Results are means ± SD (n = 3). Different superscript letters indicate a significant effect 
of diet as determined by ANOVA. DFO, decontaminated northern fish oil; FCR, feed 
conversion ratio; NFO, northern fish oil; SGR, specific growth rate; SRO, southern fish 
oil and rapeseed oil (40/60); SRO/SO, southern fish oil, rapeseed oil and soybean oil 
(40/30/30); SSO, southern fish oil and soybean oil (40/60) SGR, specific grwth rate; 
TGC, thermal growth coefficient.  
3.3.6 Apparent digestibility of gross nutrients and fatty acids 
The ADC of the DFO diet was significantly lower than all the other diets as 
evidenced by the lower values for crude protein, crude lipid and dry matter digestibility 
(Table 3.9). Within the SVO diets, the ADC of the SSO diet was significantly lower 
than the SRO and SRO/SO diets. The protein digestibilities of the NFO and SVO diets 
were over 80 % while the protein digestibility of the DFO diet was lower than 80 %. 
The dry matter digestibilities of the NFO and SVO diets were 67 - 70% while the dry 
matter digestibility of the fish fed DFO was 62 %. The lipid digestibilities of the NFO 
and SVO diets were 93 - 95% while the lipid digestibility of the DFO diet was slightly 
lower at about 91%. Consistent with this, the ADC of virtually every FA, except for 
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18:0, were generally over 92 %, but were lower in fish fed the DFO diet compared to 
fish fed the NFO diet (Table 3.9). In general, FA digestibility was highest in fish fed the 
NFO diet. In addition, the digestibilities of many FAs were often lower in fish fed the 
DFO diet compared to fish fed the SVO diets, although there were few differences in 
FA digestibilities between the fish fed the different SVO diets. 
3.3.7 Flesh and liver lipid contents and fatty acid compositions 
There was a trend for flesh lipid content to be lower in fish fed the SVO diets 
compared to fish fed the NFO or DFO diets, although this was only significant in the 
case of fish fed the SRO diet (Table 3.10). There were no significant differences in 
tissue lipid contents between fish fed the NFO and DFO diets. Similarly, there were no 
significant differences in flesh lipid content in fish fed the SVO diets (Table 3.10).  
Flesh FA compositions of fish fed the DFO diet were generally similar to fish 
fed the NFO diet. Reflecting the diet, EPA and total n-3PUFA were higher in fish fed 
DFO than NFO, whereas 18:1n-9 was lower (Table 3.10). Flesh FA compositions were 
largely changed corresponding to the FA compositions of the diets with fish fed the 
SVO diets having reduced 14:0, 16:0, EPA, DHA and ARA, but increased 18:2n-6 and 
18:3n-3 compared to fish fed the NFO and DFO diets (Table 3.10). The proportions of 
18:0 and 18:1n-9 were only increased in fish fed the diets containing SO and RO, 
respectively. Therefore, as with the diets, flesh 16:0, 18:0 and 18:2n-6 increased with 
increasing inclusion of SO so that the rank order for their proportions in salmon flesh 
was in fish fed SSO > SRO/SO > SRO, whereas flesh 18:1n-9 and 18:3n-3 increased 
with increasing inclusion of RO such that the rank order for their proportions in flesh 
was fish fed SRO > SRO/SO > SSO. Interestingly, the proportions of EPA and DHA 
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were significantly higher in fish fed the diet with highest level of SO (SSO diet) 
compared to the other SVO diets (Table 3.10). 
Liver lipid content was significantly lower in fish fed the SVO diets compared to 
fish fed either the NFO or DFO diets but there was no significant difference between the 
fish fed the NFO and DFO diets (Table 3.11). This is interesting in that generally liver 
lipid deposition of fish fed VO diet is higher than that of the fish fed FO diet. The 
proportions of 18:0, 18:1n-9, 18:2n-6 and 18:3n-3 in liver of fish fed the SVO diets 
were similar to those described above for flesh, and reflected the dietary FA 
compositions. However, it was noteworthy that increased proportions of desaturated and 
elongated products of 18:2n-6 and 18:3n-3 were clearly observed in liver of fish fed the 
SVO diets. Thus, proportions of 20:2n-6, 20:3n-6 and 20:4n-6 were all increased in 
liver of fish fed the SVO diets compared to fish fed the NFO and DFO diets. Even more 
striking was the increased proportions of 20:5n-3 in the livers of fish fed the SVO diets. 
In contrast, proportions of 22:5n-3 and, to a lesser extent, 22:6n-3 were reduced in fish 
fed the SVO diets compared to fish fed NFO or DFO (Table 3.11). 
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Table 3.9. Apparent digestibility of protein, lipid, dry matter and fatty acids in Atlantic 
 salmon after feeding the experimental diets for 10 weeks.  
Parameters NFO DFO SRO SRO/SO SSO
Protein 83.2 ± 1.3
ab
79.5 ± 0.2
c
83.4 ± 0.4
a
84.2 ± 0.6
a
81.5 ± 1.5
b
Lipid 95.0 ± 0.6
a
91.2 ± 0.4
d
94.1 ± 0.1
b
93.6 ± 0.1
bc
92.8 ± 0.8
c
Dry matter 69.3 ± 1.9
ab
62.3 ± 0.5
c
70.4 ± 0.8
a
70.8 ± 1.4
a
67.0 ± 2.7
b
Fatty acids
14:00 98.0 ± 0.3
a
94.5 ± 1.1
b
94.5 ± 0.1
b
94.6 ± 1.0
b
94.9 ± 1.2
b
16:00 97.2 ± 0.2
a
92.4 ± 1.2
c
93.9 ± 0.2
b
94.7 ± 1.2
b
96.2 ± 0.5
a
18:00 86.2 ± 1.2
b
73.3 ± 4.5
c
93.2 ± 0.6
a
94.3 ± 1.4
a
94.6 ± 2.2
a
Total saturated 95.7 ± 0.3
a
89.0 ± 1.7
c
94.0 ± 0.4
b
94.7 ± 1.2
ab
95.6 ± 0.8
ab
16:1n-9,n-7 98.8 ± 0.2
a
97.5 ± 0.6
b
97.4 ± 0.1
b
97.6 ± 0.3
b
97.7 ± 0.3
b
18:1n-9 99.0 ± 0.1
a
97.9 ± 0.5
c
98.4 ± 0.2
b
98.2 ± 0.3b
c
98.3 ± 0.3
bc
18:1n-7 98.4 ± 0.3
a
96.6 ± 0.6
c
97.4 ± 0.2
b
97.4 ± 0.4
b
97.5 ± 0.4
b
20:1n-11,n-9 98.5 ± 0.1
a
96.6 ± 0.5
c
97.4 ± 0.3
b
96.7 ± 0.6
c
97.0 ± 0.3
bc
22:1n11 97.1 ± 3.0 97.2 ± 1.6 96.5 ± 0.3 95.8 ± 1.0 96.6 ± 0.4
22:1n-9 96.6 ± 2.6 95.5 ± 1.7 95.7 ± 0.5 95.5 ± 1.4 96.7 ± 0.5
Total monoenes 98.7 ± 0.1
a
97.3 ± 0.6
c
98.2 ± 0.2
ab
98.0 ± 0.3
b
98.0 ± 0.3
b
18:2n-6 99.8 ± 0.1 99.8 ± 0.1 99.8 ± 0.1 99.8 ± 0.1 99.8 ± 0.1
20:4n-6 98.8 ± 0.1 97.4 ± 0.5 99.2 ± 1.5 98.3 ± 1.9 99.2 ± 1.5
22:5n-6 98.5 ± 0.1
a
96.9 ± 0.5
c
97.7 ± 0.2
b
97.6 ± 0.3
b
97.5 ± 0.3
b
Total n-6 PUFA 98.8 ± 0.1
b
97.6 ± 0.5
c
98.8 ± 0.1
b
99.1 ± 0.3
ab
99.3 ± 0.2
a
18:3n-3 99.3 ± 0.1
a
98.4 ± 0.4
c
98.8 ± 0.2
b
98.7 ± 0.2
bc
98.6 ± 0.3
bc
18:4n-3 99.3 ± 0.1
a
98.6 ± 0.4
b
98.7 ± 0.6
b
99.0 ± 0.1
ab
98.8 ± 0.2
b
20:5n-3 99.2 ± 0.1
a
98.2 ± 0.4
c
98.7 ± 0.1
b
98.7 ± 0.1
b
98.5 ± 0.3
bc
22:5n-3 98.9 ± 0.1
a
97.5 ± 0.5
a
96.0 ± 1.8
b
97.8 ± 0.2
a
97.8 ± 0.3
a
22:6n-3 98.8 ± 0.1
a
97.2 ± 0.5
b
96.9 ± 0.4
b
96.8 ± 0.5
b
96.7 ± 0.4
b
Total n-3 PUFA 99.0 ± 0.1
a
97.8 ± 0.4
c
98.3 ± 0.2
b
98.2 ± 0.2
b
98.0 ± 0.3
b
Total PUFA 99.0 ± 0.1
a
97.8 ± 0.4
c
98.4 ± 0.2
b
98.4 ± 0.2
b
98.4 ± 0.3
b
 
Results are means ± SD (n = 3). Different superscript letters indicate a significant effect 
of diet as determined by ANOVA DFO, decontaminated northern fish oil; NFO, 
northern fish oil; PUFA, polyunsaturated fatty acids. SRO, southern fish oil and 
rapeseed oil (40/60); SRO/SO, southern fish oil, rapeseed oil and soybean oil 
(40/30/30); SSO, southern fish oil and soybean oil (40/60). 
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Table 3.10. Lipid content (percentage of wet weight) and fatty acid composition 
 (percentage of total fatty acids) in flesh of Atlantic salmon at the initiation 
 (initial) of the trial and after feeding the experimental diets for 10 weeks.  
Parameters Initial NFO DFO SRO SRO/SO SSO
Lipid Content 4.0
 
±
 
0.8 11.3 ±
 
1.3
a
11.2 ± 1.3
a
9.8 ± 0.8
b
10.9
 
±
 
1.1
ab
10.6
 
±
 
1.2
ab
Fatty acid
14:00 4.8 ± 0.2 4.7 ± 0.2
b
4.9 ± 0.1
a
2.9 ± 0.1
c
2.9 ± 0.1
c
3.0 ± 0.1
c
16:00 16.3 ± 0.4 17.1
 
± 0.6
a
16.8 ± 0.3
a
10.9
 
±
 
0.6
d
12.2 ± 0.4
c
13.5
 
± 0.5
b
18:00 3.6 ± 0.1 2.8 ± 0.1
c
2.7 ± 0.1
c
2.7 ± 0.2
c
3.2 ± 0.1
b
3.6 ± 0.2
a
20:00 0.2 ± 0.0 0.1 ± 0.0
c
0.1 ± 0.1
c
0.3 ± 0.0
a
0.2 ± 0.0
b
0.2 ± 0.0
b
22:00 0.4 ± 0.0 0.1 ± 0.2
b
0.1 ± 0.1
b
0.2 ± 0.0
a
0.2 ± 0.0
a
0.2 ± 0.0
a
Total saturated 25.7 ± 0.6 25.3
 
± 0.8
a
25.1 ± 0.5
a
17.2
 
± 0.8
d
19.0
 
± 0.6
c
21.1
 
± 0.8
b
16:1n-9 0.1 ± 0.1 0.4 ± 0.1
b
0.4 ± 0.1
b
0.9 ± 1.4
a
0.5 ± 1.1
b
0.1 ± 0.1
c
16:1n-7 5.6 ±  0.2 6.0 ± 0.2
a
5.8 ± 0.1
a
2.6 ± 1.4
c
2.9 ± 1.1
bc
3.4 ± 0.1
b
18:1n-9 15.0 ± 0.5 25.1
 
± 0.6
c
21.9 ± 0.3
d
39.0
 
± 1.2
a
28.9
 
± 0.4
b
19.9
 
± 0.4
c
18:1n-7 3.4 ± 0.1 3.1 ± 0.2
b
3.1 ± 0.1
b
3.3 ± 0.2
a
3.0 ± 0.2
b
2.6 ± 0.1
c
20:1n-11 n.d. tr 0.2 ± 0.2
a tr tr 0.1 ± 0.1
b
20:1n-9 2.1 ± 0.2 2.5 ± 0.1
b
3.0 ± 0.1
a
1.9 ± 0.1
c
1.5 ± 0.1
d
1.1 ± 0.1
e
20:1n-7 0.3 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0
22:1n11 1.6 ± 0.2 1.8 ± 0.1
b
3.1 ± 0.2
a
0.5 ± 0.1
d
0.5 ± 0.1
d
0.6 ± 0.1
c
22:1n-9 0.4 ± 0.0 0.4 ± 0.0
b
0.5 ± 0.0
a
0.3 ± 0.0
c
0.2 ± 0.0
d
0.2 ± 0.0
d
24:1n-9 0.7 ± 0.0 1.3 ± 0.2
a
1.2 ± 0.1
b
0.4 ± 0.0
c
0.4 ± 0.0
c
0.4 ± 0.1
c
Total monoenes 29.1 ± 0.9 40.8
 
± 0.8
b
39.3 ± 0.6
c
49.0
 
± 1.1
a
38.1 ± 0.3
d
28.6
 
± 0.5
e
18:2n-6 7.7 ± 0.2 5.3 ± 0.2
d
5.8 ± 1.0
d
11.9
 
± 0.3
c
20.9 ± 0.6
b
28.1 ± 1.1
a
18:3n-6 0.2+0.1 0.2 ± 0.1
b
0.1 ± 0.1
b
0.5 ± 0.3
a
0.2 ± 0.1
b
0.2 ± 0.1
b
20:2n-6 .04 ± 0.0 0.7 ± 0.0
c
0.6 ± 0.0
d
0.6 ± 0.1
d
1.0 ± 0.1
b
1.1 ± 0.2
a
20:3n-6 0.4 ± 0.1 0.2 ± 0.1
c
0.3 ± 0.0
b
0.3 ± 0.0
b
0.3 ± 0.0
b
0.4 ± 0.0
a
20:4n-6 0.9 ± 0.0 0.6 ± 0.0
a
0.6 ± 0.0
a
0.5 ± 0.0
b
0.5 ± 0.0
b
0.5 ± 0.0
b
22:5n-6 0.3 ± 0.0 0.3 ± 0.0
a
0.3 ± 0.0
a
0.1 ± 0.1
c
0.2 ± 0.0
b
0.2 ± 0.0
b
Total n-6 PUFA 10.0 ± 0.3 7.3 ± 0.3
d
7.7 ± 1.0
d
13.8 ± 0.5
c
23.0 ± 0.6
b
30.5 ±
 
1.2
a
18:3n-3 1.8 ± 0.1 2.3 ± 0.1
d
2.3 ± 0.1
d
5.6 ± 0.2
a
4.5 ± 0.2
b
3.2 ± 0.1
c
18:4n-3 1.5 ± 0.1 1.5 ± 0.1
b
1.8 ± 0.1
a
0.8 ± 0.1
d
0.8 ± 0.0
d
0.9 ± 0.1
c
20:3n-3 0.1 ± 0.0 0.3 ± 0.0
a
0.3 ± 0.0
a
0.3 ± 0.0
a
0.3 ± 0.0
a
0.2 ± 0.1
b
20:4n-3 1.1 ± 0.0 1.2 ± 0.1
a
1.1 ± 0.1
b
0.7 ± 0.1
c
0.7 ± 0.0
c
0.7 ± 0.0
c
20:5n-3 11.8 ± 0.5 5.9 ± 0.4
b
6.9 ± 0.3
a
4.6 ± 0.4
d
4.9 ± 0.1
cd
5.2 ± 0.3
c
22:5n-3 3.4 ± 0.2 2.1 ± 0.2
a
2.0 ± 0.1
ab
1.7 ± 0.2
d
1.8 ± 0.1
cd
1.9 ± 0.2
bc
22:6n-3 15.0 ± 0.9 13.1
 
± 0.6
a
13.6 ± 0.6
a
6.4 ± 0.5
c
6.7 ± 0.2
c
7.5 ± 0.5
b
Total n-3 PUFA 35.2 ± 1.1 26.6
 
± 1.2
b
28.0 ± 1.0
a
20.0
 
± 1.4
c
20.0 ± 0.3
c
19.8 ± 0.8
c
Total PUFA 45.2 ± 1.0 34.0
 
± 1.4
d
35.7 ± 0.7
c
33.8
 
± 1.8
d
43.0 ± 0.7
b
50.4 ± 1.1
a
 
Results are means ± SD (n = 3). Different superscript letters indicate a significant effect 
of diet as determined by ANOVA. DFO, decontaminated northern fish oil; n.d., not 
detected; PUFA, polyunsaturated fatty acids; NFO, northern fish oil; SRO, southern fish 
oil and rapeseed oil (40/60); SRO/SO, southern fish oil, rapeseed oil and soybean oil 
(40/30/30); SSO, southern fish oil and soybean oil (40/60); tr,  0.05.  
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Table 3.11. Lipid content (percentage of wet weight) and fatty acid composition 
 (percentage of total fatty acids) in liver of Atlantic salmon at the initiation 
 (initial) of the trial and after feeding the experimental diets for 10 weeks.  
Parameters Initial NFO DFO SRO SRO/SO SSO
Lipid Content 6.0 ±1.0 8.0 ± 2.8 
a
7.0 ± 2.0 
a
5.0 ± 1.0 
b
4.7 ± 0.8 
b
4.4 ± 0.7
b
Fatty acid
14:00 1.9 ± 0.6 2.2 ± 0.2 
a
2.2 ± 0.5 
a
1.3 ± 0.4 
b
1.1 ± 0.2 
b
1.1 ± 0.1
b
16:00 13.4 ± 1.0 11.2 ± 1.5 
ab
10.7 ± 1.5 
ab
9.7 ± 2.1 
b
10.7 ± 1.3 
ab
12.1 ± 1.1
a
18:00 7.1 ± 0.6 4.1 ± 0.6 
b
4.0 ± 0.4 
b
4.4 ± 0.5 
b
5.5 ± 0.7
a
6.0 ± 0.6 
a
20:00 0.3 ± 0.0 0.1 ± 0.1
b
0.1 ± 0.1
b
0.2 ± 0.1
a
0.2 ± 0.2
a
0.2 ± 0.0
a
22:00 0.8 ± 0.2 0.1 ± 0.1
a
0.1 ± 0.2 
a
0.1 ± 0.1 
a n.d. n.d.
Total saturated 23.7 ± 1.4 18.0 ± 2.0
ab 
17.4 ± 2.2
ab
15.9 ± 2.8
b
17.6 ± 1.4
ab
19.4 ± 1.6
a
16:1n-9 0.2 ± 0.0 0.5 ± 0.1 0.5 ± 0.1 0.4 ± 0.0 0.4 ± 0.4 0.6 ± 0.7
16:1n-7 2.2 ± 0.6 3.7 ± 0.5 
a
3.4 ± 0.7 
a
1.7 ± 0.4 
b
1.3 ± 0.5 
b
1.0 ± 0.8 
c
18:1n-9 16.2 ± 0.9 23.1 ± 3.3 
b
24.3 ± 3.8 
b
28.3 ± 5.9 
a
20.7 ± 4.0 
b
15.7 ± 1.8 
c
18:1n-7 3.0 ± 0.1 3.8 ± 0.3 
a
3.7 ± 0.3 
a
3.0 ± 0.3 
b
2.6 ± 0.3 
c
2.2 ± 0.2
 d
20:1n-11 n.d. 0.1 ± 0.1
b
0.2 ± 0.2 
a
0.1 ± 0.1
b n.d. n.d.
20:1n-9 1.7 ± 0.4 3.3 ± 0.4
ab
3.6 ± 0.4 
a
3.1 ± 0.5 
b
2.1 ± 0.4
 c
1.4 ± 0.2
 d
20:1n-7 0.2 ± 0.0 0.2 ± 0.0
 a
0.2 ± 0.0 
a
0.2 ± 0.0
 a
0.1 ± 0.1
b
0.1 ± 0.1
b
22:1n11 0.2 ± 0.2 0.9 ± 0.3 
a
1.0 ± 0.5 
a
0.1 ± 0.3 
b tr n.d.
22:1n-9 0.3 ± 0.2 0.3 ± 0.1a 0.3 ± 0.1a 0.1 ± 0.0 a n.d. tr
24:1n-9 1.1 ± 0.1 0.9 ± 0.1
ab
1.0 ± 0.2 
a
0.8 ± 0.2
ab
0.7 ± 0.1
c
0.7 ± 0.1
c
Total monenes 25.0 ± 1.3 36.7 ± 3.9
a
38.2 ± 3.3
a
37.6 ± 5.5
a
27.8 ± 4.1
b
21.6 ± 2.5
c
18:2n-6 6.4 ± 0.4 3.6 ± 0.4 
d
4.0 ± 1.7
d
7.5 ± 2.1
c
14.1 ± 2.0 
b
17.7 ± 2.4 
a
18:3n-6 0.1 ± 0.0 0.1 ± 0.1
a tr 0.1 ± 0.1
a tr 0.1 ± 0.1
a
20:2n-6 1.2 ± 0.2 1.1 ± 0.1
c
1.2 ± 0.3 
c
1.7 ± 0.4 
b
3.2 ± 0.4 
a
3.5 ± 0.4 
a
20:3n-6 0.4 ± 0.0 0.4 ± 0.2 
bc
0.3 ± 0.0 
c
0.4 ± 0.1 
bc
0.5 ± 0.1
 a
0.6 ± 0.1
a
20:4n-6 2.8 ± 0.4 1.7 ± 0.4 
b
1.6 ± 0.3 
b
2.0 ± 0.4 
a
2.3 ± 0.3 
a
2.3 ± 0.3 
a
22:5n-6 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.1 0.4 ± 0.1 0.4 ± 0.1
Total n-6 PUFA 11.4 ± 0.5 7.3 ± 0.3 
c
7.7 ± 1.9 
c
12.1 ± 2.0 
b
20.5 ± 2.0
 a
24.5 ± 2.2
 a
18:3n-3 1.8 ± 0.2 1.6 ± 0.2
c
1.7 ± 0.6 
c
3.0 ± 0.8 
a
2.4 ± 0.4 
a
1.6 ± 0.6 
c
18:4n-3 0.3 ± 0.2 0.4 ± 0.1
a
0.4 ± 0.1
a
0.2 ± 0.1
b
0.2 ± 0.1
b
0.2 ± 0.1
b
20:3n-3 0.4 ± 0.1 0.5 ± 0.1
b
0.6 ± 0.2 
b
0.8 ± 0.2 
a
0.7 ± 0.1
ab
0.4 ± 0.0 
a
20:4n-3 0.7 ± 0.1 1.9 ± 0.2 
a
1.7 ± 0.4
 a
0.9 ± 0.2 
b
0.8 ± 0.1
c
0.7 ± 0.1 
c
20:5n-3 12.8 ± 0.6 7.7 ± 1.4 
b
7.7 ± 1.1
b
9.1 ± 0.9 
a
10.0 ± 1.3 
a
9.7 ± 0.9 
a
22:5n-3 3.7 ± 0.3 4.3 ± 0.8 
a
3.7 ± 0.7
a
2.5 ± 0.8 
b 
2.7 ± 0.2 
b
2.6 ± 0.2
 b
22:6n-3 20.0 ± 1.5 21.5 ± 1.8 
a
20.7 ± 3.0 
ab
17.7 ± 4.6 
b
17.6 ± 2.1
b
19.1 ± 2.5
ab
Total n-3 PUFA 39.9 ± 1.7 38.1 ± 2.3 
a
36.7 ± 2.8 
ab
34.5 ± 4.5 
b
34.1 ± 3.0 
b
34.5 ±2.9 
b
Total PUFA 51.3 ± 1.9 45.4 ± 2.5
 c
44.4 ± 2.0
 c
46.6 ± 2.9 
c
54.6 ± 3.1 
b
59.0 ± 1.3 
a
 
Results are means ± SD (n = 3). Different superscript letters indicate a significant effect 
of diet as determined by ANOVA. DFO, decontaminated northern fish oil; n.d., not 
detected; NFO, northern fish oil; PUFA, polyunsaturated fatty acids; SRO, southern  
fish oil and rapeseed oil (40/60); SRO/SO, southern fish oil, rapeseed oil and soybean 
oil (40/30/30); SSO, southern fish oil and soybean oil (40/60); tr,  0.05.  
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3.3.8 Flesh and liver lipid class compositions 
Dietary treatment showed no significant effects on flesh lipid class composition 
between fish fed the NFO and DFO diets (Table 3.12). In contrast, the proportions of 
neutral lipids were reduced and polar lipids increased in flesh of salmon fed the SVO 
diets compared to fish fed the NFO or DFO diets. The lower neutral lipid was primarily 
due to decreased proportions of TAG. The greater proportions of polar lipids in fish fed 
the SVO diets were mainly due to increased proportions of the two main 
phosphoglycerides, PC and PE. One of the few differences between the fish fed the 
SVO diets was that the flesh of fish fed the diet with highest level of SO (SSO diet) had 
a lower proportion of TAG and a higher proportion of cholesterol (sterol) than fish fed 
the other SVO diets. The proportion of FFA in the flesh also increased with increasing 
inclusion of dietary SO (Table 3.12). 
There were no significant effects of dietary treatment on liver lipid class 
composition between fish fed the NFO and DFO diets other than slightly higher 
cholesterol in liver of fish fed DFO (Table 3.13). Similar to the effects described above 
for flesh, the proportions of neutral lipids were reduced and polar lipids increased in 
liver of salmon fed the SVO diets compared to fish fed the NFO or DFO diets. Lower 
total neutral lipid reflected to lower level of total liver lipid content. The lower neutral 
lipid was primarily due to decreased proportions of TAG and steryl esters. The larger 
proportions of polar lipids in fish fed the SVO diets were also generally due to increased 
proportions of PC and PE. Within the SVO diets, the liver of fish fed 60 % SO (SSO 
diet) had a higher sterol level than the fish fed the SRO and SRO/SO diets, as in the 
case of flesh (Table 3.13). 
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Table 3.12. Lipid class composition (percentage of total lipid) of flesh of Atlantic 
 salmon at the initiation (initial) of the trial and after feeding the experimental 
 diets for 10 weeks. 
Lipid classes Initial NFO DFO SRO SRO/SO SSO
PC 10.0
 
±
 
2.0 4.7 ± 0.3
c
5.0 ± 0.6
bc
6.5 ± 0.7
a
5.6 ± 0.6
b
5.4 ± 0.6
bc
PE 8.7 ±1.6 3.1 ± 0.4
b
3.3 ± 0.4
b
4.1 ± 0.5
a
4.1 ± 0.6
a
4.4 ± 0.6
a
PS 1.2 ± 0.4 n.d. n.d. n.d. n.d. n.d.
PI/PG 1.3 ± 0.5 n.d. n.d. n.d. n.d. n.d.
SPC 0.8 ± 0.2 n.d. n.d. n.d. n.d. n.d.
LysoPC 1.5 ± 0.3 n.d. n.d. n.d. n.d. n.d.
Total PL 23.5 ± 4.5 7.9 ± 0.5
b
8.3 ± 1.0
b
10.5
 
±
 
1.1
a
9.7 ± 1.1
a
9.7 ± 1.1
a
Total NL 76.5 ± 4.5 92.1
 
±
 
0.5
a
91.7
 
± 1.0
a
89.5
 
±
 
1.1
b
90.3
 
±
 
1.1
b
90.3
 
±
 
1.1
b
TAG 47.7
 
±
 
1.0 82.3
 
±
 
2.5
a
83.2
 
± 1.7
a
80.3
 
± 2.5
b
79.6
 
±
 
0.6
b
75.4 ± 1.9
c
Sterol 14.1
 
±
 
2.7 6.2.± 0.8 
b
5.6 ± 0.4
b
6.1 ± 0.7
b
6.4 ± 0.6
b
8.3 ± 2.0
a
FFA 14.6
 
±
 
3.0 3.1 ± 0.7
c
3.0 ± 0.7
c
3.1 ± 0.7
c
4.4 ± 0.7
b
6.6 ± 1.0
a
 
Results are means ± SD (n = 3). Different superscript letters indicate a significant effect 
of diet as determined by ANOVA. DFO, decontaminated northern fish oil; FFA, free 
fatty acid; n.d., not detected; NFO, northern fish oil; NL, neutral lipid; PC, 
phosphatidylcholine; PE, phosphatidylethanolamine; PI/PG, phosphatidylinositol/ 
phosphatidylglycerol, PL, polar lipid; PS, phosphatidylserine; SPC, sphingomyelin; SRO, 
southern fish oil and rapeseed oil (40/60); SRO/SO, southern fish oil, rapeseed oil and 
soybean oil (40/30/30); SSO, southern fish oil and soybean oil (40/60); TAG, 
triacylglycerol.  
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Table 3.13. Lipid class composition (percentage of total lipid) in Atlantic salmon liver 
 at initial and after feeding the experimental diets for 10 weeks.  
Lipid classes Initial NFO DFO SRO SRO/SO SSO
PC 22.9 ± 1.5 13.4
 
±
 
0.4
b
15.3 ± 2.5
b
19.5 ± 0.2
a
18.4 ± 1.5
a
19.9 ± 2.3
a
PE 14.3 ± 0.9 8.7 ± 0.7
b
10.8 ± 2.4
b
13.5 ± 0.7
a
13.9 ± 0.8
a
13.4
 
±
 
1.3
a
PS 2.4 ± 0.5 2.4 ± 0.7 2.1 ± 0.0 2.4 ± 0.1 2.8 ± 0.6 2.6 ± 0.4
PI/PG 5.6 ± 0.7 5.7 ± 0.2
a
5.5 ± 0.3
a
5.4 ± 1.3
a
4.1 ± 0.5
b
4.2 ± 0.3
b
SPC 0.6 ± 1.3 2.4 ± 0.3
a
2.2 ± 0.1
a
2.3 ± 0.2
a
1.9 ± 0.3
b
1.9 ± 0.3
b
Unidentified PL 2.0 ± 1.2 1.5 ± 0.4
b
0.6 ± 1.0
b
1.3 ± 2.3
b
3.8 ± 0.6
a
3.4 ± 0.1
a
Total PL 47.7 ± 2.4 34.1
 
± 1.1
b
36.4 ± 4.0
b
44.4 ± 1.4
a
45.0
 
±
 
3.2
a
45.7
 
±
 
4.5
a
Total NL 52.3 ± 2.4 65.9
 
± 1.1
a
63.6 ± 4.0
a
55.6 ± 1.4
b
56.0
 
±
 
3.2
b
54.3 ± 4.5
b
TAG 24.9
 
±
 
2.6 39.6
 
± 1.6
a
37.2
 
±
 
3.8
ab
32.4 ± 2.7
bc
32.1
 
±
 
3.4
bc
28.8 ± 4.5
c
Sterol 14.5 ± 1.6 9.1 ± 0.4
d
10.7 ± 1.2
c
12.7 ± 0.5
b
12.3 ± 0.7
b
14.5 ± 1.0
a
FFA 2.1 ± 0.9 1.6 ± 0.3
a
1.6 ± 0.4
a
0.5 ± 0.9
b
1.6 ± 0.6
a
tr.
Sterol ester 10.8 ± 2.7 15.6
 
± 0.3
a
14.2 ± 1.4
a
10.1 ± 1.1
b
9.1 ± 1.0
b
11.0 ± 1.1
b
 
 Results are means ± SD (n = 3). Different superscript letters indicate a significant effect 
of diet as determined by ANOVA. DFO, decontaminated northern fish oil; FFA, free 
fatty acid; NFO, northern fish oil; NL, neutral lipid; SRO, southern fish oil and rapeseed 
oil (40/60); SRO/SO, southern fish oil, rapeseed oil and soybean oil (40/30/30); SSO, 
southern fish oil and soybean oil (40/60). PC, phosphatidylcholine; PE, 
phosphatidylethanolamine; PI/PG, phosphatidylinositol/phosphatidylglycerol, PL, polar 
lipid; PS, phosphatidylserine; SPC, sphingomyelin; TAG, triacylglycerol; tr.,  0.05.  
3.3.9 Dioxins, DL-PCBs and PBDEs in flesh 
The sum of dioxins + DL-PCBs in the flesh of fish at the initiation of the trial 
was 1.06 ng TEQ/kg. After feeding the experimental diets for 10 weeks, the value in the 
flesh of fish fed the NFO diet had increased significantly to 6.42 ng TEQ/kg, while in 
fish fed the DFO and SRO/SO diets the values were significantly reduced to 0.34 and 
0.41 ng TEQ/kg, respectively, compared to the initial fish (Table 3.14).  
The sum of the PBDE congeners was 0.26 ng/g wet weight in the flesh of fish at 
the initiation of the trial. After feeding the experimental diets for 10 weeks the value in 
flesh of fish fed the NFO diet had increased significantly to 0.94 ng/g, while flesh of 
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fish fed the DFO diet showed a similar level to the initial fish at 0.25 ng/g and fish fed 
the SRO/SO diet had a significantly reduced concentration of 0.09 ng/g (Table 3.14). 
 
Table 3.14. Concentrations of dioxin, DL-PCB (ng TEQ/kg wet weight) and PBDE 
 (ng/g wet weight) congeners in flesh of Atlantic salmon at the initiation (initial) 
 of the feeding trial and after feeding the experimental diet for 10 weeks. 
Congener/Diet              Initial NFO DFO SRO/SO
Sum PCDD     0.06 ± 0.02 
b        
0.57 ± 0.08 
a       
0.03 ± 0.01 
b        
0.05 ± 0.02  
b
Sum PCDF       0.12 ± 0.03 
b      
1.48 ± 0.31 
a      
0.03 ± 0.01 
b         
0.04 ± 0.01 
b
Sum mono-ortho PCB 0.18 ± 0.08 
b         
1.19 ± 0.10 
a      
0.09 ± 0.03 
b         
0.07 ± 0.01 
b
Sum non ortho PCB 0.73 ± 0.16 
b         
3.21 ± 0.19 
a      
0.20 ± 0.02 
c        
0.24 ± 0.04 
c
Sum dioxins + PCBs 1.06 ± 0.15 
b        
6.42 ±  0.40 
a      
0.34 ± 0.04 
c        
0.40 ± 0.03 
c
Sum PBDE       0.26 ± 0.01 
b           
0.94 ± 0.002 
a       
0.25 ± 0.02 
b         
0.09 ± 0.03 
c
 
Results are means ± SD (n = 3). Values in the same row assigned a different superscript 
letter are significantly different (P < 0.05).DFO, decontaminated northern fish oil; NFO, 
northern fish oil; PBDE, polybrominated diphenyl ethers; PCB, polychlorinated 
biphenyls; PCDD, polychlorinated dibenzo-p-dioxins; PCDF, polychlorinated 
dibenzofurans; SRO/SO, southern fish oil, rapeseed oil and soybean oil (40/30/30).  
3.3.10 Gene expression 
The expression of both the 6- and 5-fatty acyl desaturase (FAD) genes in 
liver was significantly increased in salmon fed the SVO diets compared to fish fed the 
diets containing FO (NFO and DFO), with the highest expression observed in liver of 
fish fed the highest inclusion of SO ( SSO diet) (Figure 3.1). The expression of 5 and 
6 FADs of salmon fed the SSO diet was 9-fold and 11-fold higher, respectively, 
compared to the fish fed NFO diet. The expression of 5 FAD was about 6-fold higher 
in livers of fish fed both SRO and SRO/SO diets compared to fish fed the NFO diet. 
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The expression of 6 desaturase was 6-fold and 5-fold higher in fish fed the in the SRO 
and SRO/SO diets, respectively, compared to fish fed the NFO diet. In contrast, there 
was no dietary effect on the hepatic expression of the PUFA elongase gene. There were 
also no significant differences in expression of any of the genes between fish fed the 
NFO and DFO diets. 
0
2
4
6
8
10
12
14
Delta5 Delta6  Elongase
Diets
R
e
la
ti
v
e
 g
e
n
e
 e
x
p
re
s
s
io
n
  
  
  
  
  
  
  
 (
N
F
O
=
1
)
NFO
DFO
SRO
SRO/SO
SSO
 
Figure 3.1. Effects of diet on the hepatic expression of 5 and 6 fatty acyl desaturases, 
and polyunsaturated fatty acid elongase in Atlantic salmon. Stars indicate the expression 
of the specific gene in fish fed a particular diet was significantly different (P<0.05) 
compared to its expression in fish fed the NFO diet. DFO, decontaminated northern fish 
oil; NFO, northern fish oil, SRO, southern fish oil and rapeseed oil (40/60); SRO/SO, 
southern fish oil, rapeseed oil and soybean oil (40/30/30); SSO, southern fish oil and 
soybean oil (40/60). 
3.4 Discussion and conclusions 
3.4.1 Growth performance, apparent digestibility of gross nutrients and fatty 
acids  
The presence of POPs, PCDD/F and DLPCB, levels in flesh was negatively 
related with the growth rate of farmed Atlantic salmon (Berntssen et al. 2005). The use 
of purification techniques by short path distillation (Breivik & Thorstad 2004) or 
activating carbon treatment, combined with stripping at low pressure and low 
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temperature (De Kock et al. 2004) has been reported the potential to reduce the level of 
lipid soluble organic pollutants while maintaining the nutritional status of the marine 
ingredients used in fish feeds (Berntssen & Lundebye 2007). In the present study, there 
were no deleterious effects on growth as measured by final weights, SGR or TGC, or on 
feed efficiency (FCR) of any of fish fed the experimental diets, including the fish fed 
the SVO diets. This was consistent with the results of several previous trials in which 
partial replacement of FO by VO, or even 100 % replacement, have had no significant 
effects on growth performance or feed efficiency in Atlantic salmon when using FM-
based diets (Bell & Waagbo 2008).  
The digestibilities of the gross dietary nutrients and individual FA were 
generally high and similar in all the diets with the exception of diet DFO. In the diet 
formulated with decontaminated FO, the ADC was slightly but significantly lower than 
that of all the other diets, including the NFO diet, although this had no impact on 
growth performance. There were some small but significant differences in FA 
composition between the DFO and NFO diets, and so some differences in FA and, 
consequently lipid, digestibility may not be entirely unexpected. However, the lower 
digestibilities of the DFO diet also included protein and dry matter and so it appeared to 
be a general effect. It is not known if the decontamination process per se was 
responsible for these effects, but the northern FO and decontaminated FO used in the 
diet manufacture were exactly the same northern oil, simply decontaminated or not. 
Therefore, it is likely that some aspect of the decontamination process affected the 
digestibility, but it cannot be certained without further evidence. Furthermore, it was 
surprising that the lower digestibilities of the DFO diet did not result in lower growth, 
as the fish fed the DFO diet attained the same final weight and showed the same SGR, 
and TGC as fish fed the NFO and the SVO diets. FCR were also unaffected and so the 
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lower digestibilities with the DFO diet were not reflected in any gross growth 
performance parameter. This apparent dichotomy between nutrient digestibilities, and 
growth and feed efficiency has been observed previously in feeding trials in salmon 
(Torstensen et al. 2000). The SGR was higher and FCR was lower in Atlantic salmon 
held in seawater compared to those in freshwater, despite lower ADC values for dry 
matter and crude protein (Krogdahl et al. 2004). In comparison to the NFO diet, the 
SVO diets also showed slightly lower lipid digestibility related to lower digestibilities 
of a number of FAs, but protein digestibility was not affected by feeding VOs. Lipid 
and FA digestibility in salmon fed VOs appears to be variable, perhaps due to 
environmental variables, (Torstensen et al. 2000; Bendiksen et al. 2003; Ng et al. 
2004), but lower lipid/FA digestibility of diets formulated with VO has been reported 
previously in trials with salmon (Menoyo et al. 2003) and other fish species including 
Murray cod (Maccullochella peelii peelii) (Francis et al. 2007). As with the DFO diet, 
the slightly lower lipid digestibility of the SVO diets did not result in any deleterious 
effect on growth performance or feed efficiency. 
3.4.2 Whole body composition, flesh and liver lipid content  
In this study, the proximate composition of whole fish was unaffected by 
feeding the DFO and SVO diets compared to the NFO diet. Furthermore, feeding the 
fish the DFO diet did not affect the flesh and liver lipid contents compared to the fish 
fed the NFO diet. Although the SVO diets also had no effect on the gross composition 
of the fish, their effect in lowering liver lipid was highly significant. In addition, it 
appeared that the liver lipid lowering effect was greater with the diets containing SO 
compared to RO, although this difference was not statistically significant. Differences 
between VOs in their effects on tissue lipid contents have been observed previously. 
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Thus, earlier trials on salmon smolts showed that substitution of FO with graded levels 
of PO had no significant effect on liver lipid (Bell et al. 2002), whereas graded 
substitution with RO tended to increase liver lipid (significantly so at 100 % 
replacement) (Bell et al. 2001). Liver lipid was not increased in salmon fed SO at higher 
water temperature (Ruyter et al. 2006). Furthermore, liver lipid content was lower in 
salmon fed a VO blend containing RO, PO and LO for 16 months but not at 14 and 22 
months of feeding (Jordal A-E.O et al. 2007). In that study, the relative proportions of 
TAG and cholesterol were increased and decreased, respectively, at all stages. Thus, the 
effects of VO diets on liver lipid levels can vary perhaps related to type of oil, water 
temperature, season and duration of trial.  
Possibly more important in terms of product quality, is the effect that different 
VOs have on flesh lipid contents in salmon. In the present trial, although there was a 
trend for flesh lipid content to be lower in fish fed the SVO diets, it was only 
significantly reduced in fish fed the SRO diet, that is, with 60 % RO substitution. 
Previously, graded RO substitution in salmon smolts tended to decrease flesh lipid, 
although this effect was only significant at the 50 % replacement level (Bell et al. 
2001). With PO substitution in salmon smolts, the flesh lipid lowering effect was very 
pronounced, with lipid levels decreasing in a graded manner as the level of PO 
substitution increased (Bell et al. 2002). In a study with larger post-smolts, feeding PO 
reduced flesh lipid content compared to fish fed sunflower oil or a blend of FO and 
sunflower oil (Torstensen et al. 2000). In a trial feeding salmon a VO blend containing 
RO, PO and LO over the entire 2-year growth cycle, flesh lipid contents were generally 
lower at all points in both the freshwater and seawater phases (Torstensen et al. 2005).  
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3.4.3 Flesh and liver lipid class compositions 
The lipid class compositions of flesh and liver were generally unaffected by 
feeding the DFO diet compared to the NFO diet but there were some effects of feeding 
the diets containing VO. In the present study, the lipid class composition of the flesh in 
fish fed the SVO diets was characterised by decreased proportions of neutral lipid and 
TAG. Previously, it was reported that neutral lipid and TAG were reduced in white 
muscle of salmon fed a VO blend compared to fish fed FO (Nanton et al. 2007). 
Overall, it is apparent that the effect that substitution of FO with VO has on tissue lipid 
contents and compositions is dependent upon a number of factors including the specific 
VO or VO blends used as well as other factors including the specific tissue itself and 
possibly growth stage and/or season as well as the genetic origin of the stock (Sargent et 
al. 2002). In the present study, the lower liver lipid level in fish fed the SVO diets was 
associated with decreased neutral lipids, especially TAG and steryl esters whereas the 
major membrane lipids, PC, PE and, possibly, cholesterol/sterol were all increased. In 
Table 3.13, sterols rather than cholesterol are reported as the TLC method is not able to 
separate cholesterol from many plant sterols. The SVO diets are likely to contain lower 
levels of cholesterol but, conversely, may contain a range of other plant sterols (Padley 
et al. 1986). Plant sterols are generally not well absorbed by animals and, indeed, are 
used to block cholesterol uptake in humans. The situation with fish is not known but it 
is likely similar. Therefore, it is likely that cholesterol is the predominant sterol in fish 
tissues, but the presence of plant sterols cannot be excluded completely. However, the 
higher cholesterol level in liver and flesh of fish fed the SVO diets may be a 
compensatory mechanism, the result of increased cholesterol synthesis in response to 
reduced dietary cholesterol (Taggart et al. 2008).  
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3.4.4 Liver and flesh fatty acid compositions 
The differences in the FA compositions of the NFO and DFO diets cannot be 
specifically attributed to the decontamination process but it is possibly a factor. For 
instance, certain FAs could be slightly more adsorbed by the activated carbon than other 
FAs resulting in lower proportions in DFO compared to NFO. However, the differences 
observed, lower levels of 18:1n-9 and 18:3n-3, and higher levels of 18:0, 20:1, 22:1, 
18:2n-6 and EPA in DFO compared to NFO, did not follow a pattern that could be 
easily explained by differential adsorption. Some of these differences, particularly the 
lower level of 18:1n-9 and higher levels of 20:1, 22:1 and EPA were reflected in flesh 
lipids but not liver lipids, that showed identical compositions in fish fed the NFO and 
DFO diets. The fact that flesh was more affected than liver by differences in dietary FA 
composition is predictable based on the lipid content of flesh compared to liver in 
salmon. The higher lipid content is associated with higher neutral (storage) lipid, 
specifically TAG, that is more readily influenced by diet than phospholipid (Sargent et 
al. 2002). This simple fact is why changes in dietary lipid have such an impact on 
salmon flesh composition and why it is, as a consequence, difficult to minimise these 
effects. This was clearly demonstrated in the present trial where the strategy with VO 
substitution was to blend them with southern hemisphere FO in an attempt to minimise 
the impact of the VO inclusion on n-3HUFA in flesh was only partially successful. 
Thus, despite 60 % of the FO being replaced by VOs, the EPA levels in the salmon 
flesh were only slightly reduced from about 6 % to 5 %. However, DHA was reduced 
more severely from around 1 3% to about 6.5 to 7.5 %. This simply reflected the diets 
that also showed quite significantly reduced DHA but relatively less effect on EPA, 
which was expected as, although southern hemisphere FOs have higher n-3HUFA than 
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northern hemisphere FOs, this is due to high percentages of EPA and a high EPA:DHA 
ratio, but reduced or similar DHA compared to northern FO.  
In contrast, the strategy was largely successful in liver as FA compositions of 
fish fed the SVO diets showed impressive levels of HUFA with ARA and EPA both 
being significantly increased, and DHA only reduced from around 21 % to about 18-19 
%. EPA actually increased from 7.7 % in fish fed the NFO and DFO diets to 9-10 % in 
fish fed the SVO diets. The only negative impact being increased 18:2n-6 and reduced 
18:1n-9 in the diets containing SO (SSO diet). It is important to emphasise that the 
increased EPA and ARA were not simply the result of increased deposition and 
retention, but were also the result of conversion of dietary 18:3n-3 and 18:2n-6, 
respectively, via fatty acyl desaturation activities as seen in previous studies (Bell et al. 
2001; Tocher et al. 2003b). This contention is supported by other evidence. The SVO 
diets, although formulated with 40 % southern hemisphere FO, which is known to be 
richer in EPA than northern hemisphere FOs (Sargent et al. 1989), were still lower in 
EPA than the NFO and DFO diets. Similarly, the ARA levels in the SVO diets were 
lower than in the NFO and DFO diets. Further evidence of active desaturation was 
provided by the increased level of the intermediate 20:3n-6 in the liver of fish fed the 
diets containing soybean, although there was also increased production of the dead-end 
FA 20:2n-6, the direct elongation product of 18:2n-6. Increased proportions of 20:2n-6 
and 20:3n-6 have been observed previously in salmon when fed diets containing high 
levels of 18:2n-6 (Lie et al. 1993; Bell et al. 2001, 2002; Tocher 2003). Thus, the 
increased proportions of EPA and ARA in liver were also the result of enhanced 
desaturation and elongation of dietary 18:3n-3 and 18:2n-6. The increased hepatic 
expression of FAD genes observed in the present trial is entirely consistent with this 
assertion. Previously studies demonstrated that increased expression of FAD genes in 
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liver of salmon fed VOs was associated with increased activity of the HUFA 
biosynthesis pathway (Zheng et al. 2004, 2005). The increased percentages of EPA 
observed in fish fed the SVO diets was especially noteworthy as it is unusual that 
dietary VO did not reduce EPA levels, let alone increase them. As mentioned above, it 
is common to observe increased levels of desaturation products of dietary 18:2n-6 
including, most commonly, 20:3n-6, in trials with salmon fed VO (Lie et al. 1993; Bell 
et al. 2001, 2002; Tocher 2003). Bell et al (1991) also found increased levels of ARA 
in phospholipids from liver, heart and retina in salmon fed sunflower oil. Increased 
ARA was also observed in total lipid from liver of salmon fed a RO/PO/LO blend 
(Zheng et al. 2005). As essentially all VO diets will increase dietary 18:2n-6, in 
comparison to FO diets, this has been a widely reported observation in salmon tissues, 
especially liver. However, a similar phenomenon has not been generally observed with 
18:3n-3. Therefore, increasing dietary 18:3n-3 levels has not been able to maintain 
tissue EPA or DHA at levels obtained in salmon fed FO. Indeed, even increased levels 
of 18:4n-3 or 20:4n-3, intermediates in the pathway from 18:3n-3 to EPA, have only 
rarely been reported. In a trial using graded substitution of FO with LO, 18:4n-3 and 
20:4n-3 were increased in salmon liver lipids in a graded manner (Tocher et al. 2002). 
However, EPA, 22:5n-3 and DHA all decreased as the level of LO substitution 
increased. Direct biochemical measurements of fatty acyl desaturation activities in 
hepatocytes and enterocytes have conclusively confirmed that HUFA synthesis is up-
regulated in salmon fed diets containing VOs, including RO (Bell et al. 2001), PO (Bell 
et al. 2002) and LO (Tocher et al. 2003b). Molecular studies demonstrated that the 
mechanism included increased FAD gene expression (Zheng et al. 2004, 2005). Thus, 
in previous trials when dietary FOs were substituted by VOs, the reductions in the levels 
of dietary EPA and DHA have been too great for the conversion of dietary 18:3n-3 by 
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the HUFA synthesis pathway to maintain the tissue levels of EPA or DHA. It was very 
interesting that EPA levels in salmon fed the SVO diets were higher than the levels of 
EPA in fish fed the NFO and DFO diets in the present trial. The increasing of EPA 
levels in the SVO diets would be related to low total lipid content and more total polar 
lipid in the flesh associated with biosynthesis from the 18:3n-3 of fish fed the SVO diets.  
Another interesting factor in the observation above is that there was a difference 
between RO and SO substitution, with the latter, especially the SSO diet with sole 
replacement by SO, showing the greatest effect. Thus, the percentages of DHA and 
EPA in both liver and flesh were higher in fish fed the SSO diet compared to fish fed 
the SRO diet with RO substitution. The difference between fish fed SSO and SRO was 
highly significant in flesh with total n-3HUFA levels of 15.7 versus 13.6 %, 
respectively, with reciprocal differences in substrate 18:3n-3 levels of 3.2 versus 5.6 %. 
Consistent with this, the induction of FAD expression in liver was greatest in the fish 
fed the SSO diet. It is not clear why this should be. Previous trials on salmonids using 
substitution of FO with SO have not shown such an effect (Hardy et al. 1987; Guillou 
et al. 1995; Ruyter et al. 2006). The current paradigm is that it is low dietary HUFA 
that induces increased FAD expression (Tocher et al. 2003b), but there was very little 
difference between the SRO and SSO diets in terms of HUFA content. In contrast, the 
SSO diet was characterised by very high levels of 18:2n-6 and lower 18:3n-3 than the 
SRO diet. In a study comparing different proportions of 18:1n-9, 18:2n-6 and 18:3n-3 
(supplied by OO, LO and sunflower oil, respectively) in diets for Atlantic salmon parr, 
the authors suggested that the desaturation and elongation of 18:2n-6 and 18:3n-3 may 
be stimulated by substrate availability as they noted the extent of conversion differed 
despite dietary HUFA levels all being identical (Rollin et al. 2003). Although it is 
known that, like most vertebrate FADs, the salmon FADs are more active towards n-3 
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than n-6 substrates (Zheng et al. 2005), how this particular combination of 18:2n-6 and 
18:3n-3 could have such a significant effect is unclear. Certainly, previous trials that 
used VO blends to produce a better balance of 18:2n-6 and 18:3n-3 including RO/LO 
(Tocher et al. 2003b; Bell et al. 2003b) or RO/PO/LO (Zheng et al. 2005) have not 
been effective in maintaining EPA. However, these trials were of longer duration and 
there may have been a transient increase in HUFA, following change of diet, that wasn‟t 
observed due to the frequency of sampling used. 
3.4.5 Dioxins, DL-PCBs and PBDEs in flesh 
In the present study, the NFO diet contained 17.4 ng TEQ/kg of dioxins + DL-
PCBs and, as such, exceeded the EU maximum permitted value of 7.0 ng TEQ/kg for 
fish feeds (EC Commission Directive 2006). Decontamination of the NFO was very 
successful with the dietary concentration of dioxin + DL-PCBs falling from 17.4 ng 
TEQ/kg in the NFO diet to 0.45 TEQ/kg in the DFO diet. It is indicated that using 
activated carbon, followed by a thin film deodourisation process, removed dioxins and 
PCBs in the DNFO diet by about 97%, compared with the NFO diet. It has been 
reported that activated carbon removed PCDD/PCDF in FO but to a lesser extent DL-
PCB (Berntssen et al. 2006). In the present study, the reduction of the PCDD due to FO 
decontamination in the DFO was 93% while over 97% of the PCDF and DL-PCB 
(mono-ortho, non-ortho PCB) were reduced, compared with the NFO diet. The results 
support the effectiveness of using the activated carbon and thin film deodourisation in 
the decontamination process for the dioxins and DL-PCB. 
Similarly the dietary concentration of dioxin + DL-PCBs was reduced to 0.53 ng 
TEQ/kg or reduction of 97% in the SRO/SO diet, compared with the NFO diet. 
Moreover, the reduction of the PCDD was about 93% whereas the reductions of the 
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PCDF, the DL-PCB and the PBDE were over 95% in the SRO/SO diet compared with 
the NFO diet. As the current EU limits values for the combined dioxins and DL-PCB 
are 7 TEQ/kg feed, in the present study the value in the DFO diets would present about 
6.3% and in the SRO/SO about 7.6% of the EU limits (EC Commission Directive 2006). 
The PBDE value in the DFO diet was higher than that of the SRO/SO diet. The 
reduction of the PBDE due to using the two step decontamination process for the DFO 
diet was about 68% compared to the NFO diet whereas the reduction of the PBDE was 
reduced about 95% due to replacing the NFO with the SRO/SO in the diet indicating 
that the use of VO in salmon diet significantly reduced POPs loadings which should 
benefit consumers. 
Reflecting the diet, replacing the contaminated northern FO with 
decontaminated northern FO or the SRO/SO blends significantly reduced the dioxin and 
DL-PCB concentrations in salmon flesh after feeding diets for 10 weeks. In the present 
study, the combined dioxins and DL-PCB concentrations in flesh of fish fed the DFO 
and the SRO/SO diet were lower than those of fish fed the NFO diet by about 94-95%. 
However, the value of the combined dioxins and DL-PCB in flesh of fish fed all of the 
experimental diets was lower than the EU limits values. The limits value of the 
combined dioxins and DL-PCBs in fish products is 8 ngTEQ/kg (EC Commission 
Directive 2006). From this study, the flesh dioxins and DL-PCB concentration for the 
fish fed the NFO diet was 6.42 ngTEQ/kg, still below the EU limits of 8 ngTEQ/kg. The 
flesh concentration of fish fed the DFO (0.34 ngTEQ/kg) and the SRO/SO (0.41 
ngTEQ/kg) would represent 3.5% and 3.0% of the EU limit values. This result was in 
agreement with previous studies substituting FOs with VOs in fish feed reduced the 
levels of dioxins and DL-PCB in Atlantic salmon flesh (Bell et al. 2005a; Berntssen & 
Lundebye 2007). The concentration of PBDEs in the initial salmon flesh was 0.26 ng/g 
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wet weight and the PBDE value in the fish fed the NFO diets increased about 73% to 
0.94 ng/g wet weight) after culture with the NFO diet for 10 weeks. In contrast, the 
value of the PBDE in fish fed the DFO diet remained similar to the initial salmon and 
the value of the PBDE in the fish fed the SRO/SO diet decreased to 0.09 ng/g. This 
suggests that that PBDE levels in the flesh were significantly reduced by 
decontamination or replacement with southern FO and VO blends. All these values for 
flesh PBDEs in the present study, however, were lower than the values previously 
reported in Atlantic salmon (Jacobs et al. 2002a; Hites et al. 2004a).  
In conclusion, blending VOs with southern hemisphere FO is a strategy that may 
result in a lower impact upon tissue n-3HUFA levels, and that the decontamination of 
FO will have no major effect on the nutritional quality of FO as a feed ingredient for 
Atlantic salmon, although longer trials may be required to confirm this over the whole 
production cycle. Neither the SVO diets nor the DFO diet had any deleterious effects on 
growth as measured by final weights, SGR or TGC, or FCR. Therefore, despite lower 
ADC, decontamination of FO did not significantly impact on its nutritional quality of 
salmon. The replacement of northern FO with blends of VOs and southern hemisphere 
FO had minimal impact on HUFA levels in liver, but a greater effect on flesh HUFA 
levels. SO had significantly less impact than RO. Decontamination of northern FO had 
no effect on the n-3HUFA content of flesh of salmon fed the oil. Flesh dioxin, DL-PCB 
and PBDE concentrations were reduced to very low levels in fish fed the DFO and 
SRO/SO diets and so both strategies were very successful.  
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Chapter 4 - Influence of genotype/phenotype on the effects of 
alternative diets in Atlantic salmon (Salmo salar L.): 
Effects of total replacement of fish oil and partial 
replacement of fishmeal on growth performance, 
and tissue lipid and fatty acid compositions 
4.1 Introduction  
Atlantic salmon flesh contains abundant n-3 LC-PUFA, notably EPA and DHA, 
both of which are well recognised as being beneficial to human health by reducing the 
risk of inflammatory pathologies including cardiovascular and neurological disease 
(Brouwer et al. 2006; Givens & Gibbs 2006; Eilander et al. 2007). The high content 
of these EFA in salmon flesh is usually derived from their natural prey e.g. capelin, 
herring, sand eels, mackerel, anchovies and sardines (Sargent & Tacon 1999). Many of 
these marine fish species have traditionally been used for FM and FO production. FM 
and FO are excellent products for aquaculture feeds in terms of their AA and FA 
profiles. In addition, both, but particularly FO, are rich sources of energy, for normal 
growth, development and reproduction of fish (Sargent et al. 1999, 2002). In recent 
years, FM and FO production has been stagnant as the feed grade fisheries are, at best, 
at their sustainable limit, and an expansion in worldwide aquaculture has created 
problems for aquafeed production. It has been estimated that in 2006, the aquaculture 
sector consumed 3,724,000 tonnes of FM and 835,000 tonnes of FO (i.e. 68.2 % of the 
total global FM and 88.5 % of the total global FO production in 2006); this is equivalent 
to 16.6 million tonnes of small pelagic forage fish (Tacon & Metian 2008). To conserve 
and preserve future production from marine fisheries, while simultaneously developing 
aquaculture production, improvements in fish feed technology are urgently required. 
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Specifically, this can be achieved by decreasing the utilisation of traditional marine 
protein and oil sources and by introducing new, alternative raw materials.  
Among the many protein sources available, plant proteins (PP) appear to be the 
most appropriate alternatives to replace FM in fish diets. A number of studies have 
investigated the utilisation of PPs as substitutes for FM at varying degrees of inclusion. 
Carnivorous fish depend on lipid and protein rather than on carbohydrates for energy 
production (Van den Thillart 1986). Thus, partial replacement of FM by PP meals has 
been accomplished without serious negative effects on the growth of many carnivorous 
fish species (Nengas et al. 1996; Refstie et al. 2001; Lozano et al. 2007). In order to 
maintain a balanced AA profile, the application of a mixture of PP sources is more 
appropriate than the inclusion of a single PP (Gomes et al. 1995; Kaushik et al. 2004; 
Torstensen et al. 2008). 
As lipids not only provide essential PUFA but also are a major source of energy 
in the diet of salmonids, and given that salmonids have a high capacity to utilise lipid 
efficiently, high lipid (energy) diets are currently used in salmonid culture to allow 
dietary protein to be maximally spared for growth (Sargent et al. 1989, 2002). A 
number of studies have investigated VOs as either partial or complete replacements for 
FO in feeds for a variety of fish species, reporting no major negative effects on the 
growth of the fish or on feed utilisation as long as the EFA requirements are met by 
inclusion of FM (Bransden et al. 2003; Bell et al. 2004; Fonseca-Madrigal et al. 2005; 
Figueiredo-Silva et al. 2005; Richard et al. 2006; Oo et al. 2007; Pettersson et al. 
2009). The oils from fish species from the northern hemisphere are rich in long-chain 
monoenes, 20:1n-9 and 22:1n-11, whereas VOs are abundant in18:1n-9 and 18:2n-6 
(Bell et al. 2003a). Therefore, when selecting potential VOs for substituting FO in fish 
feeds, the energy availability and the PUFA content in the diet must be considered. RO 
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and PO have been investigated as promising alternative oils to replace FO in fish feed. 
Thus, RO contains an n-6/n-3 ratio of only about 2:1, which is suggested as being 
potentially beneficial to human health (Simopoulos 2000). However, RO that is rich in 
18:1n-9 and PUFA, specifically 18:2n-6 and 18:3n-3, is also devoid of n-3 LC-PUFA 
(Bell et al. 2001; Izquierdo et al. 2005; Mourente & Bell 2006), and PO contains high 
levels of 16:0 and 18:1n-9 and lower levels of 18:2n-6, and no 18:3n-3 or LC-PUFA 
(Ng 2002b). CO from the plant Camelina sativa, which is known by many names 
including, false flax or German sesame, contains high levels of 18:2n-6, 18:3n-3 and 
18:1n-9 (Putnam et al. 1993; Zubr 2003) and, unusually for a VO, 20:1n-9, which is 
more commonly found in FOs from species inhabitating high-latitudes and is a rich 
energy source in fish feeds (Sargent et al. 2002). As salmon flesh FA compositions have 
been shown to be closely correlated with dietary FAs (Rosenlund et al. 2001; Lie 2001; 
Torstensen et al. 2004a), using a mixture of different VOs to provide balanced levels of 
dietary FAs may be better physiologically for salmon health and welfare (Torstensen et 
al. 2005).  
Although salmonids are capable of synthesising LC-PUFA, e.g. ARA, EPA and 
DHA, by desaturation and elongation of C18 precursors (Tocher et al. 2002; Lall et al. 
2002), this capacity might not be efficient to meet HUFA requirements for optimal 
growth and welfare of fish, and so potential deficiencies must be met from dietary FM 
and FO (Tocher et al. 2003b; Bell et al. 2004). When fish are fed a diet containing a 
blend of VOs as the sole source of lipid, the reduction of n-3 HUFA and the 
accumulation of n-6 PUFA in flesh tissues can have a major impact on the FA 
composition of the final fish product (Torstensen et al. 2000, 2005; Mourente et al. 
2005; Mourente & Bell 2006). To maximise nutritional quality in terms of high levels 
of n-3 HUFA, the application of a “finishing” diet, which contains FO has been reported 
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to restore n-3 HUFA levels in flesh, to different degrees, in a variety of fish species 
including salmonids (Robin et al. 2003; Bell et al. 2004; Caballero et al. 2004; 
Torstensen et al. 2005; Mourente et al. 2005; Mourente & Bell 2006). Most of the 
previous studies have investigated replacement of FO with VOs in commercial strains 
of fish, including Atlantic salmon. In the present study, the effects of 
phenotype/genotype on VO replacement of FO were investigated in different 
strains/families of Atlantic salmon.  
Thus, the specific aims of the present study were to investigate the effects of the 
total replacement of FO with a blend of VOs, i.e. RO, PO and CO, in combination with 
partial replacement of FM in a formulation consisting of 25 % FM and ~45 % PPs, 
when fed to three genetically different groups of Atlantic salmon post-smolts. The 
groups of salmon consisted of two families of salmon designated as “FAT” and 
“LEAN” selected from a breeding programme (Landcatch Natural Selection, Ormsary, 
Scotland) and showing extremes of flesh lipid content (muscle adiposity), in 
comparison with a commercial strain used in previous VO studies (Bell et al. 2004; 
Torstensen et al. 2005), and obtained from Marine Harvest Scotland Ltd (Caledonian 
20, Fort William, Scotland). Fish were fed low FM diets with either 100% FO or VO in 
duplicate for one year until approaching marketable size, followed by a subsequent 
washout/finishing period. The growth performance, proximate compositions, lipid class 
and FA compositions of the flesh, livers and visceral tissues were determined after 55 
weeks on the experimental diets. In addition, the lipid and FA composition of flesh 
during the finishing phase when all fish were fed a FO diet were determined.  
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4.2 Materials and Methods 
4.2.1 Experimental fish  
Two groups of Atlantic salmon post smolts were selected as being fat or lean, 
based on muscle adiposity, by Landcatch Natural Selection (LNS). Each of the FAT and 
LEAN groups comprised equal numbers of two different genotypic families (Or04 013 
& 187, FAT; Or04 107 & 132, LEAN). A third strain was obtained from Marine 
Harvest Scotland Ltd (Caledonian 20, CAL). Two thousand fish of each strain/family 
were stocked into 12 x 5m
3
 net pens at the Ardnish Fish Trials Unit (Marine Harvest 
Scotland, Lochailort, PH38 4LZ, Highland; 500 fish per pen) and the initial mean 
weights were 52, 88 and 85g for the CAL, FAT and LEAN strains, respectively. The 
temperature over the experimental period (May 2006 to December 2007) ranged from 
5.5 to 17.0
o
C with a mean temperature of 11.5 ± 2.9
o
C. Diets were supplied by 
automatic feeders controlled by an automated feed sensor system (ArvoTec, Sterner 
AquaTech UK, Scotland). Feed use and mortalities were recorded and removed daily.  
4.2.2 Experimental diets  
The fish were fed one of two experimental diets, prepared by Skretting ARC 
(Stavanger, Norway) in 3 different pellet sizes (3, 6 and 9 mm) for a period of 55 weeks 
until the fish reached a weight of ~3 kg. The diets were formulated to fully satisfy the 
nutritional requirements of salmonid fish (NRC 1993). Duplicate pens of each of the 
three groups of salmon were fed a similar basal diet containing either 100 % Northern 
FO or a VO blend comprising RO/PO/CO in a ratio of 5:3:2. The diets contained 25 – 
32 % FM and 40 – 45 % plant meals. After sampling at 55 weeks, 60 fish per pen for 
each group, weighing between 2.0 and 3.5 kg, were placed in a single pen and the fish 
that had previously been fed the VO diet were marked by adipose fin clipping. Thus, the 
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original twelve pens were reduced to three and these pens were fed a finishing diet, 
having the same basal formulation as the 9 mm ongrowing diet but coated with a 
decontaminated FO (sand eel/sprat oil, 9:1v/v; Triple Nine Protein, Denmark), for a 
further 24 weeks. The diet formulations and proximate compositions of the 3, 6 and 9 
mm ongrowing feeds and 9 mm a finishing diet are shown in Table 4.1. Dietary FA 
compositions are shown in Table 4.2. Lipid class and FA compositions of flesh, liver 
and viscera at the beginning of the trial were given in Tables 4.3-4.4.  
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Table 4.1. Feed formulations (g kg
-1
), proximate compositions (g kg
-1
) and pigment 
 contents (mg kg
-1
) of the 3, 6, 9 mm ongrowning diets and the 9 mm finishing 
 diet fed to Atlantic salmon. 
3 mm 9 mm 3 mm 6 mm 9 mm
Feed ingredients (g/kg)
LT South Americal 
fishmeal 
a 320.0 250.0 320.0 250.0 250.0 250.0
Soybean meal (extract) 
b                   
125.0 110.0 125.0 100.0 110.0 110.0
Soya concentrate 
c             
50.0 70.0 50.0 65.6 70.0 70.0
Wheat gluten 
d              
149.6 90.0 150.0 150.0 90.0 90.0
Wheat
 e                        
70.0 78.8 72.2 77.0 78.8 78.8
Corn gluten 
f                 
43.0 50.0 42.9 50.0 50.0 50.0
Fish oil (Nordic) 
g                                     
227.7 300.0 - - - 300.0
Fish oil 
h
                      
(sand eel/sprat oil, 9:1)          
Rapeseed oil 
i              
- - 110.0 140.4 150.0 -
Palm oil 
b                    
- - 70.0 80.0 90.0 -
Camelina oil
 j      
- - 45.0 55.0 60.0 -
Astaxanthin 10% 0.5 0.5 0.5 0.5 0.5 0.5
Vitamins and minerals 15.0 51.2 15.0 25.2 51.2 51.2
Proximate composition (%)
Protein 46.8 41.0 46.7 44.7 40.5 37.7
Lipid 23.5 32.2 24.0 28.3 32.3 32.6
Moisture 7.4 4.6 7.2 5.0 5.1 7.6
Ash 7.1 6.0 6.9 7.5 6.0 8.7
Pigment content (mg/kg)
Total pigment 41.1 67.5 66.4 70.9 69.8 55.7
Astaxanthin 35.5 63.7 36.4 42.0 36.8 46.9
Astacene 2.0 1.4 2.1 1.6 0.8 1.7
Beta-carotene - - 22.1 22.6 26.6 4.1
Lutein 1.8 1.2 4.1 3.3 3.9 1.7
Zeaxanthin 1.7 1.2 1.8 1.4 1.7 1.5
Components
Diet FO Diet VO Finishing 
diet (FO)6 mm
250.0
100.0
65.6
150.0
77.0
57.2
275.4
-
-
-
0.5
25.2
45.5
28.0
5.3
6.9
54.9
1.5
49.8
1.9
-
1.6
 
Values are means of triplicate analysis. 
a
, Consortio, Peru; 
b
, Defona, Norway; 
c
, ADM, 
Holland,; 
d
, Cerestar, Scandinavia, AS Denmark; 
e
, Statkon, Norway; 
f
, Cargill, USA; 
g
, 
Nordsilmed, Norway; 
h
, Triple Nine Fish Protein, Denmark; 
i
, Emmelev AS, Denmark; 
j
, Technology Crop LTD, UK. 
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4.2.3 Experimental sampling protocol 
Ten fish per pen (twenty fish per dietary treatment) were randomly sampled and 
weighed at the initiation of the trial. After 55 weeks of the growth phase 25 fish per pen 
were weighed and measured and 20 fish per pen were sampled and pooled for analysis 
of flesh NQCs. During the washout phase, twenty four fish per dietary treatment pen 
(12 each previously fed the FO or VO diet) were taken after 8, 16 and 24 weeks on the 
finishing diet. Fish were anaesthetised by metacaine sulphonate (MS222; 50 mg/L), 
killed by a blow to the head and the gut cavity opened. Each fish was weighed, 
measured and gutted weight, viscera weight and liver weight recorded. Livers were 
dissected and collected individually and several samples produced from each liver. 
Firstly, approximately 0.5 g of liver were taken into 8 ml glass tubes containing ice-cold 
chloroform/methanol (2:1, w/v) and stored at -20
o
C for lipid class composition analysis. 
A further small piece of each liver, < 0.5 g, was collected into 1.5 ml microcentrifuge 
tubes and immediately frozen in liquid nitrogen before storage at -80
o
C for gene 
expression analysis (see Chapter 5). The remaining liver was placed in10 ml plastic test 
tubes, and immediately frozen at -20
o
C for lipid content analysis and FA compositional 
analysis. The viscera (minus liver) were wrapped in foil, homogenised and stored at -
20
o
 C prior to analysis of proximate, lipid class and FA compositions. Flesh samples 
were taken using the NQC, after removal of skin and bones they were subsequently 
homogenised and stored at -20
o
 C prior to analysis of pigment content, proximate, lipid 
class and FA compositions.  
4.2.4 Proximate and pigment composition analyses 
The moisture, crude protein, crude fat, fibre and ash contents of the diets as well 
as fish flesh and viscera were determined by standard procedures (AOAC 2000). Crude 
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fat contents of the experimental diets were determined after acid hydrolysis prior to fat 
extraction. The analytical methods were thoroughly described in Chapter 2. Pigment 
analysis of the diets and homogenised fish flesh were performed by HPLC following the 
method of Barua et al (1993). Diet samples were digested with Maxatase enzyme prior 
to extraction using the same solvent mixtures as used for the flesh samples. All methods 
are as described in Chapter 2.  
4.2.5 Lipid extraction and analysis 
Liver, flesh and viscera tissues were homogenates. Total lipids of tissues and 
diet samples were extracted by homogenising in 20 volumes of ice-cold 
chloroform/methanol (2:1, by vol.) according to the method of Folch et al. (1957). Lipid 
classes were separated by HPTLC and quantified by densitometry (Henderson & Tocher 
1992). The FAME were prepared by acid-catalysed transesterification (Christie 1993), 
purified as described TLC (Tocher & Harvie 1988), separated and quantified by gas-
liquid chromatography and individual FAME identified by comparison to known 
standards and by reference to published data (Ackman 1980). The methods were 
described in detail in Chapter 2.  
4.2.6 Calculations and statistical analysis 
The FCR and SGR were calculated using the formulae presented in Chapter 2. 
All the data are presented as means ± SD (n as reported) and statistical analyses 
performed using SPSS 14 (SPSS Inc, 2005). The effects of diet and salmon group 
(strain/family) on growth performance and nutritional composition were determined by 
two-way ANOVA. Data that were identified as non-normal distribution (Kolmogorov-
Chapter 4 
 114 
Smirnov test) were subjected to square root, log or arcsin transformation before 
analysis. Differences were regarded as significant when P < 0.05 (Zar, 1999).  
4.3 Results 
4.3.1 Proximate and fatty acid compositions of the diets  
The results of proximate and FA compositions of the diets were provided by the 
Nutrition Group, Institute of Aquaculture, University of Stirling. The feed formulations, 
proximate compositions and pigment contents of the experimental diets are given in 
Table 4.1. The relative protein content decreased and the lipid levels increased as the 
size of the pellets increased in line with normal commercial practice. Thus, the protein 
and lipid contents of the 3 mm pellets were 47 % and 24 % respectively; those of the 6 
mm pellets were 45 % and 28 %, and, those of the 9 mm pellet diet were 41 % and 32 
%. The total pigment contents of the VO diets were higher than the FO diet, at least in 
the smaller pellet sizes. Astaxanthin was the major carotenoid of all diets. Its 
composition was lower in the VO diets, particularly in the 6 and 9 mm diets, in 
comparison to the FO diets. The VO diet contained more beta carotene, lutein and 
zeaxanthin derived from the plant protein components (Table 4.1). 
The FA composition of the FO diets showed higher levels of 14:0, 16:1n-9, 
20:1, 22:1, 18:4n-3, 20:4n-3, 22:5n-3 ARA, EPA and DHA, than the VO diet (Table 
4.2). The FO diets, however, had lower levels of 20:0, 18:1, 18:2n-6 and 18:3n-3. The 
percentages of total MUFA in the FO and VO diets were 42 % and 46 % respectively, 
with 18:1n-9 being the main FA in both diets, although the 18:1n-9 content of the VO 
diet was approximately double that in the FO diet. In contrast, the 20:1 and 22:1 
contents of the FO diet were 2 and 8 times greater than levels found in the VO diet. 
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Total n-6 PUFA of the VO diet was 3 times greater than that of the FO diet, with 18:2n-
6 being the most prominent n-6 FA in both diets (Table 4.2). Total n-3 PUFA content of 
the FO and VO diets was 25 % and 14 % respectively, with EPA and DHA being the 
most prevalent n-3 FAs in the FO diet and 18:3n-3 being the predominant n-3 FA in the 
VO diet. The FA composition of the finishing diet was similar to that of the 9 mm FO 
diet used in the growth phase (Table 4.2). 
4.3.2 Lipid content, lipid class and fatty acid compositions of salmon tissues at 
the initiation of the trial 
The results of lipid and FA compositions of the tissues were provided by the 
Nutrition Group, Institute of Aquaculture, University of Stirling. The lipid contents and 
lipid class compositions of the flesh, liver and viscera at the initiation of the trial are 
given in Table 4.3. The lipid contents of the flesh of the three salmon groups ranged 
from 3 – 5 %, with the FAT and LEAN groups being similar and higher than that of the 
CAL strain. The lipid contents of the livers ranged from 3.5 -3.9 % and in rank order 
CAL > FAT > LEAN. Visceral lipid contents ranged from 36 -45 %, ranked FAT > 
LEAN > CAL.  
All groups of fish showed similar class compositions, with PC and PE were the 
main polar lipid classes and TAG was the major neutral lipid in all the analysed tissues. 
Visceral tissue contained the highest proportion of total neutral lipids at over 90%, with 
about 60 -62 % as TAG. The total neutral and polar lipid contents of the flesh were 75 
% - 81 % and 19 % – 25 % respectively, in all groups, with 55 %- 63 % of total lipid 
being TAG. The total neutral and polar lipid contents of liver ranged from 45 % - 51 % 
and 45 % - 55 % respectively, with 18 %-21 % consisting of TAG. The flesh and the 
viscera of both the FAT and LEAN groups had higher levels of neutral lipid and lower 
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levels of polar lipid compared to the CAL strain, whereas liver of both FAT and LEAN 
fish had lower neutral lipid contents compared with the CAL strain. 
Total SFA of flesh of all fish groups was around 23 %, with about 14 % being 
16:0, and total MUFA ranged from 41 - 44 %, with 14 % 18:1n-9 (Table 4.4). The total 
n-6 PUFA content of the flesh was approximately 6 %, mainly 18:2n-6, and total n-3 
PUFA was about 27 %, with 5% EPA and 17% DHA. Total SFA content of the liver of 
all fish groups was 27 % of total FAs, 20% being 16:0, and MUFA ranged from 20 - 26 
%, with 10 % 18:1n-9 (Table 4.5). The liver n-6 PUFA content was about 5 % in all 
groups with 2 % being 18:2n-6, and n-3 PUFA ranged from 41 – 47 % with 32 - 36 % 
being DHA. Total SFA of viscera of all fish ranged from 22 % with 13 % being 16:0, 
and MUFA ranged from 45 – 52 %, predominantly 18:1, 20:1 and 22:1 (Table 4.6). 
Total n-6 PUFA in viscera was about 7 % with 4 % 18:2n-6, and n-3 PUFA ranged 
from 20 – 25 %, with 10 – 13 % being DHA (Table 4.6). 
 
  
 
 
Table 4.2. Fatty acid compositions (percentage of total fatty acids) of the experimental diets fed to Atlantic salmon. 
3 mm 6 mm 9 mm 3 mm 6 mm 9 mm
Fatty acid
14:0 5.7 4.9 5.8 1.2 1.2 0.9 6.8
16:0 16.0 16.5 15.0 17.3 16.8 15.9 17.1
18:0 2.3 2.3 3.0 2.9 2.7 3.5 3.8
20:0 0.3 0.3 0.4 0.7 0.7 0.8 0.4
22:0 0.2 0.3 0.0 0.3 0.3 0.0 1.2
Total saturated
1
26.3 26.0 26.1 22.7 22.0 21.7 31.1
16:1n-7 5.9 5.3 5.2 1.1 1.2 0.9 6.7
18:1n-9 11.7 17.8 10.1 36.6 37.2 37.6 11.9
18:1n-7 2.4 2.5 1.9 2.0 2.1 1.6 2.6
20:1n-11 0.6 0.6 0.4 0.0 0.2 0.1 0.5
20:1n-9 7.4 5.4 8.5 3.2 3.9 4.0 4.3
22:1n-11 10.6 7.5 13.7 0.4 1.3 1.6 6.3
22:1n-9 0.9 0.8 0.9 0.7 0.9 0.8 0.4
24:1n-9 0.9 1.1 0.9 0.3 0.3 0.4 0.6
Total monoenes
2
41.6 42.2 42.6 44.6 47.5 47.5 34.5
18:2n-6 4.6 4.7 3.5 16.4 15.0 16.5 3.3
20:2n-6 0.2 0.4 0.3 0.3 0.3 0.4 0.2
20:3n-6 0.2 0.1 0.1 0.2 0.1 0.2 0.1
20:4n-6 0.6 0.6 0.4 0.2 0.1 0.1 0.8
Total n-6 PUFA
3
6.2 6.2 4.6 17.3 15.5 17.1 5.0
18:3n-3 1.4 2.2 1.6 9.6 9.3 10.0 0.9
18:4n-3 2.5 2.3 3.5 0.3 0.4 0.4 2.2
20:4n-3 0.6 0.5 0.6 0.1 0.1 0.1 0.6
20:5n-3 8.6 7.7 8.5 1.9 1.9 1.2 12.1
22:5n-3 0.9 0.8 0.8 0.3 0.2 0.1 1.4
22:6n-3 10.3 10.8 10.1 2.3 2.3 1.5 8.9
Total n-3 PUFA
4
24.4 24.4 25.3 14.8 14.5 13.4 26.3
Total PUFA 32.1 31.8 31.3 32.7 30.5 30.7 34.3
Finishing dietParameters
Diet FO Diet VO
 
1
 included 15:0 < 0.4%, 
2
 included 16:1n-9 and 20:1n-7 <0.3%, 
3
 included 18:3n-6 and 22:4n-6 and 22:5n-6 <0.2%, 
4
 included 20:3n-3 <0.3%.
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Table 4.3 Lipid contents (percentage of wet weight), and lipid class compositions 
 (percentage of total lipid) of Atlantic salmon tissues at the start of the trial. 
CAL FAT LEAN
Flesh 
Lipid contents 3.3 ± 0.5 
b
4.9 ± 0.4 
a
4.8 ± 0.5 
a
Phosphatidylcholine 10.7 ± 0.9 
a
8.3 ± 0.2 
b
9.1 ± 0.4 
b
Phosphatidylethanolamine 8.8 ± 0.8 
a
7.3 ± 0.5 7.2 ± 0.9
Phosphatidylserine 1.1 ± 0.1 0.8 ± 0.1 0.8 ± 0.3
Phosphatidylinositol 2.3 ± 0.3 
a
1.7 ± 0.2 
b
1.8 ± 0.1 
b
Sphingomyelin 0.3 ± 0.0 0.3 ± 0.1 0.3 ± 0.0
Lysophosphatidylcholine 2.1 ± 0.2 
a
1.6 ± 0.0 
b
1.3 ± 0.1 
b
Total polar lipids 25.3 ± 2.3 
a
19.4 ± 0.7 
b
20.5 ± 1.4 
b
Total neutral lipids 74.7 ± 2.3 
b
80.6 ± 0.7 
a
79.5 ± 1.4 
a
Triacylglycerol 55.0 ± 3.1 
b 63.0 ± 2.4 
a
60.2 ± 3.1 
ab
Sterol 6.9 ± 0.2 
a 5.8 ± 0.4 
b
5.8 ± 0.8 
b
Free fatty acids 10.2 ± 0.6 10.1 ± 1.1 11.3 ± 0.3
Steryl ester 2.4 ± 0.5 1.6 ± 0.5 2.1 ± 1.1
Liver 
Lipid contents 3.9 ± 0.2 3.7 ± 0.4 3.5 ± 0.2
Phosphatidylcholine 20.6 ± 2.1 
b
27.1 ± 1.9 
a
27.1 ± 1.9 
a
Phosphatidylethanolamine 13.6 ± 0.8 
b
15.8 ± 0.7 
a
16.4 ± 1.1 
a
Phosphatidylserine 3.0 ± 0.6 2.9 ± 0.3 2.8 ± 0.3
Phosphatidylinositol 3.4 ± 0.7 3.3 ± 0.3 3.3 ± 1.1
Sphingomyelin 1.7 ± 0.2 
b
2.4 ± 0.7 
a
2.2 ± 0.4 
ab
Lysophosphatidylchlorine 0.1 ± 0.1 
b
0.4 ± 0.1 
a
0.4 ± 0.2 
a
Unidentified polar lipids 2.3 ± 0.3 
b
2.9 ± 0.4 
a
3.0 ± 0.4 
a
Total polar lipids 44.9 ± 4.4 
b
54.8 ± 3.6 
a
55.3 ± 2.9 
a
Total neutral lipids 55.1 ± 4.4 
a
45.2 ± 3.6 
b
44.7 ± 2.9 
b
Triacylglycerol 20.6 ± 2.8 18.6 ± 2.4 17.8 ± 1.4
Sterol 13.0 ± 0.9 
b
13.9 ± 1.1 
a
13.8 ± 0.7 
a
Free fatty acids 2.1 ± 0.5 1.6 ± 1.1 1.7 ± 0.6
Steryl ester 16.8 ± 3.7 8.0 ± 3.7 8.3 ± 3.6
Unidentified neutral lipid 2.6 ± 0.5 3.0 ± 0.5 3.2 ± 0.7
Viscera 
Lipid contents 36.4 ± 11.8 45.4 ± 6.6 39.9 ± 4.6
Phosphatidylcholine 3.4 ± 1.0 2.6 ± 0.5 2.8 ± 0.2
Phosphatidylethanolamine 2.3 ± 0.7 1.9 ± 0.4 1.9 ± 0.2
Phosphatidylserine 0.2 ± 0.0 
ab
0.4 ± 0.2 
a
0.1 ± 0.0 
b
Phosphatidylinositol 0.4 ± 0.1 
a
0.2 ± 0.0 
ab
0.1 ± 0.0 
b
Sphingomyelin 0.4 ± 0.1 0.4 ± 0.1 0.4 ± 0.1
Unidentified polar lipids 0.8 ± 0.2 0.5 ± 0.3 0.4 ± 0.1
Total polar lipids 7.4 ± 2.1 6.0 ± 0.9 5.7 ± 0.6
Total neutral lipids 92.6 ± 2.1 94.0 ± 0.9 94.3 ± 0.6
Triacylglycerol 59.5 ± 3.4 61.3 ± 4.1 62.7 ± 1.9
Sterol 13.7 ± 2.7 
a
13.8 ± 0.9 
a
12.7 ± 1.3 
b
Free fatty acids 13.4 ± 1.2 14.0 ± 1.1 14.1 ± 0.2
Steryl ester 6.1 ± 0.4 4.8 ± 0.7 4.8 ± 0.2
Lipid classes
Group
 
Results are means ± SD (n = 2). CAL, Caledonian 20 strain; FAT & LEAN, fat and lean 
families. 
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Table 4.4. Fatty acid compositions (percentage of total fatty acids) of flesh of 3 groups 
 of Atlantic salmon at the start of the trial.  
CAL FAT LEAN
Fatty acid
14:0 3.7 ± 0.1 4.3 ± 0.2 4.3 ± 0.1
16:0 14.0 ± 0.4 14.8 ± 0.6 14.5 ± 0.4
18:0 3.0 ± 0.2 3.6 ± 0.2 3.2 ± 0.2
20:0 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0
Total saturated 
1
22.1 ± 0.4 24.3 ± 1.2 23.3 ± 0.8
16:1n-9 0.2 ± 0.0 0.2 ± 0.0 0.3 ± 0.1
16:1n-7 5.4 ± 0.2 
b
6.6 ± 0.1 
a
6.4 ± 0.1 
a
18:1n-9 14.3 ± 0.4 14.7 ± 0.1 14.4 ± 0.1
18:1n-7 2.9 ± 0.1 
b
3.3 ± 0.1 
a
3.2 ± 0.1 
a
20:1n11 0.9 ± 0.1 
a
0.5 ± 0.1 
b
0.6 ± 0.0 
b
20:1n-9 9.1 ± 0.4 
a
7.4 ± 0.0 
b
7.2 ± 0.2 
b
20:1n-7 0.5 ± 0.0 0.5 ± 0.0 0.5 ± 0.0
22:1n11 8.5 ± 0.5 
a
6.8 ± 0.1 
b
6.6 ± 0.2 
b
22:1n-9 0.9 ± 0.1 
a
0.7 ± 0.0 
b
0.7 ± 0.0 
b
24:1n-9 0.7 ± 0.0 0.7 ± 0.1 0.7 ± 0.0
Total monoenes 43.7 ± 1.7 
a
41.9 ± 0.2 
ab
41.1 ± 0.5 
b
18:2n-6 3.7 ± 0.1 
b
4.3 ± 0.1 
a
4.3 ± 0.1 
a
18:3n-6 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0
20:2n-6 0.3 ± 0.0 
b
0.5 ± 0.0 
a
0.5 ± 0.0 
a
20:3n-6 0.3 ± 0.0 0.3 ± 0.1 0.2 ± 0.0
20:4n-6 0.5 ± 0.1 0.6 ± 0.0 0.6 ± 0.1
22:4n-6 0.4 ± 0.1 0.1 ± 0.1 0.2 ± 0.2
22:5n-6 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0
Total n-6 PUFA 5.8 ± 0.1 
b
6.2 ± 0.2 
a
6.2 ± 0.3 
a
18:3n-3 0.8 ± 0.0 
b
1.1 ± 0.1 
a
1.0 ± 0.0 
a
18:4n-3 1.4 ± 0.1 1.5 ± 0.1 1.5 ± 0.1
20:3n-3 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0
20:4n-3 0.9 ± 0.0 1.0 ± 0.1 1.0 ± 0.1
20:5n-3 4.7 ± 0.2 
b
5.1 ± 0.2 
a
5.1 ± 0.1 
a
22:5n-3 2.0 ± 0.1 
b
2.2 ± 0.1 
ab
2.3 ± 0.1 
a
22:6n-3 17.8 ± 1.2 15.6 ± 0.9 17.2 ± 0.3
Total n-3 PUFA 27.6 ± 1.4 26.5 ± 1.3 28.3 ± 0.3
Total PUFA 
2
34.2 ± 1.3 33.9 ± 1.3 35.6 ± 0.6
Parameters
Group
 
 Results are means ± SD (n = 2). 
1
 included 15:0, 17:0, up to 0.3%, 
2
 included 16:2, 16:3 
and 16:4 up to 0.5%, CAL, Caledonian 20 strain; FAT & LEAN, fat and lean families; 
PUFA, polyunsaturated fatty acids. 
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Table 4.5. Fatty acid compositions (percentage of total fatty acids) of liver of 3 groups of 
 Atlantic salmon at the start of the trial.  
CAL FAT LEAN
Fatty acid
14:0 2.3 ± 0.3 2.2 ± 0.1 2.2 ± 0.1
16:0 19.6 ± 1.2 19.8 ± 0.7 19.5 ± 0.4
18:0 3.6 ± 0.4 
b
3.9 ± 0.2 
ab
4.0 ± 0.1 
b
20:0 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0
Total saturated 
1
26.7 ± 1.4 27.1 ± 1.0 27.0 ± 0.6
16:1n-9 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.0
16:1n-7 3.2 ± 0.2 
a
2.8 ± 0.1 
b
2.7 ± 0.2 
b
18:1n-9 10.6 ± 0.5 
a
9.2 ± 0.8 
b
9.1 ± 0.4 
b
18:1n-7 2.5 ± 0.1 2.4 ± 0.1 2.4 ± 0.1
20:1n-11 0.5 ± 0.1 
a
0.3 ± 0.1 
b
0.3 ± 0.1 
b
20:1n-9 4.2 ± 0.5 
a
2.4 ± 0.2 
b
2.3 ± 0.2 
b
20:1n-7 0.4 ± 0.3 0.2 ± 0.0 0.2 ± 0.0
22:1n11 2.9 ± 0.7 
a
1.2 ± 0.1 
b
1.1 ± 0.2 
b
22:1n-9 0.4 ± 0.1 
a
0.2 ± 0.1 
b
0.1 ± 0.1 
b
24:1n-9 1.1 ± 0.1 1.0 ± 0.1 1.0 ± 0.1
Total monoenes 26.3 ± 1.9 
a
20.4 ± 1.4 
b
20.0 ± 1.1 
b
18:2n-6 2.4 ± 0.1 
a
1.8 ± 0.1 
b
1.7 ± 0.1 
b
18:3n-6 0.1 ± 0.0 0.1 ± 0.0 0.2 ± 0.1
20:2n-6 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.0
20:3n-6 0.3 ± 0.1 0.3 ± 0.1 0.4 ± 0.1
20:4n-6 1.9 ± 0.3 
b
2.4 ± 0.1 
a
2.5 ± 0.1 
a
22:4n-6 0.1 ± 0.1 n.d. 0.1 ± 0.1
22:5n-6 0.2 ± 0.0 
b
0.4 ± 0.0 
a
0.4 ± 0.0 
a
Total n-6 PUFA 5.4 ± 0.3 5.4 ± 0.3 5.5 ± 0.1
18:3n-3 0.5 ± 0.0 0.5 ± 0.0 0.5 ± 0.0
18:4n-3 0.6 ± 0.1 
a
0.4 ± 0.1 
b
0.4 ± 0.0 
b
20:3n-3 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0
20:4n-3 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1
20:5n-3 5.4 ± 0.3 
b
7.5 ± 0.3 
a
7.4 ± 0.2 
a
22:5n-3 1.8 ± 0.1 1.9 ± 0.1 1.8 ± 0.1
22:6n-3 32.1 ± 1.7 
b
35.7 ± 1.4 
a
36.3 ± 1.2 
a
Total n-3 PUFA 41.2 ± 1.9 46.9 ± 1.6 47.2 ± 1.1
Total PUFA 
2
47.0 ± 2.1 52.5 ± 1.7 53.0 ± 1.1
Parameters
Group
 
Results are means ± SD (n = 2). 
1
 included 15:0, 17:0, up to 0.3%, 
2
 included 16:2, 16:3 
and 16:4 up to 0.1%, CAL, Caledonian 20 strain; FAT & LEAN, fat and lean families; 
PUFA, polyunsaturated fatty acids. 
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Table 4.6. Fatty acid compositions (percentage of total fatty acids) of viscera of 3 groups of 
 Atlantic salmon at the start of the trial.  
CAL FAT LEAN
Fatty acid
14:0 4.3 ± 0.1 
b
4.8 ± 0.2 
a
4.6 ± 0.1 
a
16:0 12.4 ± 0.1 
b
13.7 ± 0.2 
a
13.2 ± 0.3 
a
18:0 2.4 ± 0.1 
b
3.0 ± 0.3 
a
2.8 ± 0.2 
a
20:0 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0
Total saturated 
1
20.3 ± 0.2 
b
22.9 ± 0.7 
a
22.2 ± 0.6 
a
16:1n-9 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0
16:1n-7 6.7 ± 0.0 
b
7.6 ± 0.1 
a
7.4 ± 0.1 
a
18:1n-9 16.9 ± 0.5 
a
16.3 ± 0.3 
ab
16.0 ± 0.2 
b
18:1n-7 3.2 ± 0.1 
b
3.4 ± 0.1 
a
3.4 ± 0.0 
a
20:1n-11 0.5 ± 0.2 0.5 ± 0.1 0.6 ± 0.0
20:1n-9 11.7 ± 0.7 
a
8.0 ± 0.2 
b
7.8 ± 0.1 
b
20:1n-7 0.5 ± 0.1 0.5 ± 0.0 0.5 ± 0.0
22:1n11 10.4 ± 0.4 
a
7.2 ± 0.3 
b
7.0 ± 0.1 
b
22:1n-9 1.1 ± 0.1 
a
0.7 ± 0.0 
b
0.7 ± 0.0 
b
24:1n-9 0.7 ± 0.1 0.7 ± 0.1 0.6 ± 0.1
Total monoenes 52.4 ± 1.5 
a
45.5 ± 1.0 
b
44.5 ± 0.5 
b
18:2n-6 4.6 ± 0.1 
b
4.9 ± 0.1 
a
5.1 ± 0.1 
a
18:3n-6 0.2 ± 0.0 0.3 ± 0.1 0.3 ± 0.1
20:2n-6 0.5 ± 0.0 0.5 ± 0.0 0.5 ± 0.0
20:3n-6 0.3 ± 0.1 0.3 ± 0.1 0.3 ± 0.1
20:4n-6 0.4 ± 0.1 0.5 ± 0.1 0.5 ± 0.1
22:4n-6 0.2 ± 0.2 0.3 ± 0.2 0.1 ± 0.2
22:5n-6 0.2 ± 0.1 0.2 ± 0.0 0.2 ± 0.0
Total n-6 PUFA 6.3 ± 0.1 
b
7.0 ± 0.1 
a
7.0 ± 0.4 
a
18:3n-3 0.9 ± 0.0 
b
1.2 ± 0.0 
a
1.2 ± 0.1 
a
18:4n-3 1.7 ± 0.0 
b
1.8 ± 0.1 
a
1.9 ± 0.0 
a
20:3n-3 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0
20:4n-3 1.0 ± 0.1 1.0 ± 0.1 1.0 ± 0.0
20:5n-3 3.9 ± 0.2 
b
4.9 ± 0.2 
a
5.2 ± 0.2 
a
22:5n-3 2.0 ± 0.1 
b
2.2 ± 0.1 
ab
2.4 ± 0.1 
a
22:6n-3 10.3 ± 1.1 
b
12.0 ± 1.2 
ab
13.1 ± 0.5 
a
Total n-3 PUFA 20.0 ± 1.5 
b
23.2 ± 1.7 
ab
24.9 ± 0.7 
a
Total PUFA
2
27.3 ± 1.4 
b
31.6 ± 1.6 
a
33.3 ± 1.0 
a
Parameters
Group
 
Results are means ± SD (n = 2).
1
 included 15:0, 17:0, up to 0.3%, 
2
 included 16:2, 16:3 
and 16:4 up to 0.6%, CAL, Caledonian 20 strain; FAT & LEAN, fat and lean families; 
PUFA, polyunsaturated fatty acids. 
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4.3.3 Growth performance of salmon during the 55 week ongrowing phase 
The sizes (length and weight) of the fish at the initiation of the trial and after 32 
and 55 weeks on the experimental diets are given in Table 4.7. The CAL strain fish 
were significantly smaller than the FAT and LEAN strains at the initiation of the trial. A 
significant difference in weight and length was found between fish fed the two diets 
after 32 weeks of the growth period. Significant differences were also observed between 
fish groups in weight, FCR, SGR, HSI and VSI at week 55. Regardless of diet, the CAL 
and FAT fish showed significantly lower FCR and HSI than the LEAN fish. In addition, 
the CAL strain had a significantly greater SGR than the FAT and LEAN fish (Table 
4.7). Consistent with this, the LEAN fish had a higher HSI than the FAT fish, which 
conversely had a greater VSI than the LEAN fish. No significant differences, however, 
were observed in the HSI between the CAL and the LEAN fish.  
4.3.4  Proximate compositions of flesh and viscera and flesh pigment content at 
week 55 of the growth period  
There were significant effects of both diet and group on the protein, lipid and 
moisture contents of the flesh at week 55 (Table 4.8). There were also significant effects 
of group on all parameters, but only protein and moisture contents (not lipid and ash) 
were affected by diet in viscera. All the fish fed the FO diet had a lower protein content 
in their flesh than the fish fed the VO diet, with the groups ranked LEAN > CAL > FAT 
in both diets (Table 4.8). Regarding to the diets, the flesh lipid contents of CAL and 
FAT fish fed the FO diet were higher than the same groups fed the VO diet while, 
conversely, the LEAN fish fed the VO diet had a higher lipid content than the fish fed 
the FO diet. For the fish receiving the FO diet, the flesh lipid content can be ranked 
FAT > CAL > LEAN, while for fish consuming the VO diet, the flesh lipid content can 
be ranked FAT > LEAN > CAL (Table 4.8). Similarly, the flesh of CAL and FAT fish 
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fed the FO diet had lower moisture contents than fish fed the VO diet. The reverse 
situation was observed for flesh of the LEAN fish fed the FO diet, which had a similar 
moisture content to LEAN fish fed VO. The proximate composition of the viscera was 
different from flesh. Within the FO diet, the visceral protein content was ranked CAL > 
FAT > LEAN, whereas for fish fed the VO diet it was CAL > LEAN > FAT (Table 
4.8). Lipid content of the viscera was affected by fish group (strain/family). Thus, the 
lipid contents of the viscera of the FAT and LEAN fish were higher than the CAL strain 
irrespective of diet. The viscera of all fish groups fed the FO diet had lower moisture 
content than those of fish fed the VO diet. The viscera of the CAL and LEAN strains 
had higher moisture contents than those of the FAT fish irrespective of diet.  
Diet and group produced significant differences in the total pigment and the 
astaxanthin contents of the flesh at week 55 of the growth period (Table 4.8). All fish 
fed the FO diet had higher pigment levels than those fed the VO diet due to the VO diet 
had lower levels of pigment than the FO diet. The CAL strain, however, were found to 
have the highest total pigment and astaxanthin levels which were different from those of 
FAT and LEAN strains fed either diet (Table 4.8). 
 
   
Table 4.7. Growth performance of  3 groups of Atlantic salmon.  
 
      MH       FAT    LEAN        MH FAT      LEAN    Diet Strain Diet strain
Weight 
Initial (g) 52.8 ± 1.5 92.1 ± 4.9 80.6 ± 11.6 51.6 ± 2.1 84.3 ± 8.7 89.5 ± 12.9 0.994 0.001 0.408
32 weeks (kg) 1.44 ± 0.21 1.42 ± 0.22 1.39 ± 0.31 1.43 ± 0.18 1.23 ± 0.25 1.24 ±0.30 0.027 0.058 0.211
55 weeks (kg) 2.75 ± 0.13 3.18 ± 0.08 3.13 ± 0.13 2.84 ± 0.04 2.89 ± 0.04 3.03 ± 0.09 0.118 0.019 0.027
Length (cm)
Initial 17.4 ± 0.2 20.1 ± 0.4 19.4 ± 0.9 17.3 ± 0.2 19.3 ± 0.6 20.0 ± 0.6 0.801 0.001 0.281
32 weeks 47.1 ± 0.2 46.4 ± 1.0 46.9 ± 0.4 46.2 ± 0.0 44.9 ± 0.7 45.1 ± 0.6 0.006 0.130 0.560
55 weeks 63.1 ± 1.6 63.9 ± 1.0 65.3 ± 0.5 62.8 ± 0.8 62.5 ± 0.7 63.7 ± 1.0 0.100 0.138 0.649
FCR 1.08 ± 0.06 1.08 ± 0.09 1.23 ± 0.03 1.06 ± 0.05 1.19 ± 0.03 1.39 ± 0.22 0.211 0.041 0.495
SGR 1.00 ± 0.01 0.93 ± 0.01 0.92 ± 0.02 1.01 ± 0.01 0.89 ± 0.00 0.91 ± 0.01 0.109 0.0001 0.065
HSI 0.62 ± 0.04 0.59 ± 0.03 0.71 ± 0.00 0.61 ± 0.01 0.61 ± 0.00 0.70 ± 0.07 0.935 0.010 0.829
VSI 4.97 ± 0.32 5.17 ± 0.09 4.92 ± 0.32 4.82 ± 0.01 5.51 ± 0.18   4.82 ± 0.01 0.706 0.035 0.281
Parameters
FO VO ANOVA
 
Results are means ± SD (n = 2). CAL, Caledonian 20 strain; FAT & LEAN, fat and lean families; FCR, feed conversion ratio; HSI, hepato- 
somatic index; SGR, specific growth rate; VSI, viscero- somatic index.  
   
Table 4.8. Proximate compositions (percentage of wet weight) of tissues of 3 groups of Atlantic salmon at week 55.  
CAL FAT LEAN CAL FAT LEAN Diet Group Diet Group
Proximate 
compositions (%)
Flesh
     Protein 19.3 ± 0.1 19.1 ± 0.2 19.4 ± 0.1 19.5 ± 0.1 19.2 ± 0.1 19.9 ± 0.3 0.006 0.001 0.081
     Lipid 12.0 ± 0.2 12.8 ±  0.1 11.9 ± 0.1 10.9±  0.1 12.1±  0.1 12.0 ± 0.2 <0.000 <0.000 <0.000
    Moisture 67.5 ± 0.3 66.1 ± 0.4 66.5 ± 0.2 68.2 ± 0.1 67.2 ± 0.1 66.0 ± 0.4 0.006 <0.000 0.001
     Ash 1.7 ± 0.1 1.7 ± 0.0 1.8 ± 0.2 1.6 ± 0.0 1.6 ± 0.1 1.8 ± 0.0 0.099 0.002 0.124
Viscera
     Protein 13.9 ± 0.1 13.3 ± 0.1 12.7 ± 0.1 14.6 ± 0.1 12.7 ± 0.1 13.9 ± 0.1 <0.000 <0.000 <0.000
     Lipid 25.8 ± 0.4 31.7 ± 0.7 28.0 ± 0.4 26.8 ± 0.1 29.4 ± 0.3 29.6 ± 0.3 0.702 <0.000 <0.000
    Moisture 56.8 ± 0.4 53.0 ± 0.5 57.1 ± 0.9 57.0 ± 0.1 56.0 ± 0.4 57.2 ± 0.6 0.001 <0.000 0.001
     Ash 1.2 ± 0.0 1.1 ± 0.0 1.2 ± 0.0 1.3 ± 0.0 1.2 ± 0.0 1.1 ± 0.1 0.207 <0.000 <0.000
Flesh pigment
Total pigment 6.08 ± 0.40 5.29 ± 0.19 5.01 ± 0.20 5.24 ± 0.25 5.03 ± 0.14 4.17 ± 0.14 <0.000 <0.000 0.043
Astaxanthin 5.82 ± 0.41 5.11 ± 0.19 4.85 ± 0.21 4.96 ± 0.23 4.80 ± 0.14 3.99 ± 0.15 <0.000 <0.000 0.051
Parameter
FO VO  ANOVA
 
Results are means ± SD (n = 2). CAL, Caledonian 20 strain; FAT & LEAN, fat and lean families; FO, fish oil diet; VO, vegetable oil diet. 
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4.3.5 Lipid class compositions of salmon tissues at week 55 
Neutral lipid accounted for approximately 50-60 %, 87 % and 92 % of total lipid 
in the liver, flesh and viscera, respectively, of salmon at the end of the ongrowing phase 
(Tables 4.9–4.11). There were significant effects of diet and fish group on the total polar 
and neutral lipid composition of the flesh, with polar and neutral lipids being higher and 
lower, respectively, in fish fed the FO diet compared to salmon fed the VO diet (Table 
4.9). Regardless of diet, the levels of flesh total neutral lipid can be ranked LEAN> 
FAT > CAL , while the reverse situation was observed for the polar lipid content. Flesh 
PC and PE were also influenced by diet and group, with the CAL strain having a higher 
PC and PE content than the FAT and LEAN fish irrespective of diet (Table 4.9). The 
sterol content of the flesh was significantly affected by diet, with FAT and LEAN fish 
fed the VO diet having higher levels than the same fish fed the FO diet (Table 4.9). Diet 
and group did not appear to affect flesh levels of TAG and FFA.  
The levels of total polar and neutral lipid of liver were affected by both diet and 
group, with all fish fed the FO diet having higher levels of all polar lipids. The levels of 
liver total neutral lipid can be ranked LEAN> FAT > CAL and FAT > LEAN > CAL in 
groups of fish fed the FO and VO diets, respectively. The polar lipid content was the 
reverse of the neutral lipid. All fish fed the FO diet also had higher PC PE, PI, PS and 
SM, and lower levels of neutral lipids, particularly TAG and FFA, than fish fed the VO 
diet (Table 4.10). In addition, the CAL strain had lower levels of liver TAG and FFA, 
and higher levels of all polar lipids (PC, PE, PI, PS and SM) than the FAT and LEAN 
fish irrespective of diet. In fish fed the VO diet, the CAL strain was found to have the 
highest liver sterol level, and LEAN fish showed higher levels of sterol than the FAT 
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fish irrespective of diet (Table 4.10). All fish fed the VO diet showed higher levels of an 
unknown neutral lipid than fish fed the FO diet. 
There were significant effects of diet and group, and interaction, on TAG and 
sterol levels in the viscera (Table 4.11). Thus, in fish fed FO, visceral TAG levels were 
significantly higher in CAL fish compared to FAT and LEAN fish, whereas in fish fed 
VO the opposite was observed, with CAL fish displaying the lowest level of TAG. In 
contrast, visceral sterol levels showed the opposite pattern with levels being lowest in 
CAL fish when fed FO and highest when fed VO (Table 4.11). The pattern observed in 
TAG levels was reflected in total neutral lipid levels but not to the level of significance.  
Similarly, the pattern observed in visceral sterol content was mirrored by total polar 
lipids and individual polar lipid classes, but not reaching statistical significance (Table 
4.11). Steryl esters were higher in CAL fish compared to FAT and LEAN fish, 
irrespective of diet. 
 
  
 
 
 
 
Table 4.9. Lipid class composition (percentage of total lipid) of flesh of 3 groups of Atlantic salmon at week 55. 
      CAL       FAT    LEAN      CAL      FAT     LEAN   Diet   Group Diet Group
Phosphatidylcholine 7.0 ± 0.5 6.2 ± 0.5 5.9 ± 0.2 6.3 ± 0.4 6.2 ± 0.4 4.9 ± 0.3 0.002 <0.000 0.091
Phosphatidylethanolamine 6.1 ± 0.4 5.7 ± 0.7 5.5 ± 0.2 5.5 ± 0.4 4.8 ± 0.4 4.6 ± 0.4 <0.000 0.009 0.722
Sphingomyelin 0.7 ± 0.2 0.7 ± 0.1 0.4 ± 0.0 0.5 ± 0.3 0.4 ± 0.1 0.4 ± 0.1 0.012 0.049 0.293
Lysophosphatidylcholine 0.4 ± 0.1 0.4 ± 0.1 0.4 ± 0.1 0.5 ± 0.1 0.2 ± 0.1 0.4 ± 0.3 0.708 0.196 0.173
Total polar lipids 15.3 ± 0.9 14.4 ± 1.1 13.3 ± 0.2 14.2 ± 0.4 12.4 ± 0.7 11.3 ± 0.9 <0.000 <0.000 0.380
Total neutral lipids 84.7 ± 0.9 85.6 ± 1.1 86.7 ± 0.2 85.8 ± 0.4 87.6 ± 0.7 88.7 ± 0.9 <0.000 <0.000 0.380
Triacylglycerol 72.6 ± 0.5 72.5 ± 2.8 74.1 ± 1.4 72.1 ± 1.5 73.7 ± 0.5 74.6 ± 1.1 0.521 0.046 0.542
Sterol 7.4 ± 0.3 7.4 ± 1.0 7.0 ± 0.5 7.4 ± 0.5 8.2 ± 0.5 9.1 ± 0.5 0.001 0.116 0.011
Free fatty acids 4.8 ± 0.5 5.7 ± 1.0 5.6 ± 1.0 6.3 ± 0.5 5.7 ± 0.5 5.0 ± 0.8 0.493 0.699 0.075
Steryl ester n.d. n.d. n.d. n.d. n.d. n.d. - - -
0.226 0.817 0.0351.3 ± 0.4 0.8 ± 0.4 1.0 ± 0.4
Phosphatidylserine/ 
Phosphatidylinositol
1.1 ± 0.2 1.5 ± 0.1 1.2 ± 0.3
Lipid classes
FO VO ANOVA
 
Results are means ± SD (n = 2). CAL, Caledonian 20 strain; FAT & LEAN, fat and lean families; FO, fish oil diet; n.d., not detected; VO, 
vegetable oil diet.  
  
 
 
 
 
Table 4.10. Lipid class composition (percentage of total lipid) of liver of 3 groups of Atlantic salmon at week 55. 
      CAL       FAT    LEAN      CAL      FAT     LEAN    Diet     Group Diet Group
Phosphatidylcholine 19.9  1.3 18.1  2.7 18.6  0.4 19.0  2.0 13.5  1.2 15.6  0.6 <0.000 0.001 0.085
Phosphatidylserine 3.5  0.4 3.1  0.1 2.7  0.2 2.8  0.3 2.3  0.3 2.5  0.2 <0.000 0.003 0.077
Phosphatidylinositol 4.8  0.7 4.8  0.3 4.3  0.1 4.0  0.8 3.7  0.4 3.4  0.4 <0.000 0.129 0.770
Sphingomyelin 3.1  0.1 2.6  0.1 2.1  0.4 2.5  0.2 1.7  0.3 1.4  0.5 <0.000 <0.000 0.810
Lysophosphatidylcholine 0.5  0.2 0.6  0.2        tr.        tr.        tr.        tr.        -      -          -
Unidentified polar lipid 3.0  0.3 2.1  0.3 3.2  0.3 2.9  0.4 3.0  0.3 3.0  0.8 0.480 0.734 0.989
Total polar lipids 50.0  2.4 46.7  2.0 44.3  0.6 43.9  4.5 36.9  2.9 38.3  0.6 <0.000 0.001 0.260
Total neutral lipids 50.0  2.4 53.3  2.0 55.7  0.6 56.1  4.5 63.1  2.9 61.7  0.6 <0.000 0.001 0.260
Triacylglycerol 24.1  2.8 26.7 3.1 29.8  0.8 30.8  4.7 39.8  3.8 37.6  2.2 <0.000 0.001 0.116
Sterol 14.8  0.5 14.4  0.5 15.3  0.2 15.1  0.3 12.4  1.0 12.8  0.5 <0.000 <0.000 <0.000
Free fatty acids 2.2  0.7 2.9  0.9 2.0  0.3 1.4  0.5 1.7  0.4 1.8  1.0 0.016 0.349 0.365
Steryl ester 8.4  2.9 8.5  1.5 7.1  1.2 6.7  1.4 6.9  2.4 7.2  1.7 0.194 0.863 0.587
Unidentified neutral lipid 0.5  0.1 0.8  0.2 1.4  0.2 2.1  0.5 2.3  0.5 2.3  0.8 <0.000 0.029 0.224
ANOVA
12.2  1.5
Lipid classes
FO VO
Phosphatidylethanolamine/ 
Phosphatidylglycerol/        
diposphatidylglycerol
15.2  0.8 14.8  1.1 13.1  0.3 <0.000 0.172 0.26412.6  0.9 12.1  1.8
 
Results are means ± SD (n = 2). CAL, Caledonian 20 strain; FAT & LEAN, fat and lean families; FO, fish oil diet; tr,  0.5%; VO, vegetable 
oil diet.  
  
 
 
 
 
Table 4.11. Lipid class composition (percentage of total lipid) of viscera of 3 groups of Atlantic salmon at week 55. 
      CAL       FAT    LEAN      CAL      FAT     LEAN  Diet Group Diet  Group
Phosphatidylcholine 2.4 ± 0.2 3.0 ± 0.3 2.6 ± 0.4 2.9 ± 0.3 2.8 ± 0.5 2.8 ± 0.2 0.282 0.396 0.265
Phosphatidylethanolamine 2.4 ± 0.4 2.4 ± 0.2 3.1 ± 0.4 3.2 ± 0.7 2.9 ± 0.4 2.5 ± 0.4 0.260 0.865 0.017
Phosphatidylserine 0.5 ± 0.2 0.6 ± 0.1 0.6 ± 0.2 1.0 ± 0.3 0.7 ± 0.1 0.6 ± 0.2 0.105 0.053 0.011
Phosphatidylinositol 0.7 ± 0.1 0.6 ± 0.1 0.6 ± 0.1 0.9 ± 0.2 0.8 ± 0.1 0.6 ± 0.1 0.008 0.054 0.135
Sphingomyelin tr. tr. tr. tr. tr. tr. - - -
Total polar lipids 6.5 ± 0.8 7.3 ± 0.7 7.2 ± 1.3 8.6 ± 1.3 7.8 ± 1.2 6.7 ± 0.6 0.110 0.470 0.059
Total neutral lipids 93.5 ± 0.8 92.7 ± 0.7 92.8 ± 1.3 91.4 ± 1.3 92.2 ± 1.0 93.3 ± 0.6 0.110 0.470 0.059
Triacylglycerol 61.9 ± 3.3 60.8 ± 1.8 59.4 ± 3.8 45.9 ± 2.2 57.7 ± 1.1 57.5 ± 0.6 <0.000 0.001 <0.000
Ssterol 11.9 ± 1.8 13.4 ± 0.9 13.6 ± 0.8 17.9 ± 0.9 13.0 ± 0.5 13.8 ± 0.4 <0.000 0.009 <0.000
Free fatty acids 15.6 ± 1.0 17.9 ± 0.9 16.9 ± 1.7 22.3 ± 1.1 20.1 ± 0.5 20.2 ± 2.0 <0.000 0.772 0.007
Steryl ester 4.2 ± 0.5 1.3 ± 0.4 2.8 ± 0.5 5.2 ± 0.7 1.5 ± 0.5 1.8 ± 1.5 0.431 <0.000 0.0580
Lipid classes
FO VO ANOVA
 
Results are means ± SD (n = 2). CAL, Caledonian 20 strain; FAT & LEAN, fat and lean families; FO, fish oil diet; tr,  0.5 %; VO, vegetable 
oil diet.  
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4.3.6 Fatty acid compositions of salmon tissues at week 55 
Significant effects of diet and group on the FA profiles of the salmon tissues 
were clearly observed at week 55 (Tables 4.12-4.14). Diet significantly affected FA 
composition in all tissues in all groups of fish, but quantitative differences between fish 
groups, although sometimes significant, were generally much more minor. 
Total SFA, 14:0 and 16:0 levels in the flesh were significantly higher but levels 
of 18:0 and 20:0 were lower in fish fed the FO diet compared with fish fed the VO diet. 
Total SFA levels in flesh of the CAL and FAT fish were greater than those in LEAN 
fish irrespective of diet. In addition, the percentage of 16:0 was greater in the CAL and 
FAT strains fed the VO diet than in LEAN fish. The percentage of 16:0 in the CAL 
strain was higher than that of the FAT and LEAN fish (Table 4.12). Regardless of diet, 
flesh 18:0 content in the CAL strain was higher than that found in FAT and LEAN fish 
(Table 4.12). Flesh 16:1n-7, 18:1n-7, 20:1 and 22:1 were significantly higher in the fish 
fed the FO diet, but total MUFA and 18:1n-9 levels were higher in fish fed the VO diet 
(Table 4.12). Total n-6 PUFA, and especially 18:2n-6, levels in the flesh were 
significantly higher, but ARA significantly lower, in fish fed the VO diet compared to 
fish fed the FO diet (Table 4.12). In salmon fed the VO diet, flesh 18:2n-6 was 
significantly higher in LEAN fish than in CAL and FAT fish. Total PUFA and total n-3 
PUFA contents of the flesh including the 18:4n-3, 20:4n-3, 22:5n-3, EPA and DHA, 
were higher in fish fed the FO diet, whereas the 18:3n-3 content of the fish fed the VO 
diet was about 3 times higher than in fish fed FO (Table 4.12). In fish fed the VO diet, 
flesh 18:3n-3 was significantly higher in LEAN fish compared to CAL and FAT fish 
(Table 4.12). 
   
Table 4.12. Fatty acid composition (percentage of total fatty acids) of flesh of 3 groups of Atlantic salmon at week 55. 
      CAL       FAT    LEAN      CAL      FAT     LEAN    Diet     Group Diet  Group
Fatty acid
14:0 4.5 ± 0.2 4.6 ± 0.1 4.5 ± 0.1 1.5 ± 0.2 1.5 ± 0.1 1.4 ± 0.0 <0.000 0.033 0.186
16:0 15.4 ± 0.3 15.0 ± 0.3 15.0 ± 0.3 13.8 ± 0.2 13.7 ± 0.2 13.1 ± 0.1 <0.000 <0.000 0.040
18:0 2.8 ± 0.0 2.7 ± 0.1 2.6 ± 0.1 3.2 ± 0.1 3.0 ± 0.1 2.9 ± 0.1 <0.000 <0.000 0.136
20:0 0.1 ± 0.0 0.1 ± 0.1 0.1 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 <0.000 0.523 0.467
Total saturated
1 23.1 ± 0.5 22.8 ± 0.5 22.6 ± 0.4 18.9 ± 0.3 18.8 ± 0.4 17.9 ± 0.3 <0.000 <0.000 0.148
16:1n-7 5.6 ± 0.1 5.6 ± 0.1 5.5 ± 0.1 1.9 ± 0.2 2.0 ± 0.1 1.7 ± 0.1 <0.000 <0.000 0.165
18:1n-9 18.5 ± 0.3 17.8 ± 0.7 17.7 ± 0.5 37.1 ± 0.6 37.3 ± 0.4 37.7 ± 0.3 <0.000 0.345 0.004
18:1n-7 3.5 ± 0.2 3.2 ± 0.1 3.2 ± 0.2 2.7 ± 0.2 2.6 ± 0.5 2.4 ± 0.2 <0.000 0.037 0.699
20:1n-9 7.3 ± 0.1 7.5 ± 0.1 7.6 ± 0.1 5.1 ± 0.1 5.1 ± 0.1 5.2 ± 0.1 <0.000 <0.000 0.005
20:1n-7 0.5 ± 0.1 0.5 ± 0.1 0.5 ± 0.1 0.3 ± 0.0 0.3 ± 0.1 0.3 ± 0.0 <0.000 0.311 0.380
22:1n11 7.2± 0.4 7.6 ± 0.2 7.6 ± 0.2 1.3 ± 0.2 1.5 ± 0.1 1.3 ± 0.1 <0.000 0.063 0.499
22:1n-9 0.9 ± 0.4 0.8 ± 0.1 0.9 ± 0.2 0.7 ± 0.0 0.7 ± 0.0 0.7 ± 0.0 0.030 0.843 0.905
Total monoenes 44.3 ± 0.6 43.9 ± 0.3 43.7 ± 0.5 49.6 ± 0.3 49.8 ± 0.4 49.9 ± 0.3 <0.000 0.513 0.040
18:2n-6 5.0 ± 0.1 4.9 ± 0.1 4.9 ± 0.1 13.3 ± 0.3 13.3 ± 0.2 14.0 ± 0.2 <0.000 0.004 <0.000
18:3n-6 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 <0.000 0.054 0.168
20:2n-6 0.6 ± 0.0 0.6 ± 0.0 0.6 ± 0.0 1.5 ± 0.0 1.4 ± 0.0 1.6 ± 0.0 <0.000 <0.000 <0.000
20:3n-6 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.6 ± 0.0 0.6 ±0.0 0.6 ± 0.0 <0.000 0.066 0.845
20:4n-6 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 0.2 ± 0.0 0.2 ±0.0 0.2 ± 0.0 <0.000 0.093 0.673
Total n-6 PUFA 6.6 ± 0.1 6.4 ± 0.1 6.5 ± 0.2 15.8 ± 0.3 15.7 ± 0.2 16.5 ±0.2 <0.000 <0.000 <0.000
 18:3n-3 1.8 ± 0.1 1.9 ± 0.0 1.8 ± 0.1 6.2 ± 0.2 6.3 ± 0.1 6.7 ± 0.1 <0.000 <0.000 <0.000
18:4n-3 1.5 ± 0.1 1.8 ± 0.1 1.7 ± 0.1 0.7 ± 0.0 0.8 ± 0.0 0.7 ± 0.0 <0.000 <0.000 0.012
20:4n-3 1.6 ± 0.1 1.7 ± 0.0 1.7 ± 0.1 0.8 ± 0.0 0.9 ± 0.0 0.9 ± 0.0 <0.000 <0.000 0.598
20:5n-3 5.5 ± 0.2 5.7 ± 0.2 5.8 ± 0.1 1.9 ± 0.1 1.9 ± 0.1 1.7 ± 0.1 <0.000 0.173 0.011
22:5n-3 2.8 ±0.1 2.8 ± 0.1 2.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.0 0.9 ± 0.1 <0.000 0.498 0.123
22:6n-3 12.7 ± 0.6 12.8 ±0.4 13.1 ± 0.4 4.4 ± 0.2 4.2 ± 0.2 4.1 ± 0.2 <0.000 0.904 0.048
Total n-3 PUFA
2 26.0 ± 1.0 26.9 ± 0.7 27.1 ± 0.7 15.7 ± 0.2 15.7 ± 0.4 15.7 ± 0.3 <0.000 0.075 0.087
Total PUFA 32.6 ± 1.1 33.3 ± 0.8 33.6 ± 0.8 31.5 ± 0.4 31.4 ± 0.6 32.2 ± 0.3 <0.000 0.010 0.350
Parameters
FO VO ANOVA
 
Results are means ± SD (n = 2). 
1
 includes 15:0 and 22:0 up to 0.4 %; 
2
 includes 20:3n-3 up to 0.2 %; CAL, Caledonian 20 strain; FAT & 
LEAN, fat and lean families; FO, fish oil, PUFA, polyunsaturated fatty acids; VO, vegetable oil. 
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The effects of diet on the FA compositions of liver were similar to those 
described above for flesh. Irrespective of group, All FAs were significantly affected by 
diet except for 18:0, 20:1n-9 and 18:3n-6 (Table 4.13). Total SFA, 14:0 and 16:0 were 
significantly higher in livers of fish fed the FO diet. In fish fed the FO diet, the 
percentages of total SFA and 16:0 were significantly higher in CAL and FAT fish than 
LEAN fish (Table 4.13). In fish fed the VO diet, total SFA and 16:0 was highest in the 
CAL strain than the other groups (Table 4.13). Levels of 18:1n-9 and total MUFA in 
liver were highest in fish fed the VO diet, whereas percentages of 16:1n-7, 18:1n-7, 
20:1n-7 and 22:1n-11 were higher in fish fed the FO diet (Table 4.13). In fish fed the 
FO diet, total MUFA and 16:1n-7, 18:1n-9, 18:1n-7, 20:1 and 22:1 were higher in 
LEAN fish than in CAL and FAT fish. In fish fed the VO diet, total MUFA and 18:1n-9 
were higher in the FAT and LEAN fish than in the CAL strain (Table 4.13). The 
percentages of total n-6PUFA, 18:2n-6, 20:2n-6 and 20:3n-6 were higher but that of 
ARA lower, in livers of fish fed the VO diet compared to fish fed the FO diet (Table 
4.13). Irrespective of diet, the levels of 18:2n-6 were slightly greater in LEAN fish than 
that of the CAL and FAT fish. In fish fed the FO diet, liver ARA levels were higher in 
CAL and FAT fish compared to LEAN fish whereas the ARA levels were lower in FAT 
fish compared to CAL and LEAN fish that were fed VO. The levels of total PUFA, total 
n-3PUFA, 18:4n-3, 20:4n-3, EPA and DHA were higher in livers of fish fed the FO 
diet, whereas levels of 18:3n-3 were higher in fish fed the VO diet (Table 4.13). 
Irrespective of diet, the proportion of 18:3n-3 was higher in LEAN fish than in CAL 
and FAT fish. In fish fed the FO diet, the levels of 20:4n-3 and 22:5n-3 were higher in 
the LEAN fish compared to those in the CAL and FAT fish whereas the levels of total 
PUFA, total n-3 PUFA and DHA were higher in the CAL and FAT fish (Table 4.13). In 
fish fed the VO diet, the percentages of total PUFA, total n-3 PUFA and DHA, were 
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higher in the CAL strain compared to the FAT and LEAN fish (Table 4.13).  
Diet had a significant effect on the composition of all FAs in viscera (Table 
4.14). Total SFA, 14:0 and 16:0 were significantly higher, but 18:0 and 20:0 were 
lower, in fish fed the FO diet compared to fish fed VO. Fish group, however, did not 
affect the content of SFAs in the viscera. Total MUFA and 18:1n-9 were higher in 
viscera of fish fed the VO diet, whereas levels of 16:1n-7, 18:1n-7, 20:1 and 22:1n-11 
were higher in the fish fed the FO diet (Table 4.14). In fish fed the FO diet, the 
proportion of 18:1n-9 was significantly lower in LEAN fish compared to CAL and FAT 
fish. Total n-6PUFA, 18:2n-6, 18:3n-6, 20:2n-6, 20:3n-6 were significantly higher, but 
ARA was lower, in viscera of fish fed the VO diet compared to fish fed the FO diet 
(Table 4.14). There were no significant differences in the levels of 18:2n-6 and ARA 
between the groups of salmon. Total PUFA, total n-3PUFA, 18:4n-3, 20:4n-3, EPA and 
DHA were higher, but 18:3n-3 was lower, in viscera of salmon fed the FO diet 
compared to fish fed the VO diet (Table 4.14). Regardless of diet, total PUFA and total 
n-3 PUFA were higher in LEAN and FAT fish compared to the levels in the CAL 
strain. In fish fed the FO diet, the amount of EPA and DHA in LEAN and FAT fish was 
higher than that in the CAL fish, whereas the level of EPA and DHA in FAT fish was 
slightly higher than those level in CAL and LEAN fish when fed VO (Table 4.14). 
. 
    
Table 4.13. Fatty acid composition (percentage of total fatty acids) of liver of 3 groups of Atlantic salmon at week 55. 
      CAL       FAT    LEAN      CAL      FAT     LEAN    Diet     Group Diet  Group
Fatty acid
14:0 2.3 ± 0.1 2.1 ± 0.2 2.3 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.7 ± 0.1 <0.000 0.189 0.010
16:0 19.3 ± 0.4 18.2 ± 0.6 14.9 ± 1.1 14.6 ± 0.8 12.5 ± 0.9 12.6 ± 0.8 <0.000 <0.000 <0.000
18:0 4.9 ± 0.1 5.2 ± 0.3 4.6 ± 0.4 5.0 ± 0.1 5.1 ± 0.2 4.7 ± 0.2 0.470 <0.000 0.282
Total saturated
1 26.9 ± 0.5 25.8 ± 0.8 22.1 ± 1.5 20.6 ± 0.8 19.1 ± 1.0 18.3 ± 1.0 <0.000 <0.000 0.002
16:1n-7 2.7 ± 0.1 2.7 ± 0.2 3.3 ± 0.4 1.8 ± 0.2 1.8 ± 0.2 1.7 ± 0.1 <0.000 0.026 0.001
18:1n-9 11.1 ± 0.4 12.1 ± 0.8 15.6 ± 1.4 26.6 ± 3.1 31.3 ± 2.2 29.9 ± 1.8 <0.000 <0.000 0.007
18:1n-7 2.5 ± 0.0 2.6 ± 0.1 3.2 ± 0.2 2.2 ± 0.3 2.4 ± 0.3 2.2 ± 0.2 <0.000 <0.000 <0.000
20:1n-9 2.7 ± 0.1 3.2 ± 0.3 5.1 ± 0.3 3.2 ± 0.7 3.9 ± 0.7 3.7 ± 0.4 0.711 <0.000 <0.000
20:1n-7 0.1 ± 0.1 0.2 ± 0.0 0.3 ± 0.0 0.1 ± 0.1 0.1 ± 0.1 0.2 ± 0.1 <0.000 <0.000 0.187
22:1n11 1.4 ± 0.1 1.7 ± 0.2 2.4 ± 0.4 0.5 ± 0.1 0.4 ± 0.1 0.4 ± 0.1 <0.000 <0.000 <0.000
22:1n-9 0.1 ± 0.1 0.2 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 <0.000 <0.000 <0.000
Total monoenes 21.7 ± 0.7 23.8 ± 1.3 31.1 ± 2.5 35.2 ± 4.1 40.8 ± 3.3 39.0 ± 2.5 <0.000 <0.000 0.001
18:2n-6 2.9 ± 0.1 2.9 ± 0.1 3.0 ± 0.3 9.7 ± 0.8 10.1 ± 0.2 10.4 ± 0.2 <0.000 0.011 0.124
18:3n-6 0.1 ± 0.1 0.1 ± 0.1 0.1 ± 0.1 0.1 ± 0.1 0.1 ± 0.1 0.1 ± 0.0 0.262 0.326 0.488
20:2n-6 0.5 ± 0.0 0.5 ± 0.0 0.7 ± 0.0 1.5 ± 0.1 1.6 ± 0.2 1.9 ± 0.1 <0.000 <0.000 0.801
20:3n-6 0.4 ± 0.1 0.4 ± 0.0 0.4 ± 0.0 1.3 ± 0.1 1.3 ± 0.1 1.4 ± 0.1 <0.000 0.512 0.732
20:4n-6 2.4 ± 0.3 2.2 ± 0.2 1.9 ± 0.2 1.4 ± 0.2 1.2 ± 0.2 1.4 ± 0.2 <0.000 0.023 0.009
Total n-6 PUFA
2 6.5 ± 0.3 6.3 ± 0.3 6.3 ± 0.4 14.0 ± 0.8 14.4 ± 0.3 15.3 ± 0.3 <0.000 0.088 0.007
18:3n-3 1.0 ± 0.0 1.0 ± 0.0 1.1 ± 0.2 4.5 ± 0.2 4.3 ± 0.2 4.7 ± 0.2 <0.000 0.001 0.409
18:4n-3 0.4 ± 0.0 0.4 ± 0.1 0.4 ± 0.1 0.4 ± 0.0 0.3 ± 0.0 0.3 ± 0.1 <0.000 0.395 0.377
20:4n-3 1.6 ± 0.0 1.6 ± 0.1 2.3 ± 0.3 1.2 ± 0.1 1.1 ± 0.1 1.3 ± 0.1 <0.000 <0.000 0.001
20:5n-3 8.1 ± 0.1 8.6 ± 0.3 8.2 ± 0.4 5.5 ± 0.7 4.7 ± 0.4 5.2 ± 0.4 <0.000 0.783 0.004
22:5n-3 3.8 ± 0.2 3.6 ± 0.2 4.4 ± 0.3 2.7 ± 0.4 1.9 ± 0.2 2.1 ± 0.1 <0.000 <0.000 <0.000
22:6n-3 29.8 ± 0.9 28.6 ± 1.0 23.7 ± 1.9 15.4 ± 2.6 12.6 ± 1.5 13.1 ± 1.1 <0.000 <0.000 0.001
Total n-3 PUFA
3 45.0 ± 1.1 44.1 ± 1.1 40.5 ± 1.5 30.2 ± 3.6 25.7 ± 2.4 27.4 ± 1.4 <0.000 <0.000 0.012
Total PUFA 51.4 ± 1.1 50.4 ± 1.2 46.8 ± 1.5 44.2 ± 3.4 40.2 ± 2.6 42.8 ± 1.6 <0.000 0.003 0.004
Parameters
ANOVAFO VO
 
Results are means ± SD (n = 2). 
1
 includes15:0 and 20:0 up to 0.4 %; 
2
 includes 22:5n-6 up to 0.2 %; 
3
 includes 20:3n-3 up to 0.2 %, CAL, 
Caledonian 20 strain; FAT & LEAN, fat and lean families; FO, fish oil diet; PUFA; polyunsaturated fatty acids; VO, vegetable oil diet. 
  
 
 
 
Table 4.14. Fatty acid composition (percentage of total fatty acids) of viscera of 3 groups of Atlantic salmon at week 55. 
     CAL       FAT    LEAN      CAL      FAT     LEAN    Diet     Group Diet  Group
Fatty acids
14:0 4.7 ± 0.2 4.7 ± 0.1 4.8 ± 0.2 1.5 ± 0.1 1.5 ± 0.1 1.3 ± 0.1 <0.000 0.409 0.064
16:0 14.2 ± 0.5 13.8 ± 0.4 13.7 ± 0.3 12.0 ± 0.2 12.0 ± 0.4 11.9 ± 0.2 <0.000 0.168 0.278
18:0 2.7 ± 0.1 2.7 ± 0.1 2.6 ± 0.1 3.0 ± 0.1 3.0 ± 0.1 2.9 ± 0.1 <0.000 0.046 0.346
20:0 0.1 ± 0.1 0.1 ± 0.0 0.1 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 <0.000 0.621 0.106
Total saturated
1
22.1 ± 0.8 21.6 ± 0.6 21.6 ± 0.5 17.1 ± 0.3 17.1 ± 0.5 16.8 ± 0.3 <0.000 0.162 0.523
16:1n-7 5.8 ± 0.1 5.7 ± 0.1 5.8 ± 0.0 1.7 ± 0.1 1.8 ± 0.1 1.6 ± 0.2 <0.000 0.294 0.007
18:1n-9 19.7 ± 0.4 19.5 ± 0.5 18.5 ± 0.3 38.7 ± 0.4 38.4 ± 0.6 38.7 ± 0.4 <0.000 0.012 0.002
18:1n-7 3.1 ± 0.1 2.9 ± 0.1 3.0 ± 0.1 2.4 ± 0.2 2.4 ± 0.2 2.2 ± 0.1 <0.000 0.103 0.057
20:1n-9 7.8 ± 0.1 7.9 ± 0.0 8.0 ± 0.1 5.4 ± 0.0 5.2 ± 0.1 5.4 ± 0.1 <0.000 0.004 0.005
20:1n-7 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.1 0.3 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 <0.000 0.440 0.097
22:1n11 7.3 ± 0.2 7.5 ± 0.1 7.7 ± 0.1 1.5 ± 0.1 1.6 ± 0.1 1.4 ± 0.1 <0.000 0.004 0.004
22:1n-9 0.8 ± 0.0 0.8 ± 0.1 0.7 ± 0.0 0.8 ± 0.0 0.7 ± 0.0 0.7 ± 0.0 0.126 0.352 0.718
Total monoenes 45.7 ± 0.3 45.6 ± 0.3 45.0 ± 0.2 51.3 ± 0.2 50.9 ± 0.6 50.8 ± 0.3 <0.000 0.001 0.193
18:2n-6 5.6 ± 0.2 5.6 ± 0.2 5.5 ± 0.2 14.7 ± 0.2 14.5 ± 0.3 14.7 ± 0.2 <0.000 0.540 0.233
20:2n-6 0.6 ± 0.0 0.6 ± 0.0 0.6 ± 0.0 1.5 ± 0.0 1.4 ± 0.0 1.6 ± 0.1 <0.000 <0.000 <0.000
20:3n-6 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.6 ± 0.0 0.6 ± 0.0 0.7 ± 0.0 <0.000 0.010 0.033
20:4n-6 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.1 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 <0.000 0.539 0.814
Total n-6 PUFA
2
7.3 ± 0.3 7.3 ± 0.3 7.2 ± 0.2 17.2 ± 0.2 16.9 ± 0.3 17.4 ± 0.2 <0.000 0.180 0.059
18:3n-3 1.9 ± 0.1 2.0 ± 0.1 1.9 ± 0.1 6.5 ± 0.1 6.6 ± 0.2 6.7 ± 0.1 <0.000 0.097 0.041
18:4n-3 1.7 ± 0.0 1.8 ± 0.1 1.8 ± 0.0 0.7 ± 0.0 0.8 ± 0.0 0.7 ± 0.0 <0.000 <0.000 0.176
20:4n-3 1.7 ± 0.1 1.7 ± 0.1 1.8 ± 0.1 0.8 ± 0.0 0.9 ± 0.0 0.9 ± 0.0 <0.000 0.005 0.136
20:5n-3 5.3 ± 0.0 5.5 ± 0.1 5.5 ± 0.1 1.6 ± 0.1 1.7 ± 0.1 1.6 ± 0.1 <0.000 0.016 0.424
22:5n-3 2.9 ± 0.1 2.8 ± 0.1 3.0 ± 0.1 1.0 ± 0.1 1.0 ± 0.0 1.0 ± 0.1 <0.000 0.303 0.145
22:6n-3 11.2 ± 0.3 11.4 ± 0.4 11.8 ± 0.3 3.2 ± 0.2 3.5 ± 0.2 3.3 ± 0.2 <0.000 0.004 0.016
Total n-3 PUFA
3
24.9 ± 0.7 25.5 ± 0.7 26.1 ± 0.6 14.5 ± 0.4 15.1 ± 0.6 15.0 ± 0.4 <0.000 0.002 0.233
Total PUFA 32.2 ± 0.9 32.8 ± 0.7 32.4 ± 0.5 31.7 ± 0.4 32.0 ± 0.8 32.4 ± 0.5 0.002 0.004 0.668
ANOVA
Parameters
FO VO
 
Results are means ± SD (n = 2). 
1
 includes 15:0 up to 0.4 %; 
2
 includes 18:3n-6 and 22:5n-6 up to 0.2 %; 
3
 includes 20:3n-3 up to 0.2 %;  
CAL, Caledonian 20 strain; FAT & LEAN, fat and lean families; FO, fish oil diet; PUFA, polyunsaturated fatty acids; VO, vegetable oil diet.
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4.3.7 Proximate composition, lipid content and fatty acid composition during the 
finishing diet phase  
After week 55, all fish were transferred onto a finishing diet containing a 
decontaminated FO as the sole source of lipid for a further 24 weeks. By the end of the 
24-week period, there were significant differences in the proximate composition of the 
flesh as a consequence of the fish group (strain/family) and the diet fed prior to the 
switch to finishing diet (Table 4.15). The protein content of the flesh was significantly 
higher in fish previously fed the FO diet than those previously fed the VO diet. 
Regardless of the diet previously fed to the fish, the flesh protein content of CAL and 
LEAN fish was significantly higher than that of the FAT fish. In fish previously fed the 
FO diet, the crude lipid content of flesh was highest in the FAT fish and lowest in the 
CAL strain, whereas for fish previously fed the VO diet, the crude lipid content was 
highest in the CAL strain and lowest in LEAN fish (Table 4.15). In order to investigate 
restoration of HUFA (ARA, EPA and DHA) and PUFA (18:2n-6 and 18:3n-3) levels, 
flesh samples were taken at weeks 8, 16 and 24 of the wash-out, finishing diet phase. 
Flesh lipid contents increased throughout the finishing diet period. Thus, the total lipid 
content of the flesh analysed by Folch method, which was about 8-9 % at week 8, 
increased to 12-13 % by week 24 (Tables 4.16-4.18). Previous diet did not affect the 
lipid contents of flesh but regardless of the diet previously fed to the fish, flesh lipid in 
FAT fish was significantly higher than that of CAL and LEAN fish at weeks 8 and 16 
(Tables 4.16-4.17). However, previous diet and fish group had no effects on lipid 
content of the flesh at week 24 of the finishing diet period (Table 4.18).  
Both previous diet and fish group significantly affected the FA compositions as 
determined at weeks 8 and 16 of the finishing diet phase but, by week 24, only total 
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SFA, 16:0, total MUFA, 20:1n-9, 20:3n-6, ARA, EPA and DHA were affected by both 
previous diet and fish group (Table 4.18). For fish previously fed the VO diet, the 
percentages of 18:2n-6 and 18:3n-3 in flesh decreased while the levels of ARA, EPA 
and DHA increased over the finishing diet period (Figure 4.1). In all groups during the 
finishing diet phase, the levels of 18:2n-6, 18:3n-3 ARA, EPA and DHA in fish 
previously fed VO approached those of fish fed FO throughout (Figure 4.1). The 
magnitude of these changes were greatest in the initial 8 weeks of the finishing diet and, 
in this period, the changes were greater in the LEAN and FAT fish than in the CAL 
strain (Figure 4.1). For fish previously fed FO, the finishing diet phase had few effects 
on the levels of 18:2n-6, 18:3n-3, ARA, EPA and DHA between the groups of fish. The 
levels of 18:2n-6, 18:3n-3 and ARA in fish previously fed VO, however, were slightly 
changed between weeks 16 and 24, particularly in the FAT and LEAN fish. At 24 
weeks, irrespective of diet previously fed, the level of EPA in the CAL strain was 
higher than that of FAT and LEAN fish, and the level of DHA in LEAN fish was higher 
than that of CAL strain and FAT fish.  
 
    
Table 4.15. Proximate composition (percentage of wet weight) of flesh of 3 groups of Atlantic salmon after 24 weeks feeding on the fish oil  
 finishing diet. 
CAL FAT LEAN CAL FAT LEAN Diet Group Diet Group
Protein 18.7 ± 0.0 18.4 ± 0.1 18.8 ± 0.1 18.6 ± 0.1 18.3 ± 0.2 18.7 ± 0.1 0.022 <0.000 0.454
Lipid 13.5 ± 0.1 14.7 ± 0.1 14.5 ± 0.0 15.4 ± 0.1 15.1 ± 0.2 14.1 ± 0.2 <0.000 <0.000 <0.000
Moisture 66.4 ± 0.1 65.9 ± 0.2 65.7 ± 0.1 64.7 ± 0.1 65.3 ± 0.2 65.9 ± 0.1 <0.000 0.043 <0.000
Ash 1.7 ± 0.1 1.7 ± 0.1 1.6 ± 0.1 1.7 ± 0.1 1.7 ± 0.1 1.8 ± 0.1 0.211 0.831 0.201
Compositions
FO VO ANOVA
 
Results are means ± SD (n = 2). CAL, Caledonian 20 strain; FAT & LEAN, fat and lean families; FO, fish oil diet; VO, vegetable oil diet.  
    
Table 4.16. Lipid content (percentage of wet weight) and fatty acid composition (percentage of total fatty acids) of flesh of 3 groups of 
 Atlantic salmon after 8 weeks feeding on the fish oil finishing diet. 
      CAL       FAT    LEAN      CAL      FAT     LEAN    Diet Group Diet Group
Lipid content 8.7 ± 0.6 8.9 ± 0.4 8.4 ± 0.7 8.7 ± 1.0 9.2 ± 0.4 7.6 ± 04 0.478 0.001 0.130
Fatty acid
14:0 5.4 ± 0.3 5.3 ± 0.2 5.4 ± 0.2 3.5 ± 0.1 4.9 ± 0.6 4.3 ± 0.7 <0.000 0.001 <0.000
16:0 16.6 ± 0.7 16.2 ± 0.2 16.1 ± 0.5 15.1 ± 0.4 16.3 ± 0.5 15.2 ± 0.8 <0.000 0.052 0.009
18:0 3.4 ± 0.1 3.2 ± 0.1 3.2 ± 0.1 3.5 ± 0.2 3.4 ± 0.3 3.2 ± 0.1 0.016 <0.000 0.580
20:0 0.1 ± 0.0 0.2 ± 0.0 0.1 ± 0.0 0.3 ± 0.0 0.2 ± 0.1 0.2 ± 0.0 <0.000 <0.000 <0.000
Total saturated 26.0 ± 1.1 25.3 ± 0.3 25.2 ± 0.7 22.7 ± 0.5 25.2 ± 0.9 23.3 ± 1.6 <0.000 0.071 0.005
16:1n-7 6.6 ± 0.1 6.5 ± 0.1 6.6 ± 0.1 4.3 ± 0.2 5.9 ± 0.6 5.3 ± 0.7 <0.000 <0.000 <0.000
18:1n-9 16.0 ± 0.3 16.2 ± 1.3 16.0 ± 0.3 27.8 ± 1.0 20.8 ± 3.9 22.7 ± 1.8 <0.000 <0.000 <0.000
18:1n-7 3.3 ± 0.1 3.3 ± 0.1 3.3 ± 0.1 2.9 ± 0.1 3.3 ± 0.2 3.1 ± 0.3 0.002 0.025 0.014
20:1n-9 5.5 ± 0.3 5.7 ± 0.2 5.7 ± 0.1 4.6 ± 0.1 5.3 ± 1.0 5.1 ± 0.4 <0.000 0.009 0.187
20:1n-7 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 0.3 ± 0.0 0.4 ± 0.1 0.3 ± 0.1 0.003 <0.000 0.132
22:1n11 5.4 ± 0.4 5.5 ± 0.4 5.6 ± 0.1 2.2 ± 0.1 4.4 ± 1.7 3.7 ± 0.4 <0.000 <0.000 0.001
22:1n-9 0.6 ± 0.1 0.7 ± 0.0 0.6 ± 0.0 0.6 ± 0.0 0.7 ± 0.1 0.6 ± 0.1 0.080 0.017 0.694
Total monoenes 38.6 ± 1.0 39.1 ± 0.8 38.9 ± 0.4 43.2 ± 0.8 41.4 ± 1.0 41.4 ± 1.2 <0.000 0.096 0.011
18:2n-6 4.5 ± 0.1 4.7 ± 0.5 4.5 ± 0.1 9.7 ± 0.3 6.4 ± 1.8 7.5 ± 1.0 <0.000 0.002 <0.000
18:3n-6 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.2 ± 0.0 0.2 ± 0.1 0.2 ± 0.0 <0.000 0.360 0.388
20:2n-6 0.5 ± 0.1 0.5 ± 0.1 0.5 ± 0.0 1.1 ± 0.0 0.7 ± 0.2 0.8 ± 0.1 <0.000 <0.000 0.001
20:3n-6 0.3 ± 0.0 0.3 ± 0.1 0.3 ± 0.1 0.5 ± 0.0 0.4 ± 0.1 0.4 ± 0.1 <0.000 0.011 0.086
20:4n-6 0.7 ± 0.0 0.7 ± 0.0 0.7 ± 0.0 0.6 ± 0.0 0.6 ± 0.1 0.6 ± 0.1 <0.000 0.276 0.002
Total n-6 PUFA
1 6.8 ± 0.3 6.8 ± 0.5 6.6 ± 0.1 12.2 ± 0.3 8.5 ± 2.0 9.9 ± 1.1 <0.000 <0.000 <0.000
 18:3n-3 1.5 ± 0.0 1.6 ± 0.2 1.5 ± 0.0 4.1 ± 0.1 2.6 ± 0.9 3.3 ± 0.5 <0.000 <0.000 <0.000
18:4n-3 1.4 ± 0.1 1.6 ± 0.1 1.5 ± 0.1 0.9 ± 0.0 1.3 ± 0.3 1.2 ± 0.4 <0.000 <0.000 0.007
20:4n-3 1.5 ± 0.1 1.6 ± 0.1 1.6 ± 0.1 1.1 ± 0.0 1.3 ± 0.2 1.3 ± 0.0 <0.000 0.001 0.035
20:5n-3 7.4 ± 0.4 7.4 ± 0.3 7.3 ± 0.1 5.1 ± 0.3 6.3 ± 0.7 5.9 ± 0.5 <0.000 0.006 0.002
22:5n-3 3.7 ± 0.3 3.7 ± 0.4 3.7 ± 0.1 2.5 ± 0.1 3.0 ± 0.3 3.0 ± 0.2 <0.000 0.067 0.026
22:6n-3 12.8 ± 1.0 12.7 ± 0.9 13.4 ± 0.4 7.6 ± 0.7 10.1 ± 1.6 10.5 ± 0.4 <0.000 <0.000 0.002
Total n-3 PUFA
2 28.6 ± 1.7 28.8 ± 1.5 29.3 ± 0.6 21.8 ± 1.1 24.8 ± 2.1 25.4 ± 0.6 <0.000 0.001 0.015
Total PUFA 35.3 ± 1.9 35.6 ± 1.0 35.8 ± 0.6 34.0 ± 0.9 33.4 ± 1.6 35.3 ± 0.6 0.022 0.074 0.305
Parameters
FO VO ANOVA
 
Results are means ± SD (n = 2); 
1
 includes 22:5n-6 up to 0.2 %; 
2
 includes 20:3n-3 up to 0.3 %; CAL, Caledonian 20 strain; FAT & LEAN, fat 
and lean families; FO, fish oil diet; PUFA, polyunsaturated fatty acids; VO, vegetable oil diet. 
    
Table 4.17. Lipid content (percentage of wet weight) and fatty acid composition (percentage of total fatty acids) of flesh of 3 groups of 
 Atlantic salmon after 16 weeks feeding on the fish oil finishing diet. 
     CAL       FAT    LEAN     CAL      FAT     LEAN    Diet     Group Diet Group
Lipid content 11.5 ± 0.6 13.5 ± 0.9 11.2 ± 1.1 11.0 ± 0.7 12.2 ± 1.0 11.5 ± 0.4 0.089 <0.000 0.084
Fatty acid
14:0 5.4 ± 0.1 5.4 ± 0.1 5.2 ± 0.3 4.0 ± 0.1 5.2 ± 0.5 4.9 ± 0.3 <0.000 0.004 0.001
16:0 16.2 ± 0.4 16.0 ± 0.4 15.6 ± 0.5 15.3 ± 0.2 15.7 ± 0.4 15.7 ± 0.4 0.005 0.518 0.015
18:0 3.3 ± 0.1 3.3 ± 0.1 3.3 ± 0.2 3.4 ± 0.1 3.4 ± 0.1 3.3 ± 0.1 0.008 0.386 0.564
20:0 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0 0.3 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 <0.000 <0.000 <0.000
Total saturated 25.5 ± 0.6 25.2 ± 0.6 24.7 ± 1.0 23.3 ± 0.2 24.5 ± 0.1 24.5 ± 0.6 <0.000 0.350 0.004
16:1n-7 6.7 ± 0.1 6.5 ± 0.1 6.5 ± 0.3 4.9 ± 0.1 5.6 ± 0.3 6.0 ± 0.2 <0.000 <0.000 <0.000
18:1n-9 15.7 ± 0.3 16.5 ± 0.8 15.6 ± 0.6 24.4 ± 0.3 20.9 ± 1.1 19.1 ± 0.9 <0.000 <0.000 <0.000
18:1n-7 3.3 ± 0.1 3.3 ± 0.1 3.3 ± 0.1 3.0 ± 0.1 3.3 ± 0.3 3.3 ± 0.1 0.096 0.225 0.023
20:1n-9 5.2 ± 0.1 5.4 ± 0.1 5.4 ± 0.4 4.5 ± 0.1 4.5 ± 0.1 4.7 ± 0.3 <0.000 0.055 0.361
20:1n-7 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.002 0.461 0.893
22:1n11 5.2 ± 0.1 5.3 ± 0.3 5.5 ± 0.3 3.0 ± 0.1 3.7 ± 0.4 4.1 ± 0.3 <0.000 <0.000 0.002
22:1n-9 0.5 ± 0.0 0.6 ± 0.1 0.6 ± 0.0 0.6 ± 0.0 0.6 ± 0.1 0.6 ± 0.0 0.112 0.015 0.064
Total monoenes 37.7 ± 0.7 38.6 ± 0.3 38.0 ± 1.0 41.3 ± 0.3 39.5 ± 0.7 38.8 ± 1.1 <0.000 0.004 <0.000
18:2n-6 4.4 ± 0.0 4.7 ± 0.5 4.4 ± 0.1 8.2 ± 0.3 6.7 ± 0.7 6.1 ± 0.3 <0.000 <0.000 <0.000
18:3n-6 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.015 0.230 0.010
20:2n-6 0.4 ± 0.0 0.5 ± 0.0 0.5 ± 0.0 0.9 ± 0.0 0.7 ± 0.1 0.6 ± 0.0 <0.000 0.014 <0.000
20:3n-6 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.5 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 <0.000 0.048 0.162
20:4n-6 0.7 ± 0.0 0.7 ± 0.0 0.7 ± 0.0 0.6 ± 0.0 0.7 ± 0.0 0.7 ± 0.0 <0.000 <0.000 <0.000
Total n-6 PUFA
1 5.6 ± 0.1 6.8 ± 0.5 6.7 ± 0.1 10.6 ± 0.3 9.2 ± 0.8 8.5 ± 0.4 <0.000 <0.000 <0.000
18:3n-3 1.4 ± 0.0 1.5 ± 0.2 1.4 ± 0.1 3.2 ± 0.1 2.6 ± 0.3 2.2 ± 0.2 <0.000 <0.000 <0.000
18:4n-3 1.5 ± 0.0 1.6 ± 0.0 1.5 ± 0.1 1.1 ± 0.0 1.3 ± 0.1 1.3 ± 0.0 <0.000 <0.000 0.015
20:4n-3 1.5 ± 0.1 1.6 ± 0.0 1.6 ± 0.1 1.2 ± 0.0 1.3 ± 0.0 1.4 ± 0.1 <0.000 <0.000 0.001
20:5n-3 8.5 ± 0.4 7.9 ± 0.2 7.9 ± 0.3 6.5 ± 0.2 7.1 ± 0.4 7.3 ± 0.4 <0.000 0.769 <0.000
22:5n-3 4.3 ± 0.2 4.0 ± 0.1 4.2 ± 0.2 3.2 ± 0.1 3.6 ± 0.1 3.8 ± 0.2 <0.000 0.005 <0.000
22:6n-3 12.8 ± 0.6 12.6 ± 0.2 13.8 ± 0.4 9.2 ± 0.2 10.6 ± 0.5 11.9 ± 0.5 <0.000 <0.000 <0.000
Total n-3 PUFA
2 30.2 ± 1.1 29.4 ± 0.5 30.6 ± 0.5 24.8 ± 0.4 26.8 ± 1.0 28.2 ± 1.1 <0.000 <0.000 <0.000
Total PUFA 36.8 ± 1.2 36.2 ± 0.6 37.3 ± 0.5 35.4 ± 0.5 36.1 ± 0.9 36.7 ± 1.2 0.025 0.022 0.202
Parameters
ANOVAFO VO
 
Results are means ± SD (n = 2); 
1
 includes 22:5n-6 up to 0.2 %; 
2
 includes 20:3n-3 up to 0.3 %; CAL, Caledonian 20 strain; FAT & LEAN, fat 
and lean families; FO, fish oil diet; PUFA, polyunsaturated fatty acids; VO, vegetable oil diet. 
    
Table 4.18. Lipid content (percentage of wet weight) and fatty acid composition (percentage of total fatty acids) of flesh of 3 groups of 
 Atlantic salmon after 24 weeks feeding on the fish oil finishing diet. 
      CAL       FAT    LEAN      CAL      FAT     LEAN    Diet     Group Diet  Group
Lipid content 11.9 ± 0.4 12.9 ± 1.1 12.7 ± 0.7 13.1 ± 0.6 12.7 ± 1.0 12.1 ± 0.5 0.585 0.423 0.018
Fatty acids
14:0 5.6 ± 0.2 5.5 ± 0.2 5.3 ± 0.3 4.8 ± 0.2 4.7 ± 0.1 4.6 ± 0.5 <0.000 0.119 0.825
16:0 16.3 ± 0.5 16.0 ± 0.5 15.5 ± 0.3 15.5 ± 0.2 15.4 ± 0.5 15.3 ± 0.5 0.001 0.039 0.257
18:0 3.4 ± 0.1 3.4 ± 0.2 3.2 ± 0.1 3.4 ± 0.0 3.3 ± 0.1 3.3 ± 0.1 0.351 0.064 0.351
20:0 0.1 ± 0.0 0.10 ± .0 0.1 ± 0.0 0.1 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 <0.000 0.714 0.471
Total saturated 25.9 ± 0.7 25.5 ± 0.6 24.7 ± 0.8 24.3 ± 0.5 24.0 ± 0.8 23.9 ± 1.0 <0.000 0.028 0.340
16:1n-7 6.9 ± 0.1 6.6 ± 0.3 6.7 ± 0.3 5.8 ± 0.2 5.7 ± 0.1 6.0 ± 0.4 <0.000 0.211 0.371
18:1n-9 14.9 ± 0.4 16.0 ± 1.7 15.9 ± 0.9 20.1 ± 0.5 20.8 ± 0.7 19.7 ± 2.6 <0.000 0.315 0.433
18:1n-7 3.5 ± 0.2 3.4 ± 0.1 3.4 ± 0.2 3.3 ± 0.1 3.2 ± 0.2 3.2 ± 0.2 0.003 0.238 0.871
20:1n-9 4.7 ± 0.2 4.9 ± 0.2 5.0 ± 0.2 4.2 ± 0.0 4.6 ± 0.3 4.4 ± 0.2 <0.000 <0.000 0.201
20:1n-7 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 0.3 ± 0.0 0.4 ± 0.0 0.3 ± 0.0 0.015 0.071 0.186
22:1n11 4.9 ± 0.1 5.0 ± 0.7 5.0 ± 0.1 3.5 ± 0.0 3.8 ± 0.4 3.9 ± 0.7 <0.000 0.345 0.440
22:1n-9 0.6 ± 0.1 0.5 ± 0.0 0.5 ± 0.1 0.6 ± 0.1 0.6 ± 0.0 0.5 ± 0.1 0.910 0.126 0.233
Total monoenes 36.5 ± 0.5 37.4 ± 0.8 37.6 ± 0.7 38.4 ± 0.3 39.7 ± 0.3 38.6 ± 1.2 <0.000 0.002 0.123
18:2n-6 4.4 ± 0.1 4.5 ± 0.3 4.7 ± 0.3 6.6 ± 0.2 6.7 ± 0.4 6.5 ± 1.2 <0.000 0.808 0.193
18:3n-6 0.4 ± 0.0 0.3 ± 0.0 0.3 ± 0.1 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.1 0.502 0.240 0.671
20:2n-6 0.4 ± 0.0 0.5 ± 0.1 0.5 ± 0.1 0.7 ± 0.0 0.6 ± 0.0 0.7 ± 0.1 <0.000 0.472 0.370
20:3n-6 0.3 ± 0.0 0.3 ± 0.1 0.4 ± 0.0 0.4 ± 0.1 0.4 ± 0.0 0.4 ± 0.0 0.001 0.032 0.589
20:4n-6 0.8 ± 0.0 0.7 ± 0.0 0.7 ± 0.0 0.7 ± 0.0 0.6 ± 0.0 0.7 ± 0.0 <0.000 <0.000 0.028
Total n-6 PUFA
1 6.6 ± 0.1 6.8 ± 0.4 7.0 ± 0.3 9.0 ± 0.2 8.9 ± 0.4 8.8 ± 1.2 <0.000 0.762 0.242
18:3n-3 1.2 ± 0.0 1.4 ± 0.2 1.5 ± 0.2 2.4 ± 0.1 2.5 ± 0.2 2.3 ± 0.6 <0.000 0.301 0.068
18:4n-3 1.4 ± 0.1 1.5 ± 0.1 1.5 ± 0.0 1.2 ± 0.0 1.3 ± 0.1 1.3 ± 0.1 <0.000 0.298 0.923
20:4n-3 1.6 ± 0.0 1.5 ± 0.1 1.5 ± 0.1 1.4 ± 0.0 1.4 ± 0.1 1.4 ± 0.1 <0.000 0.066 0.825
20:5n-3 8.9 ± 0.1 8.3 ± 0.4 8.3 ± 0.3 7.9 ± 0.2 7.2 ± 0.3 7.5 ± 0.5 <0.000 <0.000 0.472
22:5n-3 4.5 ± 0.1 4.4 ± 0.4 4.5 ± 0.2 4.1 ± 0.1 3.8 ± 0.2 4.0 ± 0.4 <0.000 0.051 0.663
22:6n-3 13.2 ± 0.2 12.9 ± 0.8 13.4 ± 0.6 11.0 ± 0.1 10.9 ± 0.6 11.9 ± 1.1 <0.000 0.041 0.339
Total n-3 PUFA
2 31.0 ± 0.4 30.2 ± 1.6 30. ± 0.8 28.3 ± 0.3 27.4 ± 1.0 28.6 ± 1.6 <0.000 0.069 0.696
Total PUFA 37.6 ± 0.4 37.0 ± 1.3 37.8 ± 0.7 37.3 ± 0.4 36.3 ± 0.9 37.5 ± 0.6 0.116 0.01 0.718
Parameters
FO VO ANOVA
 
Results are means ± SD (n = 2); 
1
 includes 22:5n-6 up to 0.2 %; 
2
 includes 20:3n-3 up to 0.3 %; CAL, Caledonian 20 strain; FAT & LEAN, fat 
and lean families; FO, fish oil diet; PUFA, polyunsaturated fatty acids; VO, vegetable oil diet.  
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Figure 4.1. Trend of the 18:2n-6, 18:3n-3, 20:4n-6, 20:5n-3 and 22:6n-3 contents in 
 flesh of 3 groups of Atlantic salmon at week 0 (week 55 of growth phase) and 
 weeks  8, 16 and 24 of the finishing diet period. 
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4.4 Discussion and conclusion 
4.4.1 Growth performance and proximate composition during the 55 week 
growth phase 
The aim of this trial was to investigate the effects of dual substitution of FM 
with 45 % PPs, 25% FM in diet and 100 % replacement of FO with VO on the growth 
and tissue composition of three groups (one strain and two families) of large Atlantic 
salmon. Plant proteins were included at ~45% of the formulation with the major 
components being maize and wheat glutens and soy meal concentrate. These plant 
proteins have been shown to promote good growth in previous FM replacement studies 
(Kaushik 2004; Espe et al. 2006). The oil component added to the base diet was either 
100% northern FO or a blend of VOs (RO/PO/CO; (5/3/2 by weight). RO and PO are 
commonly used in commercial fish feed without detrimental effect to fish growth 
(Torstensen et al. 2000; Ng et al. 2003; Bell et al. 2003b; Mourente & Bell 2006; 
Karalazos 2007). The oil from Camelina sativa is low in saturates, and has high levels 
of EFA 18:2n-6, 18:3n-3 and 18:1n-9 and 20:1n-9 (Putnam et al. 1993; Zubr 2003). 
The results from present study have shown that neither diet had any detrimental effects 
on the growth of the fish, with diet having no significant effects on FCR, SGR, HSI and 
VSI. Significant differences in fish final weight were attributable to fish strain and there 
was also an interaction between strain and diet. After 55 weeks and irrespective of diet, 
the FAT and LEAN groups had slightly higher weight and length than the CAL strain 
but this was likely related to these fish being larger at the initiation of the trial. 
Specifically, the FAT and LEAN fish fed the FO diet were larger than the same fish fed 
VO diet while the CAL strain fed the VO diet was larger than the same strain fed the 
FO diet. This result suggested that the CAL strain may have performed more effectively 
with the high VO diet. In addition, the CAL strain actually showed higher SGR and 
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lower FCR than either of the FAT or LEAN families showing that, although they 
attained smaller size, growth and feed efficiency were better in the commercial CAL 
strain than in the FAT and LEAN families that represented extremes of flesh adiposity. 
The results from the present study implied that growth rate of the three groups of 
salmon was at least partially under genetic control. The SGR value in the present study 
was slightly lower and the FCR value was higher than the those of previous study with 
Atlantic salmon fed diets containing high energy/lipid formulations from start feeding 
until harvest size (Torstensen et al. 2005; Berntssen et al. 2005), the levels of FM and 
VOs inclusion in the present study, however, were slightly lower and higher than those 
in the study of those previous studies. The SGR and FCR values in the present study 
were in the same range as those of studies which used high energy/lipid diets in Atlantic 
salmon for 40 weeks (Bell et al. 2004; Torstensen et al. 2004a) Hence, in the present 
trial, the diet FA contents and compositions in the VO diet appeared to supply sufficient 
energy requirement, EFA and FAs for catabolism and protein sparing and, therefore, 
there were no measurable detrimental effects on fish growth. Although the dietary lipid 
levels used in the present study (32%) were higher than those used previously (Bell et 
al. 2004; Torstensen et al. 2005) the findings are in agreement with the earlier studies 
in that the complete replacement of FO with VO from different sources, in both short 
and long duration feeding trials, had no effect on the growth and FCR of several species 
of fish (Bell et al. 2003a; Regost et al. 2004; Torstensen et al. 2004b, 2005; Fonseca-
Madrigal et al. 2005; Fountoulaki et al. 2009). In addition, the diet formulations used 
here, consisting of ~45% PPs, were in the same range as those used in studies that 
demonstrated inclusion of single PPs up to 40 % had no negative effects on fish growth 
(Nengas et al. 1996; Refstie et al. 2001; Lozano et al. 2007). Other studies, exploring 
the use of PP blends replacing up to 70 % of dietary FM, also had no detrimental effects 
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on growth of salmonids but replacement of FO with PP blends more than 70% showed 
growth reduction (Gomes et al. 1995; Espe et al. 2006; Oo et al. 2007; Torstensen et 
al. 2008). The VO diet used in the present study had much lower levels of DHA and 
EPA (1.5 and 1.2% of total FAs) compared to the diets used by Torstensen et al (2008) 
that only had 70% FO replacement and percentages of DHA and EPA of 3.0 and 2.5, 
respectively. This 50% reduction in dietary n-3 LC-PUFA resulted in no apparent 
reduction in growth compared to the salmon produced by Torstensen et al (2008). Little 
information has so far been available in the literature concerning the effects of dietary 
lipid and genetic factors on fish growth and body composition e.g. catfish (Clarias 
gariepinus) (Hoffman et al. 1995), rainbow trout (Quillet et al. 2005) and anadromous 
and landlocked Atlantic salmon (Rollin et al. 2003; Peng et al. 2003). In a study of 
dietary lipid and strain on growth in two strains of Atlantic salmon parr (landlocked or 
anadromous) fed 5 different diets varying in relative ratios of OO, LO and sunflower oil 
for 8 weeks, the authors found that growth rate was higher in the landlocked strain 
(Rollin et al. 2003). Similarly, landlocked fry fed on commercial diet revealed higher 
growth compared to anadromous fry (Peng et al. 2003). These findings imply the 
genetic influences to growth performances of fish. 
Dietary lipid influences the deposition of lipid in fish tissues, and the positive 
correlation between dietary lipid and the deposition of lipid in the flesh has been 
reported (Bell et al. 1998). In the present study, the lipid contents of the flesh and 
viscera increased as the size of the fish increased. In addition, the lipid contents of the 
three fish groups were not only reliant on the dietary lipid content but also depend on 
the strain/families as seen in the present study. These findings are supported by a 
number of studies with Atlantic salmon where the deposition of fat was seen to increase 
as the fish grew larger, which coincided with an increasing lipid content in the feed as 
Chapter 4 
 147 
pellet size of feed increased as seen in the present study (Jobling & Johansen 2003; 
Torstensen et al. 2005). The inclusion of VOs in the diet has affected flesh composition 
in different ways in different studies. Replacement of FO with PO or RO  decreased fat 
deposition in the flesh of Atlantic salmon (Bell et al. 2001, 2002) whereas substitution 
of FO with LO, RO or a blend of both oils (Bell et al. 2003b, 2004; Menoyo et al. 
2005) or SO (Ruyter et al. 2006), had no significant effect on flesh lipid content. Other 
studies have also reported that the composition of muscle was unaffected by the source 
of dietary oils (Bendiksen et al. 2003; Regost et al. 2004). However, a number of 
authors have reported that protein and moisture contents increased with decreasing 
dietary lipid content that was influenced by the replacement of FO with VO (Bell et al. 
2001; Torstensen et al. 2004a; Karalozos 2007). Genotype also has been stated as 
influencing body composition of four African sharptooth catfish strains of larvae; 
domestic, netherlands, wild and golden, fed on commercial diet. The authors 
summarised that strain strongly influenced body total lipid content, but not body protein 
content, and the body total lipid content was associated with growth rate (Hoffman et al. 
1995). Similar to rainbow trout, there were high genetic correlations between differently 
aged fish for lipid traits (lipid body weight, percent muscle and body lipid) but not for 
the protein traits (protein body weight, percent muscle and body protein) (Tobin et al. 
2006). In a study where rainbow trout had been selected on carcass adiposity using a 
non-invasive fat meter, the strains (Fat line, control line and Lean line) were all 
different from each other, based on muscle lipid content analysed by Soxhlet, in the 
order Fat line > Control line > Lean line (Quillet et al. 2005). No details of diet were 
provided except that it was a commercial diet containing 22% lipid, which would likely 
contain predominantly FO. However, in comparison to salmon in present study, where 
differences were observed in VSI and HSI % lipid, due both to strain and interaction of 
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strain and diet, no differences in those VSI and HSI % lipid between the strains was 
observed in rainbow trout (Quillet et al. 2005). The present study has indicated that 
strain/family of fish is also a factor in tissue lipid deposition that can be affected by 
replacement of FO by VO. By the end of the growth phase in the present study, the lipid 
contents of flesh of CAL and FAT fish were lower when fed the VO diet than when fed 
the FO diet. Diet did not appear to affect the lipid content of the viscera but the values 
for VSI and HSI were lower and higher, respectively, in LEAN fish compared to FAT 
and CAL fish fed either diet. The values of VSI and HSI were related to the TAG 
contents in these tissues reflecting increased fat deposition in liver of the LEAN family 
and in viscera of the FAT family. In addition, the protein contents of the flesh and 
viscera of the CAL and LEAN fish, and moisture contents of flesh and viscera of the 
CAL and FAT fish were greater in fish fed the VO diet compared to those fed the FO 
diet. These results suggest that use of different dietary oils may have different effects on 
fat deposition and resultant tissue compositions in different strains/families of salmon.  
Pigmentation of flesh is an important factor in salmon flesh quality (Regost et 
al. 2004), which is affected by several factors including fish size and age, sexual 
maturation, diet composition including the type of oil (Bjerkeng et al. 1999) and 
melting point of oils (Hardy et al. 1987), dietary concentration of carotenoids, and 
genetic factors (Storebakken & No 1992; Lie 2001). The studies of Bell et al, (2001) 
and Torstensen et al (2005), however, reported that replacement of FO with VO in 
Atlantic salmon diets did not affect the flesh pigment or astaxanthin content. In contrast 
to this, the previous studies observed significant differences in the pigment content of 
salmon fillets fed different oils (Hardy et al. 1987; Bjerkeng et al. 1999). In the present 
study, the levels of astaxanthin and total pigment in the flesh were higher in fish fed the 
FO diet, but this was due to an error in formulation that resulted in lower levels of 
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astaxanthin in the VO diet, notably the 9 mm pellet feeds. However, the CAL strain 
showed a higher pigment content than the FAT and, especially, the LEAN fish 
indicating that pigment deposition may also be affected by strain/family. The pigment 
content did not appear to be directly related to flesh lipid levels. 
4.4.2 Tissue lipid class and fatty acid compositions during the growth phase 
In the present study, significant differences effects of both diet and strain/family 
on lipid class compositions of fish tissues were observed. Flesh and liver total neutral 
lipids being higher in fish fed the VO diet compared to salmon fed the FO diet. 
Moreover, TAG composition in flesh was unaffected by feeding VO diet. The results 
was in contrast to results in Chapter 3 and a previous study by Nanton et al (2007) 
showing that salmon fed a VO blend diet decreased total neutral and TAG. The duration 
of the present study was over one year while the trial 1 (Chapter 3) was carried out for 
10 weeks. Possibly the different of duration of the study, environment, growth stage and 
strain of fish can explain these dissimilar findings. Apart from the dietary VO, specific 
tissue and other factors including growth stage, season as well as genetics also affects 
tissue lipid content (Sargent et al. 2002). Thus, the LEAN and FAT fish showed greater 
total neutral lipid in both flesh and liver tissues than the CAL strain, regardless of diet. 
The CAL strain had a high PC and PE which corresponded to that of the CAL strain that 
contained high total polar lipid content in flesh. TAG contents of flesh were affected 
insignificantly but the pattern observed in TAG levels was reflected in total neutral lipid 
levels. However, TAG content in liver and viscera tissues were affected by diet and 
groups of fish. Irrespective of diet, the FAT and LEAN fish had liver TAG contents 
higher than that of the CAL fish. In viscera tissue, the TAG content of the CAL fish was 
highest and lowest when fed the FO and VO, respectively. The sterol content of the 
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flesh, liver and viscera tissues of the fish fed the VO diet was also higher than that of 
the same fish fed the FO diet. Hence, the FAT and LEAN fish were genetically selected 
based on fat adiposity which corresponded to the finding of the present study in that 
those two fish showed higher total neutral lipid and lower polar lipid content, including 
individual polar lipid classes, than that of the CAL fish in specific tissues.  
In the present study, significant differences in both diet and strain/family on 
tissue FA compositions were observed. The flesh and viscera FA composition mainly 
was influenced by diet while liver FA composition was affected by both diet and 
strain/family. The results were in accordance with a study on FA compositions in 
landlocked and anadromous Atlantic salmon parr fed diet containing blends of OO, LO 
and sunflower oil and the authors stated that different diets had a more pronounced 
effect on carcass FA composition than that of the different strains (Rollin et al. 2003). It 
is well known that the FA compositions of fish tissues are a reflection of the dietary FA 
composition (Bell et al. 2001; Fonseca-Madrigal et al. 2005; Ruyter et al. 2006; 
Hansen et al. 2008; Pettersson et al. 2009). In the present study, all flesh FAs were 
significantly affected by diet, which is expected, and was seen in similar studies with 
salmon fed high levels of VO (Tocher et al. 2003c; Bell et al. 2004; Torstensen et al. 
2005). Specifically, increasing levels of dietary VO resulted in elevated levels of 18:1n-
9, 18:2n-6 and 18:3n-3 and decreased n-3HUFA in tissues (Bell et al. 2003b; Izquierdo 
et al. 2005; Mourente et al. 2005). Similarly, in the present study, the relative 
proportions of 18:1n-9, 18:2n-6, 18:3n-6, 20:2n-6, 20:3n-6 and 18:3n-3 were higher, 
and the percentages of 14:0, 16:0, 16:1n-7, 18:1n-7, 22:1n-11, ARA, 18:4n-3, 20:4n-3, 
EPA, 22:5n-3 and DHA lower, in the liver, flesh and viscera of fish fed the VO diet 
compared to fish fed the FO diet. The higher proportions of 18:1n-9, 18:2n-6 and 18::3 n-3 
coincided with higher levels of total neutral lipid and TAG in the flesh and liver of fish 
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fed the VO diet. In contrast, 16:0, EPA and DHA are FAs that tend to dominate in polar 
lipids (Jobling et al. 2008), and so higher levels of 16:0, 20:4n-3, EPA, 22:5n-3 and 
DHA in the flesh and liver of fish fed the FO diet coincided with higher levels of total 
polar lipids. In the present study, however, there were no dietary effects on the relative 
proportions of polar and neutral lipids in visceral tissue. Different tissues, however, 
respond to changes in dietary FA composition in different ways or to different extents. 
Atlantic salmon store large amounts of lipid in their flesh and, therefore, dietary FA 
compositions can drastically affect flesh FA compositions in salmon (Bell et al. 2004). 
Torstensen et al (2000, 2004b) concluded that both red and white muscle were 
markedly more influenced by the FA composition of the diet compared to the liver. 
Similarly, in the present study, the FA profiles of the flesh and viscera reflected dietary 
FA composition more than the FA profiles of liver. The percentages of total SFA in all 
the tissues were similar, but the proportions of total MUFA (especially 18:1n-9), 18:2n-
6 and 18:3n-3 in the flesh and the viscera were higher than those in the liver. In contrast 
to this, the levels of total PUFA, total n-3PUFA and the HUFA, ARA, EPA and DHA, 
were higher in the liver than in flesh and viscera. Therefore, the differences in the FA 
compositions between the tissues can be partially explained by the distribution of 
neutral and polar lipids in the different tissues. Hence, the higher proportion of total 
MUFA and the lower proportion of n-3 HUFA in the flesh and viscera reflected the 
higher proportion of TAG. In particular, the levels of DHA reflected the lower 
proportion of polar lipids and the lipid class composition of the flesh and the viscera. 
Previously, the belly flap, myosepta and visceral fat (adipose rich, lipid storage tissues), 
containing high proportions of TAG and lower proportions of polar lipid, had lower 
levels of n-3 HUFA compared to the levels found in lean muscle tissue (Nanton et al. 2007). 
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Differences in FA composition between tissues and the diet suggest selective 
utilisation/retention of FA in the tissues (Torstensen et al. 2004a; Karalazos 2007). 
Moreover, the selective utilisation or retention of FAs for energy production via beta-
oxidation depends upon the relative abundance of individual FAs in the diet (Henderson 
1996; Bell et al. 2003b, 2004). A number of authors have reported that SFA, MUFA, 
18:2n-6 and 18:3n-3 are the preferred FA sources for energy production via -oxidation 
in salmonids (Henderson & Tocher 1987; Kiessling & Kiessling 1993; Henderson 
1996). In the present study, the 16:0 and total SFA were significantly affected by both 
group (strain/family) and diet in flesh and liver tissues but no effects of group on those 
FA were observed in viscera tissue. Fish group was less affected on viscera FA 
composition as the distributions of individual FAs of fish fed either FO or VO diet 
showed a similar pattern in all fish. Moreover, no significant differences in total SFA 
was found which corresponded to the total neutral lipid were similar in all fish groups. 
In flesh and liver tissues, the CAL strain having higher saturates and lower monoenes 
than the LEAN and FAT fish, irrespective of diet. The higher levels of total SFA and 
monoenes indicate higher deposition of theses FAs in tissues for energy (Sargent et al. 
1989). Generally this was balanced by the LEAN fish having higher n-3 LC-HUFA 
levels, although the levels of the n-3 HUFA were not significantly different from the 
CAL strain in flesh but lower than the CAL strain in liver tissues. Tissues with less 
neutral and more polar lipid would tend to accumulate more LC-PUFA and less 
saturates and monoenes (Sargent et al. 2002). 
Total neutral lipid in flesh and liver tissues of the LEAN fish was not 
significantly different from those of the CAL and FAT at week 32 (data not shown) but 
the LEAN fish were higher in total neutral and lower in total polar lipids at the end of 
week 55, and this corresponds to the lipid content of flesh extracted by the soxhlet 
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method. However, the TAG composition of the LEAN fish was not higher than that of 
the CAL and FAT fish. This result probably indicates the differences between fish 
groups in lipid composition. 
All fish groups utilised 18:1n-9 and 22:1n-11 from VO diet but selectively 
utilised 22:1n-11 and retained the 18:1n-9 when fed a FO diet, compared to the levels of 
these FAs in diet. The levels of 18:1n-9 in liver tissue of the CAL strain were lower 
than the levels of the FAT and LEAN fish fed either diet, and the levels of 22:1n-11 in 
the CAL strain fed FO diet were also lower than that of the two groups fed the same diet 
suggesting the CAL strain had high efficiency to utilise these FAs for energy production 
to support growth, as better SGR and FCR was seen in the CAL strain. It has been 
reported that increasing the level of VO inclusion in the diet stimulates the beta-
oxidation capacity of Atlantic salmon (Stubhaug et al. 2005b). Moreover, the lower 
levels of 18:1n-9 in the flesh and the viscera of fish fed the VO diet, and in the livers of 
the fish fed both diets, compared to the levels of 18:1n-9 found in the diet suggests that 
18:1n-9 is selected for catabolism. The lower levels of 22:1n-11 in all the tissues of fish 
fed FO compared to dietary levels also indicates this FA is a preferred substrate for 
beta-oxidation as previously suggested (Henderson & Sargent 1981). The findings from 
this study support those of earlier studies as the percentages of 22:1n-11 were lower 
than those of 18:1n-9 in the flesh and the viscera of FO-fed fish although they were 
present in the FO diet in similar quantities. The level of flesh and liver 18:2n-6 and 
18:3n-3 of the LEAN fish fed VO diet were higher than that of the CAL and FAT fish. 
Moreover, the quantities of 18:2n-6 and 18:3n-3 present in all the tissues were lower 
than those in the diets, except for the levels of 18:3n-3 in the flesh and the viscera of the 
fish fed the FO diet, which suggests the selective utilisation of these FAs, especially in 
fish fed VO. These results were similar to the findings of previous studies showing that 
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the levels of 18:2n-6 and 18:3n-3 in the muscle or liver were less than those in the diet 
because these FAs were selectively utilised and metabolised for energy (Henderson & 
Sargent 1985, Caballero et al. 2002). The percentages of DHA in the tissues were 
greater than those found in the diet in the present study, with the liver showing the 
highest percentage, indicating that DHA was selectively deposited. Similarly, higher 
levels of EPA were found in the livers of fish fed both diets and in the flesh and viscera 
of the fish fed the VO diet than the levels of EPA and DHA found in the diet. Previous 
studies have reported that when FAs were provided at low concentrations in the diets, 
they tended to be preferentially retained or deposited in tissue (Henderson 1996; 
Caballero et al. 2002). In the present study, EPA was found to be preferentially 
deposited in the tissues of fish fed the VO diet and preferentially utilised in the fish fed 
the FO diet.  
The FA compositions of salmon tissues are determined by both the type of 
dietary lipid and by the ability of the individual fish species to modify that dietary input 
via both catabolism and biosynthesis pathways (Torstensen et al. 2000; Bell et al. 
2001, 2002). In addition to this, a number of previous studies have reported that fatty 
acyl desaturation and elongation activities in the liver are stimulated by the inclusion of 
VO in the diet of salmonids (Tocher et al. 2000, 2001; Bell et al. 2001, 2002). In the 
present study, tissue EPA and DHA may be obtained by their direct absorption from the 
diet and partially supplemented by synthesis by desaturation and elongation of 18:3n-3 
(Henderson 1996; Caballero et al. 2002). The effects of dietary lipid and strain on the 
PUFA composition and conversion of C18 to ARA, EPA and DHA have been 
investigated previously (Hoffman et al. 1995; Pickova et al. 1999; Rollin et al. 2003; 
Peng et al. 2003). The LEAN fish had high levels of 18:2n-6 (LA) and 18:3n-3 (ALA), 
and higher levels of biosynthesis products 20:2n-6 and 20:4n-3 than the CAL and FAT 
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fish in both diets suggesting higher capacity of elongase in the LEAN fish. In contrast, 
the CAL strain had lower levels of flesh n-3 LC-PUFA than the LEAN fish fed FO diet 
but higher than the LEAN fish in VO diet. Again, the higher levels of LC n-3 HUFA 
indicate higher capacity for ALA and LA conversion (Sargent et al. 2002; Tocher 
2003).Therefore, the above results strongly indicate that the conversions of dietary ALA 
to n-3 LC-PUFA and LA to n-6 LC-PUFA were carried out in both CAL and LEAN 
fish greater than in the FAT fish and thus the genetics influenced tissue FA composition 
in the present study. 
4.4.3 Effect of a FO finishing diet and washout phase on flesh lipid and fatty acid 
composition 
Salmon is a species with oily flesh that can deliver significant levels of n-3 LC-
PUFA to consumers and it is important to maintain a positive image for the species in 
this respect as the health benefits of increased dietary n-3 LC-PUFA, EPA and DHA, 
intake in humans are well documented (Calder 2007; Park et al. 2009; Hibbeln & 
Davis 2009). One method of n-3 LC-PUFA restoration is to dilute or wash out the VO-
derived FAs using a FO finishing diet and this has been shown to be an effective 
process (Bell et al. 2003b, 2004, 2005b; Torstensen et al. 2005). However, the effect of 
different fish strains, that have proven differences in flesh lipid deposition, may affect 
the efficacy of the wash out process. Regarding the EPA + DHA in fish previously fed 
VO diet at the end of week 24, the LEAN fish showed better levels of EPA + DHA, and 
more rapid restoration of LC-PUFA, than those of the FAT and CAL fish, with the FAT 
having lowest levels of EPA + DHA. The LEAN fish showed greater levels of EPA + 
DHA (19%) than that of those FAT and CAL fish (18% and 16%) after feeding the 
finishing diet for 16 weeks. This suggests that the LEAN strain were able to accumulate 
n-3 LC-PUFA more rapidly than the other two strains. This study does suggest that LC-
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PUFA uptake and deposition may be under genetic control and could be exploited to 
maintain or restore LC-PUFA, following a period of dietary restriction, by selecting for 
this trait.  
Regarding the restoration of EFA including LA, ALA, ARA, EPA and DHA of 
the fish previously fed VO diet compared to the same fish fed a FO diet throughout. In 
the present study, after feeding the VO diet for 55 weeks, the 18:2n-6 and 18:3n-3 
contents of the flesh were approximately 2.5- and 3-fold higher, respectively, than the 
flesh of fish fed the FO diet. After consuming the finishing diet for 24 weeks, the 
concentrations of 18:2n-6 and 18:3n-3 in the fish fed the VO diet were still higher than 
those of fish fed the FO diet throughout, although the levels of 18:2n-6 and 18:3n-3 had 
declined by around 70 % and 60 %, respectively. The results were in accordance with 
the findings of earlier studies where the levels of 18:2n-6 and 18:3n-3 after feeding VO 
to Atlantic salmon (Bell et al. 2004), red sea bream, (Glencross et al. 2003), gilthead 
sea bream (Izquierdo et al. 2005) and European sea bass (Montero et al. 2005) were 
substantially reduced, although not completely, by feeding a finishing diet. After 
consuming the finishing diet for 24 weeks, the ARA levels in fish previously fed the 
VO diet had recovered to about 86 -100 % of the values found in the fish fed the FO 
diet with the LEAN and CAL fish showing better recovery than the FAT fish. After 
feeding the VO diet for 55 weeks, the EPA concentration in flesh was significantly 
lower, approximately one third, of that in flesh of fish fed the FO diet. After feeding the 
finishing diet for 24 weeks, the levels of EPA were still lower than the fish that had 
been fed the FO diet throughout, but recovery was almost 90 %, with the LEAN and 
CAL fish showing a higher recovery than the FAT fish. A similar result was observed in 
the concentration of DHA which was found to decrease by two thirds after consuming 
the VO diet for 55 weeks, compared with the fish fed the FO diet. After feeding the 
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finishing diet for 24 weeks, the level of DHA in the tissues remained lower than the fish 
fed the FO diet throughout, although the percentage recovery of the DHA was 
approximately 83 – 90 %, with the LEAN and CAL fish showing a greater recovery 
than the FAT fish. An earlier study by Bell et al (2003a) working with Atlantic salmon 
found complete restoration of EPA in 4 weeks and that DHA was restored within 12 
weeks after feeding the finishing diet. This experiment, however, was performed over a 
shorter period, and used smaller fish, than the present study. Other, longer, experiments 
conducted in Atlantic salmon have demonstrated that about 80 % of EPA and DHA 
were restored (Bell et al. 2003b; 2004; 2005a). In European sea bass, complete 
restoration of EPA and DHA was found when a partial replacement of FO with VO in 
diet was used before switching to a FO finishing diet (Montero et al. 2005). However, 
the complete restoration of EPA and DHA was not found in gilthead seabream when fed 
a partial replacement diet with VO prior to feeding the finishing diet (Fountoulaki et al. 
2009). The fish species, fish age and the time when the finishing diet is given, as well as 
the concentrations of EPA and DHA in the finishing diet, may explain the different 
degrees of EFA restoration in tissues.  
In conclusion, the results from this study suggest that the total replacement of 
FO with VO and the partial substitution of FM with PPs in the diets had no negative 
effects on the growth performance of the experimental fish, including FCR, SGR, HSI 
and VSI. Switching the diet to one that contained FO as the sole source of lipid as a 
means of improving the nutritional quality of the fillet when given to the fish for 24 
weeks resulted in a 67 - 72 % decrease of 18:2n-6 and a 52 - 63 % reduction in the level 
of 18:3n-3. The level of ARA in the LEAN strain was successfully restored up to 100 
%. The levels of EPA and DHA were restored approximately 90 % in all the three 
groups of fish. A novel aspect of this study was the use of different strains/families to 
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investigate differences in growth and FA deposition/retention. Differences were seen 
between strains due to diet as well as interactions between strain and diet. The 
differences observed suggested that genetics had an influence on lipid deposition and 
metabolism and that selective breeding programmes could be used to select salmon 
families that retained more n-3 LC-PUFA in their flesh, particularly when fed diets low 
in these FAs.  
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Chapter 5 - Influence of genotype/phenotype on the effects of 
alternative diets in Atlantic salmon (Salmo salar 
L.): Effects of total replacement of fish oil and 
partial replacement of fishmeal on gene 
expression in liver 
5.1 Introduction  
Expansion of the aquaculture industry coupled with overfishing of wild marine 
stocks has placed increasing pressure on the supply of FM and FO, which has now 
become unsustainable. Farmed-fish feed, however, still relies heavily on marine fishery 
products for its main ingredients. It has been estimated that in 2006, the aquaculture 
sector consumed 3.7 million tonnes of FM and 0.85 million tonnes of FO, this 
represents 68 % and 89 % of global FM and FO, respectively, production in 2006 
(Tacon & Metian 2008). A number of studies have investigated the replacement of FM 
and FO with products derived from plant sources and from these studies, it is clear that 
a substantial reduction in the FM inclusion can be achieved without compromising fish 
growth. Complete replacement of FM by plant protein ingredients, however, can reduce 
growth (Gomes et al. 1995; Kaushik et al. 1995, 2004; Hardy 1996; Watanabe et al. 
1998). In addition, replacing FO with VO has been used successfully without 
compromising growth in a variety of fish species including Atlantic salmon (Bell et al. 
2004; Torstensen et al. 2005; Petropoulos et al. 2008; Fountoulaki et al. 2009; 
Pettersson et al. 2009), although flesh n-3 HUFA content and liver FA metabolism are 
both affected (Torstensen et al. 2000; Stubhaug et al. 2005a).  
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Recently, the influence of substituting FO with VO in the diet of salmonids and 
the subsequent expression of genes has been examined in liver (Jordal et al. 2005, 
2006; Leaver et al. 2008; Panserat et al. 2009), muscle (Johansen & Overturf 2006) 
and intestine (Froystad et al. 2008). FO replacement with VO has been reported to 
increase cholesterol and HUFA biosynthesis (Leaver et al. 2008; Taggart et al. 2008; 
Panserat et al. 2009). In addition, the removal of FO from the diet of rainbow trout was 
found to increase expression of genes of lipid biosynthesis and decrease expression of 
lipid catabolism genes (Panserat et al. 2008).  
In the present study, the effects of feeding a diet with 100 % of FO substituted 
with VO on liver gene expression were investigated in two families of Atlantic salmon, 
the FAT and LEAN groups, which were fully described in the previous chapter. The 
aims of this study were to investigate VO replacement and subsequent effects of 
phenotype/genotype on hepatic gene expression, particularly those related to lipid 
metabolism. Liver was specifically selected for study as the main organ involved in 
nutrient utilisation and intermediary metabolism. Atlantic salmon were fed a diet 
containing either 100 % FO or a 100 % of blend of RO, LO and CO (5:3:2) for a period 
of 55 weeks. Livers were collected, RNA extracted and global gene expression 
determined by analysis of the transcriptome using the SGR/TRAITS 17K cDNA salmon 
microarray (Taggart et al. 2008). The effects of VO inclusion on the expression of key 
genes associated with lipid metabolism including FA oxidation and HUFA synthesis 
were investigated alongside key genes involved in cholesterol metabolism.  
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5.2 Materials and methods 
5.2.1 Experimental fish and diets 
Three different groups of Atlantic salmon were used in the present study. The 
LEAN and FAT families were supplied by Landcatch Natural Selection (LNS). The 
commercial CAL strain (Caledonian 20) was supplied by Marine Harvest Ltd, (Fort 
William, Scotland, UK). The experiment was carried out from May 2006 to July 2007 at 
the Marine Harvest FTU, Ardnish, Lochailort, Scotland. The fish, trial and feeds were 
as described in detail in sections 4.2.1. and 4.2.2 in Chapter 4. Details of feed 
formulations (Skretting ARC, Norway), proximate and FA compositions are presented 
in Tables 4.1-4.3 in the previous chapter. 
5.2.2 Experimental samples 
The general sampling protocol used for the fish was fully described in section 
4.2.3 of Chapter 4. Thus, samples of approximately 0.5 g of liver were collected into 
microcentrifuge tubes from ten fish per pen (20 per dietary treatment) for molecular 
analysis and rapidly frozen in liquid nitrogen prior to storage at -80
o
C. 
5.2.3 Gene expression (microarray and quantitative PCR) 
Total RNA was extracted from individual liver samples by homogenising each 
in TriReagent as described in Chapter 2. For the microarray analysis, first strand and 
second strand cDNA synthesis of the total RNA from 6 biological replicates were 
subjected to aRNA synthesis and amplification prior to microarray hybridisation 
according to the instruction manual of the kit for RNA amplification for microarray 
analysis (Amino Allyl messageAmp II aRNA amplification kit, Ambion, UK.). 
Differential gene expression was verified by qPCR (Quantica thermocycler, Techne) as 
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described in Chapter 2, using first strand cDNA synthesis of total RNA from the above 
6 biological replicates. Microarray analysis was confined to a comparison between the 
LEAN and FAT families, whereas gene expression by qPCR was investigated in all 
three groups of fish. The PCR primer sequences for the target genes and the housekeeping 
genes using for the qPCR analysis are given in Table 5.1. 
Table 5.1. Primer sequences for target and housekeeping (normalisation) genes used in 
 real-time qPCR. 
AY458652 6 fatty acyl desaturase F CCCCAGACGTTTGTGTCAG
R CCTGGATTGTTGCTTTGGAT
AF478472 5 fatty acyl desaturase F GTGAATGGGGATCCATAGCA
R AAACGAACGGACAACCAGA
FJ237532 Elongase 2 F CGGGTACAAAATGTGCTGGT
R TCTGTTTGCCGATAGCCATT
FJ237531 Elongase 1 (elovl5b) F ACAAAAAGCCATGTTTATCTGAAAGA
R AAGTGGGTCTCTGGGGCTGTG
DY708590 Mevalonate kinase F CCCTTAATCAGGGTCCCAAT
R GGTGCTGGTTGATGTCAATG
R ACAGGTCCTTCTGGTGGTTG
DY733476 SREBP2
1 F GACAGGCACAACACAAGGTG
R CAGCAGGGGTAAGGGTAGGT
BE518590 HMG-CoA reductase
2 F CCTTCAGCCATGAACTGGAT
R TCCTGTCCACAGGCAATGTA
AM230810 Carnitine palmitoyl transferase F CCTGTACCGTGGAGACCTGT
R CAGCACCTCTTTGAGGAAGG
AF321836
Elongation factor-1  
(housekeeping)
F CTGCCCCTCCAGGACGTTTACAA
R CACCGGGCATAGCCGATTCC
-actin
(housekeeping)
R GACAACGGAACCTCTCGTTA
Unresponsive EST
(housekeeping)
R TGTTCACAGCTCGTTTACCG
GenesAccession no primers Sequence 5  -3
AF012125 F ACATCAAGGAGAAGCTGTC
AJ425111 F AGCCTATGACCAACCCACTG
DW561983 F CTTCTGGAATGAGGCATGGT7-dehydrocholesterol
 
1
Sterol regulatory element binding protein, 
2
 3-hydroxy-methyl-glutaryl-CoA reductase  
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5.2.4 Statistical analysis 
The microarray data were analysed by both two-way ANOVA and one-way 
ANOVA with GeneSpring GX version 10.0.2 (Agilent Technologies, Cheshire, UK). 
The fold change of the expression of genes that were verified by qPCR were analysed 
by REST 2005 (Pfaffl 2001).  
5.3 Results 
5.3.1 Analysis of gene expression by microarray  
Liver gene expression in two families of Atlantic salmon, LEAN and FAT, 
selected on the basis of flesh adiposity was investigated by transcriptomics using the 
SGP/TRAITS 17k cDNA microarray. To determine the effects of diet and family on 
gene expression, a two way ANOVA without multiple testing correction of the cDNA 
array data was performed. The analyses identified 712 gene features that were 
differentially expressed between the two families, and 539 gene features that were 
significantly different (P < 0.05) due to the effects of diet. In addition, a significant 
interaction between the effects of family and diet was observed for 787 of these gene 
features. All the Atlantic salmon gene clones were identified by BLASTN and 
BLASTX homolog searching against Tentative Consensus (TC) contigs from the Atlantic 
salmon gene index (ASGI) (http://compbio.dfci.harvard.edu/tgi/tgipage.html) as described in 
Chapter 2. For each factor (i.e. family, diet, and their interaction), the top 100 clones 
(i.e. based on statistical significance, the most highly significant) that were identified as 
being significantly different were categorised according to function and the results 
presented as pie charts in Figure 5.1. Note that the pie charts do not include gene 
features in the top 100 that were of unknown (i.e. unannoted clones). 
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The functional categories most affected by family and diet were those associated 
with metabolism. Over a third (35 %) of the gene features affected by diet were 
associated with metabolic processes, with the majority of these (23 %) linked to lipid 
metabolism, with 5 % involved in carbohydrate metabolism, 5 % associated with 
protein and AA metabolism and 3 % related to vitamin metabolism. Family had less of 
an effect on metabolism than diet, with just over a quarter (27 %) of gene features 
affected being related to metabolic processes of which 9 % were linked to lipid 
metabolism, 6 % to metabolic energy pathways and 12 % to protein and AA 
metabolism. Most of the observed interactions between diet and family were in genes 
associated with metabolic functions, with almost a third (32 %) of the top 100 genes 
affected being associated with metabolism. Of these, 18 % of the genes were linked 
with lipid metabolism, 4 % with carbohydrate metabolism and 10 % with protein and 
AA metabolism. In addition to metabolic genes, groups of genes related to immune / 
stress responses, and thus fish health and welfare, were also affected. Therefore, 
approximately 18 % of the top 100 responding genes affected by strain/family 14 % of 
the genes affected by diet and 8% of genes affected by their interaction were associated 
with immune/stress responses (Figure 5.1).  
Given that the two-way ANOVA found significant effects associated with both 
family and diet but that there was significant interaction between them, a series of two-
by-two comparisons were performed fixing one of the variables and using t-test to 
analyse the statistical significance of the differences. Therefore, to examine the specific 
effects of diet, that is, feeding either a FO or VO, on liver gene expression was 
separately investigated in each individual family, FAT and LEAN. Furthermore, the 
effect of family on liver gene expression was investigated when fed either a FO or a VO 
diet. Therefore, four comparisons were performed; 1) comparison of dietary FO vs VO  
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Figure 5.1. The functional categories of the top 100 significant cloned genes that were 
 differentially expressed by the FO and VO diets, the strain and the interaction 
 between diet and strain. Non-annotated and unknown cloned genes are not 
 included. 
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in the LEAN family, 2) comparison of dietary FO vs VO in the FAT family, 3) 
comparison of LEAN and FAT families fed a FO diet and, 4) comparison of LEAN and 
FAT families fed a VO diet. Diet FO and FAT fish were used as control. The results 
from the t-tests, without multiple testing correction, found that there were 272 gene 
clones whose expression was significantly different (P < 0.05) in LEAN fish fed either a 
FO or a VO diet or, in other words, diet significantly affected the expression of 272 
gene features in LEAN fish. Similarly, diet significantly affected the expression of 441 
gene features in FAT fish. Family significantly affected the expression of 563 gene 
features in fish fed the VO diet, and 246 genes in fish fed the FO diet. As with the two-
way ANOVA, the top 100 significantly different gene clones (based on statistical 
significance) in each of the four comparisons were classified according to biological 
function and are presented in Tables 5.2-5.5. Beside the top 100 responding genes, other 
lipid metabolism/transport-related and cholesterol/steroid biosynthesis-related genes 
that were found to be significantly different following the t-test analysis of the four 
comparisons were also categorised and reported in Table 5.6. 
The results of the two-by-two comparisons indicated that the levels of 
expression of metabolism-related genes in the liver differed between the two families of 
salmon when fed either a FO or a VO diet. Effects of diet on the expression of the 
HUFA biosynthesis genes, 6 and 5 fatty acyl desaturases, were observed in the 
LEAN family (Table 5.2) whereas effects on 5 desaturase were not observed in the 
FAT family (Table 5.3). Thus, the expression of 6 desaturase was approximately 1.5 to 
2.8 fold higher and that of 5 desaturase was about 2.0 fold higher in the LEAN family 
fed the VO diet than fish fed the FO diet (Table 5.2). In the FAT family, the expression 
of the 6 desaturase was around 1.9 fold higher in fish fed the VO diet compared to fish 
fed the FO diet (Table 5.3). Differences between families in the expression of FA and 
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HUFA biosynthesis genes were observed in fish fed the FO diet (Table 5.4) whereas 
there were no significant differences in those genes in fish fed the VO diet (Table 5.5). 
Thus, the liver transcript levels of the 5 desaturase and FA synthase genes were 
approximately -1.7 and -1.2 fold lower, respectively, in the LEAN family than in the 
FAT family fed the FO diet (Table 5.4). Therefore, the difference in expression of 5 
desaturase between the two families observed in the diet comparisons in Tables 5.2 and 
5.3 was reflected in the family comparisons of fish fed FO (Table 5.4) and not of fish 
fed VO (Tabel 5.5) indicating that it was the different expression level in fish fed FO 
that led to the differential expression between the families.  
Other differences in liver gene expression were observed between the families. 
The expression levels of acyl-CoA binding protein, isopentenyl-diphosphate, 
angiopoitin-like 3 (ANGPTL3) and squalene monooxygenase in the LEAN family were 
up-regulated in fish fed the VO diet compared to fish fed the FO diet (Tables 5.2 and 
5.6). The expression levels of ANGPTL3 and lipoprotein lipase (LPL) were also up-
regulated in the FAT family in fish fed VO compared to fish fed FO, whereas no 
significant effects of diet on the expression of acyl-CoA binding protein, isopentenyl-
diphosphate and squalene monooxygenase were observed in the FAT family (Tables 5.3 
and 5.6). Furthermore, in fish fed the FO diet, the expression of LPL was higher in the 
LEAN family than in the FAT family, whereas the expression levels of isopentenyl-
diphosphate, ANGPTL4 and squalene monooxygenase were lower in the LEAN family 
compared to the levels in the FAT family (Tables 5.4 and 5.6). In fish fed the VO diet, 
the levels of expression of LPL, ANGPTL3 and ANGPTL4 were higher in the LEAN 
family compared to the levels found in the FAT family (Tables 5.5 and 5.6).  
Other dietary differences in liver gene expression also showed differential 
effects between the families. Thus, many of the immune response-related genes in the 
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LEAN family showed lower levels of expression in liver of fish fed the VO diet than in 
liver of fish fed the FO diet (Table 5.2). The only exception was the heat shock protein 
(hsp90), whose expression was 1.3-fold greater in the LEAN family in fish fed VO 
compared to fish fed FO. In contrast, the levels of expression of the immune response-
related genes in the FAT family were higher in fish fed the VO diet than in fish fed the 
FO diet (Table 5.3). It should be noted that the dietary effects on the expression of 
hsp90 were not found in the FAT family. Consistent with this difference, the liver 
expression of hsp 90 in the LEAN family was 1.5 fold higher than that of the FAT 
family in fish fed the FO diet (Table 5.4) while the expression of hsp70 was 1.2 fold 
greater in the LEAN family than that in the FAT family in fish fed the VO diet (Table 5.5).  
5.3.2 Analysis of gene expression by qPCR  
To validate the microarray results, specific genes related to FA and HUFA 
synthesis, cholesterol biosynthesis, lipid transport and beta-oxidation were selected for 
qPCR analyses. These analyses showed similar trends in the differential expression of 
the genes with respect to dietary and family/strain effects, and so the qPCR data largely 
confirmed the results obtained from the microarray analyses. In the LEAN family of 
salmon, the expression of both 6 and 5 fatty acyl desaturases and elongase 
(elongase2, a gene not present in the cDNA array) were 4.0, 8.3 and 2.4 fold higher in 
fish fed the VO diet than in fish fed the FO diet (Table 5.7). In the FAT family, the 
expression of 6 desaturase was about 3.6 fold higher in fish fed the VO diet than in 
fish fed the FO diet, whereas the increased expression of 5 desaturase was not 
significant, as with the microarray results. In the CAL strain, the expression of another 
fatty acyl elongase (elongase1, not present in the cDNA array) was about 2.9 fold lower 
(reported as 0.34, down-regulation) in fish fed VO than fish fed FO (Table 5.7). 
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Furthermore, significant differences (P < 0.05) in the expression of the genes of HUFA 
biosynthesis were observed between the different families/strains of fish fed the same 
diet. For fish fed the FO diet, the expression levels of the 5 and 6 desaturases in the 
LEAN family were about 2.2 and 2.8 fold lower (0.45 and 0.36 down-regulation, 
respectively) than the levels determined in the FAT family (Table 5.8). It should be 
noted that, in contrast, the expression levels of the 6 desaturase between the LEAN 
and FAT family fed the FO diet were not significantly different as determined by the 
microarray. For fish fed the VO diet, the level of expression of elongase 2 in the LEAN 
family was 1.67 fold greater than that of the FAT family (Table 5.9). There were no 
significant differences in the gene expression between the CAL strain and the other two 
families of salmon fed either diet (Tables 5.8 and 5.9). No significant differences were 
found in the expression levels of mevalonate kinase, 7-dehydrocholesterol reductase, 
sterol regulatory element binding protein, HMG-CoA reductase or carnitine palmitoyl 
transferase-I genes between fish fed either of the diets or between the different fish 
groups fed the same diet (Tables 5.7-5.9).  
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Table 5.2. Effects of diet on liver gene expression in the LEAN salmon family.  
Accession no Clone gene VO/FO ratio p-value
No accession no. Delta-6 fatty acyl desaturase 2.1 <0.0000
No accession no. Delta-6 fatty acyl desaturase 2.0 <0.0000
No accession no. Delta-6 fatty acyl desaturase 2.8 0.0001
EG647320  Delta-6 fatty acyl desaturase 1.8 0.0026
No accession no. Delta-6 fatty acyl desaturase 1.5 0.0143
No accession no. Delta-5 fatty acyl desaturase 2.1 0.0014
No accession no. Delta-5 fatty acyl desaturase 2.3 0.0016
CK887422 Delta-6 fatty acyl desaturase 2.0 0.0002
CK876943 Similar to fatty acid synthase 1.4 0.0054
BM413891 Angiopoietin-like 4 1.4 0.0021
CK884265 Ganglioside GM2 activator 1.3 0.0083
EG648040 Acyl-coenzyme A-binding protein 1.7 0.0087
BI468158 ATP-binding cassette sub-family A member 1 2.0 0.0114
CK879648 Squalene monooxygenase  1.9 0.0030
CK875291 Isopentenyl-diphosphate 2.0 0.0086
CK886572
GSK-3-binding protein putative (glycogen synthase 
kinase) 1.9 0.0002
AJ425598 Glycogenin-1 putative mRNA 1.2 0.0039
No accession no. Alpha-enolase 1.2 0.0006
CK886932 Probable O-sialoglycoprotein endopeptidase 1.5 0.0031
CK885604 C-1-tetrahydrofolate synthase -1.5 0.0071
CO469782 Lysyl-tRNA synthetase 1.3 0.0096
EG355385 Arginase-1 1.7 0.0138
No accession no. Leukotriene B4 receptor 1 putative -1.4 0.0151
DW589721 SAPK substrate protein 1 -1.4 0.0093
CK877325 Interleukin-1 receptor-associated kinase 4 -1.2 0.0053
CK893821 Sequestosome 1or ubiquitin-binding protein P62 -1.3 0.0043
No accession no. HIG1 domain family member 1A -1.3 0.0142
AM083396 Heat shock protein hsp90 1.3 0.0139
 Apoptosis
AM042428 Tumor necrosis factor receptor number 11b -1.2 0.0043
CK880960 PREDICTED: similar to B-cell CLL/ lymphoma 10 -1.4 0.0110
Metabolic areas/pathways
          HUFA biosynthesis
          Lipid metabolism and transport
          Cholesterol and isoprenoid biosynthesis
          Carbohydrate metabolism
          Protein metabolism
Immune response / stress response / inflammatory response
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Table 5.2 (continued)  
Accession no Clone gene VO/FO ratio p-value
CK874058 Retinoic acid receptor gamma a (Rarga), coiled-coil -1.5 0.0101
CK894063 Zinc finger protein 183 -1.5 0.0105
CK894959 Transcription factor AP-1 -1.5 0.0046
CK878904 PREDICTED: zinc finger protein 423 (ZNF423), mRNA 1.3 0.0048
CK874146 Immediate early response 2 1.4 0.0049
CK897760 Retinoic acid receptor gamma a (Rarga) -1.2 0.0049
CK879361 Thioredoxin interacting protein (TXNIP) 1.4 0.0064
CK875839 Retinoic acid receptor gamma a (Rarga) -1.2 0.0078
CK887913 Transcriptional regulator 1.4 0.0148
CK883165 Hypoxia-inducible factor 1 alpha 1.3 0.0162
CK890454 Zinc finger protein XlCOF22 1.3 0.0154
CK888548 Rev protein - Human immunodeficiency virus 1 1.2 0.0130
CN181210 40S ribosomal protein S27 1.3 0.0134
CO472436 Mitochondrial 60S ribosomal protein 1.4 0.0047
CK886667 Na/K ATPase 1.5 <0.0000
CK896189 Mitochondrial solute carrier family 25 member 25 -1.7 0.0062
CK890974 Calcium-binding mitochondrial carrier protein SCaMC-2-B 1.7 0.0007
No accession no. S100-A1 calcium binding 1.4 0.0026
CK884745 Ras GTPase-activating protein1 -1.3 0.0083
CK892148 Growth factor receptor-bound protein 7 -1.5 0.0098
AJ424743 Fibroleukin precursor 1.4 0.0176
CO470718 Serine/threonine kinase 1.3 0.0143
CK882232 Stomatin-like protein 2 1.3 0.0035
EG647828 Amyloid beta A4 precursor 1.4 0.0067
AJ424583 Filamin-A putative 1.4 0.0132
DW590010 Histone H2A 1.2 0.0053
CK894173 EFHD2  (EF hand domain containing2) 1.2 0.0038
EG649410 D-dopachrome tautomerase 1.4 0.0053
No accession no. Retinoblastoma-binding protein 9 -1.5 0.0065
Cell growth / adhesion / proliferation and differentiation / cytoskeleton
 Miscellaneous / unknown
Protein transport / extracellular and intracellular transport / ion transport
Regulation of transcription
Translation / ribosome biogenesis and assembly
 Signal transduction / signal cascade
 
The top 100 liver transcripts (59 annotated and arranged by categories of biological 
function, 41 unknown) exhibiting differential expression between LEAN fish fed diets 
containing either FO or VO, identified by t-test. FO is a control diet.  
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Table 5.3. Effects of diet on liver gene expression in the FAT salmon family. 
Accession no. VO/FO ratio p-value
No accession no. 1.9 0.0054
CK887422 1.8 0.0029
CK883097 1.8 0.0005
CK894344 -1.2 0.0027
No accession no. 1.4 0.0054
CK894278 -1.2 0.0061
CK881643 1.4 0.0073
CO472476 1.7 0.0081
No accession no. -1.3 0.0109
CK891619 1.2 0.0117
BM414066 1.2 0.0121
DW589347 1.3 0.009
No accession no. 1.8 0.0119
CK888359 -1.4 0.0053
CK885069 1.3 0.0062
BI468169 1.3 0.0076
AM402530
1.3 0.009
CK897836 1.6 0.0044
EG648795
-1.4 0.0086
CK897702
1.2 0.0131
DW592075 -1.3 0.0115
AM402452 1.9 0.0093
EG648518 -1.3 0.0084
CK885098 1.2 0.0011
CK883277 1.2 0.0041
AM083373 1.6 0.0013
CK879021 -1.3 0.0124
CK897269 1.7 0.0028
AM402518 1.9 0.0115
Carnitine O-acetyltransferase
Peroxiredoxin-6 (EC 1.11.1.15) (Antioxidant protein 2) 
 Lipoprotein lipase
Delta-6 fatty acyl desaturase
          Lipid metabolism and transport
5'-AMP-activated protein kinase subunit gamma-3 
Phospholipase D3
Angiopoietin-like 3
Phosphoinositide 3-protein kinase
Endothelial lipase precursor  
Endothelial lipase precursor 
Biotinidase
          Steroids / cholesterol and isoprenoid biosynthesis
          Carbohydrate metabolism
3-beta-hydroxysteroid dehydrogenase
 Glutamine-fructose-6-phosphate transaminase 1
          Generation of metabolic energy  
Dihydrodipicolinate synthase-like, mitochondrial 
Obg-like ATPase 1 (GTP-binding protein 9) 
Cytochrome c oxidase  
NADH-ubiquinone oxidoreductase 75 kDa subunit, 
mitocondrial
Biotinidase precursor (EC 3.5.1.12) 
         Vitamin metabolism
Selenoprotein X
          Protein and amino acid metabolism
Betaine-homocysteine S-Methyltransferase (EC 2.1.1.5)
AMP deaminase 1 (EC 3.5.4.6) (Adenine monophosphate 
deaminase 1)
Gamma-glutamyl hydrolase (conjugase 
folylpolygammaglutamyl hydrolase) 
Ubiquitin-conjugating enzyme E2 D2
Serine/threonine-protein kinase
Proteasome subunit beta type 5 precursor
Proteasome subunit alpha type
Proteasome (Prosome, macropain) subunit beta type-7
Phenylalanyl-tRNA synthetase, alpha subunit
Delta-6 fatty acyl desaturase
Clone gene
Metabolic areas/pathways
          HUFA biosynthesis
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Table 5.3 (continued) 
Accession no VO/FO ratio p-value
Immune response / stress response / inflammatory response
CK887922 Tumor necrosis factor, alpha-induced protein 8-like protein 2 -1.4 0.0018
CK880083 Interleukin-15 precursor 1.3 0.0025
CK883643 Interferon-gamma receptor alpha chain 1.3 0.0034
AM402574 Peptidoglycan recognition protein 1.4 0.0047
CK888813 Complement component C3-4 1.6 0.0081
AM402762 Complement component C8 alpha chain 1.7 0.0091
CK895744 Properdin P factor 1.5 0.0096
No accession no. Scavenger receptor cysteine-rich gene 1.4 0.0127
AJ424648 Macrophage mannose receptor 1 -1.4 0.0113
AJ425750 Non-histone chromosomal protein H6 1.3 0.0005
CK896665 -1.3 0.0029
No accession no. Phosducin-like protein 3 -1.3 0.0079
EG648112 Retrovirus-related Pol polyprotein 1.3 0.0099
DW588532 Polybromo 1(PBRM1) -1.6 0.0089
CK898402 Zinc finger protein 391 putative -1.3 0.0013
BI468167 Glucocorticoid-induced leucine zipper protein 1.3 0.0026
CK876689 Class B basic helix-loop-helix 1.3 0.0111
AM041780 Butyrate response factor 1 1.5 0.0034
CK884728 Butyrate response factor 1 1.5 0.0034
No accession no. 60S ribosomal protein -1.2 0.0086
EG648737 -1.3 0.0085
No accession no. Excitatory amino acid transporter -1.2 0.0051
EG649484  Plasma retinol-binding protein II (PRBP-II) 1.2 0.0068
CK892246 Importin beta-3 (Karyopherin beta-3) 1.3 0.013
CK881430
-1.2 0.0112
AM397509 Tensin-like C1 1.3 0.004
No accession no. Guanine nucleotide-binding protein G(T) gamma-T1 1.5 0.0092
CK885828 Chemokine receptor-like 1 1.3 0.0106
CK894523 Galectin like protein 3 -1.2 0.0023
No accession no. CD9 antigen  1.3 0.0086
DW590534  Collagen alpha-2 chain type 1 1.3 0.0093
CK893640  Cyclin L1 1.4 0.0094
Clone gene
Apoptosis
Regulation of transcription
Interferon-induced protein kinase-interacting protein (P52rIPK) 
Protein transport / extracellular and intracellular transport / ion transport
Ribosome biogenesis and assembly
Cell growth / adhesion / proliferation and differentiation / cytoskeleton
Signal transduction / signal cascade
N-arachidonyl glycine receptor (Alt nane G-protein coupled 
receptor 18)
Golgi associated, gamma adaptinear containing, ARF binding 
protein 1
 
Chapter 5 
 174 
Table 5.3 (continued)  
Accession no VO/FO ratio p-value
BI468137 Plasma protease C1 inhibitor 1.4 0.0072
AM402942 Plasminogen precursor (EC 3.4.21.7) 1.3 0.0116
CK885096 1.4 0.0063
CK878707 -1.3 0.0084
CO469710 1.2 0.0129
AM402582 Surfeit locus protein 4 1.3 0.0032
AM397500 Brain protein 44-like protein 1.3 0.0100
DW588813 Ring finger protein 122 putative 1.3 0.0126
Transmembrane protein 30A
RNA-binding protein with multiple splicing (RBP-MS)
UDP-glucuronosyltransferase 1-2 precursor microsomal
Blood coagulation
Miscellaneous
Clone gene
 
The top 100 liver transcripts (69 annotated and arranged by categories of biological 
function, 31 unknown) exhibiting differential expression between FAT fish fed diets 
containing either VO or FO, identified by t-test.  FO is a control diet. 
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Table 5.4. Effects of family on liver gene expression in salmon fed diets containing FO.  
No accession no. Delta-5 fatty acyl desaturase -1.7 0.0094
CK876943 Similar to fatty acid synthase -1.2 0.0053
CK884265 Ganglioside GM2 activator -1.3 0.0038
CO472011 Peroxisomal biogenesis factor 3 (Pex3) 1.2 0.0136
CK889835
N-acylethanolamine-hydrolyzing acid amidase precursor 
-1.4 0.0136
BM414094 Phosphatidylethanolamine N-methyltransferase -1.5 0.0162
CK880279 Delta 3, 5-delta 2, 4-dienoyl-CoA isomerase -1.3 0.0152
CO470568 Lipoprotein lipase 1.2 0.0145
No accession no. Apolipoprotein B -1.4 0.0068
CK879648 Squalene monooxygenase  (Squalene epoxidase) (SE) -1.9 0.0038
CK875291 Isopentenyl-diphosphate -1.9 0.0197
BI468173 Lysosome-associated membrane glycoprotein 2 1.3 0.0145
CO469782 Lysyl-tRNA synthetase -1.2 0.0149
EG648459
5-aminoimidazole-4-carboxamide ribonucleotide 
formyltransferase
-1.4 0.0221
BM414402 Heat shock 90 kDa 1.5 0.0211
CK896665
Interferon-induced protein kinase-interacting protein 
(P52rIPK) 
-1.3 0.0212
AM041615 Barrier-to-autointegration factor 1.3 0.0222
CK890485 Interleukin-4 receptor alpha chain 1.3 0.0222
AJ424124 MHC class I (Major Histocompatibility complex ) -1.2 0.0147
AM042454
Induced myeloid leukemia cell differentiation protein 
Mcl-1
1.3 0.0225
EG648732 Phosducin-like protein 3 -1.3 0.0088
DW589311 TFG (TRK- fused gene) -1.3 0.0096
DW589427 Cullin-associated and neddylation-dissociated 1 (CAND1) 1.4 0.0019
CK898005 Homeobox protein HoxB13ab (HoxB13ab) -1.3 0.0068
CK888834
BTEB (basic transcription element binding protein)  
transcription factor alt name Kruppel-like factor 9
-1.4 0.0085
CK888955 Retinoic acid receptor gamma b -1.3 0.0086
EG647480 Retinoblastoma-binding protein 7 -1.3 0.0015
CK888548 Rev protein - Human immunodeficiency virus 1 -1.5 0.0028
Regulation of transcription
          Carbohydrate metabolism
          Protein metabolism
Immune response/stress response/inflammatory response
Apoptosis
Metabolic areas/pathways
          Fatty acid  biosynthesis
          Lipid metabolism and transport
          Cholesterol and isoprenoid biosynthesis
Accession no. Clone gene p-value
FO-fed lean/fat 
ratio 
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Table 5.4 (continued) 
FO-fed lean/fat
ratio
EG649414
Eukaryotic translation initiation factor 4E [Capsicum 
annuum]
-1.5 0.0022
CK887633
Ribosome biogenesis protein NSA2 (TGF-beta-
inducible nuclear protein 1)
-1.3 0.0150
CO470133 Pescadillo (PES1) -1.2 0.0185
CK894787 Importin 7 -1.2 0.014
CK880160 Vacuolar protein sorting-associated protein 26B-B -1.2 0.0158
CK893304
ABC-type amino acid transport/signal transduction 
system, periplasmic component/domain precursor 1.4 0.0108
CK890533 Translocon-associated protein subunit delta precursor 1.3 0.0019
CK884068 Mannose binding-like lectin precursor -1.2 0.0072
CO469716 ER lumen protein retaining receptor 2 -1.3 0.0132
CK880187
ATP-binding cassette sub-family B member 8, 
mitochondrial precursor -1.3 0.0006
EG648399 PTC7 protein phosphatase homolog -1.2 0.0112
CK885053 Disulfide-isomerase A3 1.4 0.0119
No accession no. Dual specificity protein kinase CLK2 -1.6 0.0166
AJ424743 Fibroleukin precursor (Fibrinogen-like protein 2) -1.6 0.0028
CK895984 Progestin membrane receptor component 1 1.2 0.0156
CO470718 Serine/threonine kinase  -1.3 0.0167
EG648449 Transmembrane protein 97 (Protein MAC30) 1.3 0.0155
AJ424345 Integral membrane protein 2B -1.4 0.0213
EG647863 N-myc downstream regulated family member 3a 1.2 0.0206
AJ425853 Cofilin-2 -1.4 0.0085
DW590843 Origin recognition complex subunit 3-like -1.3 0.0016
BM414303
Deoxyribonuclease gamma  (Deoxyribonuclease I-like 
3) -1.3 0.0098
AM402622 Non-POU domain containing, octamer-binding -1.7 0.0117
CK878961 Annexin A5 1.4 0.0061
AM402675 Vitamin K-dependent gamma-glutamyl carboxylase 1.3 0.0098
CK893526 Annexin A5 1.3 0.0126
CK892585 Nebulin-like 1.4 0.0064
No accession no. Collagen type X alpha 1 1.5 0.0170
EG649410 D-dopachrome tautomerase -1.2 0.0174
DW588788 Myelin P0 protein -1.7 0.0189
CO470414 N-acetyltransferase 9 -1.2 0.0217
AM402582 Surfeit locus protein 4 1.4 0.0090
AM397500 Brain protein 44-like protein 1.4 0.0132
Translation / ribosome biogenesis and assembly
Accession no. Clone gene p-value
Protein transport / extracellular and intracellular transport / ion transport
Protein processing and turnover 
Blood coagulation
Miscellaneous / unknown
Signal transduction / signal cascade
Chromosome / RNA and DNA processing
Cell growth  /adhesion / proliferation and differentiation / cytoskeleton
 
The top 100 liver transcripts (61 annotated and arranged by categories of biological 
function, 39 unknown) exhibiting differential expression between FAT and LEAN fish 
fed FO, identified by t-test. FAT strain is a control. 
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Table 5.5. Effects of family on liver gene expression in salmon fed diets containing VO.  
BI468158 ATP-binding cassette sub-family A member 1 -2.2 0.0001
CK899433 ATP binding cassette transporter -1.5 0.0001
AM397514 Apolipoprotein B -1.4 0.0019
EG647463 Cytochrome P450 reductase -1.3 0.0017
BI468162 Glucose-6-phosphatase -1.7 0.0012
CK886572 GSK-3-binding protein putative (glycogen synthase kinase) 1.8 0.0003
CK877143 Calpain 1 catalytic subunit -1.4 0.0029
EG648604 Serine protease-like protein 1.4 0.0030
No accession no. Ubiquitin fusion degradation 1-like protein -1.8 <0.0000
EG647643 Purine nucleoside phosphorelase -2 0.0001
EG648409 Heat shock 70 kDa protein 4 1.2 0.0036
CK877922 High affinity immunoglobulin 1.3 0.0037
CK886548 T cell receptor (TCR)-alpha/delta locus -1.2 0.0001
CK897993 Extracellular matrix protein 1 -1.4 0.0023
EG648888 Tumor protein p53 inducible nuclear protein 2 -1.3 0.0035
DW588967 Cellular nucleic acid-binding protein 1.2 0.0005
BM414226 DNA-directed RNA polymerase III 1.4 0.0035
CK885437 Echinoderm microtubule-associated protein-like 1 -1.4 <0.0000
AJ425468 Retinoic acid receptor gamma a (Rarga) -1.7 0.0001
CK876689 Class B basic helix-loop-helix -1.5 0.0004
CK874419 Hepatic leukemia factor -1.4 0.0004
CK881770 Hematopoietically-expressed homeobox protein -1.6 0.0001
BI468167 Glucocorticoid-induced leucine zipper protein -1.3 0.0012
EG648323 Zinc finger DHHC domain-containing protein 4 1.2 0.0014
DW591332 60S ribosomal protein L39 1.2 <0.0000
EG649017 60S ribosomal protein L24 1.3 0.0014
EG648836 60S ribosomal protein L22 1.3 0.0021
CK895350 60S ribosomal protein L36 1.3 0.0035
No accession no. 40S ribosomal protein S8 1.3 0.0011
EG648238 40S ribosomal protein S6 1.3 0.0012
No accession no. 40S ribosomal protein S23 1.3 0.0012
EG648835 40S Ribosomal protein S6 1.3 0.0015
AM412040 18S ribosomal RNA 1.8 0.0010
AJ424434 Ribosome production factor 1 1.2 0.0005
AJ425467 Eukaryotic translation initiation factor 6 -1.2 0.0005
EG649336 Eukaryotic translation elongation factor 1 1.3 0.0011
Clone gene p-value
Metabolic areas/pathways
VO-fed lean / fat 
ratio
Translation / ribosome biogenesis and assembly
Regulation of transcription
Apoptosis
Immune response / stress response / inflammatory response
          Lipid metabolism and transport
           Cholesterol and isoprenoid biosynthesis
         Carbohydrate metabolism
          Protein metabolism
Accession no.
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Table 5.5 (continued)  
Protein transport / extracellular-intracellular transport / ion transport
DW589920 Ras-related protein Rab-35 1.3 0.0010
CK884617 Ras-related protein Rab-25 -1.8 0.0006
CK886667 Na/K ATPase 1.6 <0.0000
EG647764 ADP-ribosylation factor 3 1.3 0.0038
CK896189 Solute carrier family 25 member 25 -2.3 0.0012
CK890974 Solute carrier family 25 member 25 -2.2 0.0007
BI468154 FK506-binding protein 5 putative -1.5 0.0001
DW592207 Deoxyhypusine synthase -1.2 0.0012
CK892148 Growth factor receptor-bound protein 7 (GRB7) -1.4 0.0015
CK873407 Regulator of G-protein signaling 3 -1.5 0.0024
EG647738 Transducer of ERBB2 (Tob1) -1.8 0.0031
AJ425351 Tensin-like C1 domain-containing phosphate -1.6 0.0001
CK891988 Transducer of ERBB2 (Tob1) -1.7 0.0012
CK888542 Insulin-like growth factor binding protein1 -2.5 0.0001
No accession no. Nuclear protein 1 putative -2.1 0.0002
CN181394 Nuclear lamin A -1.8 0.0007
CK879713 Zonadhesin-like gene -1.2 0.0013
AM397509 Tensin-like C1 domain-containing -1.3 0.0014
No accession no. Cyclin B2 -1.4 0.0014
CK898014 Similar to Protein fuzzy homolog -1.2 0.0002
No accession no. Ankyrin 1 -1.9 0.0027
Miscellaneous / unknown
EG647739 Ferritin, heavy subunit -1.4 0.0024
No accession no. Iron-responsive element-binding -1.2 0.0001
CK893078 Hemoglobin subunit alpha 1.5 0.0012
CK880112 Tropomyosin-1 alpha chain 1.4 0.0015
DW590534  Collagen alpha-2 chain type 1 -1.3 0.0028
EG647787 Transmembrane protein 107 1.2 0.0035
No accession no. PQ-loop repeat-containing protein 2 -1.2 0.0033
No accession no. Retinoblastoma-binding protein 9 -1.5 0.0026
Cell cycle / growth / adhesion / proliferation and differentiation / cytoskeleton
Signal transduction / signal cascade
Protein processing / folding 
VO-fed lean / fat 
ratio
Accession no. Clone gene p-value
 
The top 100 liver transcripts (65 annotated and arranged by categories of biological 
function, 35 unknown) exhibiting differential expression between FAT and LEAN fish 
fed VO, identified by t-test. FAT strain is a control. 
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Table 5.6. Annotated liver transcripts related to lipid metabolism/transport that were not 
 listed in the top 100 genes but whose expression was significantly affected by 
 family or diet as identified by t-test.  
Accession no. Clone gene LEAN (VO/FO ratio) P-value
No accession no. Acyl-CoA-binding protein 1.6474 0.0179
Accession no. Clone gene FAT (VO/FO-ratio) P-value
CO470568 Lipoprotein lipase 1.3185 0.0141
No accession no. Angiopoietin-like 3 1.6473 0.0177
CK890036 Lipoprotein lipase 1.6427 0.0251
Accession no. Clone gene FO (LEAN/FAT ratio) P-value
EG648040
Acyl-coenzyme A-binding 
protein
-1.4909 0.0333
BM413891 Angiopoietin-like 4 -1.2307 0.0394
CK890036 Lipoprotein lipase 1.3952 0.0417
Accession no. Clone gene VO (LEAN/FAT ratio) P-value
BM413891 Angiopoietin-like 4 1.2581 0.0108
No accession no. Angiopoietin-like 3 1.4144 0.0207
CK890036 Lipoprotein lipase 1.5215 0.0418  
Table 5.7. Effects of diet on the expression of selected genes in liver of the three groups 
 (CAL, LEAN and FAT families) of Atlantic salmon as determined by qPCR. 
Expression P value Expression P value Expression P value
Mevalonate kinase 0.580 0.721 1.882 0.051 0.730 0.367
7-dehydrocholesterol 
reductase
0.908 0.982 1.536 0.09 0.690 0.228
SREBP 
1 1.80 0.628 2.061 0.073 1.087 0.854
HMG-CoA reductase 
2 1.033 0.989 0.954 0.889 0.874 0.715
Carnitine palmitoyl 
transferase I
0.795 0.955 0.862 0.505 0.599 0.064
Gene
CAL LEAN FAT
0.004
Delta-5 fatty acyl 
desaturase
1.427 0.912 <0.000 1.624
Delta-6 fatty acyl 
desaturase
3.170
0.106
Elongase 2 0.588 0.865 0.002 0.768 0.3762.359  (up)
0.359Elongase1 0.045 1.1790.341 (down)
3.606 (up)
0.50 0.774
<0.0000.226
3.956 (up)
8.275 (up)
 
Results are the normalised expression ratio (with reference genes, elf 1 , -actin, and an 
unresponsive EST) and P value of the target transcripts in the CAL, LEAN and FAT fish fed 
VO diet in relation to the control FO diet (analysed by REST2005). Values are means (n = 6).  
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Table 5.8. Effects of family on the expression of selected genes in liver of the Atlantic 
 salmon fed FO as determined by qPCR. 
Expression P value Expression P value Expression P value
Delta-6 fatty acyl 
desaturase
0.90 0.946 0.452 (down) 0.046 0.401 0.805
Delta-5 fatty acyl 
desaturase
0.875 0.967 0.361 (down) 0.002 0.329 0.545
Elongase 2 1.514 0.804 0.542 0.116 0.285 0.318
Elongase1 1.765 0.546 0.716 0.477 0.324 0.52
Mevalonate kinase 1.234 0.846 0.446 0.088 0.288 0.399
7-dehydrocholesterol 
reductase
0.749 0.794 0.475 0.058 0.505 0.905
SREBP 2 
1 0.401 0.340 0.550 0.315 1.095 0.974
HMG-CoA reductase 
2 0.781 0.801 1.051 0.929 1.073 0.992
Carnitine palmitoyl 
transferase I
0.881 0.926 0.861 0.815 0.779 0.993
Gene
CAL vs FAT  LEAN vs FAT  LEAN vs CAL
 
Results are the normalised expression ratio (with reference genes, elf 1 , -actin, and an 
unresponsive EST) and P value of the target transcripts in fish fed the FO diet, between 
CAL vs FAT; LEAN vs FAT; and LEAN vs CAL (analysed by REST2005). Values are 
means (n = 6).  
Table 5.9. Effects of family on the expression of selected genes in liver of the Atlantic 
salmon fed VO diet in comparison to FO diet as determined by qPCR. 
Expression P value Expression P value Expression P value
Delta-6 fatty acyl 
desaturase
0.992 0.984 1.038 0.839 1.046 0.908
Delta-5 fatty acyl 
desaturase
0.965 0.944 0.879 0.323 0.911 0.876
Elongase 2 1.455 0.264 1.665 (up) 0.006 1.145 0.728
Elongase1 0.974 0.978 1.090 0.52 1.119 0.819
Mevalonate kinase 1.231 0.590 1.149 0.462 0.934 0.857
7-dehydrocholesterol 
reductase
1.236 0.585 1.057 0.733 0.855 0.686
SREBP 2
 1 0.832 0.638 1.043 0.855 1.254 0.542
HMG-CoA reductase 
2 1.158 0.718 1.147 0.448 0.990 0.980
Carnitine palmitoyl 
transferase I
1.468 0.206 1.240 0.196 0.845 0.694
Gene
      CAL vs FAT     LEAN vs FAT LEAN vs CAL
 
Results are the normalised expression ratio (with reference genes, elf 1 , -actin, and an 
unresponsive EST) and P value of the target transcripts in fish fed the VO diet between 
CAL vs FAT; LEAN vs FAT; and LEAN vs CAL (analysed by REST2005). Values are 
means (n = 6).  
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5.4 Discussion and conclusions 
In the present study in Atlantic salmon, liver was selected to investigate the 
effects of family/strain on the expression of metabolic genes, largely focusing on genes 
related to lipid metabolism. Liver is the primary tissue involved in the metabolic 
processing of nutrients obtained from the diet and has particular roles in distributing 
dietary lipid, and the de novo synthesis of lipids as well as participating in detoxification 
and excretion pathways (Leaver et al. 2008). The present study demonstrated that the 
expression levels of 5 and 6 fatty acyl desaturases and elongases in the liver were 
greater in salmon fed the VO diet than in fish fed the FO diet. Of particular interest in 
the present study, this effect was most pronounced in the LEAN family than in the FAT 
family. The dietary effects were in agreement with those reported in previous studies, 
which showed that either the partial or total substitution of dietary FO with VO 
increased the expression of hepatic 5 and 6 desaturases as well as elongase in 
Atlantic salmon (Tocher et al. 2003c; Zheng et al. 2004; Leaver et al. 2008). Jump et 
al (2005) reported reported that dietary FAs such as DHA and EPA regulate hepatic 
gene expression by controlling the activities of key transcription factors involved in the 
regulation of the hepatic metabolic enzymes. The authors stated that, for example, in 
vitro studies established that PPAR  and SREBP–1c-regulated genes are key targets for 
PUFA control of hepatic gene expression. PUFA activate PPAR  by direct binding, 
leading to the induction of hepatic FA oxidation. PUFA inhibit hepatic FA synthesis by 
suppressing SREBP – 1c nuclear abundance through several mechanisms, including 
suppression of SREBP–1c gene transcription and enhancement of proteasomal 
degradation and mRNA SREBP1-c decay. Moreover, Bell et al (2001, 2002) suggested 
that the stimulation of hepatic desaturation by VO substitution of FO presumably 
reflects increased availability of 18:2n-6 and 18:3n-3 substrates coupled with a reduced 
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tissue levels of end-product HUFA such as EPA and DHA. The concentrations of the 
long chain n-3 PUFA, particularly 22:6n-3, in diet are known to suppress the pathway 
conversions of 18:3n-3 to 22:6n-3 in trout as found by Buzzi (1996). This author  stated 
that the ability of trout hepatocytes to synthesise the 22:6n-3 from both 18:3n-3 and 
20:5n-3 can be markedly stimulated by a diet deficient in long chain n-3 PUFA, 
particularly 22:6n-3. 
In the current study, the replacement of FO with VO in the diet was shown to 
influence the expression of lipid metabolism and transport genes, and also that these 
effects varied between the families. Therefore, in the FAT family, the results from the 
microarray analysis revealed that the expression levels of LPL and ANGPTL3 were 
greater in fish fed the VO diet than in fish fed the FO diet. In contrast, in the LEAN 
family, no significant effects of diet on the expression levels of these two genes were 
observed, but the expression levels of ANGPTL4 and acyl-CoA binding protein were 
observed to be higher in the LEAN family in fish fed VO compared to fish fed FO. In 
addition, the levels of expression of those genes were greater in the LEAN family than 
in the FAT family, irrespective of diet, illustrating the influence of fish family/strain on 
the expression of lipid metabolism genes. ANGPTL3 and ANGPTL4, members of the 
family of angiopoietin genes, are known to regulate lipid metabolism in mice where 
both proteins increase plasma TAG levels (inducing hyperlipidemia) (Yoshida et al. 
2002). Lipoprotein lipase is another key enzyme in lipid metabolism, hydrolysing 
plasma TAG obtained from circulating chylomicrons and VLDL and promoting uptake 
of lipids into tissues (Stryer 1988). The expression of the LPL gene has been shown to 
be affected by the composition of dietary FAs in red sea bream (Liang et al. 2002a) and 
rainbow trout (Richard et al. 2006). In the present study, an increase in liver LPL 
expression may also result in increased liver TAG levels. The increased expression (and 
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presumably) activity of the ANGPTLs, LPL and the acyl-COA binding protein in the 
LEAN family fed VO compared to FO, would increase lipid transport from the liver to 
tissues and lipid uptake in the tissues and in the liver. The higher concentration of LPL 
mRNA in fish fed VO in the present study is in agreement with the previous study of 
Liang et al (2002b) which reported that LPL gene expression was increased in red sea 
bream fed a VO diet. However, later studies have contradicted this, reporting that 
rainbow trout fed a FO diet had increased levels of LPL mRNA in liver (Richard et al. 
2006), and that ANGPTL3 was down regulated in Atlantic salmon fed a VO diet 
compared to fish fed a FO diet (Leaver et al. 2008). Carnitine palmitoyl transferase I 
(CPT-I) and CPT-II are considered to be key enzymes for mitochondrial beta-oxidation 
regulation (Power & Newsholme 1997; Froyland et al. 1998; Torstensen et al. 2000, 
2009). In the present study, no significant effects of diet on the expression of CPT-I 
were observed. The results from the present study are consistent with those of previous 
studies which showed that there were no significant differences in the hepatic 
expression of CPT-I (Leaver et al. 2008) or CPT-II (Torstensen et al. 2009) between 
Atlantic salmon fed VO or FO diets. 
Previous studies have demonstrated that the complete substitution of dietary FO 
with VO increased the expression of genes related to cholesterol biosynthesis, including 
mevalonate kinase, HMG-CoA reductase, 7-dehydrocholesterol reductase and the main 
transcription factor regulating cholesterol biosynthesis, sterol regulatory element 
binding protein 2 (SREBP2) (Leaver et al. 2008). The results of the microarray analyses 
revealed that there were also differences between the LEAN and FAT salmon families 
in the response of the cholesterol metabolism genes to diet. Thus, in the LEAN family, 
the cholesterol/steroid biosynthesis genes, squalene monooxygenase and isopentenyl-
diphosphate, were up-regulated in fish fed the VO diet compared to fish fed the FO diet. 
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In contrast however, there were no significant effects of dietary treatment in the 
expression of these genes in the FAT family.  Squalene is the biochemical precursor to 
the whole family of steroids and choleserol derivatives (Stryer 1988). The results from 
the current microarray study showed that neither diet nor family had any effect on the 
expressions of HMG-CoA reductase, 7 - cholesterol hydroxylase and SREBP2 were 
not significantly different and this was also confirmed by the qPCR analysis. As 
suggested above, SREBPs play a major role in lipid and cholesterol metabolism, 
regulating the transcription of genes that encode enzymes in the biosynthetic pathways 
of cholesterol and FAs. The SREBPs are encoded by two genes, SREBP1 and SREBP2. 
SREBP1a and SREBP1c are associated with both cholesterol and FA homeostasis, 
whereas SREBP2 is preferentially involved in regulating cholesterol metabolism 
(Magana & Osborne 1996; Field et al. 2001; Desvergne et al. 2006). HMG-CoA 
reductase is involved in the synthesis of cholesterol where it is reputedly the rate-
limiting enzyme in the cholesterol biosynthesis pathway (Gornati et al. 2005), and 7 - 
cholesterol hydroxylase is the first and rate-limiting enzyme in the bile acid synthesis 
pathway that occurs exclusively in the liver (Russell & Setchell 1992). It is known that 
in VOs, cholesterol is very low whereas the sterol is present as plant or phytosterols 
including sitosterol, stigmasterol, campesterol or blassicasterol depending on source 
(Phillips et al. 2002). The phytosterols are not taken up by mammals and compete with 
intestinal cholesterol uptake and thereby reduce the uptake of dietary cholesterol 
(Orzechowski et al. 2002). From the present study, the levels of cholesterol in the liver 
were not reduced by the VO diet (Table 4.10, Chapter 4) and the expression of key 
enzymes of cholesterol biosynthesis were not generally increased suggesting that the 
levels of cholesterol in the VO diet appear to be sufficient for metabolic processes.  
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When altering the formulation and dietary ingredients in fish feed by replacing 
FM and FO with plant proteins and oils, the health and welfare of fish should also be 
taken into consideration. In the present study, it appeared that there were differences 
between the families in this aspect of metabolism and adaptation to dietary change. 
Whereas, in the LEAN family the expression of heat shock response protein 90 (hsp90) 
was significantly different between fish fed the VO diet compared to fish fed the FO 
diet, there were however no significant effects of diet in the expression of these genes in 
the FAT family. In addition, the expression levels of hsp90 and hsp70 were higher in 
the LEAN family compared to the FAT family, irrespective of diet. This suggested that 
both diet and genetic variation, at least partly, influence immune function and responses 
in salmon. It is well known that nutrients influence the immune system and resistance to 
disease (Blazer 1992; Carder 1999, 2001). The replacement of FO with VO could 
impact on the immune system of fish as well as their resistance to infectious disease, 
especially if the VOs are rich in n-6 FAs. In fish, the introduction of n-6 FA-enriched 
diets altered the dietary n-3/n-6 PUFA ratio and can influence the composition of fish 
immune cells (Thompson et al. 1996; Mourente et al. 2005). The effects of dietary 
replacement of FO with VO on some immune parameters in the FAT and LEAN 
families, and CAL strains of Atlantic salmon have been reported previously 
(Petropoulos et al. 2008). Thus, there is evidence that immune function, in terms of 
haematocrit, total number of circulating leucocytes, granulocytes and serum lysozyme 
activity may be influenced by the complete substitution of FO with a blend of VOs 
(Petropoulos et al. 2008), and that these effects were most prominently displayed in the 
LEAN family in the present study. Other studies have shown that increasing 
replacement of plant-based ingredients in the diet also induced a physiological stress 
response in rainbow trout (Panserat et al. 2008). Furthermore, feeding rainbow trout 
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diets containing 30 % of the diet as soybean-protein altered the liver protein profile and 
the levels of several stress proteins (e.g. heat shock protein), possibly related to the 
presence of increased anti-nutritional factors (Martin et al. 2003). Heat shock protein 90 
is active in supporting various components of the cytoskeleton and steroid hormone 
receptors (Iwama et al. 1998; Young et al. 2001), whereas hsp70 assists the folding of 
nascent polypeptide chains, acts as a molecular chaperone, and mediates the repair and 
degradation of altered or denatured proteins (Iwama et al. 1998; Kiang & Tsokos 
1998). Thus, the significant differences in expression of the heat shock proteins found in 
the present study may signal an early warning indicator of impaired fish performance 
and health in Atlantic salmon fed diets with high levels of replacement of marine FM 
and FO with plant-based ingredients. 
In conclusion, the results showed that liver gene expression was significantly 
affected in Atlantic salmon by the dietary oil composition and that the effects varied 
between different groups of fish. These results clearly showed that the FAT and LEAN 
families, and CAL strain, adapt differently, in terms of the expression of genes involved 
in metabolic pathways in the liver, to the complete substitution of dietary FO with a 
blend of VOs. Specifically, the LEAN family generally showed the higher levels of 
response to substitution of FO with VO. Clearly, the relationship between 
phenotype/genotype and biochemical mechanisms of regulation is an area that requires 
further study.  
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Chapter 6 - Dual replacement of dietary fish oil and fish meal 
in feeds for large Atlantic salmon (Salmo salar 
L.). I- Effects of replacement of dietary fishmeal 
with increasing levels of plant protein sources 
6.1 Introduction 
Atlantic salmon are an important high value, carnivorous fish species that are 
generally raised in intensive systems and fed high-energy extruded feeds containing 
high quality protein. Traditionally, the protein content of the feed for farmed salmon has 
been supplied by marine FM derived from the industrial, reduction fisheries (Hardy 
1996; Sargent & Tacon 1999; Pike 2005). It is clear that FM (and FO) supplies from 
these finite fisheries are strictly limited and, if aquaculture continues to expand 
worldwide, the requirements for FM and FO will soon exceed global supplies (FAO 
2006). The constraints that utilisation of these marine products impose has resulted in 
increasing investigation of the use of alternative protein and oil sources in aquafeeds to 
sustain aquaculture development.  
Many studies have investigated replacement of FM in feeds with a variety of 
plant proteins (PPs) at different levels of inclusion for a range of fish including Atlantic 
salmon (Storebakken et al. 1998a, 1998b; Refstie et al. 2000; Carter & Hauler 2000; 
Refstie et al. 2001; Opstvedt et al. 2003; Mundheim et al. 2004; Dias et al. 2005), 
gilthead sea bream (Sitja-Bobadilla et al. 2005; Lozano et al. 2007), Atlantic cod 
(Olsen et al. 2007; Hansen et al. 2007b), European sea bass (Dias et al. 2005), Atlantic 
halibut Hippoglossus hippoglossus (Berge et al. 1999) and sunshine bass (Morone 
chrysops  M. saxatilis) (Lewis & Kohler 2008). Partial substitution of FM with 
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soybean meal in diets at levels up to 30 - 40 % showed no reduction in growth of 
Atlantic salmon, rainbow trout, European sea bass and gilthead sea bream (Smith et al. 
1995; Nengas et al. 1996; Robaina et al. 1997; Opstvedt et al. 2003; Kaushik et al. 
2004; Dias et al. 2005). Substitution of FM with soybean protein concentrate up to 80 
% or 100 % in diets for Atlantic halibut (Berge et al. 1999) and rainbow trout (Kaushik 
et al. 1995) respectively, showed no adverse effects on growth performance or nutrient 
utilisation. Wheat gluten can be utilised to substitute up to 40 % of FM in diets for 
salmon and trout (Hardy 1996). Furthermore, addition of pea protein concentrate, corn 
gluten, sunflower meal, or dehulled peas at levels up to 30 % of total protein showed no 
adverse effect on growth performance or carcass composition in salmonids and sea 
bream (Mente et al. 2003; Thiessen et al. 2003; Gill et al. 2006; Lozano et al. 2007; 
Overland et al. 2008; Overland et al. 2009). 
The above studies demonstrated the potential of replacing FM with PP in fish 
feeds without growth retardation, providing the substitution of PP is not too high and 
nutritional balance is maintained. Furthermore, blends of PP are able to be used as 
replacements for FM at high inclusion levels. Thus, a mixture of soybean meal and corn 
gluten meal could be used at up to 69 % of total protein replacement without any 
negative effect on growth and feed intake in Atlantic cod (Albrektsen et al. 2006). Total 
(100 %) replacement of FM with PP, however, affected growth performance of rainbow 
trout (Gomes et al. 1995) and Atlantic salmon (Espe et al. 2006). However, using a 
blend of PP, substitution of FM in feeds close to 100% was possible in Atlantic salmon 
with no negative effect on growth if the AA profile in the feed was well balanced and if 
feed intake was comparable to a high FM diet (Espe et al. 2007). The decreased global 
availability and high utilisation of FO in feeds for farmed fish, particularly salmonids, 
has been criticised resulting in fish nutritionists searching for alternative oil sources. 
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Currently, VOs are considered the prime sustainable oil sources for FO replacement in 
aquafeeds due to the steadily increasing production, high availability and economic 
value (Fountoulaki et al. 2009).  
There are differences, however, in FA composition between VO and FO. Feeds 
for farmed Atlantic salmon have traditionally contained high levels of n-3 HUFA, such 
as EPA and DHA, due to the inclusion of marine FO. The FA compositions of VOs 
show high levels of predominantly C18 FAs such as 18:1n-9, 18:2n-6 and sometimes 
18:3n-3, but are devoid of the long chain n-3 HUFA, EPA and DHA, found in marine 
products (Bell et al. 2003a; Caballero et al. 2002; Sargent et al. 2002). For instance, RO 
has a very high level of 18:1n-9, moderate 18:2n-6 and some 18::3n-3 (Bell et al. 2001, 
2003a). Several studies have shown that the use of single VO to replace FO in 
aquafeeds at levels of > 50% replacement for all species, or indeed complete 
replacement in the case of salmon, is now feasible in practical feeds without affecting 
growth of fish, but does significantly impact on tissue FA composition and metabolism 
(Bell et al. 2001; Caballero et al. 2002; Montero et al. 2003; Bransden et al. 2003; 
Izquierdo et al. 2005; Fountoulaki et al. 2009). Therefore, replacing FM and FO with 
alternative non-marine ingredients affects not only production parameters but also the 
FA composition of fillet (Torstensen et al. 2004b; Lewis & Kohler 2008). Although 
Atlantic salmon is capable of desaturating and elongating the C18 PUFA (18:2n-6 and 
18:3n-3) found in plant ingredients into the essential HUFA, ARA (20:4n-6), EPA 
(20:5n-3) and DHA (22:6n-3), the capacity of endogenous production of these HUFA 
may not fulfill requirements for optimal growth and well being of the fish when feeding 
diets containing low inclusion of marine raw materials (Bell et al. 2001).  
In the present study, the effects of dual substitution of FM and FO were 
investigated in adult Atlantic salmon of initial weight of 1.3 Kg that were grown to 
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market size (> 3 Kg) over a period of 19 weeks on diets with 60 % of dietary FO 
replaced by RO, and increasing proportions of FM substituted by PPs (a mixture of 
sunflower meal, corn gluten meal, soybean meal, wheat gluten and field pea). The level 
of FO substitution represented the upper level of FO replacement currently used in 
commercial ongrowing diets. The control diet contained 25 % FM and 45 % PP, which 
also represented the current commercial level of FM inclusion in Norway. Three further 
diets had FM inclusion reduced to 18, 11 and 5 %, with PP inclusion increased to 50, 55 
and 60 %, of the diet. Effects on growth performance, feed utilisation efficiency, lipid 
class and FA compositions of flesh and liver were investigated. 
6.2 Materials and Methods 
6.2.1 Experimental fish  
One thousand eight hundred Atlantic salmon of initial mean weight 1.3  0.1 kg 
were randomly distributed among 12 cages of 125 m
3
 (5  5  5 m) with 150 fish/cage 
at the Marine Harvest Fish Trials Unit (FTU), Ardnish, Scotland, and fed one of four 
diets in triplicate cages. The experiment was conducted over 19 weeks from October 
2007 to February 2008 under natural photoperiod. The mean temperature, salinity and 
turbidity measured by secchi dish of seawater at the first phase of the experiment were 
11.0  1.0
o
C, 26.5  6.8 and 5.2  1.7 m while those parameters at the second phase 
were 7.1  1.4
o
C, 26.4  5.5 and 5.8  1.4 m respectively. Fish were fed to apparent 
satiation using automatic feeders (Arvo-tec, Sterner Arvo-tec UK, Inverness, Scotland). 
Mortalities, feed consumption and waste feed were recorded daily. 
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6.2.2 Sampling protocol  
All the experimental fish were bulk weighed at the initiation, at the end of week 
8 and at the termination of the trial, week 19. At the end of the trial, 2 fish per pen (6 
fish per dietary treatment) were anaesthetised with metacaine sulphonate (MS222; 50 
mg/L) and killed by a blow to the head. Flesh samples were taken from the NQC and 
were homogenised in a food processor after removal of skin and bones and stored at -20 
o
C prior to lipid analysis. Livers were also collected from the six fish and a 1-2 g sample 
placed into glass vials containing chloroform/methanol (2:1, by vol.) for analysis of 
lipid class and FA composition, and the remaining portion immediately frozen on dry 
ice (for lipid content).  Both liver samples were then stored at -20 
o
C prior to analysis. 
6.2.3 Experimental diets  
Four diets were formulated to satisfy the nutritional requirements of salmonid 
fish (NRC. 1993) and manufactured at the BioMar TechCentre, Brande, Denmark. All 
diets contained 35 % crude protein and 28 % crude lipid. The control diet (25F) was 
formulated to represent the maximum level of PP inclusion currently in commercial use 
and contained 45 % PP (a blend of sunflower meal, corn gluten, soybean protein 
concentrate and field bean) and 25 % FM (Table 6.1). The remaining three diets 
followed a regression with FM inclusion reduced to 18 % (18F), 11 % (11F) and 5 % 
(5F) and PP inclusion increased to 50 %, 55 % and 60 % of total diet, respectively. All 
diets were coated with a 60:40 blend of RO and northern hemisphere FO. All diets were 
supplemented with crystalline AAs, lecithin and carophyll pink as sources of specific 
AAs, phospholipids and pigments (Table 6.1).  
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Table 6.1. Feed formulation (g kg-
1
) and analysed feed composition (percentage) of the 
 experimental diets. 
Fishmeals (67% protein/10% lipid)
1
250 180 110 50
Sunflower meal (37% protein/10 lipid) 115 77 40 -
Corn gluten
 
(62% protein/2 lipid) 85 135 175 215
Soy concentrate (60% protein/2% lipid) 
2
85 135 175 225
Wheat gluten
 
(77% protein/3% lipid)  - 2 18 20
Binders 160 160 160 160
Rapeseed oil
3
173 175 178 180
Fish oil 
4
116 117 118 120
Vitamins and minerals 
5
12.0 17.6 23.6 29.0
L-lysine 
6
0.62 1.72 3.44 4.26
L-threonine
6
- - 0.43 0.67
DL-methionine 
6
0.57 1.03 1.56 2.01
Lecithin 5.0 5.0 5.0 5.0
Astaxanthin
7
0.4 0.4 0.4 0.4
Antioxidant 
8
4.25 4.25 4.25 4.25
Proximate composition (%)
Protein 34.3 35.1 35.0 34.7
Lipid 29.8 29.5 27.9 27.3
Moisture 6.7 6.0 6.2 6.9
Ash 6.0 5.6 5.2 4.8
Fibre 3.5 3.3 2.6 3.0
NFE 19.7 20.5 23.1 23.3
5FFeed ingredients 25F 18F 11F
 
Values are means of triplicate analysis.
 
1
 Blend of Peruvian super prime and standard fishmeals produced from Anchoveta 
2
 SPC produced from defatted soy flakes   
3
 Non-GM, double-low rapeseed oil  
4
 North-Atlantic standard fish oil  
5
 Vitamin and mineral premixes (Premier Nutrition Products Ltd., Staffordshire, UK)   
  with limestone carrier added according to the commercial standards of BioMar AS 
6
 Highly purified (99%) crystalline amino acids  
7 
Carophyll Pink CWS 10% product from F. Hoffman-La Roche Ltd., Basel, Switzerland  
8 
Blend of antioxidants and starch carrier added according to the commercial standards    
 of BioMar AS 
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6.2.4 Proximate composition analysis 
Diets were ground prior to determination of proximate composition including 
moisture, crude protein, crude fat and ash contents according to standard procedures 
(AOAC 2000). Crude lipid contents of the experimental diets were determined after 
acid hydrolysis followed by Soxhlet lipid extraction. The methods followed for the 
above extractions and analyses are thoroughly described in Chapter 2.  
6.2.5 Pigment composition analysis 
Pigment contents and compositions of the diets and flesh samples were 
determined according to the method of Barua (Barua et al. 1993). The extraction and 
measurement of individual carotenoids, beta-carotene, astaxanthin, canthaxanthin, 
astacene and lutein was carried using HPLC as described in Chapter 2.  
6.2.6 Lipid extraction and analysis 
Total lipids of tissue and diet samples were extracted and prepared according to 
the method of (Folch et al. 1957). Separation of lipid classes was performed by HPTLC, 
with quantification by densitometry according to the method of Henderson and Tocher 
(Henderson & Tocher 1992). FAMEs were prepared by acid-catalysed 
transesterification as described by Christie (Christie 1993), extracted and purified as 
described by Tocher & Harvie (Tocher & Harvie 1988), and separated and quantified by 
gas-liquid chromatography. The detailed methods are thoroughly described in Chapter 2.  
6.2.7 Calculations and statistical analysis 
Growth and feed efficiency parameters, SGR, TGC, FCR, VSI and HSI were 
calculated according to the formulae presented in Chapter 2. ADC data were obtained 
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from the BioMar AS. All data are presented as means ± SD (n value as stated). The 
effects of dietary treatments on growth performance were analysed by one way 
ANOVA. The significance of differences were determined by one-way ANOVA with P 
< 0.05 (Zar 1999). Statistical analyses were performed using SPSS version 14 (SPSS 
inc, 2005) as described in Chapter 2.  
6.3 Results 
6.3.1 Proximate and pigment composition of the diets 
The experimental diets contained protein in the range 34 – 35 % and lipid in the 
range 27-30 %. The lipid and fibre compositions of the diets were slightly decreased 
while the nitrogen-free extracts (NFE) was slightly increased when FM in diets was 
replaced with high level of PP inclusion (Table 6.1). There were some differences in 
pigment content of the diets. Generally, total pigment, beta-carotene and lutein content 
of the diets tended to increase whereas astacene content tended to decrease as PP 
inclusion in the diets increased. Astaxanthin content of the experimental diets was 
higher in the 18F diet than in the 11F and 5F diets (Table 6.2). 
6.3.2 Lipid and fatty acid composition of the diets 
Total polar and neutral lipid compositions of the experimental diets were about 
8-9% and 91-92%, respectively.  The majority of lipid supplied by the feeds was neutral 
lipid, predominantly TAG about 73-75% of total lipid (Table 6.2). The main polar lipids 
in the feeds were PC, PE, and PI / PS, and PC decreasing and PI / PS increasing as PP 
inclusion increased. All diets contained approximately 54 % total MUFA, 
predominantly 18:1n-9 (oleic acid), with around 16 % total SFA, mainly 16:0, and 30 % 
PUFA, with half of that being 18:2n-6 and the remainder being n-3 PUFA, 18:3n-3, 
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EPA and DHA (Table 6.3). However, there were some small differences in proportions 
of specific FAs among the dietary treatments. Thus, the proportions of 14:0, 16:1, 20:1, 
22:1 and DHA decreased, and percentages of 18:1n-9 and 18:3n-3 increased as PP 
inclusion increased in the diets.  
 
Table 6.2. Lipid class composition (percentage of total lipid) and pigment content (g kg
-1
) 
 of the experimental diets. 
Parameters 25F 18F 11F 5F
Lipid classes
PC 2.8 2.7 2.1 1.9
PE 3.5 3.6 3.9 3.2
PI/PS 1.5 2.0 3.1 2.8
SM 0.2 0.2 0.1 n.d.
LPC 0.1 0.1 tr. n.d.
Total polar lipid 8.2 8.6 9.3 7.9
Total neutral lipid 91.8 91.4 90.7 92.1
Triacylglycerol 74.2 72.7 73.9 75.6
Sterol 8.5 8.6 6.9 6.9
Free fatty acid 9.1 10.1 9.9 9.6
Steryl ester tr. tr. tr. tr.
Pigments content (mg/kg)
6 mm
Total pigment 47.2 65.9 66.8 75.2
Beta-carotene 4.2 5.5 7.0 7.7
Astaxanthin 27.3 34.7 25.4 26.9
Astacene 1.3 1.4 1.0 0.9
Lutein 14.4 24.3 33.4 39.7
9 mm
Total pigment 32.2 43.6 43.1 43.4
Beta-carotene 3.9 5.1 6.0 5.7
Astaxanthin 16.3 18.3 12.8 12.1
Astacene 0.5 0.5 0.4 0.4
Lutein 11.5 19.7 23.9 25.2  
Results are means of tripicate analysis. LPC, lysophosphatidylcholine; NL, neutral 
lipids. n.d., not detected; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PI, 
phosphatidylinositol, PL, polar lipids; PS, phosphatidylserine; SM, sphingomyelin;       
tr = < 0.05. 
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Table 6.3. Fatty acid compositions (percentage of total fatty acids) of the experimental 
 diets fed to salmon for 19 weeks. 
 
Parameters 25F 18F 11F 5F
Fatty acids
14:0 2.6 2.6 2.5 2.3
16:0 8.7 9.1 9.1 8.6
18:0 2.7 2.8 2.6 3.1
20:0 0.5 0.5 0.5 0.6
22:0 0.9 1.0 0.8 1.3
Total saturated
1
15.5 16.1 15.7 16.1
16:1n-9 0.1 0.1 0.1 0.1
16:1n-7 3.0 3.0 2.8 2.6
18:1n-9 38.4 38.8 41.1 41.4
18:1n-7 2.7 2.7 2.7 2.7
20:1n-9 4.5 3.8 3.6 3.3
20:1n-7 0.2 0.2 0.2 0.2
22:1n-11 4.6 3.7 3.4 3.0
22:1n-9 0.7 0.7 0.6 0.6
24:1n-9 0.3 0.3 0.3 0.3
Total monoenes 54.6 53.4 54.8 54.3
18:2n-6 15.0 15.4 15.1 15.1
18:3n-6 0.1 0.1 0.1 0.1
20:2n-6 0.1 0.1 0.1 0.1
20:3n-6 0.2 0.2 0.3 0.3
20:4n-6 0.2 0.2 0.2 0.2
22:5n-6 0.1 0.1 0.1 0.1
Total n-6 PUFA 15.7 16.1 15.8 15.8
18:3n-3 5.6 5.7 5.8 6.2
18:4n-3 1.0 0.9 0.8 0.8
20:4n-3 0.2 0.2 0.2 0.2
20:5n-3 4.1 4.3 3.9 3.9
22:5n-3 0.4 0.4 0.4 0.4
22:6n-3 3.0 2.9 2.5 2.3
Total n-3 PUFA 14.2 14.4 13.7 13.8
Total PUFA 29.9 30.5 29.4 29.6  
Results are means of tripicate replicates analysis.
 1
Totals includes 15:0 present at up to 0.2%. 
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6.3.3 Growth performance  
There were no significant differences in survival rate of fish on any of the 
dietary treatments (Table 6.4). There were also no significant differences in initial 
weight of fish. After 19 weeks, the overall growth performance of fish showed that final 
body weight and weight gain were significantly reduced by FM replacement, resulting 
in reduced SGR and TGC. There was a significant linear reduction in TGC when FM 
inclusion reduced from 25 to 5 % at all stages of the trial, while there was a significant 
linear reduction in SGR in the first phase of the trial and the overall trial (Table 6.4). 
Hence, the group of fish fed the 25F (control) diet with the highest FM inclusion had 
highest TGC and SGR of all the dietary treatments, and the group of fish fed the lowest 
FM/highest PP inclusion rate, 5F, had the lowest TGC and SGR (Table 6.4). This 
growth reduction corresponded to a significant reduction in body weight and weight 
gain associated with the reduction of FM or the increasing PP inclusion in the diets. 
Therefore, the body weight of fish was in the order 25F > 18F >11F >5F. The body 
weight and weight gain of fish fed the control diet 25F were 3.8 kg and 2.5 kg fish
-1 
at 
the end of the trial while group of fish fed the 5F diet had body weight and weight gain 
3.0 kg and 1.7 kg fish
-1
,
 
respectively (Table 6.4).  
The decreased growth was associated with decreased feed consumption, as the 
level of PP inclusion increased (Table 6.4). Feed consumption was significantly 
decreased when the FM inclusion decreased from 25 % to 5 % throughout the 
experiment, and was correlated with final fish weight. The fish fed the 25F diet showed 
the highest feed intake throughout the trial and this decreased significantly with 
reduction in FM inclusion. Consequently, FCR significantly increased with decreasing 
FM inclusion but only in the first phase of the trial, with the fish fed the control (highest 
FM) diet showing the lowest FCR.  
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Protein utilisation measured by PER showed a significant reduction with 
decreasing FM inclusion in the first phase and the overall trial, but it was not difference 
at the second phase. Thus, the group of fish fed the control diet had highest PER and the 
group of fish fed the 5F had lowest PER, 2.8 and 2.6, respectively (Table 6.4). There 
was no significant effect on the hepato-somatic index (HSI) of increasing PP inclusion 
in diets. However, the viscero-somatic index (VSI) showed a significantly increase as 
the level of FM inclusion decreased and PP inclusion increased (Table 6.4). 
The ADC of protein and fat were significantly affected by the levels of dietary 
FM and PP ((Figure 6.1). The ADC of protein significantly increased from 82.6 % to 
85.3 % while the ADC of fat significantly decreased from 94.6 % to 90.5 % with 
decreasing dietary FM and increasing dietary PP inclusion (Figure 6.1). 
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Table 6.4. Growth performance, feed efficiency and biometric parameters of salmon fed 
 the experimental diets for 19 weeks. 
Survival(%)
0-8 weeks 100 ±  0.00 99.33 ± 0.67 98.89 ± 1.02 99.56 ± 0.76
8-19 weeks 100 ± 0.00 99.77 ± 0.39 100 ± 0.00 99.78 ± 0.37
0-19 weeks 100 ± 0.00 99.10 ± 1.02 98.89 ± 1.02 99.34 ± 0.66
Body weight (kg)
Initial 1.31 ± 0.01 1.30 ± 0.02 1.30 ± 0.01 1.32 ± 0.01
8 weeks 2.47 ± 0.03 
a
2.37 ± 0.04
 b
2.16 ± 0.02 
c
1.98 ± 0.05 
d
19 weeks 3.84 ± 0.08 
a
3.64 ± 0.04 
b
3.35 ± 0.05 
c
3.00 ± 0.10 
d
Weight gain (kg fish
-1)
0-8 weeks 1.16 ± 0.02 
a
1.05 ± 0.05 
a
0.85 ± 0.05 
b
0.66 ± 0.05 
c
8-19 weeks 1.37 ± 0.11 
a
1.26 ± 0.07 
a
1.23 ± 0.11
a
1.01 ± 0.07 
b
0-19 weeks 2.53 ± 0.09 
a
2.34 ± 0.05 
a
2.08 ± 0.14 
b
1.68 ± 0.10 
c
SGR % d
-1
0-8 weeks 1.27 ± 0.01
a
1.19 ± 0.04
a
1.00 ± 0.04
b
 0.81 ± 0.03 
c
8-19 weeks 0.57 ± 0.03 0.55 ± 0.03 0.56 ± 0.01 0.53 ± 0.01
0-19 weeks 0.84 ± 0.01
a
0.80 ± 0.02 
ab
0.75 ± 0.04 
b
0.64 ± 0.01 
c
TGC
0-8 weeks 4.69 ± 0.06 
a
4.35 ± 0.17 
b
3.60 ± 0.13 
c
2.88 ± 0.11
d
8-19 weeks 3.97 ± 0.23 
a
3.81 ± 0.18 
ab
3.72 ± 0.06 
ab
3.45 ± 0.10 
b
0-19 weeks 4.32 ± 0.08 
a
4.07 ± 0.09 
b
3.65 ± 0.09 
c
3.15 ± 0.10 
d
FCR
0-8 weeks 1.04 ± 0.01 
c
1.06 ± 0.02 
c
1.17 ± 0.07 
b
1.29 ± 0.01 
a
8-19 weeks 1.03 ± 0.06 1.02 ± 0.07 1.00 ± 0.05 1.03 ± 0.06
0-19 weeks 1.03 ± 0.02 1.04 ± 0.04 1.03 ± 0.06 1.13 ± 0.04
Feed consumption
(g fish
-1
 day
-1
)
0-8 weeks 24.15 ± 0.20 
a
22.37 ± 0.91 
b
19.55 ± 0.43 
c
16.90 ± 0.93 
d
8-19 weeks 18.05 ± 0.21 
a
16.52 ± 0.93 
b
15.03 ± 0.28 
c
13.30 ± 0.05 
d
0-19 weeks 20.44 ± 0.04 
a
18.84 ± 0.81 
b
16.80 ± 0.24 
c
14.72 ± 0.35 
d
PER
0-8 weeks 2.81 ± 0.04 
a
2.68 ± 0.06 
a
2.44 ± 0.14 
b
2.23 ± 0.02 
c
8-19 weeks 2.84 ± 0.16 2.81 ± 0.20 2.97 ± 0.16 2.81 ± 0.17
0-19 weeks 2.83 ± 0.07 
a
2.75 ± 0.11
ab
2.73 ± 0.12 
ab
2.55 ± 0.09 
b
HSI (%)
0-9 weeks 1.1 ± 0.1 1.3 ± 0.1 1.2 ± 0.1 1.2 ± 0.1
VSI (%)
0-9 weeks 11.7 ± 0.7 
b
12.3 ± 0.7 
ab
13.2 ± 0.4 
a
13.6 ± 0.2 
a
5FParameters 25F 18F 11F
 
Results are means ± SD (n = 3). Values within a row with different superscript letters 
are significantly difference as determined by ANOVA. FCR, feed conversion ratio; 
HSI, hepatosomatic index; PER, protein efficiency ratio; TGC, thermal growth 
coefficient; VSI, viscerosomatic index. 
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 Figure 6.1. Apparent digestibility coefficients (%ADC)  for total protein and fat  
                             in Atlantic salmon fed the 25F, 18F, 11F and 5F diets. Values are  
                             means  SD (n = 3). 
6.3.4 Lipid content, lipid class composition of flesh and liver and pigment content 
of flesh 
 Lipid content of flesh varied between 11.6 and 13.2 % but was not significantly 
different between fish fed the different dietary treatments (Table 6.5). Similarly there 
was no statistically significant difference between lipid contents of livers from salmon 
fed the different diets, but there was a clear trend for liver lipid to decrease as the FM 
inclusion decreased and PP inclusion increased, reducing from 7.1 % in fish fed the 
highest level of FM down to 5.2 % in fish fed the lowest FM inclusion (Table 6.6). The 
dietary treatments had no significant effects on the proportions of total polar and neutral 
lipids in flesh (Table 6.5) and liver (Table 6.6). Some small differences in individual 
polar lipid classes were observed in flesh, with PC and LPC of fish fed the18F diet 
being lower than the other groups of fish. In contrast, flesh PI/PS of fish fed the 18F diet 
were higher than the other 25F and 11F diets (Table 6.5). There were no significant 
differences in the relative percentages of any individual lipid classes in liver (Table 6.6). 
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The total pigment and astaxanthin content of the flesh was unaffected by dietary 
treatment although there were slight but biologically insignificant differences in lutein 
content (Table 6.5). 
 
Table 6.5. Lipid content (percentage of wet weight), lipid class composition (percentage  
               of total lipid) and  pigment content (mg kg
-1
) of flesh from salmon fed the diets  
                for 19 weeks. 
Parameters 25F 18F 11F 5F
Lipid content 11.7 ± 1.2 13.2 ± 1.8 11.7 ± 1.8 11.6 ± 1.1
Lipid class
PC 4.4 ± 0.3
 ab
3.8 ± 0.6 
b
4.7 ± 0.7
 a
4.5 ± 0.4
 ab
PE 4.4 ± 0.9 4.2 ± 0.7 4.6 ± 0.9 3.7 ± 0.2
PI/PS 0.9 ± 0.2
 a
1.1 ± 0.2
 a
1.0 ± 0.1
 a
0.6 ± 0.1
 b
SM 0.2 ± 0.1 0.2 ± 0.1 0.3 ± 0.1 0.2 ± 0.0
LPC 0.1 ± 0.1
 b tr. 0.2 ± 0.1
 a
0.3 ± 0.1
 a
Total PL 10.0 ± 1.1 9.3 ± 1.1 10.8 ± 1.4 9.3 ± 0.5
Total NL 90.0 ± 1.1 90.7 ± 1.1 89.2 ± 1.4 90.7 ± 0.5
Triacylglycerol 78.9 ± 1.1 80.1 ± 2.0 78.7 ± 2.6 78.8 ± 0.8
Sterol 5.8 ± 0.6 5.7 ± 0.8 5.8 ± 0.7 6.4 ± 0.4
Free fatty acids 5.4 ± 0.6 5.0 ± 0.5 4.7 ± 1.0 5.5 ± 0.5
Steryl ester tr. tr. tr. tr.
Pigment content
Total pigment 5.3 ± 0.5 5.1 ± 0.9 5.2 ± 0.8 5.4 ± 0.8
Astaxanthin 4.3 ± 0.5 4.0 ± 0.7 4.1 ± 0.7 4.0 ± 0.5
Canthaxanthin 0.5 ± 0.1 0.5 ± 0.1 0.6 ± 0.1 0.7 ± 0.2
Lutein 0.5 ± 0.1 
b
0.6 ± 0.2
 ab
0.5 ± 0.0
 b
0.7 ± 0.0 
a
 
Results are means ± SD (n = 3).
 
Values within a row with different superscript letters are 
significantly different as determined by ANOVA. LPC, lysophosphatidylcholine; NL, 
neutral lipids; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PI, 
phosphatidylinositol; PL, polar lipids; PS, phosphatidylserine; SM, sphingomyelin.  
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Table 6.6. Lipid content (percentage of wet weight) and lipid class composition 
 (percentage of total lipid) of liver from salmon fed the experimental diets for  
 19 weeks. 
Parameters 25F 18F 11F 5F
Lipid content 7.1 ± 2.3 6.4 ± 2.8 5.7 ± 1.5 5.2 ± 1.2 
Lipid class
PC 16.0 ± 3.9 16.6 ± 2.6 16.5 ± 3.1 16.4 ± 1.8
PE 10.2 ± 2.5 10.4 ± 1.3 10.7 ± 2.1 10.6 ± 0.8
PI 3.6 ± 1.0 3.6 ± 0.6 3.4 ± 1.1 3.5 ± 0.8
PS 2.3 ± 0.9 2.5 ± 0.6 2.4 ± 0.9 2.7 ± 1.1
SM 1.8 ± 0.6 2.0 ± 0.3 1.8 ± 0.5 1.6 ± 0.2
LPC 0.2 ± 0.1 0.2 ± 0.2 0.1 ± 0.1 0.1 ± 0.1
UPL 2.3 ± 1.4 2.2 ± 0.5 2.4 ± 0.9 2.9 ± 0.7
Total PL 36.4 ± 9.5 37.4 ± 4.4 37.4 ± 8.3 37.8 ± 4.9
Total NL 63.6 ± 9.5 62.6 ± 4.4 62.6 ± 8.3 62.2 ± 4.9
Triacylglycerol 49.0 ± 12.7 46.9 ± 7.7 46.0 ± 11.7 46.6 ± 5.9
Sterol 10.4 ± 2.1 11.6 ± 2.7 12.7 ± 2.2 11.0 ± 0.9
Free fatty acid 0.9 ± 0.9 0.6 ± 1.5 1.8 ± 0.2 1.8 ± 0.5
Steryl ester tr tr tr tr
UNL 3.3 ± 0.8 3.5 ± 1.3 3.4 ± 1.3 2.8 ± 0.6  
Results are means ± SD (n = 3). Values within a row with different superscript letters  
are significantly different as determined by ANOVA. LPC, lysophosphatidylcholine; 
NL, neutral lipids; PC, phosphatidylcholine; PI, phosphatidylinositol; PE, 
phosphatidylethanolamine; PL, polar lipids; PS, phosphatidylserine; SM, 
sphingomyelin; tr., trace; UNL, unidentified neutral lipid, UPL, unidentified polar lipids. 
6.3.5 Fatty acid composition of flesh and liver tissues  
The gross FA composition of flesh reflected the diet compositions. Flesh FAs 
contained over 50 % total MUFA, predominantly18:1n-9, and around 17 % SFA, 
mainly 16:0. PUFA represented over 30 % of total FAs with 18:2n-6 being the most 
abundant followed by DHA, EPA and 18:3n-3 (Table 6.7). It was clear that DHA was 
retained at a higher concentration in the flesh than provided in the diet. The EPA 
retention showed a reciprocal trend with dietary levels, with the level in flesh of fish fed 
25F lower than in the diet, while EPA in flesh of fish fed the diets with lower FM 
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inclusions being higher than the diet levels (Table 6.7). The levels of 20:1 decreased 
from 5.3 % to 3.5 % and 22:1 decreased from 4.4 % to 3.3 % in the flesh with 
decreasing FM inclusion similar to the dietary trend, but other differences in FA 
composition were not related directly to dietary levels. Thus, 16:0 increased from 10.2 
% to 11.2 % and 16:1 increased from 3.4 % to 3.8 % as FM inclusion decreased. 
Similarly, the levels of 18:2n-6 tended to decrease from 12.3 % to 10.9 % and 18:3n-3 
decrease from 4.0 % to 3.7 % while the levels of desaturated and elongated products 
including 20:4n-6, 22:5n-3 and 22:6n-3 increased with decreasing FM inclusion (Table 
6.7). This may suggests some endogenous synthesis of LC-PUFA was occurring with 
reduction in FM and consequent increase of 18:3n-3. 
The FA composition of liver showed more variability between treatments, but 
was generally similar to the diet compositions, with MUFA, mainly 18:1n-9, 
predominating at between 47 and 52 %, and around 15 % SFA, mainly 16:0, and 33-38 
% PUFA (Table 6.8). There were no significant differences in total SFA, total MUFA, 
total n-3 PUFA and total PUFA in liver.  However, total n-6 PUFA tended to increase in 
fish fed the diets containing higher PP inclusion. As with flesh, the proportion of DHA 
was higher in the liver lipids than in the diets, and was the predominant PUFA followed 
by 18:2n-6, EPA and 18:3n-3. Decreasing FM inclusion resulted in slightly reduced 
14:0 and, particularly, reduced proportions of 20:1 and 22:1 in liver total lipid. In 
contrast to flesh, dietary treatments had no major effect on liver 18:2n-6 or 18:3n-3 
levels, but 20:4n-6 and 22:5n-3 were significantly increased and there were trends of 
increasing EPA and DHA in response to decreasing dietary FM inclusion (Table 6.8). 
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Table 6.7. Fatty acid compositions (percentage of total fatty acids) of flesh from salmon 
 fed the experimental diets for 19 weeks. 
Parameters 25F 18F 11F 5F
Fatty acids
14:0 2.9 ± 0.1 3.0 ± 0.1 3.0 ± 0.3 3.1 ± 0.2
16:0 10.5 ± 0.4
 ab
10.2 ± 0.1
 b
11.2 ± 0.5
 a
11.2 ± 0.4
 a
18:0 2.8 ± 0.1 2.8 ± 0.1 2.8 ± 0.2 2.8 ± 0.1
20:0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0
Total saturated
1 16.8 ± 0.5 17.3 ± 0.2 17.6 ± 0.8 17.8 ± 0.7
16:1n-7 3.4 ± 0.1
b
3.5 ± 0.3
ab
3.6 ± 0.3
ab
3.8 ± 0.2
a
18:1n-9 35.4 ± 1.0 34.6 ± 1.4 34.4 ± 1.8 34.9 ± 2.4
18:1n-7 3.1 ± 0.2 3.1 ± 0.2 3.2 ± 0.2 3.2 ± 0.1
20:1n-9 5.3 ± 0.2
 a
4.6 ± 0.4
 b
4.5 ± 0.3
 b
4.5 ± 0.1
 b
22:1n-11 3.7 ± 0.3
 a
3.0 ± 0.2
 b
2.6 ± 0.1
 c
2.6 ± 0.1
 c
22:1n-9 0.7 ± 0.1 0.7 ± 0.6 0.6 ± 0.0 0.7 ± 0.0 
24:1n-9 0.6 ± 0.2 0.5 ± 0.3 0.5 ± 0.0 0.5 ± 0.0 
Total monoenes
2 52.6 ± 1.5 50.5 ± 1.7 49.9 ± 1.9 50.7 ± 2.3 
18:2n-6 12.1 ± 0.5 
ab
12.3 ± 0.5
 a
11.4 ± 0.6
bc
10.9 ± 0.4
 c
20:2n-6 1.0 ± 0.1 
b
1.0 ± 0.1
 b
1.2 ± 0.1
 a
1.2 ± 0.0
 a
20:3n-6 0.4 ± 0.0
 b
0.5 ± 0.0
 a
0.5 ± 0.1
 a
0.5 ± 0.1
a
20:4n-6 0.3 ± 0.1
 b
0.4 ± 0.1
 ab
0.4 ± 0.1
 ab
0.5 ± 0.1
 a
Total n-6 PUFA
3
14.1 ± 0.4
 ab
14.5 ± 0.4 
a
13.9 ± 0.6
 ab
13.4 ± 0.4
 b
18:3n-3 4.0 ± 0.2
 a
4.1 ± 0.1
 a
3.9 ± 0.3
 ab
3.7 ± 0.2
 b
18:4n-3 0.7 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 
20:3n-3 0.4 ± 0.0
 b
0.4 ± 0.1
 ab
0.4 ± 0.1
ab
0.5 ± 0.4
 a
20:4n-3 0.7 ± 0.1
b
0.8 ± 0.1
a
0.8 ± 0.0
a
0.8 ± 0.1
a
20:5n-3 3.8 ± 0.3
 b
4.5 ± 0.6
 ab
4.8 ± 0.7
 a
4.7 ± 0.7
 ab
22:5n-3 1.6 ± 0.2
 b
2.0 ± 0.2
 ab
2.2 ± 0.3
 a
2.3 ± 0.4
 a
22:6n-3 5.2 ± 0.9 5.3 ± 1.1 5.7 ± 0.8 5.4 ± 1.0
Total n-3 PUFA 16.4 ± 1.3 17.7 ± 1.9 18.6 ± 1.7 18.1 ± 2.2 
Total PUFA 30.5 ± 1.4 32.2 ± 1.7 32.5 ± 1.5 31.5 ± 2.1 
 
Results are means ± SD (n = 3). Values within a row with different superscript letters 
are significantly different as determined by ANOVA. 
1
Totals includes 15:0 and 22:0 
present at up to 0.2 %; 
2
Totals includes 16:1n-9 and 20:1n-7 present at up to 0.3 %; 
3
Totals includes 18:3n-6, 20:2n-6, 22:4n-6 and 22:5n-6 present at up to 0.2 %. PUFA, 
polyunsaturated fatty acid. 
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Table 6.8. Fatty acid compositions (percentage of total fatty acids) of liver from salmon  
 fed the experimental diets for 19 weeks. 
 
Parameters 25F 18F 11F 5F
Fatty acids
14:0 1.6 ± 0.1
a
1.6 ± 0.1
a
1.5 ± 0.1
ab
1.4 ± 0.1
b
16:0 8.7 ± 1.7 9.1 ± 1.6 9.5 ± 1.9 9.0 ± 1.5 
18:0 4.0 ± 0.8 4.6 ± 0.5 4.1 ± 0.3 4.0 ± 0.6 
Total saturated
1 14.6 ± 2.4 15.6 ± 2.0 15.5 ± 2.3 14.6 ± 2.0 
16:1n-7 2.5 ± 0.6 2.2 ± 0.4 2.3 ± 0.5 2.1 ± 0.2
18:1n-9 35.8 ± 5.5 32.5 ± 4.7 33.1 ± 4.9 33.5 ± 2.3 
18:1n-7 3.4 ± 0.3 3.2 ± 0.3 3.3 ± 0.2 3.2 ± 0.2 
20:1n-9 7.5 ± 1.2
 a
6.2 ± 0.6
 ab
5.7 ± 1.0
 b
5.6 ± 0.6
 b
22:1n-11 1.6 ± 0.2
 a
1.1 ± 0.2
 b
1.1 ± 0.1
 b
1.0 ± 0.1
 b
24:1n-9 0.6 ± 0.2 0.5 ± 0.1 0.6 ± 0.2 0.6 ± 0.1
Total monoenes
2 52.4 ± 7.5 46.7 ± 6.0 47.1 ± 6.6 47.1 ± 3.2
18:2n-6 8.7 ± 0.6 
ab
9.5 ± 0.8 
a
8.4 ± 0.5 
b
8.5 ± 0.6 
b
20:2n-6 2.1 ± 0.3 2.4 ± 0.2 2.1 ± 0.3 2.2 ± 0.2
20:3n-6 0.7 ± 0.1 
ab
0.6 ± 0.1 
b
0.7 ± 0.1 
ab
0.8 ± 0.1 
a
20:4n-6 0.9 ± 0.4 
b
1.2 ± 0.4 
ab
1.3 ± 0.4 
ab
1.4 ± 0.2 
a
Total n-6PUFA
3
12.5 ± 0.6 
b
13.9 ± 0.6 
a
12.8 ± 0.5 
b
13.1 ± 0.6 
ab
18:3n-3 2.5 ± 0.3 2.5 ± 0.4 2.6 ± 0.3 2.6 ± 0.3
20:3n-3 0.5 ± 0.1 0.6 ± 0.1 0.6 ± 0.1 0.6 ± 0.1
20:4n-3 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.9 ± 0.1
20:5n-3 5.5 ± 1.6 7.0 ± 1.5 7.3 ± 1.6 7.4 ± 0.6
22:5n-3 1.4 ± 0.2 
b
2.0 ± 0.4 
a
2.2 ± 0.5 
a
2.2 ± 0.2 
a
22:6n-3 9.7 ± 4.2 10.7 ± 3.2 10.9 ± 2.9 11.3 ± 2.0
Total n-3PUFA
4 20.5 ± 5.5 23.8 ± 4.6 24.7 ± 4.8 25.2 ± 2.2
Total PUFA 33.0 ± 5.4 37.7 ± 4.3 37.4 ± 4.8 38.3 ± 2.1
Results are means ± SD (n = 3). Values within a row with different superscript letters 
are significantly different as determined by ANOVA. 
1
Totals includes 15:0 and 20:0 
present at up to 0.2 %; 
2
Totals includes 16:1n-9, 20:1n-7 and 24:1n-9 present at up to 
0.4%; 
3
Totals includes18:3n-6, 20:2n-6 and 22:5n-6 present at up to 0.2 %; 
4
Totals 
includes 18:4n-3 presents at up to 0.2 %. PUFA, polyunsaturated fatty acid. 
6.4 Discussion and conclusion 
The reduction of FM from 25 % to 5 % in the diets by progressively increasing 
replacement with the mixed PP sources (sunflower meal, soybean protein concentrate, 
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corn gluten, wheat gluten and field beans) did not affect the survival of Atlantic salmon 
(mortality less than 1 %) indicating that the experimental diets did not have any major 
negative effects on fish health. However, the dietary treatments significantly affected 
growth performance of salmon in the present study. As FM inclusion decreased from 25 
% to 5 % there was a progressive reduction in growth resulting in final body weights 
being reduced by 5 %, 13 % and 22 % in fish fed 18, 11 and 5 % FM, respectively, 
compared to fish fed 25 % FM. Moreover, SGR for the fish fed the 18F, 11F and 5F 
diets was reduced by 5 %, 11 % and 23 %, and TGC by 5 %, 16 % and 27 %, 
respectively, compared to fish fed the control 25F diet. Despite the lower growth 
performance compared to the control diet, the fish fed the 18F and 11F diets showed 
weight gains, TGCs and SGRs in a similar range to salmon of similar size fed high FM 
diets (Karalazos 2007; Torstensen et al. 2008). The level of each PP used in the present 
study was within the range used in several previous studies showing their support of 
adequate fish growth (Kaushik et al. 1995, 2004; Robaina et al. 1997; Mente et al. 
2003; Thiessen et al. 2003; Opstvedt et al. 2003; Dias et al. 2005; Lozano et al. 
2007; Hansen et al. 2007b; Overland et al. 2008). However, in general, these studies 
showed that replacement of high quality FM with PP sources could cause a reduction in 
growth depending on the sources and levels of replacement. It has been reported that 
replacing FM with PP higher than 75% resulted in dramatic reduction in growth rate in 
Atlantic salmon (Sveier et al. 2001), gilthead sea bream (Sitja-Bobadilla et al. 2005) 
and Atlantic cod (Hansen et al. 2007b). The levels of dietary FO used in previous 
studies were between 22 and 30 % of the total diet (Opstvedt et al. 2003; Espe et al. 
2006), which was much higher than the level of FO used in the present study, with FO 
being around 12 % and VO 18%, of the total diet.  Therefore, the effect of FM 
replacement on growth is dependent not only upon the level of FM replacement but also 
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on the level of FO in the diet. Therefore, in another study investigating dual 
replacement of FM and FO, Atlantic salmon fed diets with 80 % of the FM replaced by 
blends of PPs and krill meal, along with 70 % FO replaced by VOs, (LO/RO/PO) 
showed significant growth reduction, whereas diets with substitution of 40 % FM and 
70 % VO, or 80 % FM and 35 % VO showed no negative effects (Torstensen et al. 
2008). This study was supported by studies showing that gilthead sea bream had no 
growth retardation when fed diets containing 15% FM and high levels of blends of PPs 
inclusion associated with VO up to 66% replacement, but a growth reduction was found 
when dietary FO substitution was 100% (Benedito-Palos et al. 2008, 2009).  
Reduction in growth in salmonids at high dietary inclusion levels of PP has been 
explained by various factors including decreased digestible and indigestible 
carbohydrate levels (starch/fibre levels) (Opstvedt et al. 2003; Hemre et al. 2003), 
reduced feed palatability and presence of anti-nutrients (Krogdahl et al. 1994; Francis 
et al. 2001), and imbalanced dietary AA concentration (Espe et al. 2006, 2007). In the 
present study, the NFE (N-free extract plus fiber) level increased as the level of PP 
inclusion increased, but also the feed intake was reduced by feeding the diets with 
increasing levels of PP inclusion. This reduced consumption of diets containing high 
PPs and contributed to the lower growth observed in fish fed these diets. This result was 
consistent with previous studies, which reported that increasing replacement of FM by 
PPs in diets for salmonids resulted in reduced growth performance that was caused by 
reduced feed intake (Kaushik et al. 2004; Espe et al. 2006). Moderate reductions in 
feed intake in fish can severely affect cumulative nutrient absorption and consequently 
correlate with decreased growth (Refstie et al. 1998, 2001; Carter & Hauler 2000). 
Previous studies suggested that feed intake was not affected by low inclusion of PP 
sources, but the quality and quantity of FM inclusion affects feed intake, and 
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digestibility of protein and energy (Mundheim et al. 2004). In the present study, high 
and low qualities of FM were utilised in a ratio of 1:1 together with low levels of FM 
inclusion and high PP inclusion that, together, may alter the physiology, texture and 
flavour and, consequently, reduce the palatability of the diets. It was shown in previous 
studies that both the quality and levels of FM inclusion enhanced the palatability and 
feed efficacy and so reducing FM and changing the composition of ingredients likely 
influences the flavour, reducing palatability of the diets and diminishing the appetite of 
the fish (Webster et al. 1999). The palatability of diets and feed acceptance can be 
improved and enhanced by inclusion of relatively minor amounts of specific feed 
attractants including krill meal, fish protein or squid hydrolysates into diets (Espe et al. 
1999; Refstie et al. 2004; Hevroy et al. 2005; Olsen et al. 2006).  
Although reduced feed intake was the most obvious consequence of the 
reduction in dietary FM inclusion in the present study, there were also significant 
effects on nutrient utilisation between salmon fed high and low FM inclusion. FCR was 
increased and PER decreased by decreasing dietary FM inclusion in the first phase of 
the trial while there were no significant differences between any of the dietary 
treatments in these parameters in the second phase of the trial. FCR and PER in the 
present study were comparable to previous studies. This may indicate that there was 
metabolic adaptation to the diets in salmon that improved nutrient utilisation of the high 
PP diets in the later stages of the study. Previous studies indicated that PER was high in 
European eel (Anguilla anguilla) fed high dietary carbohydrate (high PPs), resulting in a 
large amount of fat being deposited in the fish (De Silva & Anderson 1995). Plant meals 
contain significant amounts of carbohydrate that may have detrimental effects on 
Atlantic salmon performance (Waagbo et al. 1994; Hemre et al. 1995), as observed in 
the present study. High energy (fat and digestible carbohydrate) levels leads to better 
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utilisation of ingested protein because of an increased contribution of the non-protein 
energy sources to energy expenditure (Cho & Kaushik 1985, 1990). The level of dietary 
lipid (32 %) used in the present study was sufficient to meet both energy and EFA 
requirements of salmon and allowed protein sparing, resulting in increasing ADC of 
protein and PER and consequently increased perivisceral lipid deposition as evidenced 
by the increased VSI in fish fed the lower levels of FM. However, the salmon showed a 
negative relation between ADC of fat and inclusion level of PPs in diets in the present 
study. The diets with higher PP inclusion levels had higher NFE contents, especially the 
11F and 5F diets. Generally, PP ingredients contain relatively high contents of 
carbohydrates, which are not well digested in carnivorous fish, including salmonids 
(Singh & Nose 1967; Hansen et al. 2007b) and that may have detrimental effects on 
Atlantic salmon performance (Waagbo et al. 1994; Hemre et al. 1995).  
The ADC of protein (90 – 95 %) and fat (80 – 83 %) measured in the present 
study were comparable to those reported in previous studies in Atlantic salmon 
(Opstvedt et al. 2003; Mundheim et al. 2004; Aslaksen et al. 2007) but lower than 
digestibilities reported in rainbow trout (Cho & Kaushik 1990). This is likely due to 
differences in the sources and levels of ingredients, and of course, fish species. In 
previous studies on smaller Atlantic salmon, increasing dietary PPs as replacement for 
up to 50 % of FM reduced the ADCs of protein and fat, and protein retention, and the 
authors concluded that protease inhibitors and interaction between fat and carbohydrate 
fractions reduced protein and lipid digestibility (Aksnes 1995; Opstvedt et al. 2003; 
Mundheim et al. 2004). The interaction between carbohydrate and lipid in that high 
carbohydrate/fibre in diet has been reported limiting the metabolic capacity of the lipid 
in distal intestine epithelium (Storebakken  2002).  Thus, the decreased ADC fat in the 
present study possibly related to the high PPs diets containing high non starch 
Chapter 6 
 210 
carbohydrates such as pectin and acidic polysaccharide in legumes (Storebakken  2002), 
which cause increasing viscosity of ingested diet possibly resulting reduced fat 
digestibility.   
As discussed above, the main reason that fish growth was reduced was likely 
related to reduce feed consumption. This would result in less lipid intake and so less 
energy available and less protein sparing. In addition, the AA provision would also 
being inadequate to meet the requirements to support maximum growth. Lewis  
Kohler (2008) suggested that dietary AA imbalance resulted in elevated FCR of 
sunshine bass fed diets with decreasing dietary FM inclusion from 24 to 8 %. Generally, 
another major consequence of diets containing high PPs, in addition to the high 
carbohydrate contents, is the unbalanced AA profile of PPs compared to FM. Protein 
utilisation was reduced when dietary lysine was limited, but it was not observed when 
dietary methionine was limited (Berge et al. 1998; Espe et al. 1999). However, dietary 
AA balance can be improved by the addition of crystalline AAs to diets (Espe et al. 
2008). Thus, several studies have demonstrated that high PP inclusion in diets did not 
effect protein utilisation as long as dietary AAs were balanced and feed intake was not 
significantly reduced (Espe et al. 2006, 2007). Dietary AA composition in the present 
study was formulated to mimic the AA composition of FM, and to meet protein and AA 
requirements of Atlantic salmon (NRC 1993), and so crystalline AAs (lysine, threonine, 
methionine) were added as supplements. All groups of salmon improved similarly with 
respect to nutrient utilisation (FCR and PER) during the second phase and at end of the 
trial indicating that the effect on FCR and PER are more related to feed intake reduction 
than to imbalanced AA composition in the diets.   
All diets contained 28 – 30 % total lipid, primarily supplied by FO and RO in 
the same proportions, and all were supplemented with equal amounts of lecithin. The 
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reducing FM content had only small and largely non-significant effects on lipid 
composition of the fish. Flesh lipid content was not affected by the dietary treatment but 
the liver lipid content showed a clear downward trend from 7.1 % in fish fed the highest 
level of FM down to 5.2 % as FM inclusion decreased and PP inclusion increased. 
Contrastingly, the dietary treatments in the present study did not affect liver lipid class 
composition but did affect flesh lipid class composition. Total polar lipid in both flesh 
and liver tissues were predominantly PC and PE that are generally the major membrane 
phospholipids in fish tissues, while PS and PI are present in smaller quantities 
(Torstensen et al. 2000; Rosenlund et al. 2001; Bell et al. 2002, 2003a, 2004). There 
are biochemical and molecular mechanisms for remodeling phospholipid classes, and 
phospholipid remodeling is certainly involved in adaptation of biological membranes to 
different environmental conditions (Tocher et al. 2008). So, it is perhaps possible that 
the interaction between dietary protein sources and lipid sources resulted in effects on 
the flesh lipid class composition, but the changes in composition were so small that it 
was unlikely to have been physiologically relevant. 
The nutritional quality of fish products is important with respect to human 
consumption, particularly in terms of flesh FA composition, specifically the n-3 HUFA, 
EPA and DHA. The strong relationship between dietary lipid and tissue FA composition 
is well documented (Bell et al. 2003b, 2004). In the present study, it was noteworthy 
that substituting FM up to very high levels did not reduce levels of EPA and DHA in the 
flesh below those observed in salmon fed the 25FM diet. In fact EPA and ARA both 
tended to increase in both flesh and liver with increasing FM replacement by PPs, and 
DHA also showed an increasing trend in liver with increasing dietary PP inclusion. 
There were also indications of decreasing 18:2n-6 and 18:3n-3 in flesh as PP inclusion 
increased. These changes in tissue PUFA composition cannot be adequately explained 
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by dietary FA compositions as ARA and EPA were constant in the diets and DHA 
decreased with increasing PP inclusion. Therefore, the effects observed are likely due to 
changes in metabolism with increased desaturation of 18:2n-6 and 18:3n-3 and/or 
increased retention of HUFA as PP inclusion increased. However, this may be partly 
related to reduced lipid levels in liver where TAG decreased and phospholipid 
increased. When FAs were provided at low concentrations in diets, they tend to be 
preferentially retained or deposited in tissue (Henderson & Sargent 1985b; Henderson 
1996; Caballero et al. 2002). Levels of ARA, EPA and, especially, DHA were higher 
in flesh, and especially liver, than in the diets suggesting retention, whereas levels of 
18:2n-6 and 18:3n-3 in tissues were less than in the diet suggesting that these FAs were 
selectively utilised for energy or for synthesis of longer chain and more unsaturated 
products. The FA composition of flesh may also reflect another metabolic effect as the 
increasing proportions of 16:0 and 16:1 with increasing PP inclusion may suggest 
increased lipogenesis in the fish with decreased feed intake. In contrast, the tissue levels 
of some FAs did reflect dietary levels, with 20:1 and 22:1 both decreasing in liver and 
flesh as FM inclusion decreased. 
In conclusion, high inclusion of PP and reduced levels of FM in dual-substituted 
diets affected growth and nutrient digestibility in Atlantic salmon. ADC of fat was 
decreased with increasing PP inclusion in the diets probably associated with increased 
carbohydrate/fiber, whereas ADC of protein was increased as PP inclusion in diet 
increased. However, the fish consumed less feed as FM inclusion in the diets decreased 
and this effect was observed throughout the trial although it appeared greater in the first 
growth phase. Changing feed ingredients may have affected the physical texture of the 
feeds and/or chemical olfactory attractants that reduced the palatability of the diets. 
Enhancing the palatability of the diets by adding additional feed attractants may help to 
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minimise detrimental effects on feed intake. The FCR and PER were improved at the 
second and at the end of the trial suggesting that there was more related to metabolic 
adaptation to the diets than AA limitation in diets. The inclusion of PPs appeared to 
decrease liver lipid content but increased visceral lipid deposition. EFA composition, n-
3 PUFA, EPA, DHA and ARA in both flesh and liver tissues were not reduced by 
reduced FM inclusion and, indeed, were slightly increased in the fish fed the lower FM 
inclusions. Therefore, reduction of FM inclusion from 25 % down to 5 % did not 
significantly affect nutritional quality of the fish product (flesh) in fish fed dual-
substituted feeds with FM content reduced to just 5 % and FO content at 12 %. 
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Chapter 7 - Dual replacement of dietary fish oil and fish meal 
in feeds for large Atlantic salmon (Salmo salar 
L.). II- Effects of different blends of alternative 
protein  sources as replacers for dietary fishmeal 
7.1 Introduction 
The supply of major fish feed ingredients such as FM and FO, the predominant sources 
of protein and lipid for carnivorous fish has become a limiting factor for expansion of 
aquaculture due to the fishing pressure on feed-grade fisheries (Sargent & Tacon 1999; 
Pike 2005). The production of these marine raw materials is not able to increase above 
current levels and, coupled with the increasing demand for feeds for both land animal 
and fish farming, this is resulting in market forces driving the price upwards. As a result 
it is no longer feasible to use FM and FO at the current high level of use either now and, 
especially, in the future (FAO 2006). Therefore, the growth in aquaculture production 
will not be sustainable if aquafeeds continue to depend substantially on these marine 
products. This has led fish nutritionists to investigate new  sustainable protein and oil 
sources as alternatives to FM and FO in aquafeeds to ensure healthy and cost-effective 
production (Greene & Selivonchick 1990; Guillou et al. 1995; Turchini et al. 2003). 
Previous studies indicated that replacement of FM and FO with unconventional protein 
and lipid sources from plant and animal sources would be possible provided the AA and 
EFA requirements are met (Steffens 1997; Sargent & Tacon 1999). 
Studies have been conducted using land animal products including poultry by-
products, meat, bone and blood meals to substitute FM in fish diets (Murai 1992; 
Smith et al. 1995; Robaina et al. 1997; Webster et al. 2000). In addition, PP sources 
seem to offer great potential as truly sustainable protein sources for aquafeeds although 
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they often may contain ANFs, such as those found in soybean meal, which affect 
growth performance and health of fish (Francis et al. 2001). Thus, rapeseed, soybean, 
sunflower, beans and peas are inexpensive and readily available in high quantities, 
although they have their own desirable and undesirable (e.g. antinutrients, fibre) 
characteristics that both support and limit their use (Krogdahl et al. 1994; Francis et al. 
2001; Krogdahl et al. 2005). Corn gluten meal has been shown to be a good alternative 
for FM replacement in salmon diets, being low in ANFs (Mente et al. 2003; Pereira & 
Oliva-Teles 2003). Wheat gluten has high digestibility and palatability but is expensive 
(Hardy 1996). Soy protein concentrates (SPC) have been reported as excellent sources 
for partial substitution of FM for many species of fish without reducing growth (Nengas 
et al. 1996; Refstie et al. 2001; Kaushik et al. 2004), and field peas and pea protein 
have been shown to be good protein sources for Atlantic salmon (Aslaksen et al. 2007). 
Partial replacement of FM with plant meals at a variety of different levels of 
substitution in fish diets has been studied in several fish species including rainbow trout 
(Smith et al. 1995; Kaushik et al. 1995), European sea bass (Kaushik et al. 2004), 
gilhead sea bream (Benedito-Palos et al. 2008), Atlantic cod (Hansen et al. 2007b) and 
Atlantic salmon (Espe et al. 2006; Torstensen et al. 2008). Generally, the replacement 
of up to 30 - 40 % FM with single plant meals does not compromise growth of fish 
(Nengas et al. 1996; Refstie et al. 2001; Lozano et al. 2007). However, replacement 
of greater than 70 % of dietary FM by blends of plant meal resulted in negative effect 
on growth performance of various fish including salmonids (Gomes et al. 1995; Espe 
et al. 2006; Torstensen et al. 2008). Although generally complete replacement of FM 
by plant meals has not been very successful, substitution of close to 100 % of dietary 
FM by blends of PP was possible in Atlantic salmon with no major negative effects on 
growth if the AA profile in the feed was well balanced, and if feed intake was 
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comparable to a high FM diet (Espe et al. 2007). This demonstrated the potential of 
replacing dietary FM with mixtures of alternative protein sources in Atlantic salmon.  
Plant (vegetable) oils have been suggested as the primary sustainable 
alternatives to marine FO in aquafeeds. However, replacing FO in aquaculture diets 
presents difficulties due to the important differences in FA compositions of FO and VO. 
Capelin oil, a northern hemisphere FO frequently used in salmon feeds, is generally rich 
in long-chain MUFAs and n-3 HUFAs (Torstensen et al. 2005). In contrast, most VOs 
are rich in C18 FAs and only a few contain much n-3 PUFA. For example, RO is rich in 
18:1n-9, has moderate levels of 18:2n-6 and some 18:3n-3 but, as with all VOs, is 
devoid of the n-3 HUFA EPA and DHA, found in marine FO (Bell et al. 2003a; 
Caballero et al. 2002; Sargent et al. 2002). In Atlantic salmon, a number of studies have 
reported that there was no growth reduction when dietary FO was substituted by single 
or blended VOs (Bell et al. 2001, 2002; Torstensen et al. 2004a, 2005), but tissue FA 
composition was altered, with reduced levels of EPA and DHA (Bell et al. 2002, 
2003b). As a result, several studies have reported the use of a high FO “finishing” diet 
to restore the n-3 HUFA levels in flesh prior to harvesting (Bell et al. 2003a, 2004; 
Torstensen et al. 2005). The study described in the previous chapter reported the effects 
of progressive reduction in dietary FM in dual-substituted feeds for Atlantic salmon. 
Compared to a control diet, formulated to represent the current upper levels of 
substitution of FM and FO, growth of Atlantic salmon was progressively reduced as the 
FM content of the diet was similarly reduced from 25 % down to 5 % (Chapter 6). The 
aim of present study was to examine the effects of different alternative protein blends 
(mixtures of sunflower meal, corn gluten meal, soybean meal, wheat gluten, field pea 
and land animal products) on growth of Atlantic salmon fed dual-substituted feeds with 
almost 90 % of FM replaced and 60 % of dietary FO replaced by RO. Large Atlantic 
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salmon of initial weight of 1.3 Kg were grown to market size (> 3 Kg) on the different 
feeds over a period of 19 weeks. All diets were supplemented with crystalline AA and 
soybean lecithin. The growth performance, feed utilisation, lipid class composition and 
FA profiles of flesh and liver were investigated. 
7.2 Materials and Methods 
7.2.1 Experimental fish  
Two thousand two hundred and fifty Atlantic salmon of initial mean weight 1.3 
 0.1 kg were randomly distributed among 15 cages of 125 m
3
 (5  5  5 m) with 150 
fish/cage at the Marine Harvest Fish Trials Unit (FTU), Ardnish, Scotland. The fish 
were fed one of five diets in triplicate cages. The experiment was conducted over 19 
weeks from October 2007 to February 2008 under natural photoperiod. The mean 
temperature, salinity and turbidity of seawater throughout the experiment were 8.6  
2.3, 26.4 6.0 and 5.6  1.6 m, respectively.  Fish were fed by automatic feeders (Arvo-
tec, Sterner Arvo-tec UK, Inverness, Scotland) to apparent satiation. Mortalities, feed 
consumption and waste feed were recorded daily. 
7.2.2 Sampling protocol  
All the experimental fish were bulk weighed at the initiation, at the end of week 
8 and at the termination of the trial, week 19. At the end of the trial, 2 fish per pen (6 
fish per dietary treatment) were anaesthetised with metacaine sulphonate (MS222; 50 
mg/L) and killed by a blow to the head. Flesh samples were taken using the NQC and 
were homogenised in a food processor after removal of skin and bones and stored at -20 
o
C prior to lipid analysis. Livers were also collected from the six fish and a 1 - 2 g 
sample placed into glass vials containing chloroform/methanol (2:1, by vol.) for 
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analysis of lipid class and FA composition, and the remaining portion immediately 
frozen on dry ice (for lipid content) subsequently to stored at -20 
o
C. 
7.2.3 Experimental diets  
Five diets were formulated to satisfy the nutritional requirements of salmonid 
fish (NRC. 1993) and manufactured at Biomar TechCentre, Brande, Denmark. All diets 
contained ~35 % crude protein and ~28 % crude lipid. The control diet was formulated 
to contain 25 % FM, the minimum level of FM inclusion currently in commercial use, 
and the remaining experimental diets contained 11 % FM. The protein ingredients of the 
control diet (25F) contained 25 % FM and 45 % alternative proteins (a blend of PPs 
including sunflower meal, corn gluten, soybean protein concentrate and field beans). 
The basal ingredients of the remaining four experimental diets were 11% FM and 55 % 
alternative proeins that were, diet 11FW (qualitatively similar blend to 25F plus some 
wheat gluten), 11FP (qualitatively similar blend to 11FW plus pea protein), 11FB 
(qualitatively similar blend to 11FW plus blood meal) and 11FK (qualitatively similar 
blend to 11FW plus kidney beans) (Table 7.1). All diets were coated with a 60:40 blend 
of RO and northern hemisphere FO and all the experimental diets were supplemented 
with crystalline AAs, lecithin and carophyll pink as sources of AAs, phospholipid and 
pigments (Table 7.1).  
7.2.4 Proximate composition analysis 
Diets were ground prior to determination of proximate composition (AOAC 
2000). Crude lipid contents of the experimental diets were determined by acid 
hydrolysis followed by Soxhlet lipid extraction. The analyse methods are thoroughly 
described in Chapter 2. 
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Table 7.1. Feed formulation (mg kg
-1
) and proximate composition (percentage) of the 
 experimental diets.  
Feed ingredients 25F 11FW 11FP 11FB 11FK
Fishmeals (67% protein/10% lipid)
1 250 110 110 110 110
Sunflower meal (37% protein/10 lipid) 115 40 4 108 40
Corn gluten
 
(62% protein/2 lipid) 85 175 130 100 175
Soy concentrate (60% protein/2% lipid) 
2 85 175 130 100 175
Wheat gluten
 
(77% protein/3% lipid) - 18 17 11 18
Binders 160 160 160 160 -
Kidney beans - - - - 160
Pea protein - - 130 - -
Bloodmeal - - - 84 -
Rapeseed oil
3 173 178 176 180 178
Fish oil
4 116 118 117 120 118
Vitamin and mineral
5 11.95 23.59 25.48 21.49 23.59
L-Lysine6 0.62 3.44 1.96 0.02 3.44
L-Threonine
6 0.43 0.59 0.08 0.43
DL-Methionine
6 0.57 1.56 2.33 2.22 1.56
Lecithin 5.0 5.0 5.0 5.0 5.0
Astaxanthin
7 0.4 0.4 0.4 0.4 0.4
Antioxidant
8 4.25 4.25 4.25 4.25 4.25
Proximate composition (%)
Protein 34.3 35 34.5 36.1 35.3
Lipid 29.8 27.9 27.5 28.8 28.3
Moisture 6.7 6.2 6.2 6.5 5.5
Ash 6.0 5.2 5.4 5.0 5.3
NFE 23.2 25.7 26.4 23.6 25.6
 
1
 Blend of Peruvian super prime and standard fishmeals produced from Anchoveta   
2
 Soy protein concentrate produced from defatted soy flakes 
3
 Non-GM low erucic acid and glycosinolates  
4
 North-Atlantic standard fish oil  
5
 Vitamin and mineral premixes (Premier Nutrition Products Ltd., Staffordshire, UK) 
with limestone carrier added according to the commercial standards of BioMar AS 
6
 Highly purified (99%) crystalline amino acids  
7
 Carophyll Pink CWS 10% product (F. Hoffman-La Roche Ltd., Basel, Switzerland)  
8
 Blend of antioxidants and starch carrier added according to the commercial standards 
  of BioMar
 
9 
NFE (nitrogen free extract) calculated by subtraction, 100 - (crude protein + crude fat 
+ moisture + ash) 
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7.2.5 Lipid extraction and analysis 
Total lipids of tissues and diet samples were extracted and prepared according to 
the method of Folch et al. (1957). Separation of lipid classes was performed by HPTLC, 
and quantification was by densitometry according to the method of Henderson & 
Tocher (1992). FAMEss were prepared by acid-catalysed transesterification as 
described by Christie (Christie 1993), extracted and purified by TLC (Tocher & Harvie 
1988), and separated and quantified by gas-liquid chromatography (Ackman 1980). The 
methods and analyses are described in detail in Chapter 2.  
7.2.6 Calculations and statistical analysis 
The FCR, SGR and TGC were calculated using the formulae presented in 
Chapter 2. The effects of dietary treatment and growth performance were analysed by 
ANOVA. Statistical analyses were performed using a SPSS version 14 (SPSS inc, 
2005). Significant differences were regarded as significant when P < 0.05 (Zar, 1999) as 
described in Chapter 2. 
7.3 Results 
7.3.1 Proximate, lipid and fatty acid composition of the diets 
The experimental diets contained protein in the range 34 – 36 % and lipid in the 
range 27-30 %. The lipid, moisture and ash contents of the 11F diets were slightly lower 
than those of the 25F diet. The nitrogen-free extract (NFE) content of the11FP diet was 
higher than the 11F and 25F diets (Table 7.1). The polar lipid contents of the diets 
ranged from 8 - 10 % whilst the neutral lipid contents ranged from 90 - 92 % (Table 
7.2). The main lipid supplied in the dietary treatments was neutral lipid, predominantly 
TAG  about 74% ot toal lipid. The major polar lipid classes in the dietary lipids were 
Chapter 7 
 221 
PC, PE, and PI /PS, with PE generally the predominant polar lipid in all diets. The 
control (25F) diet tended to have higher PC and lower PE and PI/PS in comparison to 
the diets containing the lower (11 %) FM contents (hereafter collectively termed the 
11F diets). Of the 11F diets, the 11FW diet had lowest PE content and highest PI/PS 
content.  Regarding to neutral lipid, the 25F and 11FK diets contained slightly higher 
sterol than the other three 11F diets. Among the 11F diets, the 11FW contained highest 
FFA composition (Table 7.2). 
There were a few quantitatively minor differences in the FA compositions 
among the diets. The proportion of total SFAs tended to be higher in the diets with FM 
inclusion of 11 % compared to the control diet with 25 % FM (Table 7.3). Of the 11F 
groups, the 11FB and 11FK diets had higher SFA values than the 11FW and 11FP diets. 
Dietary SFA changed mainly due to the proportions of 16:0, with the 25F diet 
containing 8.7 % compared to 9.1 - 9.4 % in the diets with FM inclusion decreased to 
11 %. Within the 11F diets, the 11FK diet had highest 16:0 content (Table 7.3). Total 
MUFA ranged from 52 to 55 %, with the 25F, 11FW and 11FP diets having higher 
MUFA than the 11FB and 11FP diets. The principal MUFA was 18:1n-9 representing 
38 – 41 % of total FAs. The 25F diet generally contained higher 16:1, 20:1 and 22:1, 
but lower 18:1 than the 11F diets. Within the 11F diets, the 11FW diet had higher 
proportions of 18:1, 20:1 and 22:1 than the other 11F diets (Table 7.3). The dietary 
treatments contained approximately 16 - 17 % total n-6 PUFA of which 18:2n-6 was the 
major FA. Of the 11F diets, the 18:2n-6 content was highest in the 11FB diet. The total 
n-3 PUFA content of the dietary treatments ranged from 14 to 15 %. The total n-3 
PUFA content of the 11FW diet was lowest in comparison to the other four diets. The 
18:3n-3 content was lowest in the 25F diet which was opposited to the 22:6n-3 
composition. In contrast, the 20:5n-3 composition was high in the 11F diets, particularly 
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the 11FB and 11FK. Total PUFA content of the diets ranged from 30 – 32 % with the 
the 11FB had highest total PUFA. 
 Table 7.2. Lipid class composition (percentage of total lipid) of the experimental diets.  
Parameters 25F 11FW 11FP 11FB 11FK
Lipid classes
PC 2.8 2.1 2.7 2.4 1.9
PE 3.5 3.9 5 5.4 4.5
PI/PS 1.5 3.2 1.9 1.7 2.3
SM 0.2 0.1 0.1 0.2 0.1
LPC 0.1 tr. 0.2 0.2 0.2
Total PL 8.2 9.3 9.9 10.1 9.1
Total NL 91.8 90.4 90.1 89.9 90.9
Triacylglycerol 74.2 73.9 74.6 73.2 73.8
Sterol 8.5 6.9 7.2 7.1 8.6
Free fatty acid 9.1 9.9 8.5 9.6 8.6
Steryl ester tr. tr. tr. tr. tr.
 
Results are means of tripicate analysis. LPC, lysophosphatidylcholine; NL, neutral 
lipids; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PI, phosphatidylinositol; 
PL, polar lipids; PS, phosphatidylserine; SM, sphingomyelin.  
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Table 7.3. Fatty acid compositions (percentage of total fatty acids) of the diets.  
Parameters 25F 11FW 11FP 11FB 11FK
Fatty acids
14:0 2.6 2.5 2.5 2.6 2.7
16:0 8.7 9.1 9.1 9.3 9.4
18:0 2.7 2.6 3.0 3.2 3.0
20:0 0.5 0.5 0.6 0.6 0.6
22:0 0.9 0.8 1.1 1.1 1.1
Total saturated
1 15.5 15.7 16.3 16.9 16.9
16:1n-9 0.1 0.1 0.1 0.1 0.1
16:1n-7 3.0 2.8 2.8 2.8 2.9
18:1n-9 38.4 41.1 40.5 39.1 39.2
18:1n-7 2.7 2.7 2.7 2.9 2.9
20:1n-9 4.5 3.6 3.3 2.8 2.9
20:1n-7 0.2 0.2 0.2 0.2 0.2
22:1n-11 4.6 3.4 3.0 2.3 2.3
22:1n-9 0.7 0.6 0.6 0.6 0.7
24:1n-9 0.3 0.3 0.3 0.3 0.3
Total monoenes 54.6 54.8 53.5 51.1 51.5
18:2n-6 15.0 15.1 14.5 15.9 15.5
18:3n-6 0.1 0.1 0.1 0.1 0.1
20:2n-6 0.1 0.1 0.1 0.1 0.1
20:3n-6 0.2 0.3 0.2 0.3 0.2
20:4n-6 0.2 0.2 0.2 0.3 0.3
22:5n-6 0.1 0.1 0.1 0.1 0.1
Total n-6 PUFA 15.7 15.8 15.2 16.6 16.3
18:3n-3 5.6 5.8 6.1 6.1 6.3
18:4n-3 1.0 0.8 0.9 0.9 0.8
20:4n-3 0.2 0.2 0.2 0.2 0.2
20:5n-3 4.1 3.9 4.5 4.9 5.0
22:5n-3 0.4 0.4 0.5 0.5 0.5
22:6n-3 3.0 2.5 2.8 2.8 2.6
Total n-3 PUFA 14.2 13.7 15.0 15.3 15.4
Total PUFA 29.9 29.4 30.2 31.9 31.7  
Values are means of  tripicate analysis. 
1
Totals includes 15:0 present at up to 0.2 %. 
PUFA, polyunsaturated fatty acid. 
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7.3.2 Growth performance  
No significant difference in survival rate was observd between the fish fed the 
different dietary treatments throughout the trial (table 7.4). There were, however, 
significant differences between dietary treatments in body weights at both week 8 and 
week 19. The fish fed the control 25F diet had the highest body weights of 2.5 and 3.8 
kg respectively at the 8
th
 week and 19
th
 week, significantly higher than the weights of 
fish fed the 11F diets, that ranged from 2.2 - 2.3 kg and 3.3 - 3.5 kg at week 8 and 19, 
respectively. Although the fish fed 11FP diet, the diet containing pea protein, had a 
slightly higher average body weight at the end of the experiment, there were no 
significant differences in body weight between fish fed the 11F diets (Table 7.4).  
The fish fed the 25F diet had the highest weight gains that were generally 
significantly higher than the fish receiving the 11F diets. Over the duration of the entire 
experiment, the control group displayed the significantly highest weight gain (> 2.5 kg), 
whilst there were no statistical differences between the 11F groups (2.0 - 2.2 kg) (Table 
7.4). Within the fish fed 11F diets, the fish fed the 11FB diet had the highest weight 
gain at 8 weeks, which was significantly different from the 11FW group. Between 
weeks 8 and 19, there were no significant differences in weight gain between the dietary 
treatments (1.2 - 1.4 kg) other than the 11FB group now had the lowest weight gain (1.0 kg). 
The fish fed the 25F diet had the highest SGR and TGC values, which were 
significantly different from the 11F groups at the week 8 assessment. Comparison 
within the 11F group at 8 weeks showed the 11FW group had lowest SGR and TGC.  
From 8 to 19 weeks though, other than the 11FB group showing significantly lower 
SGR and TGC compared to fish fed all other dietary treatments, there were no 
significant differences in SGR and TGC between the 25F and the other three 11F 
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groups. Over the whole experiment, SGR and TGC of fish fed the 25F diet were 
significantly higher than fish fed the 11F diets. Within the 11F groups, there were no 
significant differences in SGR while there was a significant difference in the TGC value 
only between the 11FP and 11FB groups (Table 7.4). 
Feed consumption of the control 25F group was significantly higher than the 
11F groups throughout the experiment. At week 8, there was no significant difference in 
feed consumption between the 11F groups, but between week 8 and 19, the 11FP group 
showed significantly higher feed consumption than the 11FW and 11FB groups. Over 
the whole trial, the 11FB group displayed the lowest feed consumption, which was 
significantly different from the 11FP and 11FK groups (Table 7.4). At week 8, fish fed 
the 25F diet had the lowest FCR and highest PER values, although it was only 
statistically different between the 25F and 11FW groups. By week 19 and over the 
entire experiment, there were no significant differences in FCR and PER between fish 
fed the different dietary treatments (Table 7.4). 
No significant differences in HSI were observed between fish fed the different 
dietary treatments in this experiment. In addition, there were no significant differences 
in VSI between the fish fed the control 25F diet and fish fed any of the 11F diets. 
Within the 11F diets, fish fed the 11FW diet had the highest VSI that was significantly 
different to fish fed the 11FP and 11FK diets (Table 7.4). 
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Table 7.4. Growth performance of Atlantic salmon fed the experimental diets for 19 
 weeks. 
Parameters 25F 11FW 11FP 11FB 11FK
Survival(%)
0-8 weeks 100 ± 0.0 98.9 ± 1.0 99.3 ± 0.0 99.6 ± 0.4 99.8 ± 0.4
8-19 weeks 100 ± 0.0 100 ± 0.0 100 ± 0.0 99.8 ± 0.4 99.8 ± 0.4
0-19 weeks 100 ± 0.0 98.9 ± 1.0 99.3 ± 0.0 99.3 ± 0.7 99.6 ± 0.6
Body weight(kg)
Initial 1.3 ± 0.0 1.3 ± 0.0 1.3 ± 0.0 1.3 ± 0.0 1.3 ± 0.0
8 weeks 2.5 ± 0.0
 a
2.2 ± 0.0 
b
2.3 ± 0.0 
b
2.3 ± 0.0
 b
2.2 ± 0.1
 b
19 weeks 3.8 ± 0.1 
a
3.4 ± 0.1 
b
3.5 ± 0.1 
b
3.3 ± 0.1 
b
3.4± 0.1 
b
Weight gain         
(kg fish
-1
)
0-8 weeks 1.2 ± 0.0 
a
0.9 ± 0.1
 c
0.9 ± 0.0
 bc
1.1 ± 0.0
 b
0.9 ± 0.1 
bc
8-19 weeks 1.4 ± 0.1 
a
1.2 ± 0.1 
a
1.3 ± 0.1 
a
1.0 ± 0.1 
b
1.2 ± 0.0
 ab
0-19 weeks 2.5 ± 0.1 
a
2.1 ± 0.1 
b
2.2 ± 0.1 
b
2.0 ± 0.1 
b
2.1 ± 0.1 
b
SGR (%)
0-8 weeks 1.3 ± 0.0 
a
1.0 ± 0.0 
c
1.1 ± 0.0
 bc
1.1 ± 0.0 
b
1.1 ± 0.1 
bc
8-19 weeks 0.6 ± 0.0 
a
0.6 ± 0.0 
a
0.6 ± 0.0 
a
0.5 ± 0.0
 b
0.6 ± 0.0 
a
0-19 weeks 0.8
 
±
 
0.0 
a
0.7
 
±
 
0.0 
b
0.7
 
±
 
0.0 
b
0.7
 
±
 
0.0 
b
0.7 ± 0.0 
b
TGC
0-8 weeks 4.7 ± 0.1
 a
3.6 ± 0.1
 c
3.9 ± 0.1
 bc
4.0 ± 0.1
 b
3.8 ± 0.2 
bc
8-19 weeks 4.0 ± 0.2 
a
3.7 ± 0.1 
a
3.9 ± 0.2
 a
3.1 ± 0.1 
b
3.7 ± 0.1 
a
0-19 weeks 4.3 ± 0.1 
a
3.7 ± 0.1 
bc
3.9 ± 0.1
 b
3.6 ± 0.0
 c
3.7 ± 0.1 
bc
FCR
0-8 weeks 1.0 ± 0.0
b
1.2 ± 0.1
a
1.1 ± 0.0
ab
1.1 ± 0.0
ab
1.1 ± 0.1
ab
8-19 weeks 1.0 ± 0.1 1.0 ± 0.1 1.0 ± 0.1 1.1 ± 0.1 1.1 ± 0.0
0-19 weeks 1.0 ± 0.0 1.0 ± 0.1 1.0 ± 0.1 1.1 ± 0.0 1.1 ± 0.0
Feed Consumption 
(g fish
-1
day
-1
)
0-8 weeks 24.2 ± 0.2
 a
19.6 ± 0.4
 b
20.2 ± 0.2 
b
20.7 ± 0.8
 b
19.8 ± 0.7
 b
8-19 weeks 18.1 ± 0.2 
a
15.0 ± 0.3 
c
15.8 ± 0.2 
b
13.7 ± 0.1 
d
15.7 ± 0.4 
bc
0-19 weeks 20.4 ± 0.0 
a
16.8 ± 0.2
 bc
17.5 ± 0.1
 b
16.5 ± 0.3 
c
17.3 ± 0.6
 b
PER
0-8 weeks 2.8 ± 0.0
 a
2.4 ± 0.1
 b
2.6 ± 0.1
 ab
2.6 ± 0.0
 ab
2.6 ± 0.1
 ab
8-19 weeks 2.8 ± 0.2 2.9 ± 0.2 2.9 ± 0.2 2.6 ± 0.2 2.7 ± 0.1
0-19 weeks 2.8 ± 0.1 2.7 ± 0.1 2.8 ± 0.1 2.6 ± 0.1 2.7 ± 0.0
HSI (%)
0-9 weeks 1.1 ± 0.1 1.2 ± 0.1 1.1 ± 0.1 1.1 ± 0.0 1.1 ± 0.1
VSI (%)
0-9 weeks 11.7 ± 0.7
 ab
13.2 ± 0.4
 a
11.4 ± 0.4
 b
12.2 ± 0.7
 ab
11.5 ± 0.6 
b
Results are means ± SD (n = 3). Values within a row with different superscript letters 
are significantly difference as determined by ANOVA. FCR, feed conversion ratio; 
HSI, hepatosomatic index; PER, protein efficiency ratio; TGC, thermal growth 
coefficient; VSI, viscerosomatic index. 
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7.3.3 Lipid contents and lipid class compositions of flesh and liver 
There were no significant differences in flesh lipid contents between the 25F and 
any of the 11F groups (Table 7.5). Within fish fed the 11F diets, the only significant 
difference was the lipid content of the flesh of fish fed diet 11FP that was higher than 
that of fish fed diet 11FK. Similarly, there were no significant differences in the 
proportions of total polar and neutral lipids in the flesh between fish fed the 25F diet 
and those fed any of the 11F diets (Table 7.5). Within fish fed the 11F diets, the flesh of 
fish fed the 11FB diet had significantly lower polar, and higher neutral, lipid compared 
to fish fed the 11FW and 11FK diets. The predominant neutral lipid in the flesh was 
TAG, with PC and PE being the major polar lipids. There were no significant 
differences in individual neutral lipid classes in flesh and the only significant 
differences in polar lipid classes were in PI/PS content with flesh of fish fed the 25F, 
11FW and 11FK diets having slightly higher levels than flesh of fish fed the 11FP and 
11FB diets (Table 7.5).  
Liver lipid content was lower in fish fed the 11F diets compared to fish fed the 
25F diet, significantly so in the case of the 11FB and 11FK groups (Table 7.5). The fish 
fed the 11FB diet also showed a lower proportion of neutral lipids (and higher polar 
lipids) in liver lipid than fish fed the 25F and 11FW diets. As with flesh, the 
predominant neutral lipid in liver was TAG with the major polar lipids being PC, PE, PI 
and PS. The higher polar lipids in liver of fish fed diet 11FB compared to fish fed diet 
25F was due to higher proportions of PE, PI and PS. The proportions of PI and PS were 
also significantly higher in the 11FB group than the 11FW group. There were few 
differences in neutral lipid classes in liver other than the 11FB and 11FP groups had 
higher FFA compared to the 25F and 11FW groups. 
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Table 7.5. Lipid contents (Percentage of wet weight) and lipid class compositions 
 (percentage of total lipid) of flesh and liver of Atlantic salmon fed the 
 experimental diets for 19 weeks. 
Parameters 25F 11FW 11FP 11FB 11FK
Flesh
Lipid class
PC 4.4 ± 0.3 4.7 ± 0.7 4.4 ± 0.7 4.3  0.7 5.0 ± 0.5
PE 4.4 ± 0.9 4.6 ± 0.9 3.9 ± 0.7 3.7  0.7 4.1 ± 0.6
PI/PS 0.9 ± 0.2 
ab
1.0 ± 0.1
ab
0.4 ± 0.4
c
0.4  0.4
c
1.2 ± 0.4
 a
SM 0.2 ± 0.1 0.3 ± 0.1 0.3 ± 0.1 0.2 0.1 0.3 ± 0.2
LPC 0.1 ± 0.1 0.2 ± 0.1 0.1 ± 0.1 0.1  0.1 0.2 ± 0.1
Total PL 10.0 ± 1.1
ab
10.8 ± 1.4 
a
8.9 ± 0.9 
ab
8.7  1.5 
b
10.9 ± 1.1 
a
TotalNL 90.0 ± 1.1
ab
89.2 ± 1.4 
b
91.0 ± 0.9 
ab
91.3  1.5
 a
89.1 ± 1.1 
b
TAG 78.9 ± 1.1 78.7 ± 2.6 80.0 ± 2.3 80.6  1.5 78.4 ± 1.9
Sterol 5.8 ± 0.6 5.8 ± 0.7 6.3 ± 0.8 5.8  0.4 5.7 ± 0.7
FFA 5.4 ± 0.6 4.7 ± 1.0 4.7 ± 0.9 4.8  0.6 4.9 ± 0.9
SE tr. tr. tr. tr. tr.
Liver
Lipid class
PC 16.0 ± 3.9 16.5 ± 3.1 19.4 ± 2.9 19.4 ± 2.7 17.5 ± 1.7
PE 10.2 ± 2.5 
b
10.7 ± 2.1 
ab
12.9 ± 2.1
ab
14.0 ± 2.0 
a
11.1 ± 1.3
ab
PI 3.6 ± 1.0
 b
3.4 ± 1.1 
b
4.1 ± 1.0
 ab
5.6 ± 1.6 
a
4.5 ± 0.6
ab
PS 2.3 ± 0.9
 b
2.4 ± 0.9
  b
2.9 ± 0.9 
ab
4.6 ± 1.7 
a
3.4 ± 0.6
ab
SM 1.8 ± 0.6 1.8 ± 0.5 2.2 ± 0.3 3.3 ± 0.7 2.0 ± 0.3
LPC 0.2 ± 0.1 0.1 ± 0.1 0.3 ± 0.2 0.3 ± 0.2 0.2 ± 0.1
UPL 2.3 ± 1.4 2.4 ± 0.9 2.7 ± 0.6 3.1 ± 1.3 3.0 ± 0.6
TotalPL 36.4 ± 9.5
 b
37.4 ± 8.3
 b
44.5 ± 7.6 
ab
49.6 ± 8.7 
a
41.9 ± 4.8
ab
TotalNL 63.6 ± 9.5
 a
62.6 ± 8.3 
a
55.5 ± 7.6 
ab
50.4 ± 8.7 
b
58.1 ± 4.8
ab
TAG 49.0 ± 12.7 46.0 ± 11.7 36.9 ± 8.9 33.2 ± 11.1 41.1 ± 5.2
Sterol 10.4 ± 2.1 12.7 ± 2.2 13.1 ± 2.2 13.4 ± 1.6 12.1 ± 1.3
FFA 0.9 ± 0.9 
d
1.8 ± 0.2 
cd
2.5 ± 0.9 
abc
3.4 ± 1.0 
a
2.2 ± 0.4 
bcd
Steryl ester tr. tr. tr. tr. tr.
UNL 3.3 ± 0.8
a
3.4 ± 1.3
a
2.9 ± 1.7
 a
0.6 ± 0.3
b
2.7 ± 1.2
 a
Lipid contents
Lipid contents
10.5 ± 0.6 
b
7.1 ± 2.3
a
5.7 ± 1.5
ab
4.7 ± 1.4
ab
4.2 ± 0.6
b
4.3 ± 0.7
b
11.7 ± 1.2
 ab
11.7 ± 1.8 
ab
13.2 ± 1.1
 a
12.2 ± 1.2 
ab
 
Results are means ± SD (n = 3). Values within a row with different superscript letters 
are significantly different as determined by ANOVA. FFA, free fatty acid; LPC, 
lysophosphatidylcholine; NL, neutral lipids; PC, phosphatidylcholine; PE, 
phosphatidylethanolamine; PI, phosphatidylinositol; PL, polar lipids; PS, 
phosphatidylserine; SM, sphingomyelin; TAG, triacylglycerol; tr., trace; UNL, 
unidentified neutral lipid; UPL, unidentified polar lipid. 
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7.3.4 Fatty acid compositions of flesh and liver  
Changes in flesh FA compositions largely corresponded to differences in the FA 
compositions of the diets (Table 7.6). Dietary treatment had no affect on flesh total 
SFA, or on total n-6 PUFA other than this being lower in fish fed diet 11FP compared 
to fish fed the other 11F diets. Total MUFA was significantly higher in flesh of fish fed 
the 25F diet compared to fish fed the 11F diets, while total n-3 PUFA and total PUFA 
were significantly lower in flesh of fish fed diet 25F compared to fish fed diets 11FW, 
11FB and 11FK. There were no significant differences in flesh total MUFA and total n-
3 PUFA between fish fed any of the 11F diets. The major SFA, 16:0, was lower in flesh 
of fish fed diet 25F compared to fish fed the 11F diets, significantly so in the case of 
diets 11FP and 11FB. In contrast, flesh 20:1 and 22:1 were significantly lower in fish 
fed the 11F diets compared to fish fed diet 25F. There were no significant differences in 
proportions of 18:2n-6 and 18:3n-3 in flesh of fish fed diet 25F compared to fish fed the 
11F diets. Desaturated and elongated products of 18:2n-6 and 18:3n-3 especially 18:3n-
6, 20:3n-6 and ARA, and EPA and 22:5n-3 were generally all significantly higher in 
flesh of fish fed the 11F diets compared to fish fed the 25F diet. Moreover, DHA tended 
to be higher in flesh of fish fed the 11F diets compared to fish fed the 25F diet. 
Liver FA compositions were more variable than flesh, but there were clear 
trends for higher SFA, total n-6, total n-3 and total PUFA and lower MUFA in fish fed 
the 11F diets compared to fish fed the 25F diet, significantly so in the cases of total 
MUFA, total n-3 PUFA and total PUFA (Table 7.7). Similar to flesh, liver FA 
compositions reflected the dietary profile. Thus, liver 16:0 increased while the 18:1, 
20:1 and 22:1 decreased in line with decreased dietary FM inclusion.  There were no 
significant differences in 18:2n-6 and 18:3n-3 in liver between fish fed the 25F and 11F 
diets but, as with flesh, the liver of fish fed the 11F diets showed significantly higher 
Chapter 7 
 230 
levels of ARA, EPA and DHA than fish fed the 25F diet. The retention levels of 
desaturated and elongated products at a higher concentration than provided in the diets 
were clearly observed in liver. 
 
Table 7.6. Fatty acid compositions (percentage of total fatty acids) of flesh of Atlantic 
 salmon fed the experimental diets for 19 weeks. 
 
Parameters 25F 11FW 11FP 11FB 11FK
14:0 2.9 ± 0.1 3.0 ± 0.3 3.1 ± 0.3 3.0 ± 0.2 2.9 ± 0.2
16:0 10.5 ± 0.4 
b
11.2 ± 0.5 
ab
11.4 ± 0.6 
a
11.3 ± 0.4
 a
11.1 ± 0.3
 ab
18:0 2.8 ± 0.1 2.8 ± 0.2 2.9 ± 0.2 2.9 ± 0.1 2.8 ± 0.1
20:0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.2 ± 0.0
22:0 0.2 ± 0.0 0.1 ± 0.0 0.1 ± 0.0 0.2 ± 0.0 0.1 ± 0.0
Total saturated
1 16.8 ± 0.5 17.6 ± 0.8 18.0 ± 1.1 17.8 ± 0.6 17.4 ± 0.6
16:1n-9 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0
16:1n-7 3.4 ± 0.1 3.6 ± 0.3 3.7 ± 0.3 3.6 ± 0.2 3.5 ± 0.3
18:1n-9 35.4 ± 1.0 34.4 ± 1.8 35.1 ± 1.3 34.8 ± 1.0 34.2 ± 1.2
18:1n-7 3.1 ± 0.2 3.2 ± 0.2 3.2 ± 0.2 3.1 ± 0.2 3.3 ± 0.2
20:1n-9 5.3 ± 0.2 
a
4.5 ± 0.3
 b
4.1 ± 0.2
 bc
3.5 ± 0.1
 d
3.8 ± 0.2
 cd
20:1n-7 0.3 ± 0.0 
a
0.3 ± 0.0
 a
0.3 ± 0.0
 a
0.2 ± 0.0
 b
0.3 ± 0.0
 a
22:1n-11 3.7 ± 0.3 
a
2.6 ± 0.1
 b
2.4 ± 0.2
 b
1.9 ± 0.1
 c
2.0 ± 0.1
 c
22:1n-9 0.7 ± 0.1
 a
0.6 ± 0.0
 b
0.6 ± 0.0
 b
0.6 ± 0.0
 b
0.6 ± 0.0
 b
24:1n-9 0.6 ± 0.2
 a
0.5 ± 0.0 
ab
0.4 ± 0.0
 b
0.5 ± 0.1
 ab
0.4 ± 0.0
 b
Total monoenes 52.6 ± 1.5
 a
49.9 ± 1.9
 b
50.1 ± 1.4
 b
48.4 ± 0.7
 b
48.3 ± 1.2
 b
18:2n-6 12.1 ± 0.5
 ab
11.4 ± 0.6 
b
11.3 ± 0.8 
b
12.6 ± 0.5 
a
12.5 ± 0.5 
a
18:3n-6 0.1 ± 0.0
 b
0.2 ± 0.0
 a
0.2 ± 0.0
 a
0.2 ± 0.0
 a
0.2 ± 0.0
 a
20:2n-6 1.0 ± 0.1
 b
1.2 ± 0.1
 a
1.0 ± 0.1
 b
1.0 ± 0.1
 b
1.1 ± 0.1
 ab
20:3n-6 0.4 ± 0.0
 b
0.5 ± 0.1
 a
0.5 ± 0.0
 a
0.5 ± 0.0
 a
0.5 ± 0.1
 a
20:4n-6 0.3 ± 0.1
 b
0.4 ± 0.1
 a
0.4 ± 0.0
 a
0.5 ± 0.0
 a
0.5 ± 0.1
 a
22:5n-6 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0
Total n-6 PUFA
2
14.1 ± 0.4
 ab
13.9 ± 0.6
 ab
13.5 ± 0.9
 b
14.9 ± 0.5
 a
14.9 ± 0.5
 a
18:3n-3 4.0 ± 0.2
 ab
3.9 ± 0.3
 b
4.0 ± 0.3
 ab
4.1 ± 0.2
 ab
4.3 ± 0.3
 a
18:4n-3 0.7 ± 0.1
 b
0.8 ± 0.1
 ab
0.8 ± 0.1
 ab
0.9 ± 0.0
 a
0.7 ± 0.0
 b
20:3n-3 0.4 ± 0.0 0.4 ± 0.1 0.4 ± 0.1 0.4 ± 0.0 0.4 ± 0.0 
20:4n-3 0.7 ± 0.1
.
0.8 ± 0.0
. 0.8 ± 0.0 0.8 ± 0.1 0.8 ± 0.1
20:5n-3 3.8 ± 0.3
 b
4.8 ± 0.7
 a
4.6 ± 0.6
 a
4.8 ± 0.3
 a
4.9 ± 0.5
 a
22:5n-3 1.6 ± 0.2
 b
2.2 ± 0.3
 a
2.1 ± 0.2
 a
2.1 ± 0.1
 a
2.4 ± 0.4
 a
22:6n-3 5.2 ± 0.9 5.7 ± 0.8 5.7 ± 0.5 5.9 ± 0.5 5.8 ± 0.5
Total n-3 PUFA 16.4 ± 1.3
 b
18.6 ± 1.7
 a
18.4 ± 1.4
 ab
19.0 ± 0.7
 a
19.4 ± 1.1
 a
Total PUFA 30.5 ± 1.4
 c
32.5 ± 1.5
 abc
31.8 ± 1.9 
bc
33.9 ± 0.7 
ab
34.3 ± 0.8
 a
 
Results are means ± SD (n = 3). Values within a row with different superscript letters 
are significantly different as determined by ANOVA. 
1
Totals includes 15:0 present at up 
to 0.1 %; 
2
Totals include 22:4n-6 presents at up to 0.1 %. PUFA, polyunsaturated fatty acid. 
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Table 7.7. Fatty acid compositions (percentage of total fatty acids) of liver of Atlantic 
 salmon fed the experimental diets for 19 weeks. 
 
Parameters 25F 11FW 11FP 11FB 11FK
14:0 1.6 ± 0.1 1.5 ± 0.1 1.6 ± 0.3 1.4 ± 0.1 1.4 ± 0.1
16:0 8.7 ± 1.7 9.5 ± 1.9 12.0 ± 3.0 11.7 ± 2.7 11.3 ± 2.7 
18:0 4.0 ± 0.8 4.1 ± 0.3 4.7 ± 0.8 4.9 ± 0.3 4.9 ± 0.4 
20:0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0
Total saturated
1 14.6 ± 2.4 15.5 ± 2.3 18.6 ± 3.8 18.4 ± 2.9 18.0 ± 2.8 
16:1n-9 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0
16:1n-7 2.5 ± 0.6 2.3 ± 0.5 2.0 ± 0.4 1.9 ± 0.2 1.8 ± 0.2
18:1n-9 35.8 ± 5.5
 a
33.1 ±
 
4.9
 ab
27.3 ± 4.6 
ab
26.1 ± 4.
9 b
27.1 ± 4.7 
b
18:1n-7 3.4 ± 0.3 
a
3.3 ± 0.2
 a
2.9 ± 0.2
 b
3.1 ± 0.2
 ab
3.1 ± 0.2 
ab
20:1n-9 7.5 ± 1.2
 a
5.7 ± 1.0
 ab
4.0 ± 1.1
 bc
3.5 ± 1.1
 c
3.7 ± 1.2 
c
20:1n-7 0.4 ± 0.1
a
0.3 ± 0.0 
ab
0.2 ± 0.0 
b
0.2 ± 0.0 
b
0.2 ± 0.1 
b
22:1n-11 1.6 ± 0.2 
a
1.1 ± 0.1 
b
0.8 ± 0.2 
c
0.5 ± 0.1 
d
0.6 ± 0.1
 cd
22:1n-9 0.4 ± 0.1 
a 
0.4 ± 0.1
 a
0.3 ± 0.1
 b
0.3 ± 0.1
 b
0.3 ± 0.1
 b
24:1n-9 0.6 ± 0.2 0.6 ± 0.2 0.7 ± 0.1 0.7 ± 0.1 0.7 ± 0.1 
Total monoenes 52.4 ± 7.5
 a
47.1 ± 6.6
 a
38.5 ± 6.2
 b
36.5 ± 6.5 
b
37.9 ± 6.2
 b
18:2n-6 8.7 ± 0.6 8.4 ± 0.5 7.9 ± 0.9 8.4 ± 0.9 8.5 ± 0.9 
18:3n-6 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0
20:2n-6 2.1 ± 0.3 2.1 ± 0.3 1.6 ± 0.3 1.9 ± 0.5 1.8 ± 0.5 
20:3n-6 0.7 ± 0.1 0.7 ± 0.1 0.6 ± 0.1 0.7 ± 0.1 0.7 ± 0.1 
20:4n-6 0.9 ± 0.4
 b
1.3 ± 0.4
 ab
1.8 ± 0.4
 a
1.9 ± 0.4
 a
2.0 ± 0.4
 a
22:5n-6 0.1 ± 0.0
 b
0.2 ± 0.0
 ab
0.2 ± 0.1
 ab
0.3 ± 0.0
 a
0.2 ± 0.0
 b
Total n-6PUFA 12.5 ± 0.6 12.8 ± 0.5 12.2 ± 0.7 13.3 ± 1.0 13.3 ± 1.0 
18:3n-3 2.5 ± 0.3 2.6 ± 0.3 2.5 ± 0.4 2.5 ± 0.2 2.8 ± 0.3
18:4n-3 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.1 0.2 ± 0.1 0.2 ± 0.1
20:3n-3 0.5 ± 0.1 0.6 ± 0.1 0.5 ± 0.1 0.5 ± 0.1 0.6 ± 0.1
20:4n-3 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.9 ± 0.1 0.9 ± 0.1
20:5n-3 5.5 ± 1.6
 b
7.3 ± 1.6
 ab
9.0 ± 2.0
 a
8.5 ± 0.6
 a
8.7 ± 1.0
 a
22:5n-3 1.4 ± 0.2
 b
2.2 ± 0.5
 ab
2.8 ± 0.6
 a
2.9 ± 0.9
 a
2.9 ± 1.0
 a
22:6n-3 9.7 ± 4.2
 b
10.9 ±
 
2.9
 ab
14.8 ± 2.5
 ab
16.5 ± 3.5
 a
14.8 ±
 
3.1
 ab
Total n-3PUFA 20.5 ± 5.5 
b
24.7 ± 4.8 
ab
30.7 ± 4.4 
a
31.9 ± 4.6 
a
30.8 ± 4.5 
a
Total PUFA 33.0 ± 5.4 
c
37.4 ±
 
4.8
 bc
42.9 ± 4.0
 ab
45.1 ± 3.7 
a
44.1 ±
 
3.7
 ab
 
Results are means ± SD (n = 3). Values within a row with different superscript letters 
are significantly different as determined by ANOVA. 
1
Totals includes 15:0 present at up 
to 0.2 %. PUFA, polyunsaturated fatty acid. 
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7.4 Discussion and conclusion 
There were no major effects of dietary treatments on survival rate, or biometric 
parameters such as HSI and VSI of salmon in present study. However, reducing 
inclusion of FM from 25 % to 11 % by substitution with a blends PP or PP and land 
animal protein significantly reduced growth of the fish, irrespective of the particular 
blend of alternative proteins used. Thus, one of the main aims of this study was not 
achieved as the growth reduction observed in the previous trial by increasing 
substitution of FM with PPs was not prevented by any of the different formulations. 
Thus, at the end of trial, final body weights of fish fed the 11FW, 11FP, 11FB, and 
11FK diets were decreased 11 %, 8 %, 13 % and 11 %, respectively, compared to the 
25F group. The reduced weight gain of fish fed all the 11F diets, except 11FB, was 
mainly in the first phase of the trial, with no statistical differences between weight gains 
of fish fed the 11FW, 11FP and 11FK diets and fish fed the 25F group observed in the 
second phase (8-19 weeks). However, weight gain of all the 11F groups was still not 
comparable to weight of the 25F group at the end of trial. The weight gain data were 
supported by SGR and TGC data. During the first phase of trial, SGR and TGC of all 
the 11F groups were significantly lower than the 25F group, while in the second phase 
SGR and TGC in the 11FW, 11FP and 11FK groups were comparable to the 25F group. 
However, at the end of trial fish fed the 25F diet had higher SGR and TGC values than 
the 11F groups. The TGC and SGR of the Atlantic salmon in the present trial were 
largely similar to those reported in previous similar studies (Menoyo et al. 2003; 
Karalazos 2007; Torstensen et al. 2008). Although weight gain of the fish fed diet 
11FP was the best and 11FB the poorest by the end of the second phase (8-9 weeks), 
there were no significant differences between fish fed the 11F diets by the end of the 
overall of the trial. The growth retardation observed in the present study was related to 
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reduced feed consumption in fish fed the low inclusion of FM (11F groups), although 
this was observed throughout the trial (i.e. in both phases). The results were consistent 
with previous studies that reported that increasing replacement of FM by PP or animal 
protein meals in salmonids resulted in reduced growth performance that was caused by 
reduced feed intake (Fowler 1991; Carter & Hauler 2000; Kaushik et al. 2004; Sitja-
Bobadilla et al. 2005; Espe et al. 2006).  
The above effects of diet on growth parameters were supported by FCR and 
PER values. Significant differences in FCR and PER between fish fed the 25F and 11F 
diets were observed during the first period of trial while these differences largely 
disappeared in the second phase of the trial. This supports the position that the 
physiology of the fish adapted to the changed feed ingredients enabling them to utilise 
the nutrients more efficiently in the later stages of the study than they were able to do in 
the first period of the experiment. Several studies had previously demonstrated that high 
PP inclusion in diets did not effect protein utilisation as long as dietary AAs were 
balanced and feed intake was not significantly reduced (Espe et al. 2006, 2007, 2008). 
Thus, in the present study, crystalline AAs (lysine, threonine, methionine) were 
supplemented in diets to meet AA requirements of Atlantic salmon (NRC. 1993). As all 
groups of salmon performed similarly with respect to nutrient utilisation (based on PER 
and FCR) at the end of the trial, this suggests that supplementation was successful and 
that AA limitation was not a factor in growth reduction.  
The present study represented dual-replacement, with FM replaced by blends of 
PPs or PPs and animal proteins together with replacement of 60 % of the dietary FO by 
RO. Growth retardation was observed in all groups of fish fed the 11F diets compared 
to fish fed control diet. This result was in accordance with several studies showing that 
replacement of FM in diet with PPs above 80% caused growth reduction in Atlantic 
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salmon (Kaushik et al. 1995; Opstvedt et al. 2003; Espe et al. 2006), Atlantic halibut 
(Berge et al. 1999), sunshine bass (Lewis & Kohler 2008) and rainbow trout (Gomes et 
al. 1995). These previous studies did not substitute FO, which was included at 22 to 30 
%, higher than the level of FO (12 %) used in the present study. The level of FO 
substitution used in the trial previously showed no detrimental effects on salmon growth 
(Torstensen et al. 2000; Bell et al. 2001, 2003a, 2004; Montero et al. 2003). Recently, 
Torstensen et al (2008) reported that salmon fed diets containing PPs and VOs at 
replacement levels of 80/35 or 80/70 showed growth reduction while a replacement 
combination of 40/70 showed no negative effect on fish growth supporting that 
replacement of FO by VO up to 70 % in diets did not reduce growth of fish.  
The inclusion levels of individual PPs or animal protein sources used in the diets 
in the present study were in the range used in previous studies that showed no growth 
retardation e.g. field pea or pea protein around 20 % to 33 % in salmonid diets (Carter 
& Hauler 2000; Thiessen et al. 2003; Overland et al. 2009), dehulled pea seed up to 
30 % in European sea bass diets (Gouveia & Davies 2000), blends of soybean protein 
concentrate and corn gluten at 21 % or corn gluten at 24 % in diets for Atlantic cod 
(Hansen et al. 2007a), and animal by-products at 20 % in diets for Pacific salmon 
(Fowler 1991). However, low nutrient digestibility and energy digestibility were found 
when Atlantic salmon were fed soy bean meal and pea protein concentrate at 20 % 
inclusion, respectively (Overland et al. 2009). In the present study, growth retardation 
in all groups of fish fed the 11F diets may be explained partially by low digestibility of 
the high NFE (carbohydrate and fibre) contents in the 11FW, 11FP and 11FK diets. 
Generally, Atlantic salmon has a low ability to utilise carbohydrate in PPs (Krogdahl et 
al. 2004; Froystad et al. 2006) and consequently PPs may reduce nutrient digestibility 
(Krogdahl et al. 2005) and have detrimental effects on growth performance (Waagbo et 
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al. 1994; Hemre et al. 1995). In contrast, the level of NFE in diet 11FB was not higher 
than in diet 25F, but feed consumption was lowest in fish fed the 11FB diet and so 
growth reduction in that group may be more related to lower palatability (Fowler 1991) 
and/or digestibility of the animal by-products (Robaina et al. 1997). The suitability of 
animal by-products for FM replacement has variable effects on growth performance 
among fish species. For instance, there was no effect on feed consumption and growth 
performance in sunshine bass and gilthead seabream fed diets with partial replacement 
of FM by poultry by-product meal or meat and bone meal (Robaina et al. 1997; 
Webster et al. 2000).  
Although effects of NFE on nutrient digestibility may be a factor in reducing 
growth in fish fed some of the diets as described above, feed consumption was lower in 
fish fed all of the 11F diets compared to the fish fed the 25F diet. Reduction of fish 
growth caused by reduced feed intake has been reported in a number of studies (Refstie 
et al. 1998, 2001; Storebakken et al. 1998a; Carter & Hauler 2000; Kaushik et al. 
2004; Espe et al. 2006), and those authors suggested this was due to lower palatability 
and decreased appetite. It was known that quality and levels of FM inclusion influence 
palatability (Webster et al. 1999), and so reducing dietary FM and changing the 
composition of ingredients likely influences the flavour, reducing palatability of the 
diets and diminishing appetite of the fish. Replacing FM by PPs in salmon disturbed the 
digestion and absorption efficiency of nutrients (Refstie et al. 2000) and they require 
time to adapt before accepting diets high in PPs (Torstensen et al. 2008). Feed 
palatability can be enhanced by application of feed attractants such as fish protein or 
squid hydrolysates (Espe et al. 1999, 2006; Dias et al. 2005; Olsen et al. 2006).  
It is well documented that tissue FA composition in fish reflects dietary 
composition (Torstensen et al. 2000; Bell et al. 2001; Rosenlund et al. 2001; Xue et 
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al. 2006; Karalazos 2007). Furthermore, previous studies showed that reduced dietary 
FM inclusion affected lipid metabolism and FA profile in sunshine bass, altering n-3 FA 
composition, especially reducing EPA (Lewis & Kohler 2008). In the present study, 
reducing dietary FM inclusion from 25 % to 11 % reduced total MUFA and increased 
total n-3 PUFA in salmon flesh and liver. However, it was unexpected and highly 
noteworthy that reducing dietary FM did not reduce levels of ARA, EPA and DHA in 
the flesh and liver of fish fed any of the 11F diets compared to fish fed the 25F diet. In 
fact, fish fed the 11FP, 11FB and 11FK diets showed the highest proportions of EPA 
and DHA resulting in higher n-3/n-6 ratios compared to the fish fed the control and 
11FW diets. That reducing dietary FM could actually result in increased levels of EPA 
and DHA without any changes in the actual lipid components of the diet changing was 
very surprising and an important finding in the present trial. This was something that 
was hinted at in the previous trial reported in Chapter 6, but the effect is much clearer in 
the three further 11F diets investigated in the present trial, 11FP, 11FB and 11FK. 
These changes in tissue HUFA composition cannot be explained totally by 
dietary FA compositions as their levels were all higher in tissues than in the diets 
suggesting they were selectively retained and deposited. Previous studies reported that 
DHA was preferentially deposited and retained in flesh lipids, regardless of the 
concentration in the diet, while EPA was progressively favored for energy production if 
it was presented in high concentration in diet (Kiessling & Kiessling 1993; Torstensen 
et al. 2000). However, more specifically, EPA was significantly higher in diets 11FP, 
11FB and 11FK, compared to the 25F and 11FW diets, whereas DHA levels were lower 
in all the 11F diets compared to diet 25F. Therefore it is possible that DHA was 
produced as a result of increased desaturation and elongation in fish fed the lower FM 
diets. Increased levels of 22:5n-3 in fish fed the 11F diets support this suggestion. The 
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increasing of tissue HUFA composition is partly due to reduction of lipid content and 
increment of polar lipid as obviously seen in the liver of fish fed the 11FB diet. 
Therefore, the increased HUFA in the tissues of fish fed the 11F diets could be due to 
greater retention and/or biosynthesis. 
In conclusion, decreasing dietary FM from 25 % to 11 % and correspondingly 
increasing substitution by alternative protein sources to 55 % of total diet, reduced 
growth of large Atlantic salmon irrespective of the combination of PP and animal 
proteins used as substitutes, and despite dietary supplementation with crystalline AAs 
and lecithin. This may be partly due to increased NFE in some of the 11F diets reducing 
nutrient digestibilities but probably mainly due to reduced feed consumption. This was 
likely due to reduced palatibilty and consequently reduced appetite as the reduced feed 
consumption was largely evident in the first phase of the dietary trial and not so 
apparent in the second phase suggesting adaptation to the feeds. The increased 
substitution of dietary FM also tended to reduce liver lipid content but there were few 
effects on flesh or liver lipid class compositions in either tissue. Perhaps the most 
surprising and interesting result was that increasing the substitution of dietary FM did 
not reduce tissue HUFA levels and, in particular, both EPA and DHA levels were 
significantly higher in flesh and liver of fish fed the 11F diets compared to fish fed the 
25F diet. Of the 11F diets, the 11FP diet, containing pea protein, has potential to be a 
good alternative feed component for Atlantic salmon as it revealed higher final body 
weight than than the other 11F diets. Enhancing the palatability of the feed and a 
longer-term study starting with smaller fish should be investigated. 
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Chapter 8 - General summary, conclusions and future 
perspectives 
8.1 General summary 
FM and FO have been traditionally used in aquafeeds due to their excellent 
nutritional qualities, with FM providing EAA, while FO is an excellent energy source 
and is a unique source of n-3 HUFA, such as EPA and DHA (NRC 1993; Sargent et al. 
2002). Nevertheless, the presence of persistent organic pollutants (POPs) in FM and FO 
and thus in farmed-fish products has given rise to media scares that can affect 
aquaculture producers (Hites et al. 2004a, 2004b; Berntssen et al. 2005; Bell et al. 
2005a). Considering that global FM and FO supplies are static and of limited 
availability, the ecological concern of using non-sustainable marine resources, along 
with issues of POP contaminant levels in these feed ingredients, further development 
and expansion in aquaculture dictates that substitution of dietary FO and FM must be 
investigated. The overall aim of the present study was to develop alternative, 
sustainable diets for Atlantic salmon. Specific objectives were to investigate alternative 
feed ingredients as replacements / substitutes for both FO and FM in Atlantic salmon 
diets. In addition, different strategies for their application and use, to ensure optimal 
growth, feed efficiency and health of the fish and at the same time maintaining the 
nutritional quality, especially flesh levels of n-3 HUFA, EPA and DHA, for the human 
consumer. In trials 1 and 2, the focus was primarily on FO replacement while in trials 3 
and 4, the focus was on the substitution of FM. In both trials 1 and 2, FM was also 
partially replaced as the diets were formulated to be practical and thus reflect current 
feed formulation practices. In line with this ethos, in trials 3 and 4, the maximum level 
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of FM used was 25 % and the oils added were FO:VO (40:60%). Thus, all the trials in 
this study were examples of dual FM and FO substitution.  
The results trial 1 and 2 in the present study revealed that the replacement of 
FOs with VOs do not have negative effects on the growth metrics of Atlantic salmon 
including SGR, TGC, FCR, VSI and HSI. These findings suggest that the lipid levels in 
the diets supply sufficient quantities of EFA and FAs for catabolism and protein sparing 
resulting in no measurable detrimental effects on fish growth. The findings from this 
study are in agreement with those of earlier studies in that the complete replacement of 
FO with VO from a variety of different sources, in both short and long duration feeding 
trials, had no effect on the growth and FCR of several species of fish (Bell et al. 2001, 
2003, 2004; Caballero et al. 2002; Torstensen et al. 2004, 2005; Regost et al. 2004; 
Fountoulaki et al. 2009). Modification in feed formulation may alter the physiology, 
texture and flavour and, consequently, reduce the palatability of the diet. In trials 3 and 
4, however, it was found that when the levels of FM included in the diet were reduced 
to lower than 25% of the diet, 60% VO substitution and combined with a high 
proportion of blended plant proteins or plant and blood meal, were found to affect the 
growth performance of fish. Reduced growth was the result of a reduced intake of feed 
possibly caused by the low palatability of the diet. The palatability of diets and the 
acceptance of feed, therefore, can be improved by the inclusion of specific feed 
attractants such as krill meal, fish protein or squid hydrolysates into the diets (Espe et 
al. 1999; Refstie et al. 2004; Hevroy et al. 2005; Olsen et al. 2006). The experimental 
findings of trials 3 and 4 follow those of a number of previous studies in that fish fed 
diets containing lower than 20% FM and 70% VOs displayed low growth performance 
(Benedito-Palos et al. 2008, 2009; Torstensen et al. 2009). Of the alternative 11% FM 
diets tested in trial 4, the fish fed formulations containing plant proteins sources (i.e. 
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pea, wheat and kidney bean), displayed better growth than those fish fed a diet 
containing blood meal. The diet containing pea protein (11FP) has the potential to be a 
good alternative source of plant protein as the fish consuming this diet had a higher 
weight gain than the fish groups fed the other 11% FM diets (i.e. wheat, kidney bean 
and blood). The fish groups fed the wheat (11FW), pea (11FP) and kidney bean (11FK) 
diets showed greater growth during the second phase of the experimental trial (weeks 8 
– 19) indicating that the fish had had time to adapt to the new diets. Evidence for this 
was shown by the improvements in FCR and PER in the second phase of the feed trial.  
In addition to the effects of dietary lipid, the genetic background of the fish has 
also been reported to affect fish growth and body composition (Peng et al. 2003; Rollin 
et al. 2003; Quillet et al. 2005), including pigment composition (Storebakken & No 
1992). The results from the present study showed that the CAL strain fed a dual 
replacement of FO and FM had greater growth and a higher flesh pigment content than 
the FAT and LEAN strains of fish. The LEAN strain, however, appeared to adapt to the 
new diets more readily than the CAL and FAT. Moreover, the microarray analysis 
clearly illustrated that the FAT and LEAN strains adapt differently in terms of the level 
of gene expression each display in their livers when presented with diets where the 
entire FO content was substituted with a blend of VOs. The qPCR results confirmed the 
microarray findings that the LEAN fish respond differently to the FAT and CAL fish.  
Replacement of FO with VOs sources did not affect nutrient and FA 
digestibilities in large Atlantic salmon in the present study. Substituting FM with high 
levels of PPs (plant proteins) in experimental diets were found to increase the level of 
protein digestibility but decreased that of fat. In addition, the ADC of protein appeared 
to increase, together with improvements of PER in the second phase of experimental 
measurement, suggesting that fish increase their utilisation of protein as dietary PPs 
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increased. The apparent digestibility of fat decreased with increasing PP inclusion in the 
diets may result from high PP content diets which contain high levels of non starch 
carbohydrates e.g. pectin and acidic polysaccharides as found in legumes (Jobling 
1993). These non-starch carbohydrates increase the viscosity of ingested materials, 
limiting the metabolic capacity of lipid in distal intestine epithelium subsequently 
reducing the digestibility of fat.  
In the present study, the consequences of altering the composition of the diet by 
reducing the utilisation of FO and / or FM on the nutrient composition of fish tissues 
were observed. In trial 2, the percentages of n-3 LC-PUFA, ARA, EPA and DHA in the 
flesh, liver and the visceral tissues of Atlantic salmon were seen to decrease by over 
50% when the fish were fed a diet containing 100% VO when compared to fish fed a 
FO diet. The replacement of FO with VO in the Atlantic salmon diets which decreased 
the n-3 LC-PUFA content of fish tissues in this study confirms the experimental 
findings of other researchers (Bell et al. 2003; 2004). The low levels of these EFAs in 
the flesh, however, were minimised when Atlantic salmon were fed a diet where the 
entire content of northern FO was substituted with  combinations of southern FO and 
VOs as seen in trial 1. In addition, the levels of n-3 LC-PUFA content, particularly EPA 
and DHA, in the flesh and the liver were not affected by the replacement of FM with 
alternative PPs or with a combination of PPs and animal proteins as seen in trials 3 and 
4. A key finding from trials 3 and 4 was that when a diet containing 5% FM, 30% lipid 
level consisting of 12% FO and 18% VO (40:60%) did not reduce the levels of tissue 
EPA and DHA, but were found to slightly increase in the fish fed the diet with the lower 
FM inclusion than those fish fed the 25FM inclusion diet. The increasing levels of 
ARA, EPA and DHA observed are a consequence of the fish obtaining these EFAs 
directly from diet and / or from  changes in metabolism with resultant increased 
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desaturation / elongation of 18:2n-6 and 18:3n-3 as the inclusion level of alternative PPs 
in the diet are increased. 
8.2 Summary of results and conclusions 
Trial 1 – Investigating alternative strategies, including dual replacement of FO and FM, 
for reducing contaminant levels and maintain n-3 HUFA simultaneously in 
farmed salmon. The objectives were to investigate the effects of the total 
replacement of NFO with decontaminated NFO and to evaluate the effects of the 
total replacement of NFO with SFO/VO blends on growth, tissue proximate 
composition, nutrients and FA digestibility, tissue FA compositions and 
contaminant levels in Atlantic salmon.  
1. The alternative strategies to reduce POPs of using decontaminated FO or 
blending VOs with southern hemisphere FO both had no deleterious effects on 
growth of salmon as measured by final weights, SGR or TGC, or on feed 
efficiency (FCR). 
2. Both strategies, decontaminated FO and blended VOs with southern hemisphere 
FO, were successful in very effectively reducing the dioxin, DL-PCB and PBDE 
concentrations to very low levels in salmon flesh. 
3. Using decontaminated FO had no major effects on either the nutritional qualities 
of FO as a feed ingredient for Atlantic salmon or on the nutritional quality of the 
salmon fillet in terms of the n-3 HUFA. The strategy of using blended VOs with 
southern hemisphere FO had more impact upon tissue n-3 HUFA levels, 
reducing them by a moderate amount. 
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Trial 2 – Investigating the effects of genetic background of salmon on responses to 
alternative, dual-substituted feeds. The effects of long-term (> 1 yr) dual 
replacement of 100 % of dietary NFO with blended VOs in dual-substituted 
diets (45% PPs and 25% FM inclusions) followed by a subsequent FO 
“finishing” diet in three groups (strain/family) of Atlantic salmon was 
investigated on growth, tissue proximate and FA composition, and liver gene 
expression.  
1. The three groups (strain/family) of Atlantic salmon showed no significant 
differences in growth performance, including SGR, or FCR, HSI and VSI when 
fed the dual-substituted diet with total replacement of NFO with VO blends 
along with partial substitution of FM with PPs.  
2. Irrespective of diet, the CAL fish showed higher growth than the FAT and 
LEAN fish, and also showed better growth when fed the VO diet compared with 
the same fish fed the FO diet. 
3. Long-term feeding with the dual-substituted feed significantly reduced the n-3 
HUFA content of the salmon fillet in all strains/families compared with the fish 
fed the control diet. The ARA level was completely restored and the EPA and 
DHA levels were about 90 % restored after feeding the finishing diet containing 
FO as the sole source of lipid for 24 weeks.  
4. There were few significant differences between the fish of different genetic 
backgrounds in FA composition but the LEAN and CAL fish tended to adapt to 
the alternative diets better than the FAT fish.  
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5. Long-term feeding of the three groups of Atlantic salmon with the dual-
substituted diet significantly affected gene expression in liver. The expression of 
several genes related to lipid metabolism, particularly fatty acyl desaturase and 
elongase genes and some genes related to cholesterol biosynthesis, were 
significantly up-regulated in fish fed the substituted diet compared with fish fed 
the FO diet. 
6. The effects on gene expression varied between fish of different genetic 
background, showing that the FAT and LEAN families, and CAL strain, adapted 
differently to the complete substitution of dietary FO with a blend of VO. The 
LEAN family generally showed higher levels of response to substitution of FO 
with VO.  
Trial 3 – Investigating effects of further reduction of FM to very low levels in salmon 
fed dual-substituted feeds. In trial 3, a regression design was employed to 
investigate the effect of graded substitution of FM with plant products in dual-
substituted diets on growth, feed efficiency, nutrient digestibility and FA 
composition in large Atlantic salmon. The primary hypothesis failed as salmon 
fed diets containing FM inclusion lower than 25 % showed growth retardation, 
mainly due to feed intake reduction. No dietary treatment affected tissue FA 
composition. 
1. High inclusion of PP and reduced levels of FM in dual-substituted diets affected 
growth most probably due to reduced feed intake and nutrient digestibility. The 
FCR and PER were improved during the latter (second) phase of the trial 
suggesting that there was metabolic adaptation to the diets and no AA limitation. 
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Changing feed ingredients may have affected the physical texture of the feeds 
and/or chemical olfactory attractants that reduced the palatability of the diets. 
1. The inclusion of graded increased levels of PPs appeared to decrease liver lipid 
content but increased visceral lipid deposition. The reduction of FM inclusion 
from 25 % to 5 %, FO contents at 12%, did not significantly affect nutritional 
quality of the fish as the n-3 HUFA (EPA and DHA) contents in the flesh (and 
liver) were not lowered by the reduced FM inclusion but, indeed, were slightly 
increased in the fish fed the lower FM inclusions.  
Trial 4 – Investigating effects of alternative FM replacers.  The effects of different 
blends of replacement proteins on growth, feed efficiency and tissue FA 
composition were determined in large Atlantic salmon fed 11 % FM, that 
induced growth retardation in trial 3. None of the alternative blends was able to 
restore growth to that observed in fish fed 25 % FM. Atlantic salmon had better 
growth when fed diet containing plant protein compared with the fish fed diet 
containing animal protein. The pea protein appeared to be a good alternative 
source of plant protein for Atlantic salmon. 
1. Decreasing dietary FM inclusion to 11 % and correspondingly increasing 
substitution by a variety of alternative protein sources to 55 % of total diet, 
reduced growth of large Atlantic salmon irrespective of the combination of PPs 
and animal proteins used as substitutes mainly due to a reduction in feed 
consumption. 
2. Comparison among the alternative feed ingredients of the 11F diets suggested 
that pea protein has potential to be a good alternative feed component for 
Atlantic salmon as it revealed higher final body weight than that the other 11F diets.  
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8.3 Future perspectives 
Considering the aforementioned effects of increasing PPs and VO levels 
associated with decreasing FM and FO inclusion on growth performance and nutritional 
quality of Atlantic salmon, several areas of research require further scientific 
investigation to ensure future aquaculture development and the sustainability of fish 
farming. 
1. Increased duration of nutritional trials. The beneficial effects of n-3 LC-
PUFA to human health are in the prevention and attenuation of a number of 
inflammatory disorders, including cardiovascular disease, immune dysfunction 
and neurological conditions. The adverse effects of persistent organic pollutions 
(POPs), dioxins, DL-PCBs and PBDEs can cause a range of diseases in humans 
including the development of cancers, disruption of the immune system etc. It is 
for these reasons, that fish nutritionists and fish farmers ensure that the farmed 
fish products maintain high n-3HUFA contents and remain low POP 
contamination. Thus, modifying feed formulation and ingredients can alter 
dietary composition which subsequently affects the final farmed Atlantic salmon 
product. Although the results from trial 1 showed that Atlantic salmon fed either 
a decontaminated FO diet or diets containing a combination of southern FO and 
VO blends (SVOs) had lower levels of dioxins, DL-PCBs and PBDEs in their 
flesh below EU limits. Interestingly, fish fed SVO diets remained high in n-3 
HUFA, EPA and DHA which was unexpected but this positive observation 
requires further trials to confirm this result. This trial, however, was only 11 
weeks long and thus the length of future trials ideally should be a minimum of 6-
months duration or cover the whole production cycle to reflect commercial 
conditions.       
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1. Alternative finishing diets. The partial or total replacement of FO in salmon 
diets with VO resulted in a reduced n-3 LC-PUFA composition of the tissues. A 
solution to the restoration of the reduced n-3 HUFA, EPA and DHA levels in the 
fillets of market sized fish was to feed fish a finishing diet, a diet containing FO 
as the sole oil source for a certain period. Adding traditional FO back to fish 
feed diets that previously contained VOs, however, may subsequently increase 
the levels of POP contaminants in the fillet. Trial 1 showed that both strategies 
of feeding fish with decontaminated FO and SVOs diets were very effective in 
reducing contaminant levels in the flesh without serious reductions in the levels 
of EPA and DHA. Therefore, further studies should consider using 
decontaminated FO or carefully selected blends of southern FO and VO as 
alternative finishing diets for Atlantic salmon. 
2. The addition of feed attractants. The formulation of future salmon feeds 
should consider decreasing the proportion of FM and FO and replacing them 
with increasing contributions of plant ingredients. The key to this in finding the 
appropriate ingredients to serve as replacements and implementing strategies to 
maintain the palatability of the feed and the appetite of the fish. The current 
study found that Atlantic salmon fed diets containing a very low FM inclusion 
(< 25 %) showed growth retardation, a consequence of the reduced intake of 
feed. The fish, however, showed greater growth after been fed on the diet for 2 
months suggesting that the fish required time to adapt to the new diet. Future 
studies, therefore, should investigate enhancing the palatability of diets by 
adding appropriate feed attractants and by conducting longer-term studies to 
clarify the palatability of the test feeds and the period of adaptation required by 
the fish. 
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3. Parallel histopathology and immunology studies. An inappropriate alteration 
to the feed ingredients of salmon diets by, for example, increasing the 
replacement of plant and land animal proteins and oils in the salmon diet may 
induce a physiological stress response in the fish with potential consequential 
cell damage to various metabolic organs, the gills, liver and the intestine etc, 
compromising the health of the fish. Lesions on the livers of Atlantic salmon fed 
high PPs / plant and blood meal proteins were observed during the collection 
and preparation samples. In addition, the gene expression studies conducted in 
the present study showed that genes of inflammatory and immune responses, 
including the heat shock protein (hsp) 70kda and 90kda, were found to be 
differentially expressed in fish fed the control, FO and VO diets. The significant 
differences in the expression of the heat shock proteins genes found in the 
present study may change in response to pathogen challenge and immune status 
that may represent an early warning indicator of impaired fish performance and 
health in Atlantic salmon fed diets with high levels of replacement of marine FM 
and FO with plant-based ingredients. Thus, to ensure that altering the feed 
ingredients of Atlantic salmon diets does not impact deleteriously on fish health 
and status, future nutrition studies should consider conducting detailed parallel 
studies to investigate gene expression, histopathology and immunology of key 
metabolic tissues to provide a comprehensive assessment of the trial diets.   
4. Further molecular analysis. As commented on above, substitution of marine 
FM and FO products with plants or land animal ingredients may affect fish 
health that may include inducing a physiological stress response in fish. Further 
scientific investigations at the molecular level are therefore required to 
understand how cells function and how their function changes in response to 
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varying environmental conditions. The altered expressions of genes in diseased 
tissues, for example, represent useful diagnostic markers. The patterns of gene 
expression vary depending on a range of factors including cell type (e.g. brain, 
liver etc), environmental factors (e.g. temperature, nutrient availability) etc. 
Transcriptomics (gene expressions), therefore, provides a global and quantitative 
analysis of differential gene expression under defined conditions and currently is 
one of tools used to study the differences in the transcription of genes in normal 
and diseased tissues. The use of modern techniques such as a transcriptomics 
(microarray) approach for determining the gene expression of nutrition induced 
changes that result in disease, therefore, should be considered as a vital 
component of future investigations. Such studies should also be expanded to 
consider and analyse other key metabolic tissues.  
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Appendix I  
Preparation of astaxanthin standard solution: 
  
Approximately 3 mg of standard of all-E-astaxanthin is weighed into 100 ml volumetric 
flask. Ten ml of chloroform were added together with ultrasonic treatment until 
completely dissolved. The solution was made up to 100 ml with n-hexane. 5 ml of this 
solution are transferred into a 100 ml volumetric flask and 4 ml of chloroform was 
added subsequent made up to the volume with iso-hexane, resulting in an astaxanthin 
concentration of about 1.5 mg per litre of n-hexane/chloroform (95.5:4.5; v/v). 
-------------------------------------- 
Preparation of buffer stock solution: 
10 X TBE (tris/borate/EDTA) electrophoresis buffer (stock solution/per litre) 
 108g Tris base (BioRad laboratory, Hercules, CA, U.S.A) 
 55g  Boric acid (BioRad laboratory, Hercules, CA, U.S.A) 
 20 ml of 0.5 M Ethylenediaminetetraacetic acid ,EDTA (BDH, poole, U.K.). 
Adjust with deionised water up to 1000 ml. 
50 X TAE electrophoresis buffer (stock solution/per litre) 
 242 g tris base (2-amino-2-hydroxymethyl-propane-1,3-diol) (= 2 mole) 
 57.1 ml glacial acetate acid (=100% acetic acid) (57.19 ml = 1mole) 
 100 ml 0.5 M EDTA (pH8.0) 
Adjust with deionised water up to 1000 ml. 
To prepare 0.5 M EDTA (pH8) 
 Add 186.1 g of disodium ethylenediaminetetraacetate .2H2O. Stir vigorously. 
Adjust the pH to 8.0 with NaOH (ca. 20 g of NaOH). Sterilise by autoclaving. (the 
disodium salt of EDTA will not go into solution until the pH of the solution is adjusted 
to ca. 8.0 by the addition of NaOH). 
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